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Chronic stress can alter the immune system, adult hippocampal neurogenesis and 
induce anxiety-and depressive-like behaviour in rodents. However, no study to date 
has discriminated between the effect(s) of different types of stress on all these 
behavioural and biological outcomes. Moreover, while the unpredictable chronic mild 
stress (UCMS) model of depression remains one of the most commonly used stress 
models, it does not entirely follow the trajectory of clinical depression, which can take 
months after stress exposure to manifest. Therefore, this PhD thesis has two main 
goals; (1) to investigate the effect(s) of physical stress, modelled by repeated 
injection, and psychosocial stress, modelled by social isolation, on behaviour, 
immune system functioning, and neurogenesis in adult male mice, and (2) to develop 
and characterise a more chronic and translatable model of UCMS that measures 
changes in behaviour, inflammation and adult hippocampal neurogenesis six weeks 
after UCMS, and incorporates a period of social isolation to represent social 
withdrawal, which can accompany or precede the development of depression.  
  
Several novel findings emanate from this thesis. First, my work highlights how the 
type of stress exposure does indeed matter, given that distinct types of chronic stress 
can differentially alter behavioural and biological responses in adult male mice. For 
instance, physical stress promotes an anxiety-like phenotype, decreases systemic 
inflammation, and decreases neurogenesis. In contrast, psychosocial stress 
promotes a depressive-like phenotype, increases systemic inflammation, and 
increases the number of mature neuroblasts in the dentate gyrus. Second, this thesis 
puts forward an alternative, yet appropriately robust UCMS model of depression, one 
that successfully induces depressive-like behaviour, alters astrocyte biology, and 
reduces neurogenesis.  
 
The work presented in the thesis contributes to our understanding of the impact of 
chronic stress on immune system functioning and adult hippocampal neurogenesis, 
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The main goal of this PhD thesis is to further understand the impact of chronic stress 
on immune system functioning, and adult hippocampal neurogenesis using a mouse 
model of depression.  
 
The introduction of this thesis will be comprised of three main sections. The first 
section will discuss the features and epidemiology of major depressive disorder 
(MDD), while the second section will give a detailed description of the three biological 
systems under study, that is, the stress system, immune system and adult 
hippocampal neurogenesis. Specifically, stress, hypothalamic-pituitary-adrenal (HPA) 
axis functioning, and its role in the aetiology of MDD will be summarised in one 
subsection. An additional two subsections will be dedicated to inflammation and 
neuroinflammation, and how they each relate to MDD, while a fourth subsection will 
be devoted to describing adult hippocampal neurogenesis (AHN) and its role in the 
pathogenesis of depression.  
 
Finally, the last section of the introduction will pertain to animal models of 
depression, given that this PhD utilises a mouse model of chronic stress to 
accomplish its objectives, and as such will provide a detailed account of the currently 
available chronic stress models of depression, and critically evaluate their associated 














1.1. Major Depressive Disorder 
 
1.1.1. Definition of Major Depressive Disorder  
 
Major Depressive Disorder (MDD) is a complex, heterogeneous disorder with a 
decidedly variable course, and as such its diagnosis is based on multiple criteria, as 
formulated by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition 
(DSM-5). To meet diagnostic criteria, an individual needs to experience a minimum 
of five out of the nine DSM-5 symptoms. Moreover, at least one of the five 
experienced symptoms must pertain to one of the two core features of MDD, which 
include depressed mood, or anhedonia.  Other symptoms can be in the form of 
significant weight change (5%) or change in appetite, insomnia or hypersomnia, 
psychomotor agitation or retardation, fatigue or loss of energy, the diminished ability 
to think or concentrate, feelings of worthlessness or excessive or inappropriate guilt, 
or suicidality. To fulfil diagnostic criteria, experienced symptoms need to be present 
for a minimum of two weeks, they must cause significant distress and/or impair 
social, occupational, or other important areas of functioning, and should not be due 
to bereavement, substance abuse, or as a direct consequence of a known medical 
condition (DSM-5; American Psychiatric Association, 2013). 
 
However, a clear diagnosis can often be difficult to achieve, especially when MDD 
symptom-based criteria often overlaps with other disorders, namely, borderline 
personality disorder and generalised anxiety disorder, which both have substantial 
co-morbidity with MDD (Zanarini et al. 1998; Newman et al. 2010; Sunderland et al. 
2010; Beatson & Rao, 2012). Furthermore, given that no biological assessment 
exists to confirm clinical diagnosis, there is often concern over the objectification of 
MDD diagnosis, and as such, these issues pose a great obstacle to clinical and 
preclinical research aimed at identifying the neurobiological alterations specific to 
MDD (Krishnan & Nestler, 2008). Nonetheless, MDD remains one of the most 
prevalent psychiatric disorders in modern society.  
 
1.1.2. Epidemiology of Major Depressive Disorder 
 
The prevalence of MDD geographically varies, and can range from 3-7% in Japan 
(Kawakami, 2007) to 21% in Afghanistan (Vaughan et al. 2014). In Europe, an 
estimated 16% of the population is at risk of developing an episode one or more 
times during their lifetime (Kessler et al. 2005; Otte et al. 2016), while specifically in 
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the UK, prevalence is estimated to be 6.4%, 12.2%, and 7.2%, for a single episode, 
recurrent moderate, and recurrent severe MDD, respectively (Smith et al. 2013). In 
addition to being highly prevalent on a fairly global scale, it has been identified as the 
second leading cause of years lost to disability (Vos et al. 2015), due to its high 
impact on functioning and early-age of onset, and subsequently, has become a 
leading cause of burden worldwide (Ferrari et al. 2013).  Moreover, the disease 
burden of MDD produces a huge economic burden on society, (e.g., reviewed in 
Luppa et al. 2007; Okumura et al. 2011; Wittchen et al. 2011; Mrazek et al. 2014), 
with the annual cost for depression in the UK estimated to be £16 billion (Fineberg et 
al. 2013), and given that the development of effective treatments for the disease are 
struggling to keep pace with the growth of prevalence (Willner et al. 2012), MDD 
therefore, represents a major challenge for society. To alleviate the burden 
depression ultimately places on individuals, families and societies worldwide, the 
factors increasing disease susceptibility need to be more fully elucidated. 
 
1.1.3. Risk factors for Major Depressive Disorder  
 
To date, several risk factors for MDD have been identified, and broadly can be 
characterised as either genetic or environmental. While each factor may influence 
disease aetiology independently, it is general consensus that combinations of 
multiple genetic and environmental factors are involved in the pathogenesis of MDD 
(e.g., reviewed in Lohoff et al. 2010; Saveanu & Nemeroff, 2012).  
 
1.1.3.1. Genetic risk factors  
 
Several genetic predispositions are known to increase the risk for developing MDD. 
These factors range from age through to specific gene polymorphisms.  In a broader 
genetic sense, age, gender and certain personality traits can all significantly increase 
the odds for depression vulnerability. Specifically, females, individuals under the age 
of 18, and personality traits, such as increased neuroticism, are all known risk factors 
for MDD (Kessler et al. 2007; Abate, 2013; Ferrari et al. 2013; De Moor et al. 2015). 
Moreover, a family history of depression is also considered to be a major risk factor 
(Monroe et al. 2014). Several studies have shown that individuals with a first-degree 
family relative with a (previous) diagnosis of MDD are 2.8-10 times more likely to 
develop depression (Wallace et al. 2002; Goodwin & Jamison, 2007), and are at 
increased risk of an early-age onset, and/or recurrent MDD (Weissman et al. 2005; 
Monroe et al. 2014). However, despite being a significant predictor, genetic 
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heritability for the disorder is relatively moderate, and is estimated to be around 35-
40% (Geschwind & Flint, 2015; Duman et al. 2016). 
 
Indeed, several genome-wide association studies thus far, have achieved limited 
success in identifying significant and replicable genetic polymorphisms associated 
with depression (Bosker et al. 2011; Ripke et al. 2013). However, given the moderate 
heritability for depression, and the highly polygenic nature, and heterogeneity, of the 
disorder, it is unsurprising that genomic studies have had little success (Hyman et al. 
2014). Nonetheless, despite these challenges, several important interindividual gene 
variants have been shown to increase susceptibility to the development of MDD. For 
example, the Val66Met polymorphism in the brain derived neurotrophic factor 
(BDNF) gene was found to significantly moderate the relationship between stressful 
life events and depression (Hosang et al. 2014), while individuals carrying one of the 
several glucocorticoid receptor (GR) polymorphisms, such as NR3C1, N363S and 
ER22/23EK, which all decrease glucocorticoid sensitivity and alter normal HPA axis 
functioning, show increased susceptibility to MDD (reviewed in DeRijk et al. 2005). 
Moreover, several polymorphisms in the serotonin transporter (5-HTT) gene have 
been found to alter serotonin (5-HT) transmission, and even increase stress 
susceptibility (Caspi et al. 2003; Eley et al. 2004; Zalsman et al. 2006). Although 
more recently, a meta-analysis found no evidence to support that the 5-HTT 
genotype confers an increased risk for developing MDD (Risch et al. 2009). 
Although some important gene variants have been identified in the context of MDD, 
most predispose individuals to, or sensitise them with, an increased vulnerability 
towards known environmental risk factors for depression, namely stress. For 
example, the ER22/23EK polymorphism only confers increased risk for MDD if the 
individual carrying it has also experienced childhood adversity (Bet et al. 2009). 
Thus, it seems that gene-environment interactions are required for some genetic 
polymorphisms to exert their effects, a concept reinforcing the notion that it is the 
combination of multiple genetic and environmental factors that ultimately results in 
the manifestation of MDD (Caspi et al. 2003; Caspi & Moffitt 2006). 
While examining the impact of specific genes is beyond the scope of this PhD thesis, 
it is notable that the biological systems under study are regulated by several genes 
that will be highlighted in the relevant subsections in section 1.2 of the Introduction. 
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1.1.3.2. Environmental risk factors 
 
In addition to the main genetic vulnerabilities aforementioned, a vast collection of 
research delineates a variety of environmental risk factors for MDD, and several 
studies have attempted to highlight the most important predictors (e.g., Hardeveld et 
al. 2010; Clark et al. 2010; Colman et al. 2014; Walker & Druss, 2014; Plant et al. 
2015).  The findings of these studies converge to show that a history of depression or 
anxiety, comorbid physical illness, exposure to maternal depression or anxiety, poor 
social support, and early life adversity (e.g., physical and sexual abuse, parental loss 
or separation, neglect and maltreatment) are moderate to strong predictors of MDD. 
Additionally, while not reported as predictors per se, several additional risk factors 
have been identified. Namely, low level of education, unemployment, poor 
socioeconomic status, being single, and exposure to adverse stressful life events in 
adulthood, which have all consistently been associated with an increased risk for 
MDD (Clark et al. 2010; de Carvalho Tofoli et al. 2011; Hölzel et al. 2011;  Colman et 
al. 2014).  
 
While these risk factors can increase the risk for MDD, not everyone exposed to, for 
example, comorbid physical illness goes on to develop MDD. It is likely that repeated 
exposure to multiple environmental factors is what eventually results in the 
development of psychopathology. Indeed, it has been proposed that persistent 
experience of psychological and/or organic stress, coupled with genetic vulnerability 
to stress, can lead to a progressive time-dependent amplification of neuronal 
responses, which can further increase susceptibility to future stress, and could 
eventually lead to the manifestation of MDD (Ursin, 2014).  
Although our understanding of the risk factors of depression has evolved 
considerably over the past century, there still remains much to learn, particularly 
given the heterogeneity of the disorder. Therefore, the work presented in my thesis 
will attempt to expand on our knowledge of the environmental risk factors of 
depression, specifically those associated with stress, by comparing the effects of 
different models of chronic stress to determine whether the severity and/or nature of 
the stressors can differentially alter depression-associated outcomes, and may be 
important risk factors in their own right.  
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1.2.  The biological basis of depression  
 
1.2.1.  Stress and depression 
 
From multiple clinical and genetic studies, exposure to stressful life events, and/or 
increased genetic vulnerability to stress, has been shown to significantly increase 
susceptibility to the development of depression (see subsection 1.1.3). Indeed, given 
the strong relationship between stress and MDD (see subsection 1.2.1.2), biological 
components of the stress system may even be potential diagnostic, and/or treatment, 
biomarkers for depression (Ising et al. 2007; Ellenbogen et al. 2011; reviewed in 
Schmidt et al. 2011).  However, in order to critically evaluate the evidence supporting 
these claims, understanding how the stress system works, and how it relates to the 
pathogenesis of MDD is essential.  
 
1.2.1.1. The function of stress and the hypothalamic-pituitary-adrenal axis   
 
The functional relevance of the biological response to stress derives from an 
evolutionary context, where thousands of years ago exposure to stress was often 
potentially life threatening. Therefore, the primary purpose of the stress response is 
to mobilise energy metabolism, enhance arousal, attention, and fear, and to 
suppress immune- and digestive functions in order to more appropriately and 
immediately respond to high threat (de Kloet et al. 2005; Gold, 2015). Ultimately, an 
appropriate biological response to stress provides organisms with increased 
protection and/or survival. 
 
As shown in Figure 1.1.A, the hypothalamic-pituitary-adrenal (HPA) axis is largely 
responsible for coordinating responses to stress. It forms a major part of the 
neuroendocrine system, and is predominately regulated by the hippocampus, and 
the amygdala (reviewed in Srinivasan et al. 2013). However, it can also receive 
circadian inputs from the hypothalamic suprachiasmatic nucleus (SCN). Under 
normal, non-stressed conditions, projections from the hippocampus inhibit the 
release of corticotropin-releasing hormone (CRH) and arginine-vasopressin (AVP) 
from the paraventricular nucleus (PVN) of the hypothalamus (Antoni et al. 1993; 
reviewed in Smith & Vale, 2006). Conversely, under stressful conditions, the 
inhibitory action of the hippocampus becomes impaired, which results in the release 
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of CRH from neurons in the PVN, which sets into motion a cascade of multiple 
biological events as schematically presented in Figure 1.1.A. Essentially, CRH 
travels from the PVN to the anterior pituitary, via the local hypothalamic-pituitary 
blood circulation system, where it subsequently stimulates the production of 
adrenocorticotropic hormone (ACTH). ACTH is then released into the systemic 
bloodstream, where once in circulation, stimulates the release of glucocorticoids 
(cortisol in humans and corticosterone in rodents) from the adrenal cortex (reviewed 
in Pariante et al. 2008; Gold, 2015).   
Glucocorticoids, which are steroid hormones, and lipophilic in nature, are able to 
diffuse freely through the cellular membrane and into the cytoplasm of target cells, 
where they can bind with two types of steroid receptors, the high affinity type I 
mineralocorticoid receptor (MR), and the low affinity type II glucocorticoid receptor 
(GR).  Both receptors are expressed throughout the body, and when activated they 
can exert system wide effects to appropriately respond to stress (Holsboer, 2000), 
reviewed in Srinivasan et al. 2013). For example, the MR is important for the 
regulation of electrolytes, blood pressure, and sympathetic drive (Gomez-Sanchez, 
2010), while the GR is involved in the mobilisation of energy resources, and 
facilitates the termination of the stress response and glucocorticoid production, as 
part of the negative feedback loop to regulate HPA axis activity (de Kloet et al. 2004; 
2007). Therefore, when glucocorticoid levels are sufficiently high, the GR initiates the 
negative feedback mechanism, effectively reinstates the hippocampal inhibitory 
system, and prevents any further release of CRH. Therefore, glucocorticoids, and 
their receptors, are important regulators of homeostasis in basal and stressful 
conditions.  
However, the ability to appropriately respond to stress will largely depend on the 
responsiveness of the HPA axis, which can be affected by repeated exposure to 
stress. Indeed, as highlighted in Figure 1.1.B, under chronic stress exposure the 
HPA axis can become dysregulated, often through inhibition of the negative feedback 
loop, which subsequently results in hyperactivity of the HPA axis. This hyperactivity 
consequently increases levels of CRH, ACTH and glucocorticoids (reviewed in 
Pariante et al. 2006; 2008), and has been widely implicated in a range of 






Figure 1.1. The hypothalamic-pituitary-adrenal (HPA) axis and the stress response  
(A) The hypothalamic paraventricular nucleus (PVN) receives circadian input from the hypothalamic suprachiasmatic nucleus (SCN) and stress inputs from 
the brain stem and regions of the limbic system such as, the hippocampus and the amygdala. The PVN projects to the pituitary gland where both 
corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) are released. CRH binds to corticotropic cells in the anterior pituitary, which then 
release adrenocorticotropic hormone (ACTH) from pre-formed vesicles into the bloodstream. ACTH then reaches the adrenal cortex where it causes the 
synthesis of cortisol (humans) or corticosterone (rodents). Glucocorticoids regulate their own release by inhibition of the PVN and of the pituitary gland via the 
glucocorticoid receptor (GR). (B) Under chronic stress the HPA axis can become dysregulated through inhibition of the negative feedback mechanism. This 
impairment is thought to be a result of impaired GR functioning, and/or reduced GR expression. The subsequent inhibition of the negative feedback loop 
results in hyperactivity of the HPA axis, with characteristic increases in levels of CRH, AVP, ACTH and glucocorticoids.  
 
Adapted from Spiga F, et al. (2014) HPA axis rhythms. Comprehensive Physiology. 4: 1273-98.
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1.2.1.2.  HPA axis hyperactivity and clinical depression: Insights from clinical 
studies   
The first line of evidence to support a causative role for HPA axis hyperactivity in the 
pathogenesis of depression stems from clinical research in patients with Cushing’s 
syndrome, a condition in which a pituitary tumour leads to the excessive production 
of ACTH, and consequently hypercortisolemia.  Interestingly, patients with Cushing’s 
syndrome are at increased risk for psychopathology, particularly clinical depression 
(Sonino et al. 1993; 1998; 2001; Dorn et al. 1995; 1997). However, a direct causative 
link between HPA axis hyperactivity and psychopathology was suggested when, in 
one such study, treatment for hypercortisolemia reduced rates of reported 
psychopathology, which consisted predominantly of depression and anxiety disorder, 
from 66% to 54% and 24% after three and twelve months of treatment, respectively 
(Dorn et al., 1997).  
Given the important association between hyperactivity of the HPA axis and the 
increased prevalence for depression in this subpopulation, researchers began to 
more closely investigate the role of hypercortisolemia in the pathogenesis of clinical 
depression. Indeed, hyperactivity of the HPA axis, a consequence of altered GR and 
MR expression/activity (Pariante and Miller, 2001; Kunzel et al. 2003; reviewed in 
Pariante et al. 2008; Juruena at al. 2009) is one of the most replicated biological 
outcomes associated with clinical depression, and it has been reported that 
approximately 50% and 80% of patients with mild/moderate and severe depression, 
respectively, show hyperactivity of the HPA axis (reviewed in Holsboer, 2000; 
Pariante and Miller, 2001; Jurena et al. 2006). Multiple lines of clinical evidence 
reveal how patients with MDD have several features characteristic of HPA axis 
hyperactivity. For instance, high levels of cortisol in saliva, blood plasma, 
cerebrospinal fluid (CSF), hair and urine are present in patients with MDD (Nemeroff 
et al. 1984; Pariante et al. 2003; 2006; 2008; Staufenbiel et al. 2013). Additionally, 
increased levels of CRH in the CSF, increased CRH mRNA levels in several limbic 
brain regions, and increased numbers of CRH immunoreactive and mRNA-
containing PVN neurons in postmortem brain tissue, taken from suicide victims and 
patients with depression, have also been reported (Raadsheer et al. 1994; 1995; 
Wong et al. 2000; Merali et al. 2004, 2006). Moreover, increased pituitary and 
adrenal gland volume, and altered diurnal rhythms of cortisol release, specifically a 
higher cortisol response to awakening, and increased cortisol elevations shortly after 
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awakening, have all been found in patients with depression (Bhagwagar et al. 2003; 
2005; Nermeroff and Vale, 2005; Vreeburg et al. 2009; Hardeveld et al. 2014). 
Interestingly, altered diurnal rhythms of cortisol persist even after MDD recovery, and 
may even be present prior to the onset of a depressive episode. Numerous studies 
show how individuals at risk for depression, that is, individuals with a familial history, 
or a history of childhood adversity, have similarly augmented cortisol-awakening 
responses (Vreeburg et al. 2010; Dienes et al. 2013; Lu et al. 2016).  
 
1.2.1.3. Hypothalamic-pituitary-adrenal axis dysregulation: does the direction 
of effect matter? 
 
Although hyperactivity of the HPA axis has consistently been associated with MDD, 
hypercortisolemia is not present in all patients with depression, and it is thought that 
HPA axis hyperactivity may be a hallmark for only a specific clinical subtype of 
depression. Indeed, several clinical studies show how patients with melancholic 
depression, a subtype characterised by consistently down and non-reactive mood, 
anhedonia, decreased sleep and appetite, and weight loss (Fink et al. 2007), are 
more likely to have increased levels of plasma cortisol and dexamethasone non-
suppression than patients with non-melancholic depression (Wong et al. 2000; Gold 
and Chrousos, 2002). This concept was further reinforced by a more recent review, 
which revealed that while increased cortisol and ACTH were associated with 
depression, it indeed differed according to the clinical subtype, with atypical 
depression being associated with lower cortisol levels than melancholic and 
psychotic depression (Stetler and Miller, 2011).  
 
Interestingly, there is also evidence to suggest that hyperactivity of the HPA axis is 
not the only form of dysregulation associated with depression. For instance, Jarcho 
and colleagues (2013) found significantly lower morning and evening cortisol levels 
in women with depression compared with healthy subjects (Jarcho et al. 2013). 
Intriguingly, this decrease in cortisol levels, an indication of HPA axis hypoactivity, 
which is a potential consequence of hypersensitivity of the GR that results in a 
blunted stress response, has likewise been associated with specific subtypes of 
depression (Yehuda et al. 2004; de Kloet et al. 2006; Stro’hle et al. 2008). For 
instance, unlike in MDD, women with depression characterised by job-stress related 
long term-sick leave showed persistent attenuation of the cortisol response to the 
combined dexamethasone/CRH test, an observation also observed in posttraumatic 
stress disorder (PTSD) patients, and in patients with depression having outlived a 
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suicide attempt (Pfennig et al, 2005; Stro’hle et al. 2008; Wahlberg et al. 2009).  
The notion that a non-linear relationship exists between HPA axis dysregulation and 
MDD was neatly demonstrated in a study of an elderly population of patients with 
depression. Specifically, patients in the lowest, and highest, deciles of mean urinary 
cortisol levels were 2.2, and 1.9, times more likely, respectively, to express 
depressive symptoms than patients in the other deciles (Penninx et al. 2007). 
Studies like this suggest that glucocorticoid output may not be a linear correlate to all 
functional activity of the HPA axis, and while impaired GR-mediated negative 
feedback may be present in patients with depression, it could manifest differently 
depending on the chronicity, severity or type of MDD.  
While it is clear that HPA axis dysregulation can manifest in two distinct ways, both of 
which have been associated with MDD, not all patients present with characteristics of 
altered HPA axis functioning. Indeed, a meta-analysis investigating levels of salivary 
cortisol and MDD found no firm evidence to support a significant difference in 
salivary cortisol between healthy controls and patients with depression (Knorr et al. 
2010). However, it is important to note that differences in cortisol quantification 
across the studies, and what types of depression were studied could all alter this 
outcome. If indeed certain subtypes of depression are more likely to show altered 
HPA dysregulation, the direction of which may also be dependent on the clinical 
subtype, it my account for null findings when studies were pooled together. 
Nonetheless, although findings from the meta-analysis show that altered cortisol 
levels may not be associated with depression in general, it importantly reflects how 
perhaps other biological systems may play a more prominent role instead. Indeed, 
several other biological systems have been implicated in MDD, including the immune 
system. Interestingly, there is a considerable degree of overlap between these other 
systems and stress, which will be discussed throughout the following subsections, so 
while the HPA axis may not directly be associated with depression for some patients, 
it may be altering other key systems whose alterations may be more easily 
identifiable in other patients. 
While HPA axis dysregulation may not be a hallmark for all types of MDD, it is clear 
that it may help to identify at the very least particular subtypes of depression, and 
thus, may still be a potentially valid biomarker. Understanding what other systems 
are associated with MDD will help to identify other potential biomarkers for 
depression, and given that depression is so heterogeneous, it seems highly unlikely 
that a single biomarker will be suitable, but rather a panel of biomarkers. Indeed, 
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research chronicling the involvement of the immune system in the pathogenesis of 
depression has helped to identify other potential biomarkers for MDD.  
 
1.2.2.  Inflammation and depression 
 
Persistent immune system activation can have multiple adverse effects on several 
biological systems (reviewed in Felger & Lotrich, 2013; Miller & Raison, 2016). 
Interestingly, although chronic stress directly activates the HPA axis, it can also 
activate the immune system, which can subsequently increase susceptibility to 
depression, through affecting multiple key systems known to regulate mood 
(reviewed in Felger & Lotlich, 2013; Miller & Raison, 2016). This subsection will 
evaluate the evidence supporting the involvement of the immune system in the 
development of depression, and will discuss the various mechanisms by which this 
could be happening.  
 
1.2.2.1. Cytokines and the immune response  
 
Efficient and appropriate immune system functioning is essential for promoting 
survival.  The immune response benefits an organism by stimulating energy 
conservation and/or resource allocation to combat infection, or to facilitate recovery 
from injury (reviewed in Chaplin, 2010).  Innate immune cells, which comprise of 
populations of white blood cells (e.g., circulating dendritic cells, monocytes, natural 
killer cells, neutrophils, basophils, eosinophils) and tissue resident mast cells and 
macrophages (Iwasaki & Medzhitov 2015), are at the frontline of defense in 
immunity. Essentially, these cells control opportunistic invasion by a plethora of viral, 
parasitic, bacterial and/or fungal pathogens, by producing and releasing cytokines, 
which communicate with other cells and ultimately orchestrate immune responses 
(reviewed in Lacy & Stow, 2011).  
 
Cytokines are small soluble signalling proteins, which can broadly be categorized as 
lymphokines, those produced by lymphocytes, monokines, those made by 
monocytes, interleukins, cytokines produced by leukocytes, and chemokines, 
cytokines with chemotactic activities (Arai et al. 1990; Zhang & An, 2007). They are 
mostly produced in a cascade, with one cytokine stimulating the release of additional 
cytokines, and they can act synergistically or antagonistically, and can be pleiotropic 
in nature, affecting multiple cells. Principally, they have three modes of action, 
ranging from autocrine action (acting on the cells that directly secrete them), through 
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to paracrine action (acting on other nearby cells), and endocrine action (acting on 
distant cells) (Üçeyler et al. 2009). Moreover, they can be broadly categorized 
according to their function, which can be either pro-inflammatory, or anti-
inflammatory in nature. However, several cytokines are known to exert both pro- and 
anti-inflammatory effects (e.g. Chang & Radbruch, 2007; Scheller et al. 2011).  
Typically, pro-inflammatory cytokines, such as interleukin (IL)-1β and tumour 
necrosis factor (TNF)-α serve to recruit and activate T lymphocytes and other cells to 
mount adaptive immune responses, and are predominantly involved in accelerating 
the inflammatory response (Hiscott & Ware, 2011). For example, they can increase 
vascular permeability to allow entry of lymphocytes, and antibodies into the damaged 
tissues (Murphy et al. 2011), and/or can activate the acute phase response. This 
response, which is a complex and rapid innate body response to inflammation and/or 
tissue damage, is initiated by the production and release of acute phase proteins, 
such as C-reactive protein (CRP), by the liver, which subsequently can destroy or 
inhibit pathogen growth (Schrödl et al. 2016). Conversely, anti-inflammatory 
cytokines, such as IL4 and IL10, principally increase proliferation of B cells, and 
control cytokine production by suppressing macrophage function (Hiscott and Ware, 
2011). Table 1.1 lists several cytokines and provides details on their source(s) of 
release, and their functional roles within the immune response. This table is not an 
exhaustive list of all cytokines, but rather reflects the main cytokines that have been 
associated with depression, and those that are therefore pertinent to the aims of this 
PhD thesis.  
The synthesis and release of cytokines is a highly regulated process that ensures the 
appropriate and efficient functioning of the immune response (reviewed in Lacy & 
Stow, 2011). Briefly, cascades of cytokines released by innate immune cells initially 
mount inflammatory or allergic responses, which is driven by the action of pro-
inflammatory cytokines. These responses subsequently subside in a timely fashion, 
which is largely driven by the action of anti-inflammatory cytokines (Hu & Ivashkiv, 
2009). Thus, the delicate interplay between pro- and anti-inflammatory responses is 
essential for regulating the immune system. However, under certain conditions the 
pro- and anti-inflammatory balance can become altered, and chronic exposure to 
elevated pro-inflammatory cytokines, for example, can lead to the development of 




















Macrophages and APCs 
 
Co-stimulation of APCs and T cells, inflammation 




Activated Th1 cells, NK 
cells 
Proliferation of B cells and activated T cells, NK 
functions  
 
TNFα Macrophages, mast cells, 
NK cells and sensory 
neurons 
 









Activated T cells 
 
Proliferation of B cells, eosinophil and mast cell 
growth and function, induces B cell class switching 
to IgE, and upregulates MHC-II production 
 
   
IL10 Activated Th2 cells, CD8+ T 
and B cells, and 
macrophages 
Inhibits cytokine production, promotes B cell 
proliferation and antibody production, suppresses 
cellular immunity, mast cell growth  
 
 





Activated Th2 cells, APCs 
and other somatic cells 
 
Acute phase response, B cell proliferation, 
thrombopoiesis, synergistic with IL-1 and TNF on T 
cells  
 
IL12 B cells and macrophages Proliferation of NK cells, IFN production, promotes 
cell-mediated immune functions  
 
IFNγ Activated Th1 cells, NK 
cells 
Induces MHC-I on all somatic cells, induces MHC-
II on APCs and somatic cells, activates 
macrophages, neutrophils, NK cells, promotes cell-
mediated immunity, antiviral effects 
 
 
IL = interleukin; APC = antigen presenting cell; Th = T helper; NK = natural killer; IgE = Immunoglobulin E; MHC = 
major histocompatibility complex; CD = cluster of differentiation; IFN = interferon; TNF = tumour necrosis factor. 
 
Adapted from Zhang JM, & An J (2007). Cytokines, Inflammation and Pain. Int Anesthesiol Clin. 45: 27–37  
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1.2.2.2.  Inflammation and depression: Insights from clinical studies   
 
Substantial evidence supports the notion that the immune system is activated in 
depressed patients and that this activation plays a role in disease progression and 
the success of antidepressant therapy (Haroon et al. 2012; Zunszain et al. 2011; 
Zunszain et al. 2013; Miller & Raison, 2016). For example, multiple empirical studies 
have shown how patients with MDD have altered immune system reactivity and/or 
functioning, evident by either increased expression levels of pro-inflammatory 
cytokines and their receptors, and/or increased levels of IL-1, IL-6, TNF-α, interferon 
(IFN)-γ, and acute phase reactants, particularly CRP, in peripheral blood and CSF 
(reviewed in Miller et al. 2009; and Raison & Miller, 2016). Indeed, meta-analyses 
verify that peripheral blood levels of IL1β, IL6, TNF-α and CRP are the most robust 
biomarkers of inflammation in patients with depression (Howren et al. 2009; Dowlati 
et al. 2010; Liu et al. 2012). Furthermore, elevated levels of the inflammatory 
mediator, prostaglandin E2, have been observed in the saliva, plasma, and CSF of 
depressed subjects (Calabrese et al. 1986, Ohishi et al. 1988, Nishino et al. 1989), 
while peripheral blood gene expression profiles consistent with a pro-inflammatory 
phenotype have likewise been associated with MDD (Mostafavi et al. 2013; Brambilla 
et al. 2014).  
 
Further evidence to support the relationship between inflammation and MDD, comes 
from genetic studies, where several functional allelic variants and single-nucleotide 
polymorphisms (SNPs) of genes encoding immune and inflammatory molecules have 
been associated with depression (Bosker et al. 2011, Bufalino et al. 2012, Raison & 
Miller, 2013). For example, polymorphisms in CRP and IL1β, which lead to increased 
peripheral levels of CRP and IL1β, respectively, have been implicated in the 
pathogenesis of PTSD and depression, in the context of trauma and/or stress 
exposure (Michopoulos et al. 2015; Tartter et al. 2015). 
Interestingly, observed inflammatory changes in patients with MDD are not solely 
confined to the periphery. Indeed several studies show increased expression of 
several innate immune genes and proteins, such as Toll-like receptor (TLR) 3, TLR4, 
IL-1β, IL-6, and TNF-α in postmortem brain samples from patients with depression 
(Shelton et al. 2011; Pandey et al. 2012; Brambilla et al. 2014). Additionally, positron 
emission tomography (PET) neuroimaging studies reveal how patients with 
depression have increased levels of translocator protein (TSPO) - a protein 
 46 
overexpressed in microglia, macrophages and astrocytes - compared with healthy 
subjects (Nagy et al. 2015; Setiawan et al. 2015), further reinforcing the association 
between neuroinflammation and depression. 
 
Finally, the effect of antidepressant treatment on inflammatory levels further supports 
the relationship between inflammation and depression. For instance, successful 
antidepressant treatment is shown to accompany reductions in cytokine levels 
(Lanquillon et al. 2000; Dahl et al. 2014), while increased levels of inflammation 
persist in patients non-responsive to treatment (O’Brien et al. 2006).  Interestingly, 
CRP may also be a valid treatment biomarker, given that 45% of patients with non-
response to antidepressants exhibit CRP levels greater than three (Raison et al. 
2013). Indeed, this also suggests that inflammation may play an important role in 
treatment resistant depression (Lanquillon et al. 2000; Cattaneo et al. 2016). 
Together, these lines of evidence substantiate the importance of inflammation in the 
aetiology of depression. 
 
1.2.2.3.  A casual role for inflammation: evidence from epidemiological and 
preclinical immune challenge studies 
 
Although the aforementioned evidence supports an association between 
inflammation and depression, the temporal relationship remains largely unclear: is 
increased inflammation a cause or an effect of MDD?  Interestingly, exposure to 
increased inflammation may indeed play a causal role in the pathogenesis of 
depression, with various epidemiological and longitudinal studies showing how 
increased inflammation can predict the future development of MDD. For example, 
peripheral blood levels of CRP, and/or IL6 were found to significantly predict 
depressive symptoms in later life in the Whitehall II study, Avon Longitudinal Study of 
Parents and Children, and in the English Longitudinal Study of Ageing (Gimeno et al. 
2009; Khandaker et al. 2014; Au et al. 2015). Interestingly, in these studies there 
were no differences in CRP levels between patients with depressive symptomology 
and healthy subjects, suggesting that increased inflammation may precede the onset 
of depression for subsets of individuals.  
Moreover, several longitudinal studies support that diabetes mellitus, obesity, and 
cardiovascular disease, all characterised as low-grade chronic inflammatory states, 
are also significant predictors of depression in later life (Mezuk et al. 2008; Nabi et al. 
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2010; Hare et al. 2014; Luppino et al. 2015), while other factors known to be 
associated with increased peripheral inflammation, particularly adulthood and 
childhood abuse, have also been show to predict future outcomes of depressive 
psychopathology (Danese et al. 2008; Carpenter et al. 2011; reviewed in Baumeister 
et al. 2015). 
Further evidence to support a causal relationship between increased inflammation 
and the subsequent onset of depression comes from research detailing how a high 
proportion of patients undergoing treatment with IFN-α, a cytokine used for cancer or 
viral hepatitis C, go on to develop depression (Bonaccorso et al. 2002; Capuron et al. 
2003; Loftis & Hauser, 2004; Raison et al. 2005; 2006). Moreover, the acute 
administration of lipopolysaccharide (LPS), a bacterial endotoxin that indirectly 
stimulates the release of cytokines, induces a sickness behaviour, which has 
features similar to those of MDD (Dantzer, 2001), while the administration of anti-
inflammatory agents, such as minocycline, or agents blocking inflammatory signalling 
pathways, such as cyclooxygenase 2, have been shown to reduce depressive 
symptomology in patients with MDD (reviewed in Köhler et al. 2014). 
Although there is substantial evidence to support the involvement of, and potentially 
even a causal role for, inflammation in the development of MDD, it is noteworthy that 
not all patients with depression show altered immune system functioning. Therefore, 
it has been posited that depression associated with increased inflammation may be 
only relevant to a particular subtype of depression (reviewed in Raison & Miller, 
2011). Nonetheless, it is biologically plausible that inflammation may serve as a 
mediator for both environmental and genetic factors that may trigger the 
development of depressive disorders, due to its ability to affect multiple biological 
systems (reviewed in Miller & Raison, 2016).  
 
1.2.2.4.  Mechanisms by which inflammation can induce clinical depression in 
medically healthy individuals 
 
Although identifying the molecular mechanisms by which chronic stress may impact 
immune system functioning is beyond the scope of this PhD thesis, it is pertinent to 
understand how chronic stress exposure may translate into immune system 
activation, and the subsequent increase in pro-inflammatory cytokines, given that this 
is one of the main outcome measures of this thesis. Moreover, since increased levels 
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of inflammation can subsequently affect multiple systems, including monoamine and 
glutamate metabolism, and neural plasticity, the latter of which is also measured in 
the research presented in this thesis, it is relevant to discuss how peripheral 
inflammation may impact the central nervous system (CNS), and subsequently the 
development of MDD. Figure 1.2 summarises the mechanisms and pathways by 
which chronic inflammation is thought to contribute to the development of MDD. The 
following subsections will elaborate on the pathways specifically shown in this Figure, 
as denoted by A, B and C.  
 
1.2.2.4.1.  How does stress translate into inflammation? 
 
The predominant mechanism thought to translate stress into inflammation is through 
the activation of the inflammasome (reviewed in Felger & Lotrich, 2013; Miller & 
Raison, 2016; see Figure 1.2.A). On a cellular level, the immune system can 
respond to non-pathogenic stimuli like stress, and release danger associated 
molecular patterns (DAMPs), such as heat shock protein (Hsp)-72 and uric acid, 
and/or microbial-associated molecular patterns (MAMPs), which are released from a 
leaky gut, through a process termed “sterile inflammation” (Maslanik et al. 2012a, 
Fleshner, 2013). Both DAMPs and MAMPs can elicit an immune response by either 
activating inflammasomes, which are cytosolic protein complexes that form in 
myeloid cells, and/or by activating inflammatory signalling pathways like the nuclear 
factor kappa B (NF-κB) pathway. Activation of NF-κB results in the translocation of 
NF-κB to the nucleus where it promotes transcription and the subsequent release of 
additional pro-inflammatory cytokines (Qin et al. 2004, Block et al. 2007; Bohannon 
et al. 2013), while activation of the inflammasome stimulates the release of caspase 
1, which cleaves the precursor forms of IL-1β and IL-18 into their active forms (Iwata 
et al. 2012, Maslanik et al. 2012b). IL-1β and IL-18 can then in turn induce the 
production and release of other additional inflammatory cytokines. Moreover, 
caspase 1 can also alter the GR and contribute to glucocorticoid resistance, which 
can inhibit the anti-inflammatory effects of glucocorticoids, and subsequently 
increase the predisposition for releasing IL-1β and other pro-inflammatory cytokines 
(Maes et al. 1993, Pariante et al. 1999, Miller et al. 2002, Pace et al. 2007, Cohen et 
al. 2012). Therefore, DAMPs, MAMPs and their effect on inflammatory signalling 




DAMPs, danger associated molecular patterns; MAMPs, microbial-associated molecular patterns; HMGB1, high mobility 
group box 1; HSP, heat shock protein; LPS, lipopolysaccharide; ATP, adenosine triphosphate; TLR, Toll-like receptor; 
NF-κB, nuclear factor kappa B; ASC, apoptosis-associated speck-like protein containing a CARD; NLRP3, NOD-, LRR- 
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Figure 1.2. Mechanisms and pathways by which increased inflammation may be 
contributing to the development of clinical depression 
(A) In response to psychological stress, catecholamines, such as noradrenaline, are released 
by an activated sympathetic nervous system, which stimulates the subsequent production 
and release of myeloid cells like monocytes from the bone marrow into the periphery. These 
monocytes then encounter DAMPs and MAMPs, which consequently activate inflammatory 
signalling pathways, such as NF-B, and the NLRP3 inflammasome. Activation of NLRP3 
stimulates the release of caspase 1, which performs two actions, (i) it cleaves to the GR, 
resulting in glucocorticoid resistance, and/or (ii) it leads to the production of IL-1 and IL-18.  
Activation of NF-B meanwhile stimulates the release of other pro-inflammatory cytokines 
including TNF and IL-6. (B) These cytokines can then either directly cross the BBB via the 
humoral route, relay cytokine signals to relevant brain regions from the vagus nerve via the 
neural route, or can, via the cellular route, stimulate the recruitment of activated immune cells 
from the periphery to the brain, which is facilitated by CCL2 released from microglial cells. (C) 
In the brain, pro-inflammatory cytokines, with the aid of activated microglial and astroglial 
cells, can reduce monoamine metabolism by reducing 5-HT, DA and NE availability, 
increasing monoamine receptor expression, and altering the function of associated 
transporters. Glial cells and cytokines can also stimulate the production and release of nitric 
oxide, and kynurenine by activating IDO, which can further reduce monoamine synthesis. 
Moreover, microglia can convert kynurenine into quinolinic acid, which can bind to the NMDA 
receptor, and alter glutamate metabolism. Additionally, the release of reactive oxygen and 
nitrogen species by activated microglia can further alter glutamate metabolism, resulting in 
excessive glutamate, which can bind to the NMDA receptor, and result in excitotoxicity and 
reduced BDNF signalling. Reduced BDNF signalling can subsequently reduce adult 
neurogenesis (see subsection 1.2.4) and alter neural plasticity.  
 
Adapted from Miller AH,  & Raison CL (2016). The role of inflammation in depression: from 









thought to be the primary mechanisms by which chronic stress can lead to increased 
inflammation, as schematically presented in part A of Figure 1.2 (reviewed in Felger 
& Lotrich, 2013; Miller & Raison, 2016). Support for this mechanism comes from 
several lines of animal research, showing how chronic stress exposure indeed 
induces the release of hsp-72, and uric acid (reviewed in Fleshner, 2013), and 
activates the NOD-, LRR- and pyrin domain- containing protein 3 (NLRP3) 
inflammasome, which consistently responds to these DAMPs (Pan et al. 2014; 
Zhang et al. 2015). Moreover, blockade of NLRP3 reverses stress-induced increases 
in IL-1β in both peripheral blood and in the brain, while also nullifying depressive-like 
behaviour in mice (Zhang et al. 2015). Additional support for the role of the NLRP3 
inflammasome in clinical depression, stems from clinical research demonstrating an 
increase in DAMPs in patients with depression (Rawdin et al. 2013; Stertz et al. 
2015), and how increased NLRP3 expression and caspase 1 in peripheral blood 
mononuclear cells is associated with increased peripheral levels of IL-1β and IL-18, 
which subsequently relates to MDD severity (Alcocer-Gomez et al. 2014; Drago et al. 
2015). Although specific features associated with the inflammasome will not be 
measured in this thesis, peripheral levels of inflammation, and microglia and 
astrocyte biology will be assessed in the context of this work. Therefore, 
understanding how peripheral inflammation could impact the CNS and subsequently 
promote aberrant behaviour will be crucial to interpreting the presented data.  
 
1.2.2.4.2.  Inflammatory signalling: from periphery to the brain  
 
As aforementioned in subsection 1.2.2.2, in addition to increased expression of 
cytokines and TLRs in postmortem brain tissue from patients with depression, 
increased microglial and astroglial activation in several brain regions have likewise 
been described, the details of which will be presented in subsection 1.2.3. Therefore, 
inflammation is not solely confined to the periphery. Evidence from several animals 
studies have elucidated three main pathways through which inflammatory signals in 
the periphery can be transmitted to the brain, as illustrated in part B of Figure 1.2. 
Specifically, cytokine signals in the periphery can reach the brain more directly 
through the humoral pathway, which involves crossing the blood brain barrier (BBB), 
either directly across regions of higher permeability, such as the circumventricular 
organs, thus enabling cytokines to passively diffuse between endothelial cells, or 
indirectly by binding to saturable transport molecules on the BBB, which then 
facilitate transportation (Banks et al. 1995; Pan & Kastin, 2003; Banks & Erickson, 
2010). Alternatively, inflammatory signals can reach the brain via the neural pathway, 
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which involves the binding of cytokines to peripheral nerve fibres, such as the vagus 
nerve, that then subsequently stimulate ascending catecholaminergic fibres in the 
brain and relay cytokine signals to the relevant brain regions (Watkins et al. 1994; 
1995). Finally, the third pathway through which cytokine signals can reach the brain 
is through the cellular pathway, which involves the recruitment of activated immune 
cells, such as monocytes, macrophages and T cells from the periphery to the brain 
vasculature and parenchyma, where these cells consequently produce cytokines in 
the brain (Shaftel et al. 2007, D'Mello et al. 2009). It is thought that this recruitment 
process is largely facilitated by the chemokines; CC-chemokine ligand 2 (CCL2), and 
CXC- chemokine ligand 1 (CXCL1), which are released by cytokine-activated 
microglial and astroglial cells, as well as from the bone marrow (D'Mello et al. 2009; 
Hennessy et al. 2015). Once in the brain parenchyma, inflammatory signals and/or 
cytokines can cause microglial and astroglial activation, both of which trigger further 
inflammatory escalation, and can impact various neurotransmitter systems, which 
consequently can induce the development of MDD.  
 
1.2.2.4.3.  Cytokine targets in the brain: microglial and astrocyte activation 
 
The inflammatory response in the brain can affect several neurocircuits that regulate 
behaviour, by altering important neurotransmitter systems that regulate mood. This 
can occur as a result of multiple alterations, but the best described include reduced 
monoamine availability, altered glutamate neurotransmission, and altered neural 
plasticity as illustrated in part C of Figure 1.2. However, this subsection will only 
describe alterations in monoamine and glutamate metabolism. Modifications in 
neural plasticity, that is, neurogenesis, as a consequence of stress or inflammation 
will be presented in subsection 1.2.4.  
 
As briefly stated, pro-inflammatory cytokines can alter several pathways that can 
consequently alter monoamine metabolism. First, they can activate mitogen-
activated protein kinase (MAPK) pathways, and subsequently increase the 
expression and function of the presynaptic reuptake pumps (transporters) for 5-HT, 
dopamine (DA) and norepinephrine (NE), thereby reducing synaptic availability of 
these monoamines (Zhu et al. 2010). Second, cytokines can also stimulate the 
production and release of reactive oxygen and nitrogen species from microglial cells, 
via the MAPK and NF-κB pathways (Qin et al. 2004, Block et al. 2007; Bohannon et 
al. 2013). These cytotoxic molecules subsequently decrease the availability of 
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tetrahydrobiopterin (BH4), a key enzyme co-factor in monoamine synthesis, and thus 
reduce monoamine production (Neurauter et al. 2008). Finally, many cytokines can 
also decrease availability of the relevant monoamine precursors by activating the 
kynurenine pathway (Zunszain et al. 2012). Specifically, this involves increasing 
indoleamine 2,3-dioxygenase (IDO) (Pemberton et al. 1997, Fujigaki et al. 2006), an 
enzyme expressed in multiple cell types, including macrophages, dendritic cells, 
microglia, astrocytes, and neurons (Guillemin et al. 2005, Huang et al. 2010), which 
catabolises tryptophan, the primary precursor for 5-HT, into kynurenine. 
In addition to reducing monoamine availability, activation of the kynurenine pathway 
can also alter glutamate neurotransmission, which is thought to play an important 
role in the behavioural effects of cytokines (Dantzer et al. 2011, Haroon et al. 2012). 
Specifically, as aforementioned, pro-inflammatory cytokines increase IDO, which 
ultimately increases the levels of kynurenine. Kynurenine is then further dissimilated 
into the neuroactive metabolites; kynurenic acid, by kynurenine aminotransferase in 
astrocytes, or quinolinic acid, by kynurenine-3-monooxygenase, in microglia (Heyes 
et al. 1992). These metabolites, particularly quinolinic acid, increase glutamate levels 
by activating receptors for glutamate, namely the N-methyl- aspartate (NMDA) 
receptor, while also stimulating glutamate release, and inhibiting glutamate reuptake 
by astrocytes (Steiner et al. 2011).  The effect of quinolinic acid on glutamate, 
together with the direct effects of cytokines on glutamate metabolism, which include 
the decreased expression of astrocyte glutamate reuptake pumps and increased 
astrocyte glutamate release (Tavares et al. 2002), essentially contributes to 
excessive glutamate levels both within and outside of the synapse (Tilleux & 
Hermans, 2007).  The binding of glutamate to extrasynaptic NMDA receptors 
subsequently leads to increased excitotoxicity and decreased production of BDNF 
(Hardingham et al. 2002), an important neurotrophin for promoting and maintaining 
neural plasticity (Lewin & Barde, 1996; McAllister, 1999; 2001; Malcangio & 
Lessmann, 2003), and one that has consistently been implicated in the pathogenesis 
of depression (reviewed in Dwivedi, 2009; Lee & Kim, 2010). 
 
1.2.2.4.4. Other potential mechanisms  
 
However, although ample evidence reports increased inflammation in the context of 
depression, several additional studies in patients with depression have reported 
normal or even reduced levels of inflammation. Indeed, decreased levels of tumour 
growth factor (TGF)-β, IL-12, IL-10 and CRP in peripheral blood have all been 
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described in patients with depression (Zorilla et al. 2001; Almeida et al. 2009; 
Dhabhar et al. 2009; Lehto et al. 2010). Moreover, they also exhibit decreased 
numbers of T cells in peripheral blood (Zorilla et al. 2001; Lehto et al. 2010), and 
increased numbers of myeloid-derived suppressor cells, known to inhibit T cell 
function (Wei et al. 2015). This is interesting given that T cells have been shown to 
reduce inflammation and support neuronal integrity (Kim et al. 2012), and it is 
thought that they may even promote resilience to stress-induced depression 
(reviewed in Miller & Raison, 2016). Given the data supporting the association 
between reduced inflammation and depression, it therefore, seems plausible that 
impairments in the neuroprotective and anti-inflammatory responses of T cells may 
be another important mechanism by which altered immune system functioning could 
lead to the development of MDD.  However, insights into the precise molecular 
pathways involving this mechanism are yet to be fully elucidated, but it is thought that 
the impaired ability of T cells to produce IL4, an anti-inflammatory cytokine that 
stimulates astrocytes to produce BDNF, and converts monocytes and macrophages 
from a pro-inflammatory M1 phenotype to a less inflammatory M2 phenotype 
(Derecki et al. 2010), plays a crucial role. Moreover, it is noteworthy that the 
activation of the inflammasome can increase myeloid-derived suppressor cells (van 
Deventer et al. 2010), which could be another potential pathway by which T cell 
functioning may become impaired.  
While it is clear that pro-inflammatory cytokines play a pivotal role in the 
pathogenesis of depression, the role of anti-inflammatory cytokines should not be 
overlooked, especially given (a) the evidence supporting a reduction in anti-
inflammatory cytokines in the context of depression (Maes et al. 1998; Dhabar et al. 
2009), and (b) that a balance between pro- and anti-inflammatory cytokines is 
needed for optimal immune system functioning as mentioned in subsection 1.2.2.1. 
Indeed, it is likely that both ultimately contribute to the development of MDD.  
 
1.2.3.  Neuroinflammation and depression 
 
Glia cells were once considered to be the silent supportive cells of neurons, however 
advancements in research have changed this perception by revealing how they 
actively participate in brain metabolism, synaptic neurotransmission and 
communication between neurons (Volterra et al. 2005). Alterations in their ability to 
adequately perform these functions, as a consequence of chronic stress exposure, 
for instance, may play an important role in the pathogenesis of depression, as 
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described in the previous section. Indeed, a multitude of evidence chronicles the 
involvement of glia in the neuropathology of MDD, which will be discussed 
throughout this subsection (reviewed in Rajkowska & Miquel-Hidalgo, 2007; Yirmiya 
et al. 2015; Bender et al. 2016). 
 
Glia constitute the most numerous cell type in the human brain, and are 
characterised according to three main types: oligodenrocytes, astrocytes, and 
microglia. Both oligodendrocytes and astrocytes originate from the ectoderm, while 
microglia originate from the monocyte-macrophage lineage (Naftel et al. 2006). Each 
type of glia is classified based on their specific morphology and function, and while 
some glia functions may be specialised and restricted to one morphological type of 
glia, as in, oligodendrocytes whose main function is to produce myelin for axon 
insulation, all glia types ultimately play a crucial role in the proper functioning of 
neurons, and any alterations in their functional activity can have important 
ramifications (reviewed in Rajkowska & Miquel-Hidalgo, 2007). However, within the 
confines of this PhD thesis, only microglia and astrocytes will be studied. This is 
based largely on their important role in the inflammatory response, as detailed in 
subsection 1.2.2.4.3, and as such this subsection will focus only on microglia and 
astrocytes. 
 
1.2.3.1.  Microglia 
 
1.2.3.1.1.  Microglia and their function 
 
Microglial cells comprise of approximately 10% of all brain cells, and are 
distinguishable from other glia cell types by their small nuclei, which are surrounded 
by scant cytoplasm, and their short, meandering processes (Lawson et al. 1990; 
Fawcett, 1994; Mittelbronn et al. 2001). They are typically referred to as the 
macrophages of the CNS, and thus, play a crucial role in host defense, responding 
quickly to any changes in the structural integrity of the brain (Tremblay et al. 2011). 
They are also critical mediators in the maintenance of ion homeostasis (Eder, 1998; 
2005; Farber & Kettenmann, 2006), and are vital for apoptosis (Yuan & Yankner 
2000), repairing damaged cells (Minghetti & Levi, 1998; Madinier et al. 2009), 
removing apoptotic neurons and neural cell debris (Neumann et al. 2008; Ransohoff 
& Perry, 2009), and regulating neurogenesis (see subsection 1.2.4)(reviewed in 
Gemma & Bachstetter, 2013). In essence, they are crucial for maintaining the 
integrity of the CNS, and unlike other cell types are uniquely capable of expeditiously 
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activating, moving from one morphological state to another, in response to 
pathological stimuli (reviewed Beynon & Walker, 2012).   
 
1.2.3.1.2. Microglial activation 
 
Under non-pathological conditions, microglia manifest a quiescent phenotype, one 
that is characterised by a ramified morphology in the form of a small soma with 
numerous fine cellular processes (Kreutzberg, 1996). In this state, they are 
commonly referred to as “ramified” or “resting” microglia, and until recently, were 
considered to be functionally dormant, given their low or absent expression of 
activation-associated molecules, and immunological inactivity (Kreutzberg, 1996). 
However, while in this state, microglial cells actively survey the extracellular space 
and cellular neighborhood using their fine motile processes, which are in constant 
motion (Davalos et al. 2005; Nimmerjahn et al. 2005), monitoring for DAMPs, pro-
inflammatory cytokines, cell necrosis factors, and glutamate receptor agonists (de 
Haas et al. 2008). Multiple studies have demonstrated how this surveillance is 
preferentially targeted towards the synapse, which strategically enables them to 
monitor and modulate synaptic activity (Wake et al. 2009; Tremblay et al. 2010). 
 
In response to any pathological stimuli that they encounter, “resting” microglia 
transform into their “activated” state, which is characterised by both a functional and 
morphological transformation (Stence et al. 2001; Dheen et al. 2007; Graeber, 2010). 
Typically, activation occurs in a graded manner, starting from the quiescent state, 
through to a number of intermediary stages, and ending in an activated amoeboid 
state as depicted in Figure 1.3. Phenotypically, the initial stages of activation involve 
an increase in the size of the cell soma, and a shortening and thickening of the cell’s 
processes. This morphological transformatory state is referred to as being 
hypertrophic, and it is during this intermediary state of activation that microglial cells 
become essentially primed for an immunological response (Kreutzberg, 1996). From 
this hypertrophic state, microglia can subsequently either return to their quiescent 
state, if the pathological problem initiating activation is resolved, or can continue to 
transform into a reactive state, upon further stimulation. During this process, 
microglia undergo further morphological modification, involving the almost full 
retraction of the cellular processes, and an increase in soma size, such that they take 
on an amoeboid appearance (Stence et al. 2001; reviewed in Kettenmann et al. 













Figure 1.3. Structural and functional changes associated with microglial activation 
Schematic renderings of microglial cells in the various stages of activation. (A). A quiescent 
microglial cell associated with non-pathological conditions. In this state microglial cells are 
characterised by their long extensive processes and small cell soma, and their primary 
function is to survey and monitor the central nervous system. (B). In response to injury, 
microglial cells initially become hyper-ramified or hypertrophic. During this intermediary stage 
of activation, the microglial cell undergoes rapid process extension and reorientation to the 
site of injury, and is capable of synthesizing various inflammatory cytokines. (C). Upon further 
stimulation, hypertrophic cells enter a reactive state, where their processes rapidly thicken 
and retract. (D). Following further stimulation, reactive microglia transform into an amoeboid 
or phagocytic phenotype, where the cell some increases in size, and the processes fully 
retract. In this state, the cell can release various inflammatory cytokines and cytotoxic 
molecules.  
 
Adapted from Beynon, SB & Walker FR (2012). Microglial activation in the injured and healthy 
brain: What are we really talking about? Practical and theoretical issues associated with the 








(A) Quiescent microglia  (B) Hyper-ramified microglia 
(C) Reactive microglia (D) Phagocytic microglia 
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Once in the final stage of activation, that is, the reactive state, microglia can then 
rapidly proliferate through the mitosis of resident microglial cells, and migrate to the 
site of damage, where they engage in phagocytosis, and/or can synthesise various 
pro-inflammatory cytokines or cytotoxic molecules, such as reactive oxygen species. 
Moreover, they can induce changes in intracellular enzymes, rearrange surface 
molecules for cell-cell and cell-matrix interactions, and can unfold their phagocytotic 
activities to remove tissue debris, damaged cells, or microbes (reviewed in 
Kettenmann et al. 2011; Beynon & Walker, 2012). Through the persistent activation 
of microglia multiple systems can become altered, as described in section 1.2.2.4, 
and this is ultimately thought to play a pivotal role in the pathogenesis of depression.  
 
1.2.3.1.3.  Markers for microglia  
 
 
Immunohistochemistry is the predominate method used for detecting and evaluating 
microglial location, distribution, morphology and density.  It enables the detection of 
microglial cells on a single cellular level in the brain, by using molecular markers, that 
is, antibodies, specific to antigens associated with microglial cells. The most 
commonly utilised molecular markers for the detection of microglia include ionized 
calcium adaptor protein-1 (Iba1), cluster of differentiation (CD) 11b, CD68, and major 
histocompatibility complex II (MHC-II).  
 
Iba1 is a member of the calcium-binding group of proteins, which are specifically 
expressed in macrophages and microglia, and are upregulated during the activation 
of these cells. Indeed, there is no evidence to suggest immunolabelling of astrocytes, 
neurons or oligodendrocytes (Imai & Kohsaka, 2002; Kettenmann et al. 2011). 
Moreover, Iba1 protein is quite uniformly distributed in the cytoplasm and processes 
of ramified microglia, and is often used to study the complex organization of 
microglial processes (Korzhevskii & Kirik, 2016), and as such is perhaps the most 
commonly used of all the aforementioned markers.  Immunohistochemistry using 
antibody Iba1 to visualise and examine microglial cell density and morphology was 
performed in this PhD thesis as described in section 2.5.3.  
 
The remaining three molecular markers are often used to detect activated microglia. 
For example, CD11b, a protein part of the type-3 complement receptor, essentially 
binds to the complement receptors located on the plasma membranes of neutrophil 
granulocytes, most mononuclear phagocytes, and natural killer cells (e.g., Todd, 
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1996; Kawai et al. 2005), while CD68, a transmembrane protein present in 
monocytes and tissue macrophages and microglia, is used largely due to its clear 
visualisation of amoeboid microglial cells (e.g., in Smith et al., 2013; Shikuma et al. 
2014). The utility for MHC-II as a molecular marker of activated microglia is based on 
the premise that in states of activation microglia are known to actively express MHC-
II, the expression of which increases in response to neurodegeneration (Block et al. 
2007; Wojtera et al. 2012). 
 
1.2.3.1.4.  Microglia and depression  
 
Impairments in microglia functioning can have an important impact on the structural 
integrity of the brain and could ultimately alter neurotransmitter metabolism (see 
subsection 1.2.2.4.3), and neural plasticity (see subsection 1.2.4), and thus, likely 
contribute to the pathophysiology of depression. Indeed, several lines of evidence 
support the involvement of microglia in the development of MDD. 
 
1.2.3.1.4.1.  Clinical evidence 
 
As briefly mentioned in section 1.2.2.2, clinical evidence for the association between 
microglial activation and depression stems from studies utlising PET ligands for the 
marker TSPO.  The TSPO protein is primarily localised in the outer mitochondrial 
membrane and is important for mitochondrial functioning, cell proliferation and 
apoptosis, and is predominately expressed in microglia in the brain, albeit non-
exclusively (reviewed in Rupprecht et al. 2010).  Several studies report a significant 
positive correlation between levels of TSPO binding in the prefrontal cortex, insula, 
anterior cingulate cortex, and hippocampus and depressive-symptomology and 
severity (Haarman et al. 2014; Colasanti et al. 2014; Setiawan et al. 2015).   
However, while some studies find a significant increase in TSPO in patients with 
depression, several other studies find no significant changes between healthy 
subjects and patients (Steiner et al. 2008; Hannestad et al. 2013; Torres-Platas et al. 
2014; Schneider et al. 2014). Although given that depression may be associated with 
microglia activation or decline, averaging the microglia status of all individuals may 
have contributed to these null findings. Moreover, it is also noteworthy that different 
TSPO PET ligands have different patterns of binding affinity, which may also 
contribute to the inconsistencies observed.  
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While TSPO neuroimaging studies have provided some invaluable insights into the 
role of neuroinflammation in MDD in a clinical setting, findings from these studies 
should be interpreted with caution, irrespective of the result. Currently this 
methodology, which has only been validated in neuropathology, may not be sensitive 
enough for detecting changes associated with psychiatric disorders, such as 
depression. Furthermore, TSPO is not specific to microglia, and is also upregulated 
in Schwann cells, macrophages, astrocytes and neurons (Lacor et al. 1999; 
Karchewski et al. 2004; Mills et al. 2005; Ji et al. 2008). 
 
1.2.3.1.4.2.  Preclinical evidence 
 
Although the clinical evidence looking at microglia activation may be limited and 
inconsistent, preclinical animal studies have provided more direct evidence for the 
role of microglia in depression aetiology. Much of this evidence stems from animal 
studies administering LPS, and from studies using acute or chronic stress exposure 
(reviewed in Walker et al. 2013; Yirmiya et al. 2015). For example, multiple studies 
demonstrate how an inflammatory insult, in the form of LPS, induces microglia 
activation in the hypothalamus, thalamus, prefrontal cortex (PFC) and hippocampus, 
and increases depressive-like behaviour in rodents, which can be prevented or 
reversed by antidepressant treatment (Yirmiya, 1996; Buttini et al. 1996; Monje et al. 
2003; Qin et al. 2007; Clark et al. 2015). Further evidence to corroborate the 
involvement of microglia in LPS-induced depression comes from studies showing 
how IDO activation in microglia is necessary for the development of depressive-like 
behaviours and microglial activation (Henry et al. 2008; O’Connor et al. 2009; Dobos 
et al. 2012), and how depressive-like phenotypes and increased levels of IDO can be 
mitigated by minocycline treatment, a microglial inhibitor (Henry et al. 2008).  
 
Regarding stress-induced depression, ample evidence demonstrates that both acute 
and chronic stress exposure can induce microglial activation, altering both the 
structure and function of microglia, and increase anxiety- and depressive-like 
behaviour in rodents (reviewed Walker et al. 2013; Yirmiya et al. 2015). Specifically, 
acute stress has been shown to alter depressive-like behaviour and increase 
microglial immunoreactivity, that is, the density or area covered by Iba1 positive cell 
bodies and processes, in the hypothalamus and hippocampus (Sugama et al. 2007; 
2009; 2013). Moreover, microglial function has been shown to alter under acute 
stress, with increased microglial production of CCL2, pro-inflammatory cytokines, 
especially IL1β, TNFα, and IL6, and MHC-II expression all consistently reported in 
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stress exposed animals (Shimoda et al. 2006; De Pablos et al. 2006; Blandino et al. 
2006; 2009; Frank et al. 2007; 2010; 2012).  
Similarly, chronic stress exposure has also consistently been associated with 
increased anxiety- and/or depressive-like behaviour, together with increased 
microglial immunoreactivity in various brain regions, as depicted in Figure 1.4 
(Bradeshi et al. 2009; Tynan et al. 2010; Wohleb et al. 2011; 2012; 2013; 2014; 
2016; Farooq et al. 2012; Kopp et al. 2013; Kreisel et al. 2014). However, what these 
changes in microglial immunoreactivity specifically relate to is unknown, but could 
reflect a change in either the density and/or morphology of microglial cells. Indeed, 
several studies specifically quantifying microglial cell number and morphology report 
alterations in these domains. For instance, several accounts of an increase in 
microglial proliferation and number in the hippocampus, PFC, and amygdala of 
stress-exposed animals have been demonstrated (Nair & Bonneau, 2006; Bian et al. 
2012; Hinwood et al. 2012; Wohleb et al. 2012). Moreover, several additional studies 
have now established the ability for chronic stress to alter microglial morphology 
(Bian et al. 2012; Farooq et al. 2012; Hinwood et al. 2012; Kopp et al. 2013; Couch 
et al. 2013), showing specifically, for example, how microglia in the PFC have an 
increased number of processes, increased branching and process length, and 
therefore, increased structural complexity (Hinwood et al. 2012). Interestingly 
however, while these studies do demonstrate a change in the morphology of 
microglial cells, corresponding increases in IL1β and/or MHC-II were not observed 
for some of these studies, suggesting how neuroinflammatory changes may not be a 
necessary requirement for changes in microglial morphology. 
In addition to the structural changes observed, functional alterations in microglia 
have also been detected with respect to chronic stress exposure. Specifically, 
increased mRNA expression of several microglial activation markers has been 
shown (Nair & Bonneau, 2006; Kreisel et al. 2014), together with enhanced 
recruitment of peripheral macrophages into the brain from the bone marrow (Brevet 
et al. 2010; Wohleb et al. 2011; 2012; 2013; 2014; 2016; Ataka et al. 2013), 
increased stimulation of the microglial NLRP3 inflammasome, and ameliorated IL1β 
production (Pan et al. 2014). Moreover, minocycline treatment has been shown to 




Figure 1.4 Regional specificity of altered microglial immunoreactivity in response to 
chronic stress exposure.  
The schematic shows the mean percentage difference in Iba1 immunoreactivity in chronically 
stressed animals compared with handled controls. A single box denotes a 10% increase from 
baseline, while red and blue boxes represent significant and non-significant differences, 
respectively. The data presented here helped provide the rationale for focusing specifically on 
the prefrontal cortex and hippocampus, with respect to Iba1 alterations, in this PhD thesis, 
which will be further discussed in section 1.4.1.1.3.  
 
Taken from Tynan RJ, et al. (2012). Chronic stress alters the density and morphology of 








CA3, Cornu ammonis 3 
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Overall, a plethora of evidence supports that microglia function and structure is 
altered under stressful conditions. Moreover, preclinical research clearly 
demonstrates a direct association between microglial activation and depressive-like 
behaviour, showing how changes in microglial function, associated with an increase 
in number and structural complexity, can ultimately influence depressive-like 
phenotypes in rodents.  Furthermore, given that microglia are the immune cells of the 
brain, are directly involved in the inflammatory response, alterations of which have 
been in itself strongly implicated in the pathogenesis of depression (subsection 
1.2.3.1.4), and can be heavily influenced by stress exposure, another key biological 
system implicated in depression aetiology (see subsection 1.2.1), they are 
particularly relevant within the context of depression and this PhD thesis. As such, 
this thesis will examine the impact of different types of chronic stress on microglial 
number and morphology.  However, microglia are not the only glial cells to be 
implicated in the pathogenesis of depression. Indeed, astrocytes have likewise been 
associated with MDD, and pertinently, microglia can directly affect astrocyte 
functioning as described in subsection 1.2.2.4.3.  
 
1.2.3.2.  Astrocytes 
 
1.2.3.2.1.  Astrocytes and their function 
 
Astrocytes are the most abundant and adaptable of all the glial cells, performing 
multiple important functions. Three main subtypes of astrocyte exist, radial, 
protoplasmic and fibrous astrocytes, which are morphologically distinct and located in 
both the grey and white matter of the CNS (Miller & Raff, 1984). Radial glia, 
represent a form of astrocyte particularly abundant during development. They are 
generally known to retract their processes and transform into star-shaped astrocytes 
during maturation in the perinatal period (Hunter & Hatten, 1995). Protoplasmic 
astrocytes are predominately located throughout the grey matter, and they have 
large spherical nuclei, with several stem branches that give rise to multiple finely 
branching processes, which envelope synapses. In contrast, fibrous astrocytes are 
found in the white matter, and have ovoid nuclei with fewer, longer fibre-like 
branches that contact nodes of Ranvier (Fawcett, 1994). Both protoplasmic and 
fibrous astrocytes form gap junctions between the distal processes of neighboring 
astrocytes (Sofroniew & Vinters, 2010; Middeldorp & Hol, 2011), communicate with 
other astrocytes and neurons via a calcium dependent mechanism, (Pasti et al. 
1997; Araque, 2008), and are also often attached to the blood vessels, forming 
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expansions called end-feet, which surround blood vessels to form a limiting 
membrane (Naftel et al. 2006).  
 
The understanding of astroglial functioning has significantly evolved over the years, 
with the cell now recognised to be centrally involved in regulating many fundamental 
processes. Essentially, astrocytes are thought to have four primary functions, (a) 
they are important for synaptogenesis and the maintenance of synaptic integrity 
(reviewed in De Pittà et al. 2016), (b) promoting and regulating synaptic signalling 
and functioning - it is estimated that a single astrocyte can contact several hundred 
dendrites from multiple neurons to surround more than 100,000 synapses (Ogata & 
Kosaka, 2002; Halassa et al. 2007), (c) facilitating myelination (reviewed in Lungaard 
et al. 2014), and (d) building and maintaining the BBB (reviewed in Kettenmann & 
Ransom, 2005; Cabezas et al. 2015). However, as part of these primary functions, 
astrocytes have a multitude of responsibilities, ranging from neurotransmitter 
modulation to immune system functioning (reviewed in Rajkowska & Miguel-Hidalgo, 
2007; Rajkowska & Stockmeier, 2013; Bender et al. 2016).  More specifically, for 
instance, astrocytes are responsible for glucose metabolism, glucose being the main 
energy substrate for neurons and glia. Briefly, astrocytes absorb glucose from the 
capillary walls via their astrocytic end-feet, which are enriched with glucose 
transporters, where glucose subsequently undergoes glycolysis and oxidative 
phosphorylation (reviewed in Falkowska et al. 2015). To help facilitate this, 
astrocytes are also able to control blood flow requirements by inducing local 
vasoconstriction or vasodilation (Zonta et al. 2003; Parri et al. 2003).  
Another key responsibility is the control of the synaptic microenvironment. Astrocytes 
regulate both the availability and reuptake of neurotransmitters at the synapse, 
through transporters, channels and enzymes, several of which are highly and/or 
exclusively expressed by astrocytes (Verkhratsky et al. 2000). In vivo studies 
demonstrate that these glia are able to reuptake gamma aminobutyric acid (GABA), 
histamine, 5-HT, DA and NE (Hertz et al. 1978; Minelli et al. 1996; Hirst et al. 1998; 
Takeda et al. 2002; Inazu et al. 2003a; 2003b; Wu et al. 2006). Moreover, they can 
release enzymes such as catechol-O-methyl transferase (COMT) and monoamine 
oxidase (MAO), which regulate the extracellular concentration of these 
neurotransmitters (Fitzgerald et al. 1990; Hansson et al. 2000), and release 
“gliotransmitters”, which alter neuronal activity (reviewed in Harada et al. 2015).  In 
essence, astrocytes promote efficient signalling between neurons, forming a crucial 
part of the tripartite synapse, which involves the presynaptic neuron (axonal 
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terminal), astrocytic processes, and the postsynaptic neuron (dendritic spine) 
(Volterra et al. 2002; Barres, 2008; Perea et al. 2009; Kimelberg & Nedergaard, 
2010).  
In addition to glucose metabolism and neurotransmitter modulation, astrocytes 
perform a range of functions pertaining to glutamate, which in excess is cytotoxic. 
First, they actively regulate the extracellular levels of glutamate predominately 
through a specialised transporter expressed solely on astrocytes, the excitatory 
amino acid transporter (EAAT)-2 in humans, and the glutamate transporter (GLT)-1 
in rodents (Rothstein et al. 1994; Huang et al. 2004; Bezzi et al. 2004; Furuta et al. 
2005). Second, they facilitate the synaptic release of glutamate by metabolising and 
recycling glutamate, via the glutamate-glutamine cycle (Shen et al. 2006). 
Specifically, once astrocytes uptake glutamate, it is converted into glutamine by the 
astrocytic specific enzyme, glutamine synthetase (Rothman et al. 2002). Glutamine is 
then subsequently released, taken up by neuronal terminals, and reconverted to 
glutamate or GABA to replenish these neurotransmitter pools (Pfrieger & Barres, 
1997). Third, astrocytes also regulate glutamate neurotransmission by regulating 
NMDA receptor activity through coordinating the availability of D-serine, an important 
endogenous ligand for NDMA receptor activation, which is exclusively sourced from 
astrocytic foot processes (Johnson & Ascher, 1987; Panatier et al. 2006). 
 
Finally, like microglia, astrocytes play a central role in neurodegenerative and 
inflammatory processes (see subsection 1.2.2.4.3). Under pathological conditions, 
astrocytes become activated, increase in number and size, and increase the 
expression of their cytoskeletal protein, glial fibrillary acidic protein (GFAP), as 
exemplified in Figure 1.5 (Laping et al. 1994; Mongin et al. 2005). Activated 
astrocytes can subsequently synthesise and release various inflammatory cytokines 
(IL and TNF), neurotrophic factors (e.g., BDNF, glial cell-derived neurotrophic factor 
[GNDF]), and endothelins (e.g., vascular endothelial growth factor [VEGF]), which 
respond to injury and participate in the neurodegenerative process (Lindahl et al. 
1997; Connor et al. 1998; Acker et al. 2001; Malin et al. 2006). Moreover, the growth 
factors that astrocytes release are important for neuronal precursor migration, 
neurogenesis (see subsection 1.2.4), and the enhancement of synaptic plasticity and 
efficiency (e.g., Rossi, 2006; Lu et al. 2014; Kirby et al. 2015; Ottoboni et al. 2017).  
 
In summary, astrocytes perform a myriad of important functions pertaining to 















Figure 1.5. Astrocytic response to injury: Non-reactive versus reactive astrocytes 
In response to injury, astrocytes increase in size, their cellular processes become 
hypertrophic, and GFAP is upregulated. (A). Astrocytes in non-pathological mouse 
hippocampus (left) and activated (reactive) astrocytes in mouse hippocampus post injury 
(lesion) (right) as visualised by GFAP immunodetection. (B). Schematic representations of 
non-reactive vs. reactive astrocytes. Processes of reactive astrocytes become thicker and 
visible over a longer distance compared with non-reactive astrocytes.  
 
Taken from Pekny M, et al. (2014). The dual role of astrocyte activation and reactive gliosis. 










important implications for general brain functioning, and can even contribute to the 
development of MDD. Indeed, given that several systems regulated by astrocytes, 
such as glutamate metabolism, monoamine neurotransmission, and neural plasticity, 
have all been strongly associated with depression, it is unsurprising that astrocyte 
dysfunction may be involved in the pathogenesis of the disorder. 
 
1.2.3.2.2.  Markers for astrocytes 
 
Like with microglial visualisation, immunohistochemistry is the predominate method 
used for detecting astrocytes. The most common markers include antibodies to 
GFAP and S100β, both of which were utilised in this PhD thesis as described in 
section 2.5.3. However, several additional markers can also be used, for example, 
connexin (Cx), and a variety of glutamate markers.  
 
GFAP is the core component of cytoskeletal intermediate filaments, and is strongly 
expressed in the CNS by mature and reactive astrocytes (Jacque et al. 1978; 
Herrmann & Aebi, 2004; Middeldorp et al. 2011). It is typically found in astrocyte 
main processes, and is thought to have several functions including, the maintenance 
of the mechanical strength and shape of astrocytes, astrocyte cell movement 
facilitation, and cell-to-cell communication (Simard et al. 2003; Cullen et al. 2007; 
Middeldorp et al. 2011). Therefore, markers of GFAP reflect not only structural 
changes, but also functional ones, and together with its prevalence in astrocytes, it is 
commonly used in immunohistochemical analyses. However, it is noteworthy that 
antibodies to GFAP only identify approximately 15–20% of astrocytes expressed in 
the cortex of mature animals (Middeldorp et al. 2011). 
 
S100β, the most abundant of the S100 family of calcium binding proteins, has also 
been extensively used as a marker for astrocytes (Donato, 1999). Typically, this 
protein is predominantly expressed and secreted by astrocytes located in the grey 
matter (Pinto et al. 2000; Marenholz et al. 2004; Steiner et al. 2007), and is a late 
marker of astrocyte development, expressed long after GFAP (Raponi et al. 2007). 
Moreover, using this marker could also reflect changes in astrocyte functioning, 
particularly with respect to cell communication, which in astrocytes is preformed via a 
calcium dependent mechanism. Specifically, S100β acts as a calcium sensor that 
when activated interacts with several other proteins, subsequently affecting broad 
cellular functioning (reviewed in Donato et al. 2013). However, unlike GFAP, S100β 
is not expressed in the main processes, and therefore, cannot identify any structural 
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changes in the astrocytic processes.  
 
Finally, Cx, glutamate transporters and glutamine synthetase, which are all 
specifically associated with astrocytes, have all served as additional markers used 
primarily to examine astrocytic cell function. Specifically, Cx30 and Cx43, which are 
gap junction-forming membrane proteins expressed in astrocytic end-feet, help to 
facilitate communication between astrocytes. As such, any changes in these proteins 
could reflect altered astrocytic communication (Giaume & Theis, 2010). Regarding 
the glutamate transporters, EAAT-1 and EAAT-2 in humans, which are glutamate-
aspartate transporter (GLAST) and GLT-1 in rodents, respectively, are frequently 
measured to assess glutamate neurotransmission (Bezzi et al. 2004; Furuta et al. 
2005).   
1.2.3.2.3.  Astrocytes and depression  
 
1.2.3.2.3.1.  Clinical evidence  
 
Several lines of evidence demonstrate an association between altered astrocyte 
structure and function, and clinical depression. However, evidence from clinical 
research predominantly comes from histopathological studies of postmortem brain 
tissue (reviewed in Rajkowska & Stockmeier, 2013). Specifically, decreased GFAP 
immunoreactivity, and decreased protein and gene expression levels of GFAP have 
been observed in patients with MDD in several fronto-limbic cortical regions of the 
brain, particularly the dorsolateral prefrontal cortex, orbitofrontal cortex and the 
hippocampus (cornu ammonis (CA) 1 and CA2) (Miquel-Hidalgo et al. 2000; 2010; 
Muller et al. 2001; Wang et al. 2013), and in subcortical regions, such as the 
cerebellum, amygdala and locus coeruleus (Fatemi et al. 2004; Altshuler et al. 2010; 
Ordway et al. 2012). Interestingly, however, the opposite outcome has been 
observed for older patients with depression, who show increased GFAP 
immunoreactivity in the dorsolateral prefrontal cortex (Miquel-Hidalgo et al. 2000; 
Davis et al. 2003), an outcome that may reflect a compensatory reaction to the 
neuronal damage seen in these patients (Rajkowska et al. 2005). Therefore, reduced 
GFAP immunoreactivity, and/or a down-regulation in GFAP expression may be a 
pathological phenotype specific to younger subjects with MDD (Khundakar et al. 
2009; Paradise et al. 2012).  
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Further clinical evidence to support the involvement of astrocytes in the development 
of depression, come from postmortem studies using additional astrocyte markers for 
gap-junction proteins and glutamate transporters. For instance, decreased protein 
and gene expression levels of Cx30 and Cx43 have been found in the dorsolateral 
prefrontal cortex and locus coeruleus of subjects with MDD (Ernst et al. 2011; 
Bernard et al. 2011; Miguel-Hidalgo et al. 2014). Similarly, reduced protein and 
mRNA expression levels for EAAT1, EAAT2 and glutamine synthetase have also 
been found in various fronto-limbic cortical and subcortical regions in subjects with 
MDD (Miquel-Hidalgo et al. 2000; Choudary et al. 2005; Sequeira et al. 2009; 
Bernard et al. 2011; Ordway et al. 2012; Chandley et al. 2013), in addition to reduced 
plasma and brain levels of glutamate and glutamine (Altamura et al. 1995; Auer et al. 
2000; Pfleiderer et al. 2003; Michael et al. 2003; Mirza et al. 2004; Rosenberg et al. 
2005; Hasler et al. 2007). Interestingly, these changes in glutamate-related gene 
expression have been associated specifically with astroglial pathology, as Bernard 
and colleagues (2011) show how these alterations do not occur in neurons (Bernard 
et al. 2011). Together these studies on Cx and glutamate suggest a more global 
dysfunction of astrocyte communication and glutamate signalling in MDD. 
 
Finally, astrocyte damage has also been associated with depression. In response to 
damage, astrocytes release S100β into the extracellular compartment and CSF, 
which subsequently enters the bloodstream (Rothermundt et al. 2001). As such, 
serum levels of S100β represent damage to astrocytes, and it has been suggested 
may serve as potential biomarker for depression. Indeed, alterations in S100β in 
patients with MDD have been observed, and were found to be elevated in the brain, 
CSF and serum (Rothermundt et al. 2001; Grabe et al. 2001; Schroeter et al. 2002; 
2008; Arolt et al. 2003; Hetzel et al. 2005). However, it is important to note that 
S100β is also expressed in oligodendrocytes and other body cells, so the respective 
contribution of astrocytes to the plasma and CSF levels remains uncertain.  
While alterations in astrocyte function have been consistently associated with clinical 
depression, albeit from postmortem analyses, more direct evidence for the 
involvement of astrocytes in the disorder comes from preclinical animal research.  
 
1.2.3.2.3.2.  Preclinical evidence 
 
 
Similar to the findings observed in clinical research, animal studies consistently 
report a reduction in the number of GFAP positive cells in the hippocampus, 
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amygdala and PFC, in addition to increased depressive-like behaviour in chronically 
stressed rodents (Czeh et al. 2006; Banasr & Duman, 2008; Gosselin et al. 2009; Ye 
et al. 2011; Liu et al. 2009; 2011; Sun et al. 2012; Cao et al. 2013; Tynan et al. 
2013). Moreover, significant morphological alterations have also been observed in 
chronically stressed rodents, with astrocytes showing significant reductions in soma 
cell size, and in the number and length of GFAP positive main processes (Tynan et 
al. 2013). However, not many morphological assessments have been performed to 
date, and this area is still largely understudied. 
 
While reductions in the number of GFAP positive cells have been consistently 
reported in rodents with a depressive-like phenotype, it is unknown whether these 
reductions are a consequence of cell death, or are attributed to reduced GFAP 
expression, where astrocytes cease to produce GFAP, making levels difficult to 
detect immunohistochemically. Some insight into this comes from a study performed 
by Gosselin and colleagues (2009), who in addition to measuring the number of 
GFAP positive cells evaluated the total number of S100β cells, neurons, and overall 
cell number. Interestingly, the authors found reductions in GFAP positive cell 
number, but no changes with respect to overall cell count, number of neurons, or the 
number of S100β cells, which suggests that astrocytes are not degenerating, but that 
GFAP is being downregulated. Indeed, the authors also found a significant reduction 
in the protein levels of GFAP in the PFC and amygdala (Gosselin et al. 2009), which 
has been replicated in several additional studies (Liu et al. 2009; Araya-Callis et al. 
2012). Moreover, the downregulation of GFAP is thought to operate on a 
transcriptional level, with additional studies reporting reduced mRNA expression 
levels of GFAP in the hippocampus and PFC (Banasr & Duman, 2008; Liu et al. 
2009; Cao et al. 2013). Taken together these data support that the observed 
reductions in GFAP may be a consequence of GFAP downregulation, rather than 
astrocyte cell loss. 
 
However, not all forms of chronic stress exposure consistently reduce the number of 
GFAP positive cells. Indeed, chronic restraint stress has been shown to increase the 
number of GFAP positive cells, and GFAP protein levels in the hippocampus of 
stress exposed rodents (Jang et al. 2008; Kwon et al. 2008). Interestingly, while this 
could reflect methodological differences across the various studies, it could equally 
suggest that the type of stress exposure may differentially alter astrocyte structure 
and function.  
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In addition to alterations in GFAP, several studies have demonstrated how chronic 
stress exposure can increase S100β levels in the hippocampus and PFC, implying 
that chronic stress may be altering calcium waves and thus, astrocyte 
communication (Ye et al. 2011; Tynan et al. 2013). Evidence to support this notion 
comes from an additional study, which showed gap-junction alterations, evident by a 
downregulation in Cx43, and reductions in intra-infralimbic diffusion in chronically 
stressed rodents (Sun et al. 2012). Moreover, alterations in glutamate metabolism 
have also been observed in rodents exposed to stress, where reductions in 
glutamate, glutamine and GABA levels were observed. However, glutamate-related 
gene expression levels were unchanged in these stressed rodents, ruling out any 
transcription level alterations (Banasr et al. 2010).   
 
Although multiple studies consistently report that chronic stress can induce astrocyte 
morphology and/or functionality, it is important to consider the casual role that 
astrocyte plasticity may play in the development of stress-induced depressive-like 
behaviours. Indeed, several of the aforementioned studies have also shown how 
antidepressant treatment both prevents stress-induced astrocyte changes and 
stress-induced behavioural changes (Czéh et al. 2006; Liu et al. 2009; Sun et al. 
2012). Moreover, gliotoxin administration, which selectively decreases the number of 
GFAP positive cells, has been shown to increase depressive-like behaviour (Banasr 
& Duman, 2008; Sun et al. 2012; John et al. 2012; Lee et al. 2013; Domin et al. 
2014), the effects of which can be prevented by antidepressant treatment (Domin et 
al. 2014). While it seems clear that astrocytes play an important role in the 
pathogenesis of depression, this is still a relatively unexplored area of depression 
research. More clinical and preclinical studies are needed to fully understand how 
astrocytes contribute to MDD. Indeed, the impact of different types of chronic stress 
on astrocyte biology, specifically focusing on the characterisation of GFAP, and the 
quantification of GFAP and S100β postive cell density in two stress-sensitive brain 
regions, will be investigated in this thesis to help expand on this relatively new area 
of depression research.  
 
1.2.4.  Neurogenesis and Depression  
 
1.2.4.1.  Adult neurogenesis 
 
Neurogenesis involves the generation of functional neurons from neural precursors, 
and was traditionally believed to occur solely in the embryonic and perinatal stages 
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of development (Koelliker, 1896; His, 1904; Ramon y Cajal, 1928). However, it has 
subsequently been shown to occur throughout the life course in the adult mammalian 
brain, including that of humans (Eriksson et al. 1998; Roy et al. 2000; Wang et al. 
2011; Spalding et al. 2013; Welberg, 2013).  Active neurogenesis occurs in two 
specific neurogenic brain regions, (a) the subventricular zone (SVZ) of the lateral 
ventricles, where new neurons are created and subsequently migrate through the 
rostral migratory stream to the olfactory bulb to become interneurons, and (b) the 
subgranular zone (SGZ) in the dentate gyrus (DG) of the hippocampus where new 
dentate granule cells are generated (Gage, 2000). Although the SVZ is an active 
neurogenic region, the work in this PhD thesis will focus on adult neurogenesis in the 
SGZ of the hippocampus, given that this is the most well described neurogenic niche. 
Therefore, research pertaining to adult hippocampal neurogenesis (AHN) specifically 
will be presented from this point onwards.   
 
1.2.4.2. Stages of adult hippocampal neurogenesis 
 
The SGZ is a small region on the inner boundaries of the granular layer in the DG of 
the hippocampus (see Figure 1.6). It provides a neurogenic microenvironment that 
facilitates the proliferation and differentiation of neural stem cells, and given that it is 
a highly vascularised region, growth factors, such as BDNF and VEGF, can more 
efficiently regulate these processes (Fournier & Duman, 2012). Moreover, in addition 
to neural progenitors and immature neurons, it contains glial progenitors, mature 
astrocytes and microglia, which define neural stem cell fate, and help to further 
regulate neurogenesis (Kempermann, 2010). Thus, AHN is a dynamic, and highly 
regulated process, and one that in adult humans has been shown to occur at a 
relatively high rate of 700 new neurons per day, with a relatively high turnover, where 
a third of all existing neurons are replaced by new ones (Spalding et al. 2013; 
Welberg et al. 2013).  
AHN essentially consists of four stages, as illustrated in Figure 1.6, originating from 
a population of proliferating radial and non-radial glia-like precursor cells, which 
develop into neural progenitor cells (NPCs). NPCs will continue to proliferate and 
develop into neuroblasts or immature neurons (Ehninger & Kempermann, 2008), 
which migrate into the granular cell layer and begin to branch out processes 














Figure 1.6. Stages of adult hippocampal neurogenesis in the subgranular zone of the dentate gyrus 
Quiescent radial glia-like stem cells (referenced as type 1 cells in the top illustration) proliferate into neural progenitor cells (referenced as type 2 cells in the top illustration) within approximately 25 
hours. These cells characteristically express the stem cell markers, GFAP, Nestin and SOX2.  Between four and ten days, neural progenitor cells differentiate into immature neurons, which express 
the early neuronal markers DCX and PSA-NCAM, and later the intermediate neuronal marker TuJ1. During this differentiation phase immature neurons will migrate up into the granular cell layer, 
extend dendrites towards the molecular layer, and project axons through the hilus of the dentate gyrus towards the CA3, which involves tonic activation by GABA. At approximately two weeks, 
immature neurons will develop into mature neurons, which characteristically express the mature granule markers NeuN and Calbindin. During this final stage of maturation, neurons will undergo 
synaptic integration, receiving glutamatergic synaptic inputs from the entorhinal cortex, and generating mossy fibre synaptic outputs to the hilar and CA3 neurons.  
Adapted from Lucassen PJ, et al. (2010). Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: implications for depression and antidepressant 
action. Eur Neuropsychopharmacol. 20: 1–17.
A. 
B. 
CA3, cornu ammonis 3; GCL, granular cell layer; Mol, Molecular layer; GABA, gamma-aminobutyric acid; GFAP, glial fibrillary acidic protein; SOX2, sex determining region Y box 2; DCX, 
doublecortin; PSA-NCAM, polysialic acid-neural cell adhesion molecule; TuJ1, Class III β-tubulin; NeuN, neuronal nuclei; LTP, long term potentiation.   
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neurons will extend dendrites towards the molecular layer and project axons through 
the hilus towards the CA3, until finally maturing into newborn granule cell neurons 
(Zhao et al. 2006; Toni et al. 2007). Finally, after 3-4 weeks, newborn neurons will 
undergo synaptic integration, forming synaptic connections with the fibers from the 
entorhinal cortex (Kempermann, 2010). Throughout neuronal development a variety 
of electrophysiological inputs are typically required, initially involving tonic activation 
of NPCs and neuroblasts by GABA released from neighboring interneurons, followed 
by GABAergic synaptic inputs, and then finally glutamatergic synaptic inputs and 
mossy fibre synaptic outputs to the hilar and CA3 neurons (see Figure 
1.6.A)(Esposito et al. 2005; Ge et al. 2006; Overstreet-Wadiche et al. 2006; 
Bhattacharyya et al. 2008).  
Several intrinsic regulators, including various morphogens, neurotransmitters, 
cytokines and growth factors, tightly control each stage of this lineage progression. 
Together these factors ensure that the levels of proliferation remain appropriate, and 
that differentiation, migration and integration of newborn neurons are accurate and 
efficient (reviewed in Braun & Jessberger, 2014).  Immature neurons require 
approximately two months to reach the full morphological and functional maturity of 
granule neurons, and during this time there are two critical periods of susceptibility, 
where several factors can particularly affect their survival. Specifically, these critical 
windows of susceptibility pertain to (i) the early transition phase from NPC to 
neuroblast, and (ii) the synaptic integration phase (Tashiro et al. 2006; Mouret et al. 
2008; Platel et al. 2010; Sierra et al. 2010). Factors affecting neuronal fate will be 
discussed in subsection 1.2.4.5.  
 
1.2.4.3.  Markers for adult hippocampal neurogenesis 
 
Proliferation of NPCs and their differentiation can be studied with specific markers for 
these cell types. During the four stages of neurogenesis, certain protein markers are 
expressed, which are specific to a particular phase as schematically presented in 
Figure 1.6.B. Endogenous markers that label proliferating NPCs include proteins for 
GFAP, nestin, sex determining region Y box 2 (SOX2) and Ki67. These proteins are 
specifically expressed in proliferating progenitor cells, and are not found in more 
mature neurons (reviewed in Von Bohlen & Halbach, 2007; Lucassen et al. 2010). 
When NPCs exit the cell cycle and develop into immature neurons they 
characteristically express polysialic acid-neural cell adhesion molecule (PSA-NCAM), 
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and doublecortin (DCX), and will no longer express any stem cell markers. As these 
immature neurons continue to develop, at approximately three to four weeks post cell 
cycle exit, DCX and PSA-NCAM will give way to the expression of proteins 
associated with mature granule cells such as, neuronal nuclei (NeuN), microtubulin-
associated protein 2 (MAP2) and calbindin, a calcium-binding protein (reviewed in 
Von Bohlen & Halbach, 2007; Lucassen et al. 2010). Several studies have utilised 
the aforementioned markers to study neurogenesis either as a whole, or at particular 
stages, and in this PhD thesis, markers for Ki67 and DCX were used to study 
proliferative cells and immature neurons, respectively, as will be described in section 
2.5.3.     
 
1.2.4.4.  Functions of adult hippocampal neurogenesis  
 
Adult neurogenesis is considered to have two important functions, cognitive 
processing (Deng et al. 2010), and emotional regulation (Snyder et al. 2011). Indeed, 
several studies demonstrate an association between increased levels of 
neurogenesis and improved performance in hippocampal-dependent learning and 
memory (Nilsson et al. 1997; van Praag et al. 1999). Direct evidence implicating 
neurogenesis in memory and learning comes from studies using transgenesis, which 
is a virus-based strategy to either deplete or selectively enhance neurogenesis. 
These studies have specifically identified a role for AHN in fear conditioning, spatial 
and object recognition, synaptic plasticity and pattern separation  (Saxe et al. 2006; 
Jessberger et al. 2009; Clelland et al. 2009; Sahay et al. 2011; Nakashiba et al. 
2012). 
 
In addition to playing an important role in memory and learning, AHN has been linked 
with emotional regulation, and. also plays an important role in modulating the effects 
of stress, with reduced neurogenesis correlating with increased anxiety-like 
behaviours, and lowered rates of recovery in rodents (e.g., reviewed in Sahay & Hen, 
2007; Murray et al. 2008; Snyder et al. 2011), while conversely, increased AHN can 
promote positive effects on stress responsivity, and reverse behavioural disturbances 
(Spalding et al. 2013; Hill et al. 2015).  
 
1.2.4.4.1. The dorsal-ventral axis functional divide 
 
Interestingly, it has now become widely accepted that the hippocampus is 
functionally heterogeneous along its longitudinal axis, that is, the dorsal (septal pole), 
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and the ventral (temporal pole), hippocampus (reviewed in Kheirbek & Hen, 2011; 
Kheirbek et al. 2013). Lesion studies reveal that the dorsal hippocampus controls 
learning and memory, while the ventral hippocampus regulates emotional processing 
and stress responsivity (Fanselow & Dong, 2010). Anatomical connectivity and gene 
expression analyses corroborate these functional differences (reviewed in Sahay & 
Hen, 2007). Specifically, the dorsal and ventral regions of the hippocampus have 
distinct gene expression profiles, and ones that are similar to other brain regions 
associated with either cognitive or emotional processing, respectively (Leonardo et 
al. 2006). Moreover, connectivity analyses demonstrate how the dorsal hippocampus 
receives projections originating in the lateral and caudomedial portion of the 
entorhinal cortex, whereas the ventral hippocampus receives inputs from the most 
rostromedial part of the same region (Witter et al. 1989; Dolorfo & Amaral, 1998). 
Furthermore, the ventral hippocampus also has reciprocal connections to brain 
structures associated with emotional processing, such as the amygdala and PFC, 
and with structures associated with the HPA axis (Swanson & Cowan, 1977; Jay & 
Witter, 1991; Pitkanen et al. 2000; Thierry et al. 2000). Unsurprisingly, several 
studies have indeed shown how chronic stress preferentially affects the ventral part 
of the hippocampus (Jayatissa et al. 2006; Brummelte & Galea, 2010; Oomen et al. 
2010). Given these functional differences, alterations associated with the ventral 
region of hippocampus may be more closely associated with depression, and 
therefore, in this PhD thesis all analyses pertaining to the hippocampus will be 
stratified by the ventral-dorsal axis as described in subsection 2.5.3.5.1.  
 
1.2.4.5. Factors affecting adult hippocampal neurogenesis: impact of stress 
and inflammation 
 
AHN is not a static process, but rather one that is dynamically regulated by a range 
of intrinsic and extrinsic environmental cues. Positive regulators of AHN include, 
exercise, environmental enrichment, and learning, which all enhance NPC 
proliferation and/or neuronal survival (e.g., Kempermann et al. 1997; Gould et al. 
1999; Nilsson et al. 1999; Van Praag et al. 1999; Alonso et al. 2006). Conversely, 
negative regulators, which reduce proliferation and/or survival, can include stress, 
inflammation, high fat diet, age, and alcohol abuse, to name but a few (e.g., Gould et 
al. 1992; 1998; Alonso et al. 2004; Galvan & Jin, 2007; Park et al. 2010; Belarbi et al. 
2012; Wu et al. 2012; Geil et al. 2014). Although a range of factors can alter 
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neurogenesis, the focus of this thesis pertains to stress and inflammation. As such, 
this subsection will describe the effects that these two factors have on AHN.  
 
1.2.4.5.1.  Inflammation and neurogenesis  
 
1.2.4.5.1.1. The role of microglia and astrocytes in neurogenesis under non-
pathological conditions 
 
Microglia and astrocytes are important regulators of neurogenesis. They each 
perform multiple functions (see subsections 1.2.3.1.1 and 1.2.3.2.1), many of which 
contribute to the maintenance and regulation of proliferation and/or newborn neuron 
survival. For example, ramified microglia perform two neurogenesis-specific 
functions. First, they are responsible for the pruning of newborn neurons during the 
first critical phase of survival (Sierra et al. 2010). Essentially, as newborn cells 
become integrated into the existing circuitry, other cells become apoptotic. Ramified 
microglia, subsequently phagocytise these apoptotic cells via an immunologically 
silent process, that is, without inducing inflammation. Moreover, they may even play 
an important role in regulating synaptogenesis in the adult DG, having previously 
been shown to contribute to synaptic pruning by actively engulfing synaptic 
components (Paolicelli et al. 2011; reviewed in Hong et al. 2016). Second, they can 
directly influence proliferation, differentiation and survival (reviewed in Gemma & 
Bachstetter, 2013). Indeed, some evidence shows that microglia can release growth 
factors, such as insulin-like growth factor (IGF-1), which typically promotes 
neurogenesis via a chemokine fractalkine receptor (CX3CR1) dependent mechanism 
(Ziv & Schwartz, 2008; Vukovic et al. 2012). Therefore, under non-pathological 
conditions microglia perform a central role in regulating proliferation, and/or survival 
of newborn neurons, and moreover help to maintain synaptic plasticity.  
Astrocytes likewise, play a central role in regulating neurogenesis, by releasing 
several key factors known to stimulate and promote differentiation and/or survival. 
For example, astrocytes can release BDNF, VEGF and IGF-1 all of which promote 
neurogenesis (Mu et al. 2010; Waterhouse et al. 2012; Fournier & Duman, 2012). 
They also actively regulate glutamate metabolism, and glutamatergic input plays a 
key role in the differentiation and survival of newborn neurons (Tashiro et al. 2006). 
Moreover, astrocytes can also encourage differentiation by promoting canonical Wnt 
signalling through the release of Wnt3, which subsequently upregulates the 
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expression of NeuroD1, an important transcription factor involved in neuronal 
differentiation (Lie et al. 2005; Kuwabara et al. 2009). Therefore, astrocytes, like 
microglia, play a central role in neurogenesis, predominately through facilitating 
and/or promoting differentiation and/or survival. However, under pathological 
conditions, which can lead to microglial activation, and astrocyte functional 
impairment (see subsection 1.2.3), neurogenesis can become diminished. 
 
1.2.4.5.1.2.  Pathological effects of inflammation 
 
Evidence for the direct effect of (neuro)inflammation on neurogenesis comes from 
LPS-based animal research which shows a significant decrease in AHN in response 
to immune activation, and increased inflammation (Ekdahl et al. 2003; Monje et al. 
2003; Fujioka & Akema, 2010; Ekdahl et al. 2012; Ormerod et al. 2013; Graciarena 
et al. 2013; Valero et al. 2014). Specifically, a recent study demonstrated how LPS 
exposure increased in the number of microglial/macrophage cells, while decreasing 
the number of immature neurons in the hippocampus (Valero et al. 2014). Moreover, 
evidence to support a more causal role of activated microglia in impaired 
neurogenesis comes from earlier work showing how LPS-induced reductions in 
neurogenesis can be subsequently rescued by inhibiting microglia activation through 
the administration of minocycline (Ekdahl et al. 2003; Monje et al. 2003).  
 
Additional evidence to support an anti-neurogenic role for microglia and astrocytes is 
shown by studies measuring the effect of inflammatory cytokines on AHN.  
Specifically, several studies have demonstrated how the overexpression of IL-6 and 
IL-1β in the brain, and the systemic administration of TNF-α, can reduce 
neurogenesis in the hippocampus (Vallières et al. 2002; Seguin et al. 2009; Wu et al. 
2012). Both microglia and astrocytes can release these pro-inflammatory cytokines 
under pathological conditions, which suggests that they may be important mediators 
between neuroinflammation and neurogenesis (reviewed in Borsini et al. 2015). 
Similarly, increased levels of cytotoxic molecules, such as reactive oxygen species, 
have likewise been shown to decrease AHN (reviewed in Maes et al. 2009), and 
thus, may represent yet another mediator between neuroinflammation and 
neurogenesis. As described in subsection 1.2.2.4.3, activated microglia actively 
release these molecules in response to pathological stimuli.  
 
Alternatively, the release of pro-neurogenic factors such as, BDNF and VEGF from 
microglia and astrocytes under normal physiological conditions can become inhibited 
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in response to pathological stimuli (see subsections 1.2.2.4.3 and 1.2.3). Thus, the 
inhibition of important intrinsic regulators of neurogenesis could account for 
decreased proliferation and/or survival of newborn neurons in response to increased 
inflammation.   
 
Moreover, in addition to reducing proliferation and differentiation of newborn neurons, 
activated microglia can also significantly alter dendritic remodelling.  Several studies 
demonstrate how microglial activation can induce dendritic destabilisation and result 
in neuronal dendritic atrophy (e.g., Kondo et al. 2011; Milior et al. 2015). This has 
been shown to occur through the increased phagocytic activity of microglial cells, in 
response to pathological stimuli, which can result in the subsequent reduction in the 
number of axon terminals and dendritic spines (Milior et al. 2015).  
 
In summation, under normal physiological conditions microglia and astrocytes play a 
central role in the regulation of AHN. However, under pathological conditions, such 
as chronic stress exposure or immune activation, these glia cells can undergo 
functional and morphological alterations (see subsection 1.2.3), which can 
subsequently reduce neurogenesis in the hippocampus, or impair dendritic 
remodelling, and thus, ultimately impact neural plasticity and hippocampal 
functioning.   
 
1.2.4.5.2.  Stress and neurogenesis  
 
Stress is an extrinsic factor that can also regulate AHN, and indeed multiple lines of 
evidence chronicle how both acute and chronic stress exposure can significantly 
reduce cell proliferation, differentiation, and the survival of newborn neurons in the 
hippocampus of shrews and rodents (Gould et al. 1992; 1997; 1998; Czeh et al. 
2001; Malberg & Duman, 2003; Mineur et al. 2007; Ferragud et al. 2010; Surget et al. 
2011). However, in addition to the anti-neurogenic effects of stress, it can also 
deteriorate the dendritic morphology, and dendritic spine density of mature neurons 
in various brain regions, including the hippocampus, prefrontal cortex, nucleus 
accumbens, and amygdala (Sousa et al. 2000; Liston et al. 2006; Bessa et al. 2009; 
Hains et al. 2009; Yuen et al. 2012; Qiao et al. 2016). For example, Sousa and 
colleagues (2000) demonstrate how chronic stress exposure alters the dendritic 
morphology of hippocampal pyramidal neurons, significantly reducing dendritic length 
and branching complexity. More recently, additional studies have shown how chronic 
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stress can selectively decrease immature neurons with a more complex dendritic 
arborisation (Lussier et al. 2013), an outcome of which is also significantly associated 
with increased corticosterone levels (Vega-Rivera et al. 2016). Together this 
research highlights the capability of chronic stress to significantly impair dendritic 
remodelling, which together with its ability to reduce AHN can have important 
implications for neural plasticity.  
 
1.2.4.6.  Adult hippocampal neurogenesis and depression  
 
It has become consensus that AHN is a necessary requirement for therapeutic 
antidepressant action (Santarelli et al. 2003; Jiang et al. 2005; Esposito et al. 2005; 
Ngwenya et al. 2006; Surget et al. 2008; David et al. 2009; Perera et al. 2011). This, 
together with the observation that most antidepressants and environmental factors 
that bestow antidepressant-like effects stimulate AHN (van Praag et al. 1999; 
Malberg et al. 2000; Madsen et al. 2000; Perera et al. 2007), it is thus unsurprising 
that neurogenesis has become a focal point in depression research.  
 
1.2.4.6.1.  Clinical evidence for the involvement of neurogenesis in depression 
 
To date, direct clinical evidence for the role of AHN in depression comes from 
postmortem studies. However the findings from these studies have been 
inconsistent, with some demonstrating a decreased level of neurogenesis in patients 
with depression (Boldrini et al. 2009; 2012; Lucassen et al. 2010), others reporting no 
difference (Reif et al. 2006), and even one reporting an increase in AHN in young 
women with depression (Epp et al. 2013).  However, while the direct clinical evidence 
to date may be inconclusive, there is some indirect evidence to support the 
involvement of neurogenesis in clinical depression. For example, an increased 
prevalence of depression has been observed for cancer patients, which has been 
attributed to altered neurogenesis as a consequence of their treatment with anti-
proliferative cytotoxic drugs (Dias et al. 2014; Yang & Moon, 2015). Furthermore, two 
studies focusing on pattern separation, an important function attributed to AHN, have 
demonstrated a negative association between pattern separation and depressive 
symptomology (Déry et al. 2013; Shelton & Kirwan, 2013), providing further evidence 
to support the contribution of neurogenesis in depression aetiology. Although some 
clinical evidence exists to support the association between neurogenesis and 
depression, their temporal relationship remains to be elucidated.  Until more direct 
methods of assessing neurogenesis in humans becomes available the field will 
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continue to rely on preclinical animals studies to ascertain whether neurogenesis has 
a more causal role in the development of depression.  
 
1.2.4.6.2. Preclinical evidence for the involvement of neurogenesis in 
depression 
 
The causal role of neurogenesis decline on the development of depression has been 
called into question with the advent of multiple studies showing how the ablation of 
neurogenesis, either by irradiation or though genetic modification, does not induce 
depressive-like behaviour in rodents (Santarelli et al. 2003; Bessa et al. 2009; David 
et al. 2009; Surget et al. 2008; 2011; Snyder et al. 2011). However, while most of 
these studies support that reduced AHN is insufficient to promote a depressive-like 
phenotype, two studies demonstrate how it may account for certain depressive 
symptoms. Specifically, rodents with reduced AHN were shown to exhibit increased 
anxiety-like behaviour in the novelty suppressed feeding task (see subsections 1.3.2 
and 2.3.2.3.1.2), but had no other behavioural alterations (Bessa et al. 2009; David 
et al. 2009). Thus, although reduced AHN was insufficient to elicit a full spectrum of 
depressive-like symptoms in these studies, nonetheless, it may be important for 
specific facets of the disorder.   
 
Interestingly, while it is clear that a reduction in neurogenesis is unable to 
independently induce a depressive-like phenotype in rodents, all aforementioned 
studies have demonstrated how in the presence of stress this no longer applies. 
Thus, stress appears to be an important mediator between neurogenesis and 
depression, and it is generally thought that neurogenesis may precipitate depressive-
like symptoms by impairing stress modulation (reviewed in Petrik et al. 2012). For 
example, Snyder and colleagues (2011), using a transgenic mouse model of reduced 
hippocampal neurogenesis, demonstrated how reduced AHN alone was unable to 
elicit behavioural alterations. However, in the presence of chronic restraint stress, 
reduced neurogenesis accelerated the rate of depressive-like symptom onset, while 
stressed animals with intact neurogenesis took significantly longer to develop 
anxiety- and depressive-like behaviours (Snyder et al. 2011). Therefore, the 
combination of reduced neurogenesis and stress exposure may be important for the 
development of depression, with reduced neurogenesis exacerbating the effects of 
chronic stress. In fact, further evidence chronicling the synergistic role of 
neurogenesis and stress, comes from a recent study by Hill and colleagues (2015), 
who show how increased neurogenesis can significantly reduce anxiety and 
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depressive-like behaviour induced by chronic glucocorticoid administration (Hill et al. 
2015).   
 
Although stress appears to be an important mediator between neurogenesis and 
depression, the relationship is somewhat more complicated given that neurogenesis 
can modulate the effects of chronic stress, as shown by Surget and colleagues 
(2008; 2011). In their research, the authors demonstrate how the antidepressant 
action of neurogenesis may relate to HPA axis suppression, based on several 
important findings. First, the authors show how neurogenesis ablation, through 
irradiation, does not elicit depressive-like behaviour, but does prevent the therapeutic 
action of antidepressant treatment on stress-induced depressive-like behaviour, and 
in reverting HPA axis dysregulation. Second, they also show how administration of 
SSR125543, a corticotrophin-releasing factor 1 receptor antagonist, which 
subsequently inhibits HPA axis activity, was able to prevent depressive-like 
behaviour in neurogenesis-ablated mice. These findings have several important 
implications. They corroborate that neurogenesis alone is unable to contribute to the 
development of depression, but that it is required for effective antidepressant action, 
not only for behaviour, but also for correcting HPA axis dysregulation. Moreover, 
these studies highlight how HPA axis suppression may be the mechanism by which 
neurogenesis facilitates therapeutic antidepressant action, given how SSR125543 
did not require neurogenesis to exert any therapeutic effect (Surget et al. 2008; 
2011).  
 
Based on the preclinical evidence, it is clear that neurogenesis plays an important 
role in stress-induced depression. However, the relationship between stress and 
neurogenesis is a particularly complicated one. Further understanding of this 
synergistic relationship will ultimately help to clarify the role that these two systems 
play in the pathogenesis of depression. Indeed, understanding how different types of 
chronic stress may alter AHN, with respect to neuronal cell, proliferation and 
differentiation, is one of the key objectives of this PhD thesis, which will help to 
further our understanding on the relationship between AHN and stress-induced 
depression.  
 
1.2.5.  Cross talk between the biological systems 
 
Despite the wealth of research chronicling the independent effects of the HPA axis, 
immune system, and neurogenesis on the development of clinical depression, it is 
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the synergistic interaction between these systems, in addition to others that are 
beyond the scope of this thesis, that is thought to play a vital role in MDD 
vulnerability, onset and disease progression.  
 
Cytokines interact with almost every system and process thought to be involved in 
MDD, and in particular the HPA axis and neurogenesis. As aforementioned, 
dysregulation of the immune system and the HPA axis have been independently and 
strongly implicated in the pathogenesis of MDD. However, communication between 
the HPA axis and the immune system exists and moreover, it is bidirectional. 
Research shows how acute administration of pro-inflammatory cytokines can 
stimulate and regulate the production and release of ACTH and cortisol (Pace et al. 
2007; Nanus et al. 2013), while chronic administration can flatten the diurnal curve of 
cortisol release, a consequence of glucocorticoid resistance (Raison et al. 2010). 
Pro-inflammatory cytokines can even alter GR function by either inhibiting GR 
translocation to the nucleus (Engler et al. 2008), or disrupting GR-DNA binding (Hu 
et al. 2009). However, by the same token, stress can influence immune system 
functioning as discussed in subsection 1.2.2.4. Chronic activation of the stress 
response, known to result in the chronic production of glucocorticoid hormones, can 
dysregulate the immune system by altering microglial and astrocyte cell morphology 
and functioning, and by interfering with NF-κB functioning, which is a key regulator in 
the activity of cytokine-producing immune cells (Maier & Watkins, 1998; Padgett & 
Glaser, 2003; Ziemssen & Kern, 2007). Moreover, chronic stress in childhood has 
also be shown to program a pro-inflammatory phenotype, with newborns, children 
and adolescents exposed to stressful environments exhibiting larger inflammatory 
responses to microbial challenge in later life, suggesting a priming or sensitisation 
effect of stress on immune functioning (Miller et al. 2009; Miller & Chen, 2010; 
Wright, 2010). Therefore, it seems fundamental to investigate the synergistic effects 
of both HPA axis reactivity, and immune system functioning in the aetiology of MDD.  
Interestingly, research has also implicated a role for AHN in the pathogenesis and 
progression of depression. Although most studies do not support a causal role for 
impaired neurogenesis in depression neurobiology, the majority of studies do confirm 
the requirement of hippocampal neurogenesis for therapeutic antidepressant action 
(Santarelli et al. 2003; Tanti & Belzung, 2013; Petrik et al. 2012). Moreover, both 
stress and inflammation, which may have a causal role in the development of 
depression, at least for a subset of patients, can significantly alter AHN. Specifically, 
elevated glucocorticoid levels can inhibit neurogenesis, and reduce neuronal growth 
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in the hippocampus, in addition to reducing the size and complexity of the dendritic 
arborisation of neurons (Alonso et al. 2004; Mineur et al. 2007; Schoenfeld & Gould, 
2013). Similarly, increased inflammation, specifically with respect to IL-6, TNF-α and 
IL-1β, and altered microglia and astrocyte functioning can also reduce cell 
proliferation and neuronal differentiation in the hippocampus, and alter dendritic 
remodelling (Vallières et al. 2002; Seguin et al. 2009; Wu et al. 2012). These lines of 
evidence support the involvement of neurogenesis in depression pathology, and 
given the importance of hippocampal neurogenesis in the success of antidepressant 
therapy, it seems essential to explore the role of neurogenesis in combination with 
immune system activation, and chronic stress exposure to further elucidate the role 
of each in the pathogenesis of clinical depression, which forms the basis of this 
thesis.  
 
1.3.  Animal Models of Depression 
 
Animal models play a central role in the scientific investigation of behaviour, and of 
the underlying substrates and mechanisms controlling normal and pathological 
behaviour (reviewed in Abelaira et al. 2013; Kaiser & Feng, 2015; Monteggia, 2016). 
Their purpose is two-fold; to enhance understanding of disease pathology in order to 
identify new targets, pathways and mechanisms of drug action, or to assess the 
effects and associated risks of putative anti-degenerative, neuroprotective, and/or 
cognition-enhancing compounds or treatments (reviewed in Abelaira et al. 2013). 
Ultimately, the aim of which is to translate insights into the pathology and treatment 
of disease from a preclinical setting to that of a clinical one, and/or vice-a-versa 
(reviewed in Abelaira et al. 2013; Kaiser & Feng, 2015; Monteggia, 2016).  
 
Essentially, they typically involve two main elements, (a) an input, a procedure used 
to elicit a change in behaviour, and (b) an output, a behavioural and/or 
neurobiological endpoint used to measure the effect of the input (Willner & Belzung, 
2015). Both the output and input(s) used in each animal model need to be sufficiently 
valid as defined by the three main concepts of validity, that is, predictive, face and 
construct validity (Willner, 1984).  
 
Briefly, predictive validity reflects the accuracy by which the test can predict the 
response found in humans based on the responses from the animal model, and/or 
the ability of a drug screening or animal model to correctly identify the efficacy of a 
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putative therapeutic (Wilner, 1984; Wright, 2002).  Face validity represents the 
degree of similarity between the behaviour(s) exhibited by the animal model and the 
specific symptoms of the human condition, while construct validity refers to the 
degree of similarity between the mechanisms underlying behaviour(s) in the model 
and those underlying the behaviour(s) of the condition being modelled (Wilner, 1984; 
Epstein et al. 2006). Throughout subsection 1.3.3, the validity of each of the 
presented chronic stress models of depression will be evaluated in the context of 
these three principles, which is the basis for which the various chronic stress models 
were selected for use in this PhD thesis.  
 
1.3.1.  Animal models of depression: types of input 
 
The type of input can be in the form of either an internal or external environment 
manipulation. Inputs in the form of an internal environment manipulation represent 
those that either permanently or temporarily alter at least one biological system 
within the rodent. Genetic based models, models of vulnerability through selective 
breeding, or injuries that alter a specific internal biological system, represent inputs of 
permanent change, while temporary manipulations are typically achieved through the 
administration of a chemical agent known to transiently alter a particular biological 
system (reviewed in  van der Staay et al. 2009; Abelaira et al. 2013; Czeh et al. 
2016).   
 
However, given that there are many environmental risk factors for clinical depression, 
most of which are stress based (see subsection 1.1.3.2), a plethora of animal models 
have been developed to essentially simulate these risk factors. Thus, inputs 
characterized as external environment manipulations typically involve exposure to 
stressful environmental stimuli. Over the years, environmental and psychosocial 
stress exposures, in various forms and across various life stages, have been utilised 
in many animal models of depression, ranging from maternal deprivation through to 
restraint stress models (reviewed in van der Staay et al. 2009; Abelaira et al. 2013; 
Czeh et al. 2016). Given that this PhD thesis examines the effect of chronic stress 
exposure in adulthood on the development of depressive-like behaviour and 
associated neuropathological changes, the various existing adult stress models of 




1.3.2.  Animal models of depression: types of output 
 
The behavioural and neurobiological changes induced by the input are the outputs of 
an animal model of depression, and various assays are used to measure them. A 
valid animal model of depression will have both behavioural and neurophysiological 
outputs. Table 1.2 summarizes the main outputs used in animal models of 
depression, and the various assays used to assess them.  
 
1.3.2.1.  Main behavioural outputs  
 
As highlighted in Table 1.2, several behavioural outputs exist, all of which are 
thought to be analogous to a specific symptom, or feature of clinical depression. 
Some animal models may use a single behavioural output to assess the effect(s) of 
the input used, but this limits face and construct validity, given that clinical 
depression has multiple associated symptoms (see subsection 1.1.1). To overcome 
this, most animal models of depression will use behavioural batteries, evaluating 
multiple domains of behaviour, and thus, providing a more informative assessment.  
The most commonly used behavioural assays measure either anxiety- or depressive-
like behaviour in rodents, and are highlighted in bold within Table 1.2. Most of these 
highlighted assays will be used in this thesis, and as such their validity will be 
discussed in the Discussion in section 4.4. 
 
1.3.2.1.1.  Measuring depressive-like behaviour 
 
Depressive-like behaviour is most typically represented by increased anhedonic-like 
behaviour, as measured in the sucrose preference test (SPT), or by increased 
behavioural despair in the forced swim test (FST) and/or tail suspension test (TST). 
Therefore, by today’s standards, a reliable depressive-like phenotype is 
characterised as one with increased anhedonic-like behaviour, in addition to several 
other behavioral perturbations, which could include changes as seen in the FST 
and/or TST. The SPT is based on the notion that a healthy rodent will choose to drink 
sucrose solutions over water (Berridge, 2007), due to the stimulating effect that 
sucrose has on the dopamine system, and its subsequently rewarding properties 
(e.g., Hajnal & Norgren, 2001; 2004; Cannon & Palmiter, 2003; Marella et al. 2012). 
However, when a rodent is stressed it will show a decreased sucrose preference, 
displaying diminished sensitivity to reward (Willner, 1987), which can be reversed by  
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Table 1.2. Animal model of depression output parameters: Symptoms and potential 
biomarkers associated with clinical depression and the corresponding behavioural 
and physiological measures in experimental models 
 
Clinical features of Depression  
 
Related behavioural and 
physiological phenotypes in 
experimental animals 
 
Assays used to measure 
behavioural phenotypes and 
methods used to assess 
physiological change 
 
DSM-V diagnostic criteria   
Depressed Mood 
Diminished interest or pleasure in 
all/almost all activities 
Anhedonic-like behaviour Sucrose Preference Test, 
Intracranial Stimulation, Female Urine 
sniffing, Conditional Place Preference 
 
Weight loss or gain Weight loss or gain Body weight measurements 
Insomnia or hypersomnia Altered diurnal rhythm Measuring diurnal activity, Homecage 
activity  
 
Psychomotor agitation or 
retardation 
Altered locomotor activity Open Field Test, Homecage activity, 
Treadmill running 
 
Fatigue or loss of energy Behavioural despair or altered 
locomotor activity 
Forced Swim Test, Tail Suspension 
Test, Homecage activity, Treadmill 
running 
 
Feelings of worthlessness or 
inappropriate guilt 
 
No phenotype equivalent in animals 
 
Not applicable 
Diminished ability to think or 
concentrate 
Cognitive deficits Morris Water Maze, Y-maze, Novel 
Objection Recognition Test, Modified 
Holeboard 
 
Recurrent thoughts or death or 
suicide 
No phenotype equivalent in animals Not applicable 
Additional typical symptoms or comorbidities  
 




Open Field Test, Novelty 
Suppressed Feeding Test, Elevated 
Plus Maze, Light-Dark Box Test, 
Marble Burying Test 
 
Altered social functioning 
Anger or irritability 
Altered social functioning Social Interaction Test, Three 
Chambers Test, Resident Intruder 
Test 
 
Altered (poor) self care Self maintenance, grooming deficits Coat state, Splash Test, Nest building 
Potential biomarkers of depression  
 
Dysregulation of the HPA axis 
 
Altered HPA-axis activity 
 
Corticosterone levels 
Dexamethasone Suppression Test 
 
Altered immune functioning Markers for inflammation Pro-inflammatory cytokines IL1β, IL6, 
TNFα, IFNγ  
 
DSM-V: Diagnostic and Statistical Manual of Mental Disorders; HPA: hypothalamic-pituitary adrenal; IL1β: 
interleukin-1β, IL6: interleukin-6, TNF-α: tumour necrosis factor-α, IFNγ: interferon-γ 
 
Note: Assays highlighted in bold represent the most commonly used of all the assays. Further detail on some of 
these assays, and their validity in depression research is discussed in subsection 1.3.2.1, and throughout subsection 
1.3.3. 
 
Adapted from Czeh B, et al. (2016). Animal models of major depression and their clinical implications. Prog 
Neuropsychopharmacol Biol Psychiatry. 64: 293-310. 
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chronic administration of various antidepressants (reviewed in Powell et al. 2012).  
As such, the SPT is thought to be a simple measure of anhedonia in rodents. 
 
As aforementioned, the FST and TST are interpreted to measure behavioural despair 
or learned helplessness in animals subjected to an inescapable highly stressful 
situation, such as forced swimming in a cylinder, or tail suspension (FST and TST, 
respectively). In such contexts, animals will initially demonstrate escape-orientated 
behaviours, followed by an immobile posture, thought to represent a sense of “giving 
up” (Porsolt et al. 1977; 1978), which, similarly to the SPT, is reversed by 
administration of multiple antidepressant drugs (reviewed in Powell et al. 2012). 
 
1.3.2.1.2.   Measuring anxiety-like behaviour 
 
Three main behavioural assays are typically used to characterise anxiety-like 
behaviours. These include the open field test (OFT) (Gould, 2009), the elevated plus 
maze (EPM) (Pellow et al. 1985), and the novelty suppressed feeding test (NSFT) 
(Britton & Britton, 1981).  Essentially, the premise for all three assays is based on the 
approach/avoidance paradigm, which is the conflict an animal experiences between 
anxiety and reward. All assays are thought to capture this conflict between exploring 
a new environment (OFT/EPM), or approaching and consuming a desirable food 
(NSFT), and avoiding open potentially harmful spaces. For each test, anxiety-like 
behaviour is measured by the time it takes, and/or the amount of time an animal will 
spend in the open parts of the arena. Specifically, increased latency to feed, 
decreased time spent in the centre zone, and decreased time spent in the open 
arms, all represent increased anxiety-like behaviour in the NSFT, OFT and EPM, 
respectively.  For all assays, as with those pertaining to the assessment of 
depressive-like behaviours, a variety of antidepressant treatments are successful in 
reversing anxiety-like behaviour (e.g., Dulawa et al. 2004; Bondi et al. 2008; NSFT 
reviewed in Powell et al. 2012).  
 
1.3.3.  Chronic stress models of depression 
 
Clinical depression is characterized as a chronic disorder, one not likely triggered by 
a single acute event (see 1.1). Therefore, models of stress have become chronic in 
nature to increase translational value. Based on the chronicity of clinical depression, 
likely induced by multiple chronic exposures, this PhD thesis will utilise chronic stress 
exposure to elicit aberrant behaviour and associated neuropathology. Thus, models 
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of chronic, not acute, stress will be reviewed in subsequent subsections.  
 
Chronic stress models of depression vary both in their degree of chronicity and 
severity, the type of stress exposure, and when during the life course they are 
applied. Essentially, the type of exposure can broadly be classified as either physical 
or psychosocial in nature, while the application of stress pertains to either early life 
(in utero through to adulthood) or later life (adulthood).  Given that this PhD thesis 
focuses on stress exposure in adulthood, models incorporating exposure in early life 
will not be discussed.   
 
Moreover, since one of the main objectives of this thesis will be to investigate the 
impact of different types of chronic stress on behaviour and physiology, subsequent 
subsections on the most commonly used chronic stress models will be categorized 
according to the type of stress they embody. For each category type, the stress 
models currently utilised will be presented, and for each model, the associated 
behavioural and physiological changes will be described, and their validity as models 
evaluated. However, given that thesis is particularly interested in the involvement of 
the stress, immune, and neurogenic systems in depression aetiology (see section 
1.2), most of the induced neurobiological alterations described, for each stress 
model, will predominately pertain to these three biological systems.   
 
Finally, as this thesis will use a mouse model of depression, and while several stress 
studies in other species, e.g., prairie voles (Grippo et al. 2007; 2008; 2009; 2010; 
2011; 2014) tree shrews (Kramer et al. 1999; Kohlhause et al. 2011), lizards 
(Summers et al. 2003), pigs (van der Staay et al. 2010) and primates (Willard & 
Shively, 2012; Shively & Willard, 2012), have provided evidence for inter-species 
constants, and helped gather crucial information on the pathogenesis of stress-
induced depression, only research generated from mouse and rat models will be 
presented.  
 
1.3.3.1.   Physical stress exposure  
 
1.3.3.1.1.  Restraint stress 
 
Repeated restraint stress typically involves securing animals in a well-ventilated 
restraint tube for a specified period of time, generally on a daily basis, and repeatedly 
for several days or weeks (reviewed in Buynitsky & Mostofsky, 2009). It is an 
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especially attractive method for stressing animals given its cost effectiveness, ease 
of application, and it rarely, if ever, results in bodily harm. In essence, it is particularly 
useful for ensuring that any long-term associated behavioural and/or physiological 
aberrations are due to the stressor itself, and not as a consequence of any 
secondary induced chronic injury.  
 
However, despite its obvious advantages, it presents with inconsistent findings within 
the field of depression research, and its ability to reliably produce behaviours 
associated with the disorder has been called into question. For example, behavioural 
results from multiple studies range from reports of an increased effect (Sandi et al. 
2001; Wood et al. 2003; Svegi et al. 2006; Bravo et al. 2009; Joo et al. 2009; 
Regenthal et al. 2009; Veena et al. 2009a;b), to no effect (Perrot-Sinal et al. 2004; 
Gregus et al. 2005; Lussier et al. 2009), and to even a decreased effect (Platt & 
Stone, 1982; Dunn & Swiergiel, 2008) of repeated restraint stress on anxiety- and/or 
depressive-like behaviours. However, the restraint model has more consistently 
shown stress-induced atrophy of specific brain regions, and increased cognitive 
impairment in stressed animals (Beck & Luine, 2002; Bowman et al. 2003; Pham et 
al. 2003; Vyas et al. 2002; Kleen et al. 2006).  
 
With respect to the neurobiological changes associated with repeated restraint, the 
available literature, although limited, is relatively inconsistent. Specifically, some 
studies report increased levels of corticosterone as a consequence of repeated 
restraint (Pitmann et al. 1988; Gameiro et al. 2006; Chiba et al. 2012; Yang et al. 
2014), while others report no such differences (Inoue et al. 1993; Rogers et al. 2004; 
Liu et al. 2013). Moreover, while Hashikawa and colleagues (2015) showed 
decreased proliferation in the dentate gyrus of the hippocampus, Nacher and 
colleagues (2004) report increased neuroblast and neuron cell density (Nacher et al. 
2004; Hashikawa et al. 2015). However, it is important to note that the number of 
studies investigating the physiological changes associated with depression is fairly 
limited, making it difficult to formulate any conclusions. This is partly because the 
chronic restraint stress model has only gained momentum in more recent years. In 
the past, restraint stress has predominately been used as an acute stress exposure, 
with research facilities favouring other stress models to examine the effect of chronic 
stress.  
 
The aforementioned behavioural and physiological inconsistencies likely arise from 
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differences in (a) methodology, and (b) in the gender, strain or species used, which 
can impact response to stress treatment. The duration of stress exposure, in terms of 
frequency and length of restraint, can have important implications on the data 
obtained. For example, Munhoz and colleagues (2004) report increased inflammation 
in stressed animals, but only beyond a certain level of chronicity, emphasizing the 
importance that the length of exposure can have on, at least, biological readouts 
(Munhoz et al. 2004). Moreover, the severity of restraint could also contribute to 
some of these inconsistencies, with some protocols completely limiting limb 
movement, and others merely restricting the range of locomotion (reviewed in 
Buynitsky & Mostofsky, 2009).  
 
Consistencies aside, one of the main reasons the use of other types of chronic stress 
models have been preferred is due to the limited construct validity afforded by 
repeated restraint stress. It is a single stressor, and one that is not ethologically 
relevant to the human experience. Moreover, the human experience of stress 
incorporates exposure to multiple stressors, and for this reason the use of a single, 
repeatable stress limits the validity of such a model. In addition, repeated stress 
exposure is known to induce habituation (Galea et al. 1997; Gregus et al. 2005; 
Grissom et al. 2008), which can essentially diminish behavioural outcome (Girotti et 
al. 2006). Indeed, this could partially explain why conflicting behavioural results have 
been reported in the context of repeated restraint, and why some studies report no 
change in corticosterone. Finally, one of the largest problems associated with 
experimenter-applied stress, such as restraint stress, is that it offers no control over 
individual differences in responsivity to stress. The biological response to stress can 
differ dramatically based on one’s perception of that stress, meaning that the same 
stressor can elicit a different biological response in two different individuals. This has 
implications for most stress models of depression, which cannot control the 
inevitability that differing corticosterone levels are likely to arise between different 
animals exposed to the same stressor. Consequently, this effect increases 
experimental variability. In an attempt to gain more control over an animal’s response 
to stress, the corticosterone model of depression was developed.  
 
1.3.3.1.2.   Corticosterone exposure 
 
Models of corticosterone exposure offer a distinct advantage over other stress 
models because they enable the direct examination of the impact of glucocorticoids 
on the development of depressive-like behaviour, and the associated physiological 
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changes (Sterner & Kalynchuk, 2010). It remains the only stress model described in 
this subsection that is a drug exposure manipulation, and one that directly alters the 
stress system through the administration of exogenous corticosterone. Furthermore, 
it is the only stress model to allow for more stringent control over corticosterone 
levels, and one that is not influenced by habituation or individual differences to stress 
experience. Generally, exposure to corticosterone lasts from weeks to months, and is 
administered via one of four ways, (i) injection, most typically subcutaneous, (ii) pellet 
implantation, (iii) osmotic pump infusion, or (iv) passively through drinking water or 
food.  
 
A large body of evidence supports that the corticosterone model is a valid model of 
depression, one that produces reliable and robust changes in a variety of behaviours 
considered to be analogues of symptoms related to clinical depression. Specifically, 
rodents chronically administered corticosterone show both increased anxiety- and 
depressive-like behaviours, inhibited sexual behaviour, and altered spatial learning 
and executive functioning (Lupien & McEwen, 1997; Gorzalka & Hanson, 1998; 
Sapolsky, 2000; Gorzalka et al. 2001; 2003; Gregus et al. 2005; Skorzewska et al. 
2006; Brummelte et al. 2006; Gourley et al. 2008; Pego et al. 2008; Murray et al. 
2008; David et al. 2009; Marks et al. 2009; Zhang et al. 2015). Moreover, many of 
these behavioural changes can be reversed with chronic antidepressant treatment 
(Ago et al. 2008; David et al. 2009), further highlighting the predictive validity of this 
stress model.  
 
Furthermore, corticosterone administration results in a variety of neuropathological 
changes associated with depression, including dysregulation of the HPA axis 
(Johnson et al. 2006), decreased adrenal weight (Bush et al. 2003; Murray et al. 
2008), and even reduced neurogenesis, with reductions in proliferation and survival 
of newborn neurons being documented in several studies (Sapolsky et al. 1985; 
Fuchs & Gould, 2000; Huang & Herbert, 2006; Murray et al. 2008; Alahmed & 
Herbert, 2008; David et al. 2009). Additionally, glucocorticoid exposure has shown 
impairment in both cAMP response element-binding protein (CREB) and BDNF-
mediated signalling in various brain regions (Jacobsen & Mork, 2006; Gourley et al. 
2008), a similar impairment of which has been seen in patients with depression 
(Karege et al. 2002; 2005; Shimizu et al. 2003; Sen et al. 2008). 
 
Although the validity of the corticosterone exposure model is well regarded, primarily 
due to the multiple behavioural and physiological changes associated with 
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depression that it consistently emulates, it has two main limitations that impact its 
validity. First, like restraint stress, it is not an ethologically relevant model of 
depression, and does not realistically reflect the human experience of encountering 
stress in daily life. Moreover, the dosage of corticosterone required to induce a 
depressive phenotype is supraphysiological (Johnson et al. 2006), which limits its 
construct validity. Second, it comes with some methodological considerations, 
namely the route of administration, which can profoundly impact behavioural and 
physiological outcomes as recently shown by Kott and colleagues (2016).  
 
Kott and colleagues (2016) demonstrated how the way corticosterone was 
administrated could differentially alter behavioural outcomes, for example, in the 
FST.  Specifically, they found that animals injected with corticosterone showed 
increased immobility, animals with an implanted pellet showed no behavioural 
change, while those receiving corticosterone passively, via drinking water, presented 
with decreased immobility (Kott et al. 2016). These findings could potentially be 
explained by the fact that passive administration is stress free, while chronic injection 
can, in of itself, be considered a mild stressor. Indeed, saline injections can induce 
dendritic remodelling similar to that observed in corticosterone-exposed animals 
(Seib & Wellman, 2003).  Alternatively, the differing rates of hormone release 
between methods could account for the observed differences between exposure 
groups. With passive administration, animals gradually consume corticosterone, and 
not consistently or constantly, which can lead to fluctuations in circulating 
corticosterone between and within individual groups.  Although, injection and pellet 
administration can prevent this outcome, given that they are more tightly controlled, 
injection, unlike pellet administration, cannot provide a more constant hormone level, 
and usually delivers corticosterone all at once. Therefore, at the time of testing, 
animals from the various groups may, indeed, have differing levels of circulating 
corticosterone, which could impact observed behavioural outcomes.  
 
However, despite the aforementioned limitations, when methodological issues are 
controlled for, the behavioural and neurobiological changes associated with 
corticosterone exposure remain fairly consistent within the literature, across the 
various administration methods, reinforcing that chronic corticosterone exposure is a 
valid and useful animal model to study stress induced depression. Therefore, in the 
context of this PhD thesis, corticosterone exposure would be the most appropriate 
model of physical stress given that it has a greater degree of validity and consistency 
compared with restraint stress. However, corticosterone exposure is a model that 
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directly manipulates the stress system, and although a strong advantage to using this 
model, in the context of this work, it cannot be compared with any of the 
psychosocial stress models, because they are all experimenter applied. Therefore, to 
have an appropriately comparable physical stress treatment, corticosterone will be 
replaced with saline, and as such, chronic injection stress will be used to model 
physical stress in this thesis.  
 
1.3.3.1.3.  Impact of chronic injection stress: pre-existing evidence 
 
Although a limited number of studies have investigated the impact of injection stress 
on behavioural and biological outcomes, some studies in mice and rats have shown 
how injection with vehicle solutions such as, saline can reduce activity and body 
weight, increase anxiety- and depressive-like behaviour, alter stress responsivity, 
reduce dendritic remodelling, and increase Fos immunoreactivity and gene 
expression in the brain (Sharp et al. 1991; Izumi et al. 1996; Ryabinin et al. 1999; 
Seib & Wellman, 2003; Waters & McCormick, 2011; Drude et al. 2011; Deymuser et 
al. 2016). Moreover, it can also alter immune system functioning, specifically by 
altering blood lymphocyte numbers and leading to lymphocytopenia in both male and 
females (Drude et al. 2011), and therefore, chronic injection stress could be a useful 
physical stress model.  
 
Furthermore, there are several advantages to using repeated injection as a physical 
stress model. First, it is cost effective, and can be quickly and easily administered in 
a consistent manner. Second, it also has some translational value within the context 
of physical stress. Clinically perhaps the most obvious physical stressor would be 
that pertaining to illness, injury, and/or pain, of which injection could be highly 
relevant. Individuals with chronic illness/injury would be exposed to multiple medical 
testing, and possibly injection, throughout the course of their illness/injury. Chronic 
injection therefore, would be an appropriate proxy for the discomfort inflicted by 
medical testing and/or associated treatment plans. However, chronic pain is not a 
risk factor for all types of depression, which does call into question the translational 
relevance of this model. Finally, evaluating the impact of chronic injection has some 
important implications within the preclinical field regarding drug testing. Often 
injection is the selected route of antidepressant administration, and therefore it is 
pertinent to fully understand the effects of injection to more confidently interpret data 
pertaining to these studies. In the context of work within our laboratory, testing the 
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effects of chronic injection in this experiment will ensure that more informed 
decisions are made regarding any potential drug studies that may be carried out in 
future based on findings pertaining to this PhD thesis. Therefore, using this particular 
model has a dual purpose, and will contribute to reducing the number of animals to 
be used in future pilot studies.  
 
However, like with restraint stress this model has two main disadvantages, it (a) falls 
victim to the effect of habituation and, (b) being an experimenter-applied stress 
paradigm, offers no control over individual differences in responsivity to stress. 
Despite these disadvantages though, repeated injection remains the most 
appropriate physical stress model for the purposes of this PhD thesis as further 
discussed in subsection 2.2.4.1.2.1. 
 
1.3.3.2.   Psychosocial stress exposure  
 
Although chronic stress models, primarily physical in nature, have low throughput, 
and their degree of validity is mostly robust, their ethological relevance however, is 
limited. Social stress models address this issue, primarily because social 
relationships play a major ecological role in both animals and humans (Robinson et 
al. 2008). Moreover, stress is mainly of social origin, may occur throughout the life 
course (Björkqvist. 2001; Wood et al. 2012), and is increasingly impacting our daily 
lives (Lederbogen et al. 2011).  Indeed, social factors are considered to be important 
risk factors for clinical depression (see subsection 1.1.2). Thus, social stress models 
have become increasingly attractive and useful, being, perhaps, the most 
ethologically relevant of all the animal models of depression.  
 
Essentially, social stress models use social perturbations as stressors, in the form of 
isolation and/or social defeat, and consequently investigate the impact of these 
environmental challenges, which an animal may likely encounter in its daily life, on 
the development of depressive-like behaviours and associated pathophysiology.  
 
1.3.3.2.1.  Social defeat stress 
 
One of the most widely used stress models to date is the social defeat stress (SDS) 
model. It is primarily based on the premise that the process of fighting for control and 
losing control are centrally important to the psychosocial situation of individuals 
(Barnett, 1958; 1964; Henry & Stephens, 1977).  In animals, behaviour during social 
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conflict plays a detrimental role in the genesis of hierarchy, which then determines 
access to food resources and sexual mating (Buwalda et al. 2005; Huhman, 2006; 
Koolhaas et al. 2011; Shively & Willard, 2012), and thus, can have an profound 
impact on an animals wellbeing. Similarly, in humans the loss of social status, rank 
and/or control, which are increasingly recognized as specific life events, can increase 
the risk for depression (Gilbert, 2000).  Based on this, the SDS model has become 
increasingly utilised as a tool to investigate the impact of social defeat on the 
development of depressive-like phenotypes.  
 
Classically, the experimental setting of the SDS paradigm involves transferring an 
intruder to the home cage of an often superiorly aggressive resident. Sometimes, the 
intruder will be transferred to a singly housed resident, or may replace a cohabiting 
partner, but irrespective of the setting, the intruder is quickly attacked and 
subjugated. After physical exposure, the intruder is often then housed in a separate 
cage next to the resident, so as to be further exposed to stressful psychogenic 
signals emitted by the resident (Miczek et al. 2008; Golden et al. 2011; Hollis & 
Kabbaj, 2014; Vasconcelos et al. 2015).  
 
Fairly consistent across the literature, chronically defeated rodents show multiple 
behavioural alterations, including increased anxiety- and depressive-like behaviour, 
hypolocomotion, and increased social avoidance (Razzoli et al. 2007; 2009; Kieran et 
al. 2010; Fanous et al. 2011; Furay et al. 2011; Paul et al. 2011; Iio et al. 2011; 
Olivares et al. 2012; Chen et al. 2012; Grunewald et al. 2012; Ordway et al. 2012; 
Buwalda et al. 2013).  From a pathophysiological perspective, while the direction of 
effect is less constant, chronically stressed mice do exhibit alterations in some key 
biological systems linked with depression. Specifically, defeated animals exhibit 
altered HPA axis activity, revealing either reduced or increased corticosterone levels, 
CRH levels and/or altered GR mRNA expression (Avistur et al. 2001; Gomez-Lazaro 
et al. 2011; Audet et al. 2011; Olivares et al. 2012; Chen et al. 2012; Grunewald et al. 
2012; Wu et al. 2013). Moreover, increased inflammation, specifically with reference 
to TNF-α, IL6 and IL1β has been reported (Audet et al. 2011; Gomez-Lazaro et al. 
2011; Sukoff Rizzo et al. 2012; Patki et al. 2013; Wu et al. 2013), in addition to 
altered levels of BDNF expression (Berton et al. 2006; Fanous et al. 2011; Wu et al. 
2013). Finally, although neurogenesis has been poorly studied in the context of SDS, 
both increased proliferation (Buwalda et al. 2013) and decreased neurogenesis (Yap 
et al. 2006) has been reported.  
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Despite the high ethological relevance of the SDS model, in addition to its high face, 
construct and, to a lesser extent, predictive validity, like all aforementioned models it 
has some drawbacks. First, and perhaps one of the most significant weaknesses of 
the SDS paradigm lies in its agonistic nature, for which it is solely based. Thus, as 
opposed to restraint stress, whose true behavioural and physiological impact of 
stress is accounted for by the perception of that stress by the individual, SDS stress 
depends on the interaction between the resident and intruder animal. Resident 
animals can show high variability in their aggressiveness and willingness to protect 
their environment, which can alter the dynamic of the interaction, and the intruder’s 
experience of stress.  Moreover, the social status of intruder animals can also 
influence behaviour in the SDS paradigm, and can even promote resilience to social 
stress (Morrison et al. 2011; 2014). Indeed, research shows that the hierarchical 
status of animals can have important implications regarding their response to stress 
in general. For example, dominant animals have been shown to display decreased 
anxiety-like behaviours (Davis et al. 2009), and increased neurogenesis 
(Kozorovitskiy & Gould, 2004), and when exposed to stress, they show decreased 
levels of IL1 and IL6 (Aghajani et al. 2013), and increased BDNF mRNA expression 
in the hippocampus (Fiore et al. 2003), all when compared with subordinates. Thus, it 
remains plausible that social hierarchy can affect defeated outcomes observed in 
SDS for intruder mice. Therefore, in summation, the experience of, and response to, 
stress can greatly vary between individuals, and may partially explain why some 
mice display resilient phenotypes, or why the direction of effect for some the 
neurochemical changes observed is not always consistent across studies.  
 
Second, the prevalence for susceptibility to social defeat is reported to be 
approximately 55% (Krishnan et al. 2007), which is considerably higher than the 
reported prevalence for clinical depression (see subsection 1.1.2). However, this is 
limitation is one that can be attributed to all current animal models of depression.  
 
Third, SDS is argued to be a more accurate representation of PTSD than depression, 
given the extreme and specific nature of the stress it evokes. Moreover, symptoms of 
SDS can just as easily represent analogues to clinical and pathophysiological 
symptoms of PTSD (Stam, 2007; Siegmund & Wotjak, 2007; Pitman et al. 2012). 
One line of evidence that reinforces this idea is that increased startle amplitude – a 
characteristic of PTSD – has been observed in socially defeated animals (Pulliam et 
al. 2010).  
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Fourth, SDS has predominately being used in male rodents, due to it being largely 
inefficient in females because of their lack of aggressive interaction. Therefore, given 
that it seems unable to effectively model depression in females it has limited 
construct validity. However, recently some studies are reporting social defeat in 
females when using older, lactating individuals as residents (Holly et al. 2012; 
Jacobson-Pick et al. 2013), and as such this limitation may fall away in the future.  
 
Finally, the SDS paradigm has some methodological concerns. Chiefly, it is a more 
complicated paradigm than those previously described, one that requires aggressive 
residents to ensure success, and one that involves a host of dyadic interactions 
between the resident and the intruder, which can impact outcomes (Fernandez-
Espejo & Mir, 1990; Miczek et al. 2001; 2008). Moreover, interactions often result in 
physical injury to the intruder, which can likewise affect outcomes, and can make 
acquiring ethical approval for its use difficult due to animal welfare concerns. 
Together, these issues can compromise and attenuate the attractiveness of using 
such a model of depression.  
 
1.3.3.2.2.  Social isolation 
 
Social isolation, in the form of solitary housing, has been utilised as a potent stressor 
for gregarious animals. It is an incredibly simple model, and one that is deemed 
highly relevant in the context of depression, with several clinical studies reinforcing it 
potency as a potential risk factor (e.g., Paykel, 1994; Alpass & Neville, 2003; Teo, 
2012; Steptoe et al. 2012). In addition to being ethologically relevant, it also has two 
distinct advantages over SDS. First, it does not suffer from the effects of social 
hierarchy, as its sole intended use is to prevent social contact, and second, although 
males are receptive to social isolation’s impact on behaviour and physiology, females 
appear to be particularly sensitive (Hatch et al. 1965; Brown, 1995; Palanza, 2001; 
Palanza et al. 2001), further reinforcing its construct and face validity as an animal 
model of depression.  
 
An extensive body of work demonstrates the impact of social isolation on multiple 
behavioural parameters. Specifically, chronically isolated rodents show increased 
anxiety- and depressive-like behaviour across a variety of behavioural assays 
(Heidbreder et al. 2000; Brenes et al. 2008; Koike et al. 2009; Martin & Brown, 2010; 
Djordjevic et al. 2012; Carnevali et al. 2012; Takatus-Coleman et al. 2013; Aguiar et 
al. 2014; Zlatkovic et al. 2014), increased memory impairment (Huang et al. 2011; 
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Famitafreshi et al. 2015), increased aggression (Miczek & O’Donnell, 1978; 
Malkesman et al. 2006) and sleep alterations (Greco et al. 1989; Kaushal et al. 
2012).   
 
With respect to physiological changes associated with depressive-like behaviours, 
several studies report alterations in HPA axis activity for isolated animals (Serra et al. 
2005; Stranahan et al. 2006; Kinsey et al. 2008; Martin & Brown, 2010; Djordjevic et 
al. 2012; Liu et al. 2013; Takatsu-Coleman et al. 2013). However, like with SDS, the 
direction of effect is inconsistent. Furthermore, it is noteworthy that many other 
studies report no changes with respect to basal corticosterone levels (Bartolomucci 
et al. 2003; Arndt et al. 2009; Finger et al. 2012; Zlatkovic et al. 2014). One potential 
explanation for these inconsistencies could be reflected by the way in which 
corticosterone was measured across the various studies. Some studies measure 
basal levels, while others measure corticosterone several hours after acute stress 
exposure. While the latter cannot be used to represent stress reactivity, with samples 
collected too long after stress exposure, it equally cannot be representative of basal 
levels. Additionally, differences in blood sampling, collection, storage and 
assessment can have important impacts on hormone data (Hoff, 2000; Bielohuby et 
al. 2012). Indeed, these methodological considerations could potentially account for 
the inconsistencies in corticosterone data observed for socially isolated animals and 
for animals exposed to SDS (see 1.3.3.2.1).   
 
In addition to alterations in HPA axis activity, altered immune functioning, kynurenine 
metabolism, BDNF expression, and hippocampal neurogenesis have all been 
observed in isolated animals. Specifically, studies have shown an increase in the 
pro- versus anti-inflammatory balance, increased TNF-α and IL6 levels, decreased 
levels of IL2 (Bartolomucci et al. 2003; Kinsey et al. 2008, Moller et al. 2013), a 
decrease in the neuroprotective components of the kynurenine pathway (Moller et al. 
2013), and decreased mRNA BDNF levels in the hippocampus (Scaccianoce et al. 
2006). With regards to neurogenesis, the suppressed generation, and decreased 
survival, of newborn neurons in socially isolated animals has repeatedly been shown 
(Westenbroek et al. 2004; Stranahan et al. 2006; Spritzer et al. 2011; Lieberwirth & 
Wang, 2012). 
 
In summary, social isolation has numerous advantages; (a) it is ethologically 
relevant, and has good face and construct validity, (b) it is simple and easy to model, 
(c) it is not influenced by an animal’s social status, and (d) it induces multiple 
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behavioural and pathophysiological alterations associated with depression. However, 
like the other social stress models, it also has some disadvantages. First, depriving 
animals of any, and/or all, social contact is a relatively extreme form of stress, and 
one that is perhaps not wholly representative of the human experience. It is not often 
that humans are devoid of all social contact. Second, habituation to social isolation 
may influence some of the observed outcomes. Indeed, it could potentially account 
for why some of the studies report no differences in basal corticosterone levels.  
Finally, like with all forms of experimenter-applied stress, we cannot control for the 
variability that may arise due to differences in the rodent’s perception of isolation as a 
stressor. However, given that the disadvantages to this particular model are fewer 
than those pertaining to social defeat stress, social isolation will form the basis of the 
psychosocial stress paradigm used in this thesis.  
 
1.3.3.3.   Combined physical and psychosocial stress exposure 
 
Thus far, the most commonly used physical and psychological stress models have 
been defined, and their validity evaluated, which forms the basis for why repeated 
injection and social isolation were selected to model physical and psychosocial 
stress, respectively, in the context of this PhD thesis.  However, in an attempt to 
develop a more translational model of depression, previous research has combined 
physical and psychosocial stressors into a single paradigm, that is, the unpredictable 
chronic mild stress (UCMS) model of depression, in order to mimic the 
heterogeneous human experience of stress. Given that the second part of this thesis 
will use a modified version of UCMS, it is therefore pertinent to describe this model, 
and discuss the behavioural and biological profiles associated with UCMS.  
 
1.3.3.3.1.  Unpredictable chronic mild stress  
 
The unpredictable chronic mild stress (UCMS) model of depression is considered to 
be one of the most robust and realistic models for studying the neurobiological basis 
of depression (reviewed in Willner, 2017a). This is largely based on its variable, 
episodic and chronic nature, which more closely resembles the human experience of 
chronic stress more than any other stress model of depression (Kendler et al. 1999; 
Willner, 2005). Moreover, its validity as a robust model of depression makes it 
additionally appealing.  It has good face and construct validity, reinforced by the long-
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lasting changes in almost all behavioural and neuropathological parameters that it 
induces (reviewed in Hill et al. 2012; Wiborg, 2013; Willner et al. 2013; 2014; Willner; 
2017a). Likewise, it also has good predictive validity, strengthened by the fact that 
behavioural and biological deficits can only be reversed with chronic, not acute, 
antidepressant treatment, and that almost all classes of chronic antidepressant 
treatments and strategies are effective in reversing UCMS induced effects (Surget & 
Belzung, 2009; Dournes et al. 2013; Wang et al. 2014; Lim et al. 2015). Therefore, 
based on these concepts, UCMS is a particularly attractive model for depression, 
which is reflected by its use in more than 1,300 published studies (Willner, 2017a). 
 
In essence, the UCMS paradigm involves exposing animals to a range of mild 
stressors in an unpredictable fashion over a period of several weeks to months. 
Stressors are both physical and psychosocial in nature, and include, to name but a 
few, social isolation, alterations in housing conditions, removal of environmental 
enrichment, food or water deprivation, exposure to predator sounds and odours, and 
disruption of the dark-light cycle (Willner, 2005). Therefore, it exposes animals to 
multiple types of uncontrollable stress, overcoming any associated issues of stress 
habituation, while more naturalistically modelling chronic stress exposure.  
 
As briefly mentioned, UCMS induces a full range of behavioural changes, which 
correspond well to the clinical symptoms associated with depression. Specifically, 
UCMS exposed animals show increased depressive-like behaviours across various 
assays including the sucrose preference test, and the forced swim test (Santarelli et 
al. 2003; Surget et al. 2011; You et al. 2011; Bessa et al. 2013; Khemissi et al. 
2014). Moreover, while not universally observed, anxiogenic effects have also been 
described (Surget et al. 2008; Zhu et al. 2014; Franceschelli et al. 2015; Papp et al. 
2016; 2017), in addition to cognitive impairments in spatial learning and object 
recognition (Song et al. 2006; Orsetti et al. 2007; Elizalde et al. 2008; Erburu et al. 
2015). Furthermore, reductions in body weight (Bekris et al. 2005, Nollet et al. 2013; 
Liu et al. 2014), altered sleep disturbance (Logan et al. 2015), and inhibited sexual 
behaviour (Gronli et al. 2005) has also been reported. Finally, UCMS animals are 
described as having altered locomotor ability, although the direction of effect is less 
clear according to the available literature. For example, some studies report 
hyperactivity (Duncko et al. 2001; Zheng et al. 2010); other studies cite hypoactivity 
(You et al. 2011; Jin et al. 2013); while further still, some report no such differences 
(Elizalde et al. 2008; Lin et al. 2014). These inconsistencies could be partially 
explained by the way in which activity was measured across these studies. 
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Methodological differences, such as light intensity, for example, can modulate activity 
measures in novel environments (Strekalova & Steinbusch, 2010). Although, the 
literature seems variable with respect to locomotor activity, all other UCMS induced 
behavioural changes are, for the most part, consistent across most studies (e.g., 
reviewed in Willner, 2005; 2017a;b; Willner et al. 2013; 2014).  
 
Given the abundance of published studies using this particular model, UCMS has 
provided more insight into the neurobiological basis of depression more than the 
other described stress models. It has been implicated in almost all systems currently 
linked to depression (e.g., reviewed in Hill et al. 2012; Willner, 2017a), but only those 
systems relevant in the context of this PhD thesis will be described.  
 
Looking at the stress system, a plethora of research chronicles the effect of UCMS 
on HPA axis functioning. Specifically, an increased level of corticosterone, increased 
CRH gene expression in the hypothalamus, and reduced GR gene expression in 
both the hippocampus and hypothalamus has been described (Ayensu et al. 1995; 
Grippo et al. 2005; Goshen et al. 2008; Garcia et al. 2009; Pan et al. 2010; Ge et al. 
2013; Liu et al. 2014; Kvarta et al. 2015;). However, it is noteworthy that several 
studies also report no changes in peripheral corticosterone (e.g., Duncko et al. 2000; 
Lin et al. 2014; Remus et al. 2015), and while inconsistencies in corticosterone data 
across studies is not unusual in stress research, they could be attributable to 
differences in the methodologies used to collect, store and quantify corticosterone 
(Hoff, 2000; Bielohuby et al. 2012). 
 
With regard to immune system functioning, increased levels of IL1β, IL6, TNF-α, and 
IFNγ both systemically, and with respect to brain protein and gene expression levels, 
have been consistently reported (Kubera et al. 1998; Grippo et al. 2005; Goshen et 
al. 2008; Li et al. 2008; You et al. 2011; Mutlu et al. 2012; Liu et al. 2014; Xue et al. 
2015; Lu et al. 2017). Moreover, an increased level of neuroinflammation, in the form 
of increased microglial activation and cell density, has also been repeatedly reported 
in both the hippocampus and PFC of animals exposed to UCMS (reviewed in Farooq 
et al. 2012; Zhu et al. 2015; Liu et al. 2015).  
 
Moving on to the impact of UCMS on the hippocampus with respect to volume and 
neurogenesis, several studies report reduced hippocampal volume in stressed 
animals (e.g., Bessa et al. 2009; Delgado y Palacias et al. 2011), which is consistent 
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with changes observed in patients with clinical depression (Videbech & Ravnkilde, 
2004; Geerlings & Gerritsen, 2017).  Moreover, while one study reports no change in 
cell proliferation or differentiation in the hippocampus (Lee et al. 2006), several other 
studies report reduced cell proliferation and/or neurogenesis in animals exposed to 
UCMS (e.g., Alonso et al. 2004; Mineur et al. 2007; Oomen et al. 2007; Li et al. 2008; 
Jiang et al. 2012; Nollet et al. 2012). Furthermore, expression of VEGF, an important 
trophic factor associated with active sites of neurogenesis (Palmar et al. 2000), has 
previously been show to be reduced in the hippocampus (Heine et al. 2005). 
However, more recently this finding failed to be replicated (Kiuchi et al. 2012).  
 
Although several multiple relevant behavioural and neurobiological changes are 
induced by UCMS, and the model is valid and well established, it does have a few 
limitations. First, out of all the models described, it is substantial amount of time and 
effort to establish and run, which consequently makes it the least cost effective of all 
the models. Moreover, it is susceptible to subtle variations in design, which has 
affected its overall reproducibility across and within laboratories (Cryan & Holmes, 
2005; Willner, 1997), and as such, the reliability of UCMS has been previously called 
into question. Interestingly, however, a recent survey, which sought to establish the 
extent of UCMS’s reproducibility, found that, between the years 2010 and 2015, 
75%, 21% and 4% of respondents reported UCMS to work reliably, most of the time, 
or not at all, respectively (Willner, 2017b). The author concludes that UCMS is 
indeed a reproducible model. However, we should be mindful that publication bias 
can heavily alter our perceptions of the reproducibility of UCMS. Indeed, the author 
does concede that one limitation to their survey is that they may have excluded many 
research groups working with UCMS, who could not be identified through publication, 
predominately because the model was unsuccessful in their hands. Therefore, the 
result of this survey could likely overestimate the reproducibility of UCMS. Without 
full disclosure of all findings pertaining to UCMS, it is impossible to truly know how 
reproducible the model is. However, given that literally thousands of studies have 
successfully used UCMS in the context of their work, it may not be as irreproducible 
as previously thought. While in it’s infancy as a model of depression, it may have 
clearly lacked reproducibility (Willner, 1997) this concern appears to have diminished 
over time (Willner, 2017b).  Therefore, given it’s ethological validity, that it is a well-
established model, and it’s translational value, using UCMS in the context of this PhD 
thesis seems highly appropriate to further understand how chronic stress may impact 
immune system functioning and adult hippocampal neurogenesis.  
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1.3.4.  Does the type of stress matter? Important considerations 
 
The distinction between the effect of different types of stress on animal behaviour 
and physiology has been largely unexplored, and may have some important 
implications, both practically, and in terms of depression aetiology. Is one type of 
stress exposure more potent than another, and if so does this matter? Does chronic 
physical stress induce a slightly different depressive phenotype to that of chronic 
psychosocial stress? The answers to these questions are, currently, unknown. 
Indeed, Anisman and Matheson (2005) argue in their review that not all stressors 
have the same effects, and although they may promote several comparable 
behavioural and neurochemical outcomes, stressor appraisal processes for the 
different types of stress do not occur in the same manner. Thus, they conclude that 
different stressors should not be expected to induce identical behavioural and/or 
physiological effects (Anisman & Matheson, 2005).  
 
Interestingly, a few preclinical studies have provided some insight into this idea. For 
example, Zhu and colleagues (2014) demonstrate how only UCMS, and not restraint 
stress, can induce depressive-like phenotypes (Zhu et al. 2014). Explaining this 
finding consequently leads to three potential hypotheses; (1) psychosocial stress 
may be a more potent stressor than physical stress, (2) the additive effect of multiple 
stressors, irrespective of type, may be what matters, and/or (3) the combination of 
both physical and psychosocial stress is important, given that this is essentially what 
UCMS models.  
 
Evidence for the first hypothesis comes from two studies, both of which compare 
psychosocial stress with either physical stress, or UCMS (Barnum et al. 2012; Liu et 
al. 2013).  Barnum and colleagues (2012) demonstrate how both UCMS and 
predator stress (PS), a psychological stressor, can independently induce a 
depressive-like phenotype. However, they also reveal how PS has a significantly 
more severe impact on outcomes than UCMS, suggesting that psychological stress 
could be more potent.  Although, we should be mindful that stress severity is an 
important factor in depression aetiology, and PS is a very severe stressor. Further 
evidence to support the notion that psychosocial stress may be more effective than 
other types of stress comes from a study performed by Liu and colleagues (2013). 
The authors show how the combined effect of both chronic social isolation and 
restraint stress can induce depressive-like phenotypes. Interestingly, however, they 
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also show how social isolation, but not restraint stress, can independently induce the 
same phenotype, suggesting that the effects observed in combined stress may be 
driven by social isolation.   
 
Evidence to potentially support the second hypothesis, and refute the third 
hypothesis comes from studies utlising UCMS, whose stressors are entirely physical 
in nature (e.g., Roman et al. 2014; Garabadu et al. 2015). These studies show 
animals with both behavioural and physiological changes in response to UCMS 
exposure, despite the stressors being entirely physical. This supports the idea that it 
is quantity, i.e., exposure to multiple stressors, that is important, and that it does not 
necessarily matter whether stressors are physical or psychosocial. However, it is 
noteworthy that in most UCMS paradigms animals are singly housed, and as such 
are subjected to psychosocial stress. Often studies will not report on housing 
conditions, as in the aforementioned examples, so it is difficult to reliably evaluate the 
evidence.   
 
Finally, there is little evidence to support the third hypothesis other than the fact that 
UCMS is seemingly the most robust model available (see subsection 1.3.3.3.1). 
However, multiple studies have demonstrated how physical and psychosocial stress 
can independently induce depressive-like phenotypes (see subsections 1.3.3.2.1 and 
1.3.3.2.2), and as such make it difficult to fully support this, or, indeed, the other two 
hypotheses. Studies directly comparing the impact of different types of stress are, 
therefore, greatly needed. Given the evidence, albeit limited in quantity, it remains 
entirely plausible that starkly different stressors could elicit different behavioural 
and/or pathophysiological phenotypes in rodents. Therefore, the first part of this PhD 
thesis will examine whether the type of stress can indeed make a difference.  
 
1.4.  Aims and hypotheses 
 
The overall goal of this PhD thesis is to further understand the impact of chronic 
stress on immune system functioning, and adult hippocampal neurogenesis using a 
mouse model of depression. This thesis can be essentially broken down into two 
main parts, each with their own aims. The first part will address whether the type of 
stress can differentially affect behavioural and biological outcomes, while the second 
part, will develop and characterise a more chronic and translational UCMS model of 
depression.  
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1.4.1. PART A: Does the type of stress matter? Effect(s) of physical, 
psychosocial, and both physical and psychosocial, stress on behaviour, 
inflammation and adult hippocampal neurogenesis 
 
Interestingly, only one study to my knowledge has examined the effect of the type of 
stress on both behavioural and pathophysiological outcomes, which demonstrates 
the need for more research relating to this scientific question. Liu and colleagues 
(2013) demonstrate how the type of stress exposure can alter behavioural outcomes, 
with psychosocial stress proving to be the more severe stressor. However, while this 
study did directly compare the three distinct types of stress, it was limited in the 
behavioural and biological domains it assessed, focusing specifically on the 
neuroendocrine system. For example, the authors did not use any anhedonic 
measures in the study, making it difficult to characterise any depressive-like 
behaviours, nor did they assess other important systems, such as the immune 
system, which is not only independently associated with depression, but also has a 
bi-directional relationship with many of the neuroendocrine systems. Therefore, a 
more comprehensive evaluation is needed, one that focuses on multiple behaviours 
and biological outcomes associated with depression. Therefore, this makes up the 
first part of this thesis, which has four associated aims. Each aim pertains to a 
particular outcome or group of associated outcomes, and will examine the effect of 
physical stress, modelled by chronic injection, psychosocial stress, modelled by 
permanent social isolation, and combined stress, both permanent social isolation and 
chronic injection, on each of these outcomes.  
 
1.4.1.1.  Aims pertaining to PART A  
 
1.4.1.1.1. AIM 1: Examining the effect of physical, psychosocial and 
combined stress on behaviour 
 
For this aim, a range of anxiety- and depressive like behaviours will be assessed. 
Specifically, a large behavioural test battery will be carried out to measure 
anhedonic-like behaviour in the SPT, anxiety-like behaviour in the OFT and NSFT, 
and behavioural despair/fatigue in the FST.  Moreover, body weight, food 
consumption, olfaction, social hierarchy and activity in the OFT and NSFT will also 
be assessed for a more comprehensive understanding of any potential behavioural 
alterations that may be associated with the three categories of stress. 
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1.4.1.1.2.  AIM 2: Examining the effect of physical, psychosocial and 
combined stress on stress responsivity, and systemic 
inflammation  
 
Multiple lines of evidence support the involvement of the HPA axis, and the immune 
system in depression aetiology (see subsections 1.2.1, and 1.2.2). Therefore, to gain 
a more comprehensive understanding on how chronic stress impacts HPA axis and 
immune system functioning, evaluating some aspect of these systems are the 
objective of this particular aim. Specifically, blood will be collected from animals at 
the end of exposure, at two time points, one before, and one after, acute stress 
exposure to assess stress responsivity. Plasma levels of corticosterone, and a 
variety of pro- and anti-inflammatory cytokines will then be quantified for each animal 
at both time points. Given the bi-directional relationship between the HPA axis and 
immune system, hallmarks associated with immune system and HPA axis 
dysregulation may be more easily identified when peripheral levels of corticosterone 
and inflammation are assessed simultaneously. 
 
1.4.1.1.3.  AIM 3: Examining the effect of physical, psychosocial and 
combined stress on microglia and astrocyte biology 
 
It is now widely accepted that glial cells play a key role in the pathogenesis of 
depression (see subsection 1.2.3). Moreover, glial cells are important regulators of 
the neurogenic niches of the brain, and play an important role in immune system 
functioning (see subsections 1.2.2.4.3 and 1.2.4). Therefore, this aim will focus on 
identifying whether stress impacts two types of glia cells, microglia and astrocytes, 
and in relation to the three distinct types of stress. Given that the observed changes 
in microglia and astrocytes have been more strongly and consistently implicated in 
the hippocampus and PFC, these two brain regions will be studied with respect to all 
measured parameters. Moreover, given that the hippocampus is a large structure, 
specifically the DG will be investigated given that the evidence supports that this is 
one of the structures most susceptible to change within the hippocampus with 
respect to neuroinflammation (Tynan et al. 2012). Furthermore, since glia play an 
important role in the regulation and maintenance of hippocampal neurogenesis in the 
DG (see 1.2.4), which is another outcome of interest, it would be pertinent to study 
both processes in the DG. Additionally, each of the parameters measured in the DG 
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will be stratified by region, that is, dorsal and ventral due to reasons described in 
subsection 1.2.4.4.1.  
 
To gain a comprehensive understanding of how chronic stress impacts glia biology, 
several parameters pertaining to this aim will be measured. In the first instance, 
given that several studies show differences in the immunoreactivity of both microglia 
and astrocytes in relation to depression (see subsection 1.2.3), this parameter will be 
quantified using markers Iba1 and GFAP. Second, based on immunoreactivity 
analyses, two further parameters will be measured for experimental groups showing 
significant differences in Iba1 and/or GFAP positive immunoreactivity compared with 
control animals. Specifically, cell density and cell morphology will be assessed to 
help ascertain whether immunoreactivity is likely representing a change in cell 
number, or morphology. Although some studies do report differences in astrocyte 
morphology, this parameter will not be assessed for GFAP positive cells in this thesis 
due to (a) time constraints, and (b) the challenges associated with attaining reliable 
morphological assessments of GFAP positive cells, due to GFAP positive stain 
density.  However, given that GFAP is also a marker for neural stem cells, both 
s100β (a marker for mature astrocytes), and immunofluorescence double staining  
(double stained for GFAP and SOX2) will be performed for those experimental 
groups showing significant changes in GFAP immunoreactivity compared with 
controls. This will provide a more comprehensive insight into any astrocyte-
associated alterations observed for experimental groups.  
 
1.4.1.1.4.  AIM 4: Examining the effect of physical, psychosocial and 
combined stress on adult hippocampal neurogenesis 
 
Section 1.2.4 of this thesis presents the evidence to support that AHN is affected in 
depression.  While it seems unlikely that neurogenesis plays a causal role in 
depression (see subsection 1.2.4.6), nonetheless many systems implicated in the 
pathogenesis of depression, such as stress and inflammation, can heavily influence 
neurogenesis in the hippocampus (see subsection 1.2.4.5). Therefore, given its 
relationship with depression, stress and inflammation, the effect of distinct types of 
stress on AHN will be assessed under this aim. Several parameters pertaining to this 
outcome will be measured based on evidence from the literature. First, reductions in 
both the proliferation and differentiation of newborn neurons have been shown in 
several preclinical studies (see subsection 1.2.4.6.2), and as such cell density in the 
DG for both proliferative cells, using Ki67, and immature neurons, using DCX, will be 
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measured. Second, given that multiple changes in neuroblast and neuron 
morphology have been recorded in response to stressful stimuli (see 1.2.4.5.2), DCX 
cell morphology will also be characterised. Finally, given the functional differences 
between the dorsal and ventral parts of the hippocampus (see 1.2.4.4.1), each of the 
aforementioned parameters will be stratified by region of the DG.  Rationale for 
specifically studying neurogenesis in the hippocampus is based on the premise that it 
is the most-well defined neurogenic niche to date (see subsection 1.2.4.1).  
 
1.4.1.2.  Hypotheses relating to PART A 
 
Based on the literature, hypotheses in relation to what outcomes to expect for each 
type of stress cannot adequately be made. Moreover, given that only one study as 
directly compared the effects of distinct types of stress, I am unable to hypothesise 
how each of the stressors, with respect to each outcome, will directly compare with 
each other. Therefore, most hypotheses will be based on the literature pertaining to 
the impact of chronic stress in general, with the exception of Hypothesis 2, where 
there is more available literature to hypothesise on the effect of specific types of 
stress.  
 
Hypothesis 1: Exposure to chronic stress will independently induce anxiety- and/or 
depressive-like behaviour. Moreover, exposure to multiple stressors will have an 
additive effect and induce depressive-like behaviour. 
 
Hypothesis 2: Exposure to physical stress will promote HPA axis hyperactivity and 
consequently increase plasma levels of corticosterone and decrease levels of 
inflammation. Meanwhile, exposure to psychosocial stress, and multiple stressors, 
will increase circulating corticosterone and peripheral inflammation, with respect to 
IL1β, IL6 and/or TNF-α. 
 
Hypothesis 3: Chronic stress exposure will increase Iba1 positive immunoreactivity, 
decrease GFAP positive immunoreactivity, and increase s100β cell density. 
Moreover, chronic stress will alter Iba1 cell density and/or morphology.  
 
Hypothesis 4: Chronic stress exposure will decrease levels of hippocampal 
neurogenesis, both in terms of neuronal proliferation and differentiation.  
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1.4.2. PART B: Effect(s) of UCMSI on behaviour, inflammation and adult 
hippocampal neurogenesis 
 
Based on the literature, UCMS is a well established and validated animal model of 
depression, with more ethological relevance than most, if not all, of the other 
established models (see 1.3.3). However, although the model currently has multiple 
advantages, it does not entirely follow the trajectory of the disorder, where 
depressive symptomology can often present months after exposure. Therefore, in an 
attempt to rectify this, the second part of this thesis aims to modify UCMS and create 
a more chronic and even more translational model of depression.  To achieve this, a 
period of social isolation will be instated directly after six weeks of UCMS, which in 
addition to mimicking a more representative trajectory of the disorder will add another 
important element to the model, that is, one of social withdrawal. For instance, 
patients with stress-induced clinical depression are indeed, more likely to be exposed 
to a variety of stressors prior to the onset of a depressive episode. However, they are 
also more likely to withdraw from friends, family and society in response to their 
stressful experience, or as a symptom of their depressive pathology, and this 
withdrawal or isolation can further exacerbate the stressful experience and/or 
depressive symptomology (Beck et al. 1961; Kawachi & Berkman, 2001; Cacioppo et 
al. 2006). Therefore, this modified UCMS model, hereafter referred to as 
unpredictable mild chronic stress and isolation (UCMSI), tries to mimic this 
experience of stress exposure followed by social withdrawal, while simultaneously 
following the clinical trajectory of depression. As such, PART B will develop a stress 
model, which includes six weeks of UCMS, followed by six weeks of permanent 
social isolation, based on the UCMS protocol previously used in the laboratory, and 
on the social isolation protocol used in PART A.  
 
1.4.2.1.  Aims pertaining to PART B  
 
1.4.2.1.1.  AIM 1: Behavioural characterisation of UCMSI  
 
For this aim, a range of anxiety- and depressive like behaviours will be assessed 
both during, and at the end of, stress exposure. Specifically, anhedonic-like 
behaviour in the SPT, both during the first six weeks of UCMSI, and after twelve 
weeks of exposure, will be assessed. Moreover, body weight and coat state will be 
monitored throughout UCMSI exposure. After twelve weeks of UCMSI, anxiety-like 
behaviour in the OFT and NSFT, behavioural despair/fatigue in the FST and social 
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interaction will all be measured.  Additionally, food consumption, olfaction, social 
hierarchy and activity in the OFT and NSFT will also be assessed as potential 
covariates.  
 
1.4.2.1.2.  AIM 2: Biological characterisation of UCMSI 
 
For this particular aim the same biological outcomes as described in AIMS 2-4 in 
section 1.4.1.1 will be measured, with one exception, that is, GFAP positive cells will 
not be characterised due to time constraints. Therefore, the impact of UCMSI on 
plasma levels of corticosterone and a variety of pro- and anti-inflammatory cytokines, 
all in the absence and presence of novel acute stress, will be assessed. Moreover, 
Ki67 and DCX cell density, and DCX cell morphology in the DG of the hippocampus 
will be quantified, in addition to Iba1 and GFAP immunoreactivity, and s100β cell 
density in the DG and PFC.  
 
1.4.2.2.  Hypotheses relating to AIM 2 
 
 
Hypothesis 1: UCMSI will increase anxiety- and/or depressive-like behaviours, 
decrease weight gain, increase coat state deterioration, and decrease social 
interaction.  
 
Hypothesis 2: UCMSI will increase stress responsivity, increase peripheral 
inflammation, specifically IL1β, IL6, and TNF-α, increase Iba1 positive 
immunoreactivity, decrease GFAP positive immunoreactivity, and increase s100β cell 
density. Moreover, it will also decrease hippocampal neurogenesis, both in terms of 












2. MATERIALS AND METHODS	
 
2.1.  Ethical approval statement  
All housing and experimental procedures were carried out in compliance with the 
local ethical review panel of King’s College London, and the U.K. Home Office 
Animals Scientific Procedures Act 1986. All procedures regarding animal care and 
use were regulated by the 2010 EU directive on animal research, and as such all 
efforts were made to minimize animal suffering, and to reduce the number of animals 
used in this PhD thesis. 
 
2.2.  Study design 
 
Two animal experiments were conducted within the context of this work to address 
the main aims of this PhD thesis (see section 1.4).  
 
2.2.1.  Animals 
 
For all experiments a total of 80 adult, and 10 young, male BALB/cAnNCrl mice were 
used, which were obtained from Charles River Laboratories (Margate, Kent, U.K.) as 
either littermate pairs or non-littermates depending on experimental group. Figure 
2.1 demonstrates the number of animals used for each experiment with a breakdown 
of the numbers per experimental group, the age and weight range of animals on 
arrival, whether animals were littermates or not, and the number of animals that were 
lost during experimental stress exposure, with the associated reason. Additionally, 
young non-littermate male BALB/c mice were purchased for use in the social 
interaction test in Experiment 2, the details of which are described in subsection 
2.3.2.3.4.1. Finally, 10 adult littermate male BALB/c mice were purchased for the 
repeated sucrose preference test pilot study, the details of which are described in 
subsection 2.3.2.3.2.1.3. 
 
2.2.1.1.    Why this mouse strain and gender?  
 
BALB/c mice were selected for study because they typically exhibit low levels of 
sociability (Southwick & Clark, 1968; Moy et al. 2004; reviewed in Brodkin, 2007), 
high levels of anxiety-related behaviours in the open field test (OFT), elevated plus  
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Figure 2.1. Flow chart depicting the number of animals used for each experiment in 
this thesis 
A total of 70 animals were used; 50 in Experiment 1, and 20 in Experiment 2. For each 
experiment, a total of 10-20 animals were assigned per group. Throughout the course of this 
PhD a total of five animals were culled during experimental exposure due to illness and/or 
injuries sustained from fighting between sibling pairs.  
Investigating the impact of stress on inflammation, 
neurogenesis and depression 
 
Animals; n = 70 
PART A: Does the type of stress matter?  
 
 
Experiment 1: The effect(s) of physical, 
psychosocial, and both physical and psychosocial, 
stress on behaviour, inflammation and adult 
hippocampal neurogenesis. 
 
Animals; n = 50 
 
Age at arrival: 6-7 weeks 
Body weight at arrival: 22-26g 
Laboratory habituation: 1 week 
 
PART B: Effect of UCMSI exposure on 
behavioural and biological phenotypes 
 
Experiment 2: Using a modified version of UCMS 
to determine the impact of stress on behaviour, 
inflammation and adult hippocampal neurogenesis.  
 
 
Animals; n = 20 
 
Age at arrival: 5-6 weeks 
Body weight at arrival: 18-22g 
Laboratory habituation: 3 weeks 
 
Group 1:  
Stress free controls 
 
n = 20 
- Littermate pairs 
Group 2:  
UCMSI animals 
 
n = 10 
- Littermate pairs 
Group 1:  
Stress free controls 
 
n = 10 





n = 10 












n = 10 
- Non-littermates 
Attrition; n = 3 
 
Group 1: Stress free controls; n = 1. Sibling 
pair lost due to fighting related injuries. 
 
Group 2: Physically stressed; none. 
 
Group 3: Psychosocially stressed; n = 1. 
Animal was self-harming and immediately 
culled. 
 
Group 4: Both physically and psychosocially 
stressed; n = 1. Animal developed ascites and 
immediately culled. 
 
Attrition; n = 2 
 
Group 1: Stress free controls; n = 1. Sibling 
lost due to fighting related injuries. 
 
Group 2: UCMSI; n = 1. Animal become 
unwell and was subsequently culled. 
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maze (EPM) and light dark box (Crawley et al. 1997; Bolivar et al. 2000; Kim et al. 
2002; Tang et al. 2002; Francis et al. 2003), higher stress sensitivity (Priebe et al. 
2005), and reduced levels of brain serotonin (Zhang et al. 2004) when compared with 
other inbred strains. Therefore, given their sensitivity to stress, their genetically 
altered synthesis of serotonin, and their susceptibility to the development of anxiety- 
and depressive-like behaviour, they are an ideal mouse strain for detecting 
exposures that will ameliorate these behavioural phenotypes, and were thus deemed 
the most appropriate strain for the purposes of this thesis.  
 
Female mice were not assessed in these experiments as the phase of the oestrous 
cycle can differentially alter behavioural performance (Meziane et al. 2007), and 
stress responsivity (reviewed in Lovick, 2014). Therefore, a number of additional 
control groups would need to be included to correctly assess females (e.g., 
anoestrous groups, and groups housed in female only housing rooms), and given the 
size and scope of the current experiments, this would not have been practical for this 
thesis. However, future studies clearly need to assess both sexes given the high 
prevalence of clinical depression in women (Cyranowksi et al. 2000; Ford & Erlinger, 
2004). 
 
2.2.2.  Housing conditions 
 
All animals were housed in the Biological Services Unit (BSU) at the Institute of 
Psychiatry, Psychology & Neuroscience under standard conditions, which included a 
constant room temperature (19-22°C) and level of humidity (55%), a 12:12h light: 
dark cycle with lights on and off at 07.00 and 19:00, respectively, and food (Rat and 
Mouse No. 1 Diet; Special Diet Services, Essex, UK) and water ad libitum. Animal 
husbandry was carried out for all animals every two weeks by BSU technicians. For 
each experiment, animals were housed in one of two conditions depending on 
experimental stress exposure as depicted in Figure 2.2. Essentially, all stress 
exposed animal groups, with the exception of one experimental group (see 2.2.4.1), 
were singly housed in small Techniplast cages (32x16x14cm) with a 1cm layer of 
sawdust (Litaspen premium, Datesand Ltd, Manchester, UK), a handful of nesting 
material (Datesand Ltd, Manchester, UK) and a cardboard shelter/house (LBS 
Biotech, Horley, UK). Stress-free control animal groups (and Group 2 of Experiment 
1, see 2.2.4.1) were housed in sibling pairs in large Techniplast cages (45x32x20cm) 
with a 1cm layer of sawdust (Litaspen premium, Datesand Ltd, Manchester, UK), two 
handfuls of nesting material (Datesand Ltd, Manchester, UK), a red plastic house 
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Figure 2.2. Animal housing conditions  
(A). Housing for singly housed animals: Small tecniplast cages (32x16x14cm) were set up 
with sawdust, a white house and nesting material (B). Housing for sibling pair housed 
animals: Large techniplast cages (45x32x20cm) were set up with sawdust, a red house, white 





























(LBS Biotech, Horley, UK), a cardboard shelter/house (LBS Biotech, Horley, UK), 
and a plastic tube (LBS Biotech, Horley, UK). Given that BALB/c male mice display 
high levels of aggression (reviewed in Brodkin, 2007; Dow et al. 2011), using larger 
cages with more nesting material, shelter and enrichment were deemed necessary to 
reduce aggression between sibling pair housed animals, and to optimise housing 
conditions, as based on previous recommendations (Deacon, 2006; Charles Rivers 
Laboratories International, Inc., 2012; www.criver.com).  
 
2.2.3. Mouse identification  
 
On the day of arrival all animals were either temporarily or permanently marked to 
ensure group and individual sibling identification. Specifically, all animals pertaining 
to Experiment 1 were temporarily marked on their tails, with an identifiable stripe 
using an indelible marker pen, the process of which was repeated on a weekly basis. 
Conversely, due to the additional handling and time taken to mark animals in 
Experiment 1, animals in Experiment 2 were permanently ear marked. Briefly, 
animals were scruffed, and quickly received a single or double hole punch in either 
the left or right ear on the day of arrival.  
 
2.2.4.  Chronic stress models 
 
2.2.4.1.  Experiment 1: The differential effects of different types of stress 
 
2.2.4.1.1.  Experimental design  
 
This study incorporated four main stages: (1) arrival and habituation, (2) stress 
exposure, (3) behavioural testing and (4) biological sample collection, the timeline of 
which is depicted in Figure 2.3. On arrival, mice were tail marked (see 2.2.3), 
weighed, and housed according to their designated experimental group (see 2.2.2), 
and were subsequently allowed to acclimatise to the BSU for one week. After 
habituation, animals were exposed to the relevant stress, which lasted 8-9 weeks in 
duration (see 2.2.4.1.2.3). Throughout stress exposure, on a weekly basis, all 
animals were tail marked, weighed, and food intake assessed to monitor general 
physical health (see 2.3.1). Six weeks after arrival, all animals underwent a battery of 
behavioural testing for a period of three weeks, the details of which are described in 
section 2.3.2. In the last week of behavioural testing, whole blood 
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Figure 2.3. Experimental timeline and experimental groups for Experiment 1 
Animals were assigned to one of four groups from the day of arrival: (Group 1) stress free 
controls (n=20), which were pair housed and injection naïve for nine weeks, (Group 2) 
physically stressed animals (n=10), which were pair housed for nine weeks, and repeatedly 
injected with saline for eight weeks, (Group 3) psychosocially stress animals (n=10), which 
were permanently singly housed and injection naïve for nine weeks, and (Group 4) animals 
exposed to both physical and psychosocial stress (n=10), which included them being 
permanently singly housed for nine weeks and repeatedly injected for eight weeks. However, 
the injection regime only began one week after habituation to the animal unit. After six weeks 
of relevant stress exposure, animals underwent behavioural testing for a period of three 
weeks. In the final week of exposure, whole blood was collected at two time points, and 24-
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Group 1: Stress level 0: Stress free 
controls; no injection/isolation (n=20) 
Group 2: Stress level 1: Physical stress;  
chronic injection (n=10) 
Group 3: Stress level 1: Psychosocial stress; 
social isolation (n=10) 
Group 4: Stress level 2: Both physical and psychosocial 




B, Whole blood collection time point; P, postnatal day; H, habituation period; i.p., intraperitoneal.   
EXPERIMENT 1 
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samples were collected (see subsection 2.4.1), and 24-48h after the final behavioural 
test, animals were culled, and brain tissue collected (see subsection 2.5.1).  
 
2.2.4.1.2.  Stress exposure 
 
2.2.4.1.2.1.  Modelling physical stress  
 
Chronic injection was used to model physical stress given that it (a) has the capacity 
to alter both behavioural and biological phenotypes in BALB/c mice, (b) is more 
appropriately comparable to an external stress than that of corticosterone exposure, 
which directly manipulates the stress system, (c) is easy and economical to 
administer, and (d) has some translational value (see subsection 1.3.3.1.3). 
Moreover, given that most drug studies use chronic injection to administer 
antidepressant treatment, it seems highly appropriate to test the effect(s) of chronic 
injection, and by doing so here will better inform the design of future drug studies 
using BALB/c mice within our laboratory.   
 
2.2.4.1.2.2.  Modelling psychosocial stress  
 
Permanent social isolation was used to model psychosocial stress in this experiment, 
due to its high ethological relevance, good validity and ease of application. Moreover, 
it has the capacity to consistently alter both behavioural and biological phenotypes in 
rodents of various strains, and has a high degree of translational value (see 
subsection 1.3.3.2.2). 
 
2.2.4.1.2.3.  Stress protocols 
 
Mice in Experiment 1 were exposed to one of three stressors, which each comprised 
of either physical and/or psychosocial stress as aforementioned. Three groups of 
mice were exposed either to physical stress, psychosocial stress, or to a combination 
of both stressors, while one group remained stress free. Specifically, mice were 
either socially housed in sibling pairs, or permanently singly housed for nine weeks, 
as described in subsection 2.2.2. In addition, animals were either injection naïve or 
received a single injection of 0.9% saline (Aquapharm, Argyll, UK) on a daily basis 
between 10:00 and 12:00 for eight weeks. Stress free animals were left undisturbed 
throughout the exposure period, but were handled on a weekly basis as previously 
described (Deacon, 2006). Specifically, mice were removed from their cages by the 
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proximal parts of their tails, and then were subsequently placed in the hand or on the 
arm of the experimenter for 2-3 minutes between 10:00 and 12:00. Figure 2.3 
summarises the different stress exposures for each of the experimental groups used 
in this study. To note, Experiment 1 had two control groups, which were combined 
into one group using appropriate statistical analyses (see subsection 2.6.1), and 
hence why there were 20 animals for this particular experimental group. This was 
because the study of permanent social isolation only (Group 3) was conducted at a 
separate time point, and thus needed it’s own representative control group.  
 
2.2.4.1.2.3.1.  Intraperitoneal injection procedure 
 
Given that intraperitoneal (i.p.) injection is one of the most commonly used injection 
routes, this particular mode of injection was used in this experiment, and was carried 
out according to recommended guidelines, and as previously described (Shimizu, 
2004; Deacon, 2006). Animals were scruffed and injected using a 1ml syringe 
(Terumo, Kruuse U.K. Ltd, Yorkshire, U.K.) with a 25-gauge needle (Appleton 
Woods, Birmingham, U.K.). Specifically, the injection was made with the needle at 
45° to the abdominal skin surface, penetrating 3-4 mm into the peritoneal cavity. For 
each animal, the injection process lasted approximately 1-2 seconds, with saline 
volumes of 10ml/kg body weight being administered. A new needle was used for 
each animal, and the site of peritoneal administration, that is, on the left or right side, 
was alternated on a daily basis. 
 
2.2.4.2.  Experiment 2: Effect of UCMSI on behavioural and biological 
phenotypes 
 
2.2.4.2.1.  Experimental design  
 
This study also included four main stages: (1) Arrival and habituation, (2) UCMSI 
exposure, (3) behavioural testing, and (4) biological sample collection, the timeline of 
which is depicted in Figure 2.4. On arrival, mice were weighed, ear marked (see 
2.2.3), housed in sibling pairs (see 2.2.2), and subsequently were given three weeks 
to acclimatise to the BSU. After habituation, animals were divided into one of two 
groups, and were either permanently singly housed, or housed in sibling pairs as per 
conditions described in subsection 2.2.2.  Group 2 singly housed animals were 
exposed to UCMSI for a total period of fifteen weeks, the details of which will be 
described in the next subsection. Group 1 stress free animals were pair housed and  
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Figure 2.4. Experimental timeline and experimental groups for Experiment 2 
Upon arrival mice were pair housed and allowed to habituate to the animal unit for three 
weeks. Animals were then assigned to one of two groups: (1) stress free controls (n=10), 
which were pair housed and stress free for twelve weeks, (2) unpredictable chronic mild 
stress and isolation (UCMSI) animals (n=10), which were singly housed for twelve weeks; 
chronically stressed with a variety of mild stressors for six weeks, followed by continued 
social isolation for another nine weeks. Throughout stress exposure coat state condition and 
body weight was measured on a weekly basis. In addition, a running measure for anhedonic-
like behaviour (SPT) was carried out on a bi-weekly basis during the first six weeks of stress 
exposure. Animals then underwent behavioural testing after twelve weeks of exposure, which 
lasted three weeks. In the final week of behavioural testing, whole blood was collected at two 
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held in a different room to UCMSI animals, and were left undisturbed throughout the 
stress exposure, but were handled on a weekly basis as described in subsection 
2.2.4.1.2.3. Throughout the experimental paradigm, body weight and coat state were 
assessed on a weekly basis (see 2.3.1), and during the first six weeks a running 
sucrose preference test (SPT) was carried out on a bi-weekly basis for all animals to 
confirm the effect of stress exposure (see 2.3.2.3.2.1). After twelve weeks of UCMSI, 
all animals underwent a battery of behavioural testing for a period of three weeks 
(see 2.3.2). In the last week of testing, whole blood samples were collected (see 
2.4.1), and 24-48h after the final behavioural task all animals were culled and brain 
tissue collected (see 2.5.1).  
 
2.2.4.2.2.  UCMSI paradigm 
 
During the first six weeks of UCMSI, animals were exposed to a variety of stressors 
based on a UCMS protocol designed by Nollet and colleagues (2013). Animals were 
exposed to four mild stressors per day in an unpredictable manner between 10:00 
and 18:00. Stressors included either cage tilt, water bath, cage swap, exposure to 
predator odour and sound, removal of sawdust and enrichment, wet bedding, 
confinement in a restricted space and/or alteration of the dark-light cycle. A 
description of each these stressors can be found in Table 2.1, with some 
photographic examples seen in Figure 2.5, while the exact stress schedule used is 
shown in Table 2.2.  In addition to exposure to these mild stressors, animals were 
socially isolated throughout these six weeks. In the last six to nine weeks of UCMSI, 
animals were left undisturbed, but remained permanently socially isolated as per 
conditions described in Experiment 1 (see 2.2.4.1.2.2; psychosocial stress 
exposure). 
 
2.3.  Physical health and behavioural assessment  
 
As part of the first aim (see 1.4.1.1.1 and 1.4.2.1.1) for both parts of this thesis, 
several physical and behavioural outcomes were assessed based on the literature 
(see 1.3.2.1) to behaviourally characterise each stress model.  
 
2.3.1.  General physical health assessment  
 
Body weight, food intake, and animal coat state was assessed to ethically evaluate 








Table 2.1. Stressors used in the unpredictable mild chronic stress and isolation 
(UCMSI) model  
Stressor Description  
Cage swap Each mouse was removed from its homecage and placed into an empty 
cage of another mouse for a designated time period before being 
returned to its homecage. 
Cage tilt Cages were tilted backwards using a wooden pole to prop each cage at 
a 45° angle (see Figure 2.5.A). 
Confinement Mice were confined in a wire mesh ventilated cup (10cm height x 8cm 
diameter) within their homecage. The confinement permitted animals to 
turning within the cup, but prevented free movement within the 
homecage (see Figure 2.5.B). 
Water bath Each cage was completely emptied and 1cm (125ml) of water at a 
temperature of 20°C was added (see Figure 2.5.C). 
Predator odour 3ml of 100% fox urine (Wildlife Research Centre, Amazon, UK) was 
sprayed onto paper towel, which was repeated four times. Paper towel 
was then placed in each corner of the room. 
Predator sound Recordings of birds of prey cries were broadcasted in the room 
(Birdsong CD: Birds of Prey and Crows, Music Digital 2009). 
Wet nesting 
material 
125ml of water at a temperature of 20°C was equally distributed over all 
the sawdust and nesting material throughout the cage. 
Empty cage  All sawdust, nesting material and the white cardboard house was 
removed from the cage. 
Remove some 
nesting material 
Sawdust and white cardboard house left undisturbed, but all other 
nesting material was removed. 
New sawdust All sawdust was removed and replaced with 250ml (one beaker) of 
fresh sawdust. 
New nesting 
material, no house 
All nesting material was removed and replaced. The white cardboard 
house was removed. 
Nest disruption The structure of the nest was destroyed by equally distributing the 
nesting material throughout the entire cage. 
New nesting 
material and house 
All nesting material and white housing was removed and replaced. 
Return to home 
cage with intruder 
odour 
This stressor follows directly on from cage swap, where each animal 
was placed into the homecage of an intruder and vice-a-versa. 
Light pulses Lights were automatically timed to switch on and off at one-hour 
intervals throughout the dark phase of the light: dark cycle. 
 
Based on a protocol from Nollet M, et al. (2013). Models of Depression: Unpredictable Chronic Mild Stress in 



























Figure 2.5. Photographs representing three of the stressors used in the unpredictable 
chronic mild stress and isolation (UCMSI) protocol  
(A) Photographic representation of cage tilt. Cages were tilted at a 45° angle using wooden 
poles to position them. (B) Photographic representation of confinement. Mice were restrained 
in a wire mesh ventilated cup. Water bottles were placed on top of the wire cups to prevent 
animals from tipping them over and escaping. (C) Photographic representation of water bath. 








Table 2.2. Unpredictable chronic mild stress and isolation (UCMSI) weekly stressor schedule 
 
Week Day Stressor 1 Duration Start 
time 
Stressor 2 Duration Start 
time 
Stressor 3 Duration Start 
time 
Stressor 4 Duration Start 
time 




Tuesday  Cage tilt 30 min 10:00 Wet nesting 
material 
2h 10:30 New nesting 
material and 
house 
2h+ 12:30 Predator sounds  30 min 16:30 
Wednesday Water bath 30 min 11:00 New nesting 
material/no house 






30 min 11:00 Cage swap 2h 11:30 Return to home 
cage with intruder 
scent 
+ 13:30 Cage tilt 2h 15:30 
Friday Weight and 
coat state 
2h 10:00 Nest disruption 3h 12:00 Confinement 2h 15:00 Remove nesting 
material  
+ 17:00 





















































* Mice were exposed to a variety of four mild stressors on a daily basis between the hours of 10:00 and 18:00, except on weekends when mice were exposed to night-time light pulses only between 21:00 
and 05:00. The stress regime lasted a total of six weeks, during which the stressors, and the order in which they were carried out varied on a daily basis exactly as detailed. Different stressors are colour 
coded to reflect the unpredictable nature of the paradigm. However, the overall detailed schedule remained the same for each week of stress exposure.  
 
+ No specified time, exposure lasts until next day 
 
Abbreviations: h, hour; min, minutes 
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2.3.1.1.  Body weight  
 
In both experiments body weight was reported as absolute body weight, as a 
percentage weight change relative to baseline. Baseline measures for Experiment 1 
were taken on the day of arrival, and subsequent measurements were obtained on a 
weekly basis for a period of six weeks (see Figure 2.3). Baseline measures for 
Experiment 2 were taken three weeks after arrival, on the Friday before the start of 
UCMSI. Body weight was subsequently measured weekly for six weeks, and then bi-
weekly for a further six weeks (see Figure 2.4). All body weight measures were 
taken on a Friday between 10:00 and 12:00 for all animals. 
 
2.3.1.2.  Food intake 
 
Food intake was also measured and reported as an absolute change in the amount 
of food consumed. Specifically, food pellets were weighed before, and after, a 24h 
period starting at 10:00. Food inside the cage at baseline measurement was 
discarded, but any food found inside the cage post testing was weighed and included 
in this measurement as it may have fallen into the cage from the food hopper, or 
been pulled into the cage by the mouse during the measurement period. For animals 
housed in sibling pairs, food intake was averaged out across the pair. In Experiment 
1, food intake was measured weekly (Thursday/Friday) during the first six weeks of 
stress exposure alongside body weight assessment (see Figure 2.3). In Experiment 
2, food intake was measured on a bi-weekly basis for a period of six weeks together 
with the SPT (see Figure 2.4 and 2.3.2.3.2.1). 
 
2.3.1.3.  Coat state assessment  
 
The quality of a rodent’s coat state is thought to be a function of the frequency and 
extent of grooming behaviour, and as such acts as a measure of the animal’s 
motivation toward self-centered activities (Yalcin et al. 2005; 2008). UCMS exposed 
animals typically show signs of diminished grooming ability compared with control 
animals (Kalueff & Tuohimaa, 2004a;b; Nollet et al. 2013), and given that attenuated 
motivation towards appropriate self care is a symptom of MDD (see 1.1.1 and Table 
1.2), it was used as an outcome measure in Experiment 2 only. Given (a) the lack of 
published evidence supporting a change in coat state in isolated and injected 
animals, and (b) the vast number of readouts already measured, it was deemed 
unnecessary to expose animals to another measure in Experiment 1.  
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Coat state was evaluated using a protocol established by Nollet and colleagues 
(2013), which was subsequently validated in male BALB/c mice by Khemissi and 
colleagues (2014). Specifically, six body areas were evaluated: head, neck, back, 
abdomen, forepaws and hindpaws, by an experimenter blinded to the animal’s group 
and stress exposure.  For each area, a score of 0 was given for a well-groomed coat, 
0.5 for a moderately groomed coat, and 1 for an unkempt coat. Individual scores for 
all body parts were combined to obtain a global coat state score, with a maximum 
possible score of 6. Figure 2.6 highlights the body regions of interest, and provides a 
representative example of a well groomed versus an unkempt animal, and 
associated scoring. Coat state condition was only evaluated in Experiment 2, in 
parallel with body weight assessment on either a weekly or bi-weekly basis (see 
Figure 2.4).  
 
2.3.2.  Behavioural assessment  
 
2.3.2.1. General conditions 
  
Given that several housing and test environment factors can impact behavioural 
performance (Crabbe et al. 1999; Wahlsten et al. 2003) behavioural conditions were 
standardised across all experimental groups for both experiments. Specifically, no 
husbandry procedures were performed before, or on, the day of behavioural testing 
as cage changing can typically increase general activity and stress levels in rodents 
(Van Loo et al. 2004; Bailey et al. 2006; Crawley, 2007). Moreover, to further 
minimise stress the same experimenter, familiar to all animals following repeated 
handling, carried out all behavioural testing, under stringent environmental control, 
using standardised test procedures each of which will be described in subsequent 
subsections. All behavioural testing, with the exception of the SPT, was performed 
during the light phase of the light: dark cycle between 08:00 and 15:00, and a 
minimum 24h period of rest was included for each animal between rounds of testing 
as per recommendations (Paylor et al. 2006; Lad et al. 2010). For each behavioural 
test, the test order of mice was altered so that the same animal was not tested in the 
same order every day to control for test order effects/influences on performance. 
Moreover, all animals were allowed to habituate to the experimental room for at least 
1h before testing as per recommendations (Bailey & Crawley, 2009). During testing, 
all animals were placed in the same start location within each test, and after each 
trial, boli and urine were removed from the test arena, which was subsequently  
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Figure 2.6. Coat state assessment  
The coat state score is determined by the qualitative scoring of coat condition for various 
parts of the body as depicted in the photographic images. Individual scores of 0 (for smooth 
and shiny fur without piloerection or patches), 0.5 (for slightly piloerected fur) and 1 (for 
piloerected, dirty and stained fur) are assigned to each region and combined to provide a 
global coat state score. (A) Photograph of a non-stressed animal. In this example, as 
highlighted by the orange circle, the animal scores 0.5 for the neck and 0 for all other body 
parts. (B) Photograph of a stressed animal. In this example, as highlighted by the orange 
rings, the animal scores 1 for the head, neck and back, 0.5 for the abdomen (not visible in the 
image), and 0 for other body parts, obtaining a global score of 3.5.    
 
Image taken from Nollet et al. (2013). Models of Depression: Unpredictable Chronic Mild Stress 








cleaned with 1% Anistel® solution (Tristel Solutions Ltd, Suffolk, UK). Light levels 
were task specific (described in each test in subsequent subsections), but remained 
constant, within each test, for all experimental groups. All tests were recorded using 
a camera positioned above the test arena, and for some tests the animal’s 
movement was tracked using EthoVision software (Noldus Information Technologies, 
Wageningen, The Netherlands). For manual scoring of behaviour, experimenters 
were blinded to animal group and stress exposure, and behaviours were recorded by 
pressing keys on a keyboard, which had been assigned to specific behaviours in 
EthoVision. At the end of testing, mice were returned to their home cage, and then to 
the housing room. 
 
2.3.2.2.  Behavioural schedules 
 
For both Experiments 1 and 2 behavioural batteries were performed as these 
combine a number of tests to acquire information more efficiently than with single 
tests, drastically reducing the number of animals required. Test batteries that 
combine well-established, robust tests of behaviour allow us to extract latent traits 
that may better represent the underlying construct and be less affected by test-
specific or laboratory-specific effects. In addition, the battery will include several 
models of complex behaviour, further refining the behavioural assessment of the 
mice (Powell et al. 2012). The order of testing was carried out as per 
recommendations (Deacon, 2006; Lad et al. 2010), starting with the tasks requiring 
maximal levels of novelty (anxiety tests) and ending with the most stressful tasks. 
Figures 2.7 and 2.8 show the precise weekly schedules for each experiment. 
Essentially, each behavioural battery comprised of 6-7 different assays. The test 
conditions and assays used were identical across both experiments, except that 
Experiment 2 included an additional assay to measure social interaction, since 
sociability is also one of the domains affected in depression (see Table 1.2). Based 
on the findings of Experiment 1, and given that so few studies have included this 
measure, it seemed pertinent to include and expand on the behavioural 
characterisation of the UCMSI model. 
 
2.3.2.3.  Behavioural assays 
 
As discussed in subsection 1.3.2.1, and summarised in Table 1.2 several 
behavioural outputs exist, all of which are thought to be analogous to a specific 
symptom, or feature of clinical depression. In this PhD thesis, multiple assays were  
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Figure 2.7. Behavioural test order and schedule for Experiment 1 
Animals in Experiment 1 underwent three weeks of behavioural testing after six weeks of 
exposure. Mice were assigned to one of two batches, randomly comprising of half of the 
animals from each experimental group, as not all animals could be tested in one day. Each 
task was carried out over a two-day period to give animals 24h to recover before the next 
test, and testing was performed between 08:00 and 15:00. The schedule began with testing 
for anxiety-like behaviours, which require novelty, using the Open Field Test (OFT), and 
ending with the most stressful task, that is, the Forced Swim Test (FST). Moreover, whole 
blood was collected to measure corticosterone levels and stress responsivity, and as such 




A; B: Groups were randomised into two batches so that testing could be carried out over two days and allow animals to rest for one 
day between tests; half of each group was assigned to either batch A or B. 
B1: First blood collection carried out 24h prior to the FST 
B2: Second blood collection carried out 30 minutes after the FST, to measure stress response 
 
OFT, Open Field Test; SPT, Sucrose Preference Test; NSFT, Novelty Suppressed Feeding Test; FST, Forced Swim Test 






and social hierarchy: 
1. Olfaction 
2. Dominance 





EXPERIMENT 1: Behavioural Testing Order and Schedule 
Behavioural Test Schedule  
Week Behavioural task MONDAY TUESDAY WEDNESDAY THURSDAY FRIDAY 
1 OFT 09:00-15:00 A 09:00 – 15:00 B    
1 SPT   10:00-13:00  19:00 – 09:00  19:00- 09:00 
2 OLFACTION 09:00-15:00 A 09:00 – 15:00 B    
2 DOMINANCE   14:00 -15:00 14:00- 15:00  14:00- 15:00 
3 NSFT 09:00-15:00 A 09:00 – 15:00 B    
3 B1   08:30-12:00 A 08:30-12:00 B  




Figure 2.8. Behavioural test order and schedule for Experiment 2 
After twelve weeks of UCMSI, all animals underwent behavioural testing that lasted three 
weeks. During each round of testing, each task was carried out within a single day, and 
animals were given 24h to recover before the next test. As such, testing was performed every 
second day, between 08:00 and 15:00. The behavioural schedule began with testing for 
anxiety-like behaviours, using the Open Field Test (OFT), and ending with the most stressful 
task, that is, the Forced Swim Test (FST). Moreover, whole blood was collected to measure 
corticosterone levels and stress responsivity, and as such was collected 24h before, and 30 






















EXPERIMENT 2: Behavioural Testing Order and Schedule 
B1: First blood collection carried out 24h prior to the FST 
B2: Second blood collection carried out 30 minutes after the FST, to measure stress response 
 
OFT, Open Field Test; SPT, Sucrose Preference Test; SI, Social Interaction; NSFT, Novelty Suppressed Feeding Test; FST, Forced 
Swim Test 
Behavioural Test Schedule 
Week Behavioural 
task 
MONDAY TUESDAY WEDNESDAY THURSDAY FRIDAY SATURDAY 
1 OFT 09:00-15:00       
1 DOMINANCE  14:00-15:00  14:00-15:00  10:00-11:00 
2 SPT 09:00-13:00 19:00-09:00 19:00-09:00    
2 SI    09:00-15:00   
2 OLFACTION      09:00-15:00 
3 NSFT 09:00-15:00      
3 B1   08:30-12:00    
3 FST and B2    08:00-12:30   
 
WEEK 2 WEEK 3 
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used to obtain a more comprehensive view of any behavioural disturbances 
associated with stress exposure, the findings of which formed part of the behavioural 
characterisation process of this thesis.  
 
2.3.2.3.1.  Assessing anxiety-like behaviour 
 
2.3.2.3.1.1.  The Open Field Test 
 
The Open Field Test (OFT) is based on the approach/avoidance conflict between the 
animal’s tendency to explore a novel area, and its avoidance of the aversive nature 
of the exposed, novel environment. Developed for use in rats (Hall, 1951), and later 
mice (Christmas & Maxwell, 1970), rodents tend to avoid the central zone of the 
arena, staying in close contact with the walls (thigmotaxis) of the arena (Candland & 
Nagy, 1969; Webster et al. 1979), and as such, avoidance of the central zone has 
been used as a measure of anxiety induced by exposure to a novel environment.   
 
In both experiments, the OFT was carried out as previously described by Gould  
(2009).  Mice were placed in the outer zone of a 40cm diameter round arena, evenly 
illuminated with white light (10 lux) for ten minutes (see Figure 2.9.A.i;ii). The arena 
was virtually divided into three zones: the centre zone (20cm diameter), inner zone 
(30cm diameter) and the remaining outer zone (see Figure 2.9.A.iii), using 
EthoVision software (EthoVision Program 3.1, Noldus, Wageningen, The 
Netherlands). EthoVision was used to determine the number of entries into, time 
spent in, and latency to enter, the centre zone of the arena. In addition, the total 
distance travelled in the outer zone, the least anxiogenic zone of the arena, was also 
assessed as a measure of locomotor activity (Lad et al. 2010). 
 
2.3.2.3.1.2.  The Novelty Suppressed Feeding Test  
 
The Novelty Suppressed Feeding Test (NSFT) is thought to reflect both anhedonia 
and anxiety-like behaviour, as food restricted mice are placed into a situation where 
their desire to eat conflicts with avoidance of a novel, potentially threatening 
environment (Powell et al. 2012). As with all anxiety-based assays, most mice will 
avoid the brightly lit centre, but feeding in this environment is used as a measure of 





Figure 2.9. The Open Field Test and the Novelty Suppressed Feeding Test 
(A) The Open Field Test; (I) Photograph of the open field arena and camera positioning. (II) Close up 
of the arena. (III) The arena was divided into three zones using Ethovision software, an outer, inner and 
centre zone. Animals were placed directly into the arena, all in the same position: in the outer zone, 
facing the wall, as depicted in the schematic. Number of entries, latency to enter, and duration of time 
spent, in the centre zone were all measured during the ten-minute test using Ethovision. (B) The 
Novelty Suppressed Feeding Test; (I) Photograph of the test arena, which was a large rectangular 
acrylic cage filled with 3cm of fresh sawdust. (II) Photographs depicting how the food pellet was fixed to 
white card to prevent the animals from taking the food away from the centre to less anxiogenic outer 
parts of the arena. Two small holes were drilled into a plastic petri dish, through which an elastic band 
was threaded. The elastic band was then threaded through the white card and tied to create a loop at 
the top through which the food pellet could be firmly held. (III) Schematic showing overall set up. The 
food pellet attached to the white card was positioned directly in the centre of the brightly lit arena (300 
lux). The mouse was placed into the arena as depicted and the latency to feed manually recorded over 
a five-minute period. (IV) Photograph taken from Samuels & Hen (2011) showing live testing.      
III. 
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Mouse starting position  
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In both experiments, the NSFT was implemented as previously described (Samuels 
& Hen, 2011). Mice were food restricted, but not water restricted, 24h prior to testing, 
and were then placed into a brightly lit open arena (59.5x38x20cm; 300 lux) for five 
minutes, with a food pellet positioned on white card (13x8cm), fixed in place, in the 
arena centre (see Figure 2.9.B).  Latency to feed, and food consumption in the 
arena was manually measured by weighing the pellet before and after testing, both of 
which were used to determine anxiety-like behaviour. Animals that did not feed in the 
arena scored a maximum latency (300 seconds). After each trial, mice were returned 
to their homecage and food consumption in the homecage was subsequently 
measured, for an additional five minutes, to assess anhedonic-like behaviour in a 
familiar environment, again by weighing food pellets after testing. Moreover, 
locomotor activity for each mouse was assessed by measuring the number of 
crossings over the centre of the arena within a one-minute time frame to account for 
any locomotor-related effects. Finally, mice were also weighed before food 
deprivation and directly after testing to control for the effects of body weight loss on 
behavioural performance. Increased latency to feed and reduced food consumption 
in the homecage represented increased anxiety-like and anhedonic-like behaviour in 
this task. 
 
2.3.2.3.2.  Assessing anhedonic-like behaviour  
 
2.3.2.3.2.1.  Sucrose Preference Test 
 
The Sucrose Preference Test (SPT) essentially measures a rodent’s appetite for a 
highly palatable, rewarding substance (sucrose), with decreased intake and/or 
preference for the palatable solution an indication of hedonic deficit (Willner et al. 
1992; Bessa et al. 2013). 
 
In both experiments, SPT was performed based on a protocol established in BALB/c 
mice (Jorgensen et al. 2014), and was conducted over a 48h period. However, in 
Experiment 1 the SPT was done only once, as part of the behavioural battery (see 
Figures 2.3 and 2.7), while in Experiment 2 the SPT was carried out on five 
occasions; once as a baseline measure two days before UCMSI, then bi- weekly for 
six weeks during UCMSI to confirm the effects of stress exposure, and then finally 
once as part of the large behavioural battery to determine the long-term effects of 
UCMSI on anhedonic-like behaviour, as in Experiment 1 (see Figures 2.4 and 2.8). 
The running measure of the SPT was validated by pilot work run alongside 
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Experiment 1 (see 2.3.2.3.2.1.3).   
 
2.3.2.3.2.1.1.  General protocol  
 
The day before testing, mice were habituated to a 2.5% sucrose solution (made with  
99.9% sucrose granules; Sigma-Aldrich, Poole, UK) for four hours starting at 09:00. 
Following baseline habituation, starting and ending at 10:00, animals were 
subsequently given a free choice between two bottles, one with 1% sucrose solution 
and another with fresh tap water for a period of 48h (see Figure 2.10). The positions 
of the bottles in each cage were switched 24h into testing to minimise any possible 
effects of side-preference on drinking behaviour. The consumption of water, sucrose 
solution, and total liquid intake was subsequently measured in all experimental 
groups by weighing all bottles before and after testing. The preference for sucrose 
was calculated as a percentage of the consumed sucrose solution relative to the total 
amount of liquid (water and sucrose solution) drunk. For animals housed in sibling 
pairs, sucrose preference was represented as an average for the pair. Mice were not 
restricted of food or water before each test, and to ensure that food consumption was 
not influencing sucrose consumption, food intake was also measured as previously 
described (see 2.3.1.2).   
 
2.3.2.3.2.1.2.  Spillage control 
 
To account for any spillage during testing, ‘spillage tests’ were carried out during 
each SPT trial. For example, liquid may have been spilled when the bottles were 
added and removed from the cages, and/or when the cages were moved. Three 
spillage cages, each with a sucrose and water bottle whose position was alternated 
midway through testing, were set up for each rack. Spillage cages were positioned 
randomly in different areas of the rack and bottles were weighed before and after 
each SPT trial to estimate liquid spilled. An average spillage for water and sucrose 
was estimated for each test day, and was subtracted from animal consumption rates, 
which provided a more real measure of sucrose and water consumption.  
 
2.3.2.3.2.1.3.  Pilot study for establishing a repeated sucrose preference test  
 
Before committing to conducting a repeated SPT, I needed to be sure that such an 
approach would work, and ensure that preference levels would be maintained across 


























Figure 2.10. The Sucrose Preference Test 
(A) Photograph of standard set up for pair-housed animals. Bottles were situated in the centre 
of the hopper and food was positioned inside the cage at the back equidistant from the 
bottles. Coloured stickers distinguished sucrose bottles from water bottles. (B) Photograph of 
standard set up for singly housed animals, with the exception of food pellets, which were 
stored inside cages at the back. This image was captured for demonstration purposes only, 
which is why food is visibly seen in the hopper.  (C) Photograph of rack on days of SPT. 
Three spillage cages, one of which can been seen, were randomly placed in each rack to 
measure any sucrose solution and water spillage caused when placing the bottles in the cage 








detailed in subsection 2.3.2.3.2.1.1. Briefly, test subjects were male, littermate 
BALB/cAnNCrl mice aged 7-8 weeks (n=10). Mice were pair housed in conditions 
specified in subsection 2.2.2 and were allowed to acclimatise to the BSU for one 
week before being used in the pilot study. First, mice were habituated to a 2.5% 
sucrose solution 24h prior to testing. The following day, mice were exposed to two 
bottles: a 1% sucrose solution, and tap water, and a baseline sucrose preference 
measure was obtained. On a bi-weekly basis, over a six-week period, mice were re-
tested and sucrose preference measures were obtained. As illustrated in Figure 
2.11, these non-stressed mice had an average baseline sucrose preference of 63%, 
which was maintained across the six weeks, with no significant differences observed 
over time (M: 63-66%; F [3,36] = 0.4, p = .75).  
 
2.3.2.3.3.  Assessing fatigue and/or behavioural despair 
 
2.3.2.3.3.1.  The Forced Swim Test  
 
The Forced Swim Test (FST), which was developed originally in rats (Porsolt et al. 
1977) and later in mice (Lucki, 1997; Lucki et al. 2001), is another commonly used 
behavioural assay. In both experiments, the FST was used as both a behavioural 
readout, and as an acute stressor to measure stress responsivity, and the protocol 
was carried out as previously described (Lucki, 1997; Lucki et al. 2001). Briefly, mice 
were introduced to a clear perspex cylinder (50x15x15cm) filled with 40cm of water, 
at room temperature, evenly illuminated with white light (10 lux), for six minutes (see 
Figure 2.12.A;B). Behaviour during the test was recorded and manually scored 
using Ethovision (Ethovision Program 3.1, Noldus, Wageningen, The Netherlands). 
Behavioural parameters, which included swimming, struggling, and immobility (see 
Figure 2.12.C for details) were all assessed with the latency, frequency and duration 
for each parameter, except swimming for which only duration, was manually 
recorded. Increased immobility duration in the FST represented increased fatigue 
and/or behavioural despair.  
 
Given that the FST was used to also measure responses to acute stress, unlike other 
assays, which were carried out between 09:00 and 15:00, the FST was conducted 
between 08:00 and 12:00 in both experiments. This was to minimise the effect of 
diurnal variation on blood sampling as per recommendations, with the morning being 






















Figure 2.11. Pilot study: sucrose preference across a six-week period in control 
animals 
Stress free control animals had a minimum sucrose preference of 63%, which was 
maintained across the six-week testing period.  
 
 
Data represents mean ± SEM     
Subjects: adult male BALB/c mice 
Sample size: n=10 
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Figure 2.12. The Forced Swim Test  
(A) Photograph of standard set up, which consisted of a clear perspex cylinder filled with 
water, positioned against a dark background, with the camera angled directly in front of the 
cylinder. (B) A close up of a live test captured from the computer. (C) Schematic 
representation of the types of behaviour typically observed and scored in this assay. 
Essentially, mice will either (i) float or become immobile, as defined by an absence of 
movement except that necessary to keep afloat; (ii) swim in circles, as defined by a horizontal 
posture with limb movement; and/or (iii) struggle, as defined by a vertical posture with limb 
movement.  
 
Image C adapted from Cryan JF, et al. (2002). Assessing antidepressant activity in rodents: recent 







(C) Schematic representation of the types of behaviour typically observed and scored in 
this assay. Essentially, mice will either swim in circles, as defined by a horizontal posture 
with movement; struggle, as defined by a vertical posture with movement; and/or float or 
become immobile, as defined by an absence of movement. (C) Schematic representation 
of the types of behaviour typically observed and scored in this assay. Essentially, mice will 
either swim in circles, as defined by a horizontal posture with movement; struggle, as 
defined by a vertical posture with movement; and/or float or become immobile, as defined 
by an absence of movement. 
A. B. 
C. 
(ii) Swimming (iii) Struggling (i) Immobility 
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1967; Dunn et al. 1972). To assess stress responsivity, two blood samples were 
collected over a two-day period. A baseline measure was collected 24h prior to FST 
testing, and another sample was collected 30 minutes after FST testing, a time-point 
at which corticosterone levels in mice are at their highest peak following acute stress 
(Thoeringer et al. 2007; Gong et al. 2015).  Details on blood collection, storage and 
processing will be provided in subsections 2.4.1 and 2.4.2. 
 
2.3.2.3.4.  Assessing sociability 
 
Based on the findings from Experiment 1, social functioning was additionally 
assessed in Experiment 2. 
 
2.3.2.3.4.1.  The social interaction test 
 
Social behaviours were assessed based on two protocols previously used in mice 
(Winslow, 2003; McFarlane et al. 2008), in which the interaction of experimental 
animals with an unfamiliar, sex-matched juvenile conspecific was observed. 
Conspecifics were male, non-littermate BALB/cAnNCrl mice aged 4-5 weeks (n=10) 
Juveniles were singly housed in conditions specified in subsection 2.2.2 and were 
allowed to acclimatise to the BSU for one week before being used in the social 
interaction test (SI).  In this test, all mice were weighed, paired mice were separated, 
and all animals were subsequently transferred to a small Techniplast ‘test’ cage 
(32x16x14cm) with a 1cm layer of clean sawdust, without access to food and water. 
Animals were left to habituate to these conditions, and to the test room for one hour. 
After habituation, a juvenile conspecific mouse was placed into each test cage, which 
was evenly illuminated with white light (10 lux) (see Figure 2.13). Animal behaviour 
between the test subject and conspecific was recorded over a five-minute period, 
and five main behaviours were later scored, as described in Figure 2.13. 
Specifically, the total amount of time spent exhibiting each type of behaviour, that is, 
investigative, play soliciting, affiliative, aggressive and non-social behaviour, was 
manually measured for each animal. Conspecifics were re-used throughout testing 
for each of the study animals, and as such, each conspecific was exposed to four 





Figure 2.13. The Social Interaction Test 
(A) Photograph depicting the standard set up of the social interaction test (SI). The camera 
was positioned directly above the test cage (not visible in image). (B) Photograph of study 
animals habituating to test room and to pre-test conditions. All animals were transferred from 
their homecage and were individually housed for one hour without food and water. (C) 
Schematic representation of SI. Study animals were placed facing away from the wall in the 
top part of the test cage. At the same time juvenile conspecifics were placed at the other end 
of the test cage, also facing away from the wall. Animals were then left undisturbed for five 
minutes, during which behaviour was recorded and later scored. (D) Description of the types 
of behaviour scored in the SI as stratified by category.  
 
Zone 1: Study Animal 









Types of social 
behaviour* 
Description* 
Investigative 1. Sniffing of the conspecific’s anogenital region 
(anogenital sniff), head and snout (nose-to-nose 
sniff), and/or any other part of the body (body 
sniff). 
2. Following conspecific around the cage without 
any fast, sudden or running movements. 
Affiliative 1. Grooming the conspecific on any part of the 
body (allogrooming). 
2. Close physical contact while lying or standing 
still. 
3. Close physical contact while engaged in self-
directed behaviours such as, grooming. 
Play soliciting 1. Pushing underneath the conspecific’s anterior 
body area  
2. Pushing between the conspecific and test arena 
wall. 
3. Traversing over the conspecific’s body by 
crawling over the back from one side to the other.  
4. Traversing the conspecific’s body by crawling 
under from one side to the other. 





2. Investigating the test arena 
3. Digging 
 
*Based on parameters described in previously published protocols (1) and (2). 
  
(1) Winslow JT (2003). Mouse social recognition and preference. Current 
protocols in neuroscience / editorial board, Jacqueline N. Crawley ... [et 
al.], Chapter 8, Unit 8.16.  
(2) McFarlane HG, et al.  (2008). Autism-like behavioral phenotypes in 




2.3.2.3.5.  The importance of olfaction and social status 
 
Dominance and subordination in mice have been shown to result in several 
behavioural and physiological alterations (Ader et al. 1991; Hurst et al. 1996; 
Bartolomucci et al. 2001; Fiore et al. 2003; Kozorovitskiy & Gould, 2004; Davis et al. 
2009; Aghajani et al. 2013). To assess whether dominance status could potentially 
confound behavioural phenotypes seen in pair-housed animals, social hierarchy 
status for each pair was ascertained. Moreover, olfaction, which is essential for a 
wide range of rodent behaviour, including social interaction, mate choice, food choice 
and intake, and navigation (Doty, 1986; Keverne, 2004; Restrepo et al. 2004; 
Kavaliers et al. 2005), was likewise assessed in both experiments for all animals.   
 
2.3.2.3.5.1.  Dominance tube test 
 
To determine which of the pair housed siblings was dominant; a protocol established 
in mice was used as previously described (Lindzey et al. 1961). Briefly, sibling pairs 
were placed head first at opposite ends of a clear plastic tube (30x3.3x3.5cm), set up 
in an arena evenly illuminated with white light (10 lux), and mice were then 
simultaneously released. Dominant animals were recognized as those that forced the 
subordinate completely out of the tube within two minutes. Three trials of the 
dominance tube test were performed for each pair over the course of three days.  
Figure 2.14.A shows how the assay was set up for each trial.  
 
2.3.2.3.5.2.  Cookie/food burying test 
 
To ensure that no impairment in olfaction (anosmia) may be influencing behavioural 
performance in the SI, SPT and NSFT, the cookie/food-burying test was conducted 
as previously described (Yang & Crawley, 2009). Briefly, mice were placed into the 
bottom part of an evenly illuminated (10 lux) Tecniplast cage (32x16x14cm), with a 
3cm level of sawdust. All animals were left to habituate to the test arena for five 
minutes, after which they were temporarily removed and returned to their homecage. 
A small cookie (Nestle Cookie Crisp®, Welwyn Garden City, U.K.) was then 
randomly buried to a depth of 1cm in the top section of the cage in one of three 
positions as illustrated in Figure 2.14.B. Animals were subsequently returned to the 
test arena and the latency to find the buried cookie was visually observed over a 
maximum period of fifteen minutes. Mice unable to locate the cookie within the time  
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Figure 2.14. Dominance Tube Test and Cookie/Food Burying Test 
(A) Dominance Tube Test: (I) Photograph of standard set up. A plastic tube was taped down 
across the open arms of an elevated plus maze to support and prevent movement of the 
tube, and to ensure a standardised set up each time. (II) Schematic representation of the test. 
Sibling pairs were placed at each end of the tube and simultaneously released as depicted. 
The dominant animal would push the subordinate out of the tube within two minutes. (B) 
Cookie/Food Burying Test: (I) Photograph of standard set up. (II) Schematic representation 
of the cookie/food burying test, which essentially measures how quickly an animal can find a 
familiar small cookie piece. The cookie piece was buried in one of three positions in the 
cookie zone area. Mice were placed in the empty zone as depicted, and the latency to find 
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period were likely to have some deficit in olfactory ability. For each trial a new test 
arena was used, and the cookie location alternated between the three positions 
randomly throughout testing. For this test, mice were habituated to the cookie pieces 
on a daily basis for a week prior to testing to avoid any neophobia, and animals were 
not restricted of food or water before testing. 
 
2.4.  Biochemical assessment  
 
In addition to behaviourally characterising each stress model, several biochemical 
outcomes were assessed under the second aim (see 1.4.1.1.2 and 1.4.2.1.2) of 
Experiments 1 and 2. Specifically, plasma levels of corticosterone and inflammation 
were assessed for all experimental groups. 
 
2.4.1.  Blood sampling 
 
Blood was sampled at two time points in the final week of behavioural testing for all 
animals in both experiments (see subsection 2.2.2, Figure 2.7 and Figure 2.8). 
Blood sampling at both time points took place between 08:30 and 12:30, and more 
specifically 24h before, and 30 minutes after, the FST (see 2.3.2.3.3.1). To control for 
diurnal variation the sampling order was randomised across experimental groups, 
and to minimise the confounding effects of the procedure itself on corticosterone 
measures, all blood samples were collected within three minutes, before activation of 
the HPA axis (Davidson et al. 1968) for all animals. Before sampling, animals were 
removed from the housing room, or test room, and were habituated just outside the 
procedure room for 30 minutes. After this time, whole blood was subsequently 
collected by incision method from the lateral tail vein as previously described (Hoff, 
2000; Sadler & Bailey, 2013). Briefly, a small incision using a sterilized razor blade 
was made along the lateral tail vein, and whole blood droplets were collected into 
microvette CB 300 tubes (Sarstedt, Leicester, UK). Animals were returned to their 
homecage, but remained in the procedure room until all animals had been bled, to 
prevent the smell of blood from stressing any animals awaiting sampling.   
 
2.4.2.  Blood processing and storage 
 
Plasma was prepared from the whole blood samples following centrifugation for 10 
minutes at 4°C, at 3,000rpm. Plasma samples were divided into two aliquots for the 
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subsequent measurement of corticosterone and inflammation, that is, cytokine levels 
(see subsections 2.4.4 and 2.4.5) and stored at -80°C.  
 
2.4.3.  Biological samples and technical replicates 
 
All biological samples, whether for corticosterone or inflammation were measured in 
duplicate. For all biological measures, samples from each stressor group were 
randomised across the assay plates to avoid batch effects. For a representative 
example of the assay plate layout for both Experiments 1 and 2 see Table 2.3. In 
order to ascertain the precision, or reproducibility, of any of the immunoassay test 
results, the intra-assay coefficient of variation (CV), that is, technical replicate 
consistency, was calculated for each immunoassay in both experiments (i.e., 
SD/mean). Biological samples with a CV above 15% were repeated, or otherwise 
excluded from further analyses as per recommendations (Bielohuby et al. 2012).  
Inter-assay variability, that is, plate-to-plate consistency, was reported to be below 
the recommended 10% CV for all commercial kits used across both experiments.  
 
2.4.4.  Plasma corticosterone quantification using enzyme immunoassays  
 
Plasma levels of corticosterone were measured using commercially available 
competitive enzyme-linked immunosorbant assay (ELISA) kits (Enzo Life Sciences, 
Lausen, Switzerland), according to the manufacturer’s instructions. Data were 
analysed using a four parameter logistic algorithm to derive concentrations of 
corticosterone samples from known standards using the “my assays” online data tool 
(MyAssays Ltd., http://www.myassays.com/four-parameter-logistic-curve.assay). For 
representative examples of the standard curve for corticosterone see Appendix 2.1. 
 
2.4.4.1.  Corticosterone ELISA protocol 
 
Briefly, 10µl of each plasma sample was diluted 1:40 with steroid displacement 
reagent and ELISA buffer. Next, five corticosterone standards were made from a 
200ng/ml corticosterone standard solution using a serial dilution method, thereby 
generating five corticosterone standards of 20, 4, 0.8, 0.16 and 0.032 ng/ml. Blank 

















Table 2.3. Representative example of commercial kit plate layout for Experiment 1 
showing total number of biological samples and technical replicates per mouse, and 
the random sample arrangement based on experimental group  




























































































































































































Each mouse had two biological samples, each with a technical replicate. Animals were arranged randomly across the 
plate, such that five animals per group were assigned per plate for Experiment 1.  The standard curve and blank 
were always on the left side of the plate.  
 
B, Blank sample; Std, standard curve sample; S, biological sample; S1 pre-FST sample; S2, post-FST sample; M, 















onto the ELISA microtitre plate pre-coated with corticosterone antibody (donkey anti-
sheep IgG). Corticosterone conjugate, a solution of alkaline phosphatase conjugated 
with corticosterone, and a solution of sheep polyclonal antibody to corticosterone, 
were subsequently added, and the plate incubated for two hours at room 
temperature on a plate shaker moving at 220rpm. After incubation, the plate contents 
were discarded and the plate washed three times with tris-buffered saline. Finally, a 
substrate solution of p-nitrophenyl phosphate was added, and the plate was 
incubated at room temperature without shaking for one hour, before being terminated 
with a stop solution of trisodium phosphate. Absorbance was immediately read at a 
wavelength of 405nm using a DTX 880 Multimode Detector (Beckman-Coulter). 
 
2.4.5.  Plasma cytokine and growth factor measurement 
 
A panel of ten analytes based on the literature (see subsection 1.2.2.2) were 
simultaneously measured using the multiplex screening assay based on magnetic 
Luminex® xMAP® technology as described by Hye and colleagues (2014). 
Specifically, eight inflammatory markers (interleukin (IL) 1β, IL2, IL4, IL6, IL10, IL12, 
tumour necrosis factor (TNF) α, and C-reactive protein (CRP) were measured. In 
addition, two growth factors, insulin growth factor (IGF)-1 and vascular endothelial 
growth factor (VEGF), which both play a role in neurogenesis and neural plasticity 
(see subsection 1.2.4.5.1.1.), were also assessed.  
 
2.4.5.1.  Multiplex protein quantification using the Luminex platform 
 
In both experiments, custom-made mouse premixed multi-analyte kits were used 
(R&D systems, Minneapolis, USA), according to the manufacturer’s instructions. 
Briefly, 20µl of each plasma sample was diluted 1:5 with calibrator diluent, which was 
a buffered protein base with preservatives. Next, six standards were made by a 1:3 
serial dilution, generating standard curves for each of the ten analytes. Standards 
and samples were then incubated with microparticle cocktail solution, which 
contained ten antibodies to the ten chosen analytes, for two hours, in the dark, at 
room temperature, and on a plate shaker operating at 800rpm. All efforts were made 
to minimise light quenching of the fluorochrome by covering plates with foil 
throughout the procedure. After incubation, the plate was washed three times with 
wash buffer, specifically; buffered surfactant, and samples were subsequently 
incubated with diluted biotinylated detector antibody for one hour as per the first 
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incubation stage. After the second incubation step, the plate was washed as 
previously described, and then incubated with diluted streptavidin-PE solution, which 
was streptavidin conjugated to the fluorescent protein, phycoerythrin, for 30 minutes 
under exactly the same previously described incubation conditions. Finally, the plate 
was then washed, microparticles were resuspended with wash buffer, and the plate 
was read using the Luminex 200 platform. Data were analysed using a five 
parameter logistic algorithm to derive concentrations of samples from known 
standards using the “my assays” online data tool (MyAssays Ltd., 
http://www.myassays.com/five-parameter-logistic-curve.assay). For representative 
examples of the standard curves for each analyte see Appendix 2.1. 
 
2.5.  Histological Assessment 
 
Under the third and fourth aim of Experiment 1, (see 1.4.1.1.3 and 1.4.1.1.4) and the 
second aim of Experiment 2 (see 1.4.2.1.2), changes in microglia and astrocyte 
biology, and alterations in hippocampal neurogenesis, specifically with respect to 
proliferation and the early stages of neuronal differentiation, were all assessed, the 
details of which will be provided in subsequent subsections.  
 
2.5.1.  Anaesthesia, perfusion fixation, and brain collection 
 
One to two days after the final behavioural test, all animals were weighed and 
20mg/ml sodium pentobarbital (Euthatal, Merial Animal Health Ltd, Harlow, UK) was 
administered via i.p. injection, using a 25-gauge needle and 1ml syringe. Once a 
surgical plane of anaesthesia had been reached, as determined by the toe-pinch 
response method (Collier et al. 1961), animals were transcardially perfused as 
described by Gage and colleagues (2012).  
 
2.5.1.1.  Perfusion surgery  
 
A 5-6cm lateral incision through the integument and the abdominal wall just beneath 
the ribcage was made, and the liver was subsequently carefully separated from the 
diaphragm. Then an incision in the diaphragm was made and continued along the 
entire length of the ribcage, exposing the pleural cavity. The lungs were then 
carefully displaced, and a cut through the ribcage up to the collarbone was made on 
each side. The sternum was lifted away, clamped with a hemostat, and positioned 
over the head. In doing so, the thymus lifted away from the heart along the sternum, 
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and provided a clear view of the major vessels. A 25-gauge perfusion needle was 
then pierced through the left cardiac ventricle, and the needle secured to prevent 
movement and/or leakage. Finally, a small incision in the right cardiac atrium was 
then made, at which point the animal was then ready to be perfused.  
   
2.5.1.2.  Perfusion fixation  
 
Briefly, a rapid, controlled and uniform fixation procedure using 4% 
paraformaldehyde (PFA, Sigma-Aldrich, Poole, UK) in 0.1M phosphate-buffered 
saline (PBS, pH 7.4, from PBS tablets, Gibco by Life Technologies, Paisley, UK) was 
performed for each animal. Specifically, 100-200ml of PBS was first flushed through 
the body via the vascular system until the liver become clear, an indication of a good 
perfusion.  At this point, 60-100ml of PFA was subsequently flushed through the 
vascular system to fix all tissues. On average, it took 20 minutes to successfully 
perfuse and fix each mouse. For the PFA recipe see Appendix 2.2.1. 
 
2.5.1.3.  Brain dissection, collection and storage 
 
Once fixed, intact brains were carefully removed as previously described (Gage et al. 
2012). Briefly, the head of each animal was removed from the body, and a midline 
incision along the integument from the neck to the nose was made, exposing the 
skull. Next, two cuts were made starting from the foramen magnum and extending to 
the distal edge of the posterior skull surface, one on either side. The skull around the 
cerebellum was then removed. Next, a cut along the inner surface of the skull from 
the dorsal distal posterior corner to the distal frontal edge was made, again on both 
sides, so that the dorsal surface of the skull could be peeled away from the brain. 
Finally, the brain was then teased away from the head, trimming any dura still 
connecting the brain to the skull, and was placed in a vial of 10ml 4% PFA solution at 
4°C for a 24h period. After this post-fixation period, brains were washed with PBS 
and finally stored in 30% sucrose solution (Sigma-Aldrich, Poole, UK) in PBS for 
cyroprotection, with 0.05% sodium azide (Sigma-Aldrich, Poole, UK) to prevent 
bacterial growth, and kept at 4°C. 
 
2.5.2.  Brain tissue sectioning  
 
One to two months after collection, all brain tissue was sectioned using a Leitz 
freezing microtome (Microm HM430, Carl Zeiss Ltd, Cambridge, UK) as previously 
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described (Bible et al. 2004; Pontikis et al. 2004; Kielar et al. 2007).  Given that the 
work in this thesis focused on changes in the forebrain of the mouse, the cerebellum 
of each intact brain was first removed with a single coronal cut using a sterile razor 
blade (Thermo Fisher Scientific, Loughbrough, UK). Next, since only half of the 
forebrain was used for histological analyses, each forebrain was dissected sagittally 
along the longitudinal fissure, and the right-brain hemisphere was then mounted onto 
the microtome platform, frozen with dry ice, and coronally sectioned at a thickness of 
40µm as depicted in Figure 2.15.A. Coronal sections were subsequently stored in 
six-well plates in an anti-freeze cryoprotectant solution (TBS-AF; 30% glycerol, 15% 
sucrose and 0.05% sodium azide in tris-buffered saline [TBS: 50mM Tris, pH 7.6, 
150mM NaCl]; all Sigma Aldrich, UK), and kept at 4°C, until required for 
immunoperoxidase or immunofluorescent labelling. All cerebellum and left-
hemisphere forebrain tissue was stored for future analysis in 30% sucrose solution 
with 0.05% sodium azide at 4°C. For the TBS-AF recipe see Appendix 2.2.2 
 
2.5.3.  Immunohistochemistry 
 
2.5.3.1.  Free-floating immunoperoxidase labelling 
 
In both experiments, changes in several different proteins expressed in brain tissue 
were measured used free-floating methods. The details for each protein marker are 
given in sections 1.2.3.1.3, 1.2.3.2.2 and 1.2.4.3, and for simplicity, a breakdown of 
the antibodies to these markers, which were used for immunohistochemistry, can be 
found in Figure 2.15.B. For representative images of the various 
immunohistochemical stains see Figure 2.16. 
 
2.5.3.1.1.  General protocol 
 
For all immunohistochemistry a 1 in 6 series of sections were stained, the staining 
protocol was performed over a two-day period, and in each instance, sections from 
eleven mice, and one negative control, that is, tissue sections without primary 
antibody were simultaneously stained. Briefly, sections were washed, and then 
incubated in 1% hydrogen peroxide (H2O2) solution in methanol for 30 minutes at 















Figure 2.15. Immunohistochemistry  
(A) Photographic representation of the coronal sectioning technique. The cerebellum was 
removed from the forebrain, which was then dissected sagittally in two along the longitudinal 
fissure, and subsequently the right hemisphere was sectioned coronally as shown at a 
thickness of 40µm. (B) Table of the five primary antibodies used for immunoperoxidase 
labelling of proliferative cells, immature neurons, microglial cells, and astrocytes in brain 
tissue.  



























Proliferative cells Ki67 rabbit Poly Abcam ab15550 1:200 
Immature neurons DCX rabbit Poly Abcam ab18723 1:1000 
Microglia and 
macrophages  





neural stem cells 
GFAP rabbit Poly DAKO Z0334 1:3000 





specific binding was blocked by incubating sections in 10% normal goat serum 
(NGS; Vector Laboratories, Peterborough, UK) in 0.1M TBS (pH 7.6) with 0.25% 
TritonX (TBST; Sigma-Aldrich, Poole, UK) for 1h at room temperature. Finally, 
sections were incubated overnight for 16h in 10% NGS in TBST with primary 
antibody (see Figure 2.15.B) at 4°C. The next day, sections were washed, incubated 
with a biotinylated secondary antibody (goat anti-rabbit, 1:1000; Vector Laboratories, 
Peterborough, UK) for 2h at room temperature, washed again, and subsequently 
incubated for 2h at room temperature in avidin-biotin complex for signal amplification 
(Elite ABC Kit solution, Vectastain, Vector Laboratories, Peterborough, UK). Finally, 
sections were washed, and staining was subsequently visualised by incubating 
sections in 0.05% 3,3-diaminobenzidine tetrahydrochloride (DAB; Sigma-Aldrich, 
Poole, UK) and 0.001% H2O2 in TBS (filtered before use) for 1-3 minutes, depending 
on the target antigen. The DAB reaction was terminated using ice cold TBS once 
optimal staining with minimal background had been achieved, and stained sections 
were subsequently washed. All wash steps throughout the protocol included a triple 
incubation in 0.1M TBS (pH 7.6) for five minutes, and for all incubation and wash 
steps, sections were placed on a plate shaker set at 115rpm. All stained tissue not 
immediately mounted was stored in TBS, and kept at 4°C. For the TBS recipe see 
Appendix 2.2.3. 
 
2.5.3.2.  Section mounting 
 
Within one week of staining, sections were mounted on pre-prepared gelatin-chrome 
alum coated Superfrost Plus microscope slides (Thermo Scientific, UK) in anatomical 
order using the Allen Mouse Brain Atlas (Allen Institute, 2011; www.mouse.brain- 
map.org). Mounted sections were then air-dried for 24h before being counterstained 
and/or coverslipped.  
 
2.5.3.3.  Section counterstaining 
 
Mounted sections stained for Iba1 and GFAP were counterstained with Harris’ 
haematoxylin (VWR, Lutterworth, UK) to visualise brain anatomy, before being 
subsequently covered. Briefly, sections were rehydrated in decreasing 
concentrations of industrial methylated spirit (IMS; Thermo Scientific, UK) in distilled 
water, that is, 100%, 95%, and 70%, at five minute intervals, followed by an 
incubation with Harris’ haematoxylin for 40-60s. Sections were subsequently washed  
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Figure 2.16. Representative images of immunohistochemistry stains in the dentate gyrus of the hippocampus 
(A). Top: Ki67 negative control counterstained with haematoxylin to visualise hippocampus. 20x magnification. Scale bar = 50µm. Bottom: Ki67 positive stain from 
representative control animal. 40x magnification. Scale bar = 40µm. (B). Top: DCX negative control counterstained with haematoxylin to visualise hippocampus. 20x 
magnification. Scale bar = 50µm. Bottom: DCX positive stain from representative control animal. 40x magnification. Scale bar = 40µm. (C). Top: Iba1 negative control 
counterstained with haematoxylin to visualise hippocampus. 20x magnification. Scale bar = 50µm. Bottom: Iba1 positive stain counterstained with haematoxylin taken from 
representative control animal. 40x magnification. Scale bar = 40µm. (D). Top: GFAP negative control counterstained with haematoxylin to visualise hippocampus. 20x 
magnification. Scale bar = 50µm. Bottom: GFAP positive stain counterstained with haematoxylin taken from representative control animal. 40x magnification. Scale bar = 
40µm. (E). Top: S100β negative control counterstained with haematoxylin to visualise hippocampus. 20x magnification. Scale bar = 50µm. Bottom: S100β positive stain from 
representative control animal. 40x magnification. Scale bar = 40µm.  
Abbreviations: DCX, Doublecortin; Iba1, Ionizing calcium-binding adapter molecule 1; GFAP, Glial fibrillary acidic protein.
A. B. C. D. E. 
Ki67 DCX IBA1 GFAP S100β 
50µm 50µm 50µm 50µm 50µm 
40µm 
20x 20x 20x 20x 20x 
40x 40x 40x 40x 40x 40µm 40µm 40µm 40µm 
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in tap water until haematoxylin stopped leeching, and then dipped in 1% hydrochloric 
acid solution in 70% IMS for one minute to differentiate. Finally, slides were washed 
in tap water for five minutes to initiate the haematoxylin colour change, washed in 
distilled water for five minutes, and dehydrated and coverslipped as described in the 
following subsection.  
 
2.5.3.4.   Section dehydration and coverslipping  
 
All mounted sections were dehydrated in graded dilutions of IMS in distilled water. 
Specifically, this involved incubating slides for five minutes in 70% and 95% IMS 
solution, followed by a ten minute incubation in 100% IMS.  Lastly, slides were 
cleared in xylene (Thermo Scientific, UK) for ten minutes, and subsequently 
coverslipped with distyrene plasticiser xylene mountant (Sigma-Aldrich, Poole, UK) 
using either 24x60mm or 24x40mm borosilicate glass coverslips (VWR, Lutterworth, 
UK).  
 
2.5.3.5.  Image processing 
 
Whole slide digital images were provided by the UCL IQpath slide scanning service, 
using a Leica SCN400F scanner.  Representative images of the hippocampus and 
the prefrontal cortex (PFC) were captured with Aperio Imagescope software v12.2.2 
(Leica Biosystems, UK) at 2x magnification as shown in Figures 2.17.A and 2.17.B. 
 
2.5.3.5.1.  Identifying regions of interest and distinguishing between the 
dorsal and ventral hippocampus 
 
Based on the literature changes in neurogenesis and neuroinflammation were 
assessed in the hippocampus and/or the PFC, given that these two brain regions are 
consistently reported to have significant alterations in these biological outcomes (see 
1.2.3 and 1.2.4). In both experiments, neurogenesis was specifically assessed in the 
dentate gyrus (DG) of the hippocampus, while for neuroinflammation changes in both 
the DG of the hippocampus, and the PFC were measured. Moreover, with respect to 
both biological parameters, sections from the dorsal and ventral hippocampus were 





Figure 2.17. Image capture and regions of interest  
(A) Whole slide digital images were uploaded into Aperio Imagescope software. (B) For each 
section, regions of interest were identified at 2x magnification, and were subsequently 
extracted. (C) Coronal representation of the PFC, as highlighted in blue, of an adult mouse. 
(D) Coronal representation of the dentate gyrus of the dorsal hippocampus of an adult mouse, 
highlighted in purple. (E) Representative examples of the dorsal and ventral hippocampus on 
the left and right side of the central image. Guidelines for differentiating between the two 
regions was based on previously published work and determined by the stereotaxic mouse 
atlas, and the Allen Brain Atlas.  
Image C was taken from Bizon et al. (2012). Characterizing Cognitive Aging of Working Memory and 
Executive Function in Animal Models Characterizing cognitive aging of working memory and executive 
function in animal models. Front Aging Neurosci. 4:19.; Image D was taken from the Allen Mouse Brain Atlas, 
which was used to identify regions during the extraction phase (A-B); and Image E was taken from Banasr et 
al. (2006). Agomelatine, a New Antidepressant, Induces Regional Changes in Hippocampal Neurogenesis. 






To determine the anatomical location of these regions of interest (ROI) both the 
stereotaxic mouse brain atlas (Paxinos & Franklin, 2012) and the Allen Brain Atlas 
were used (Allen Institute, 2011; www.mouse.brain-map.org). Specifically, sections 
of the PFC were captured within the range of approximately +1.70 and +2.22mm 
from bregma, while sections of the hippocampus were captured between -1.06 and -
3.80mm from bregma. Distinguishing between the dorsal and ventral hippocampus 
was done as previously described (Banasr et al. 2006), and typically sections 
pertaining to the dorsal hippocampus were obtained between -1.06 and -2.18mm 
from bregma, while those pertaining to the ventral hippocampus were between -
2.18mm and -3.80mm from bregma. The Allen Brain Atlas was used to further 
identify the DG using anatomical landmarks. Figure 2.17 (C-E) provides 
representative examples of each of the ROIs used for analyses in this thesis.    
 
2.5.3.6.  Threshold analyses of immunoreactivity for Iba1 and GFAP 
 
To quantify and compare relative levels of immunoreactivity for Iba1 and GFAP 
positive cell staining, thresholding analyses were performed as previously described 
(Pontikis et al. 2005; Kielar et al. 2007). Briefly, blinded for stress group, 30 unbiased 
non-overlapping images, across six sections/mouse were captured at 40x 
magnification from the regions of interest (ROI) mentioned in subsection 2.5.3.5.1, 
using a macro (Lim, UCL) and ImageJ software (v1.51; Rasband, 1997; Schneider et 
al. 2012). Specifically, from each delineated ROI, images of five random sampling 
frames, each 200x200µm in size, were captured based on random coordinates 
generated from a python macro coordinator generator (Lim, UCL). Using 
thresholding analysis in ImageJ, an appropriate threshold was then chosen to 
distinguish between positive immunostaining and non-specific background, and was 
typically set at 0 for all images/mouse. However, for one batch of staining the 
background was much higher and the threshold level for these sections/mouse were 
set at 100.  All images were processed according to the same basic parameters 
(hue: 0-30; brightness: mean thresholding method), and a percentage surface area 
immunoreactivity score was subsequently generated for each captured image. See 
Figure 2.18 (A-C) for a visual guide of the thresholding process.  
 
2.5.3.6.1.  Further analyses based on immunoreactivity data 
 
For any experimental groups showing significantly altered Iba1 immunoreactivity, 
stereological (see 2.5.3.7.1) and morphometric (see 2.5.3.7.3) analyses were 
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subsequently carried out to ascertain whether cell density and/or morphology was 
being altered in response to stress exposure. For any significant changes in GFAP 
immunoreactivity, stereological analyses (see 2.5.3.7.1) and further labelling, that is, 
immunoperoxidase labelling for s100β, and immunofluorescent double labelling for 
SOX2/GFAP (see 2.5.4), was carried out to further characterise observed changes 
for GFAP.     
 
2.5.3.7.  Assessing changes in neurogenesis and further analyses for 
Iba1 and GFAP  
 
2.5.3.7.1.  Stereological analyses of volume and immunopositive cell 
density 
 
The cell density of immunopositive Ki67, DCX, Iba1, GFAP and s100β cells were 
estimated by stereological analyses with StereoInvestigator software (MBF 
Bioscicence, Williston, VT) using the optical fractionator module, as previously 
described (Thuret et al. 2009). Briefly, an Axioskop 2 MOT Zeiss microscope and a 
semiautomatic stereology system were used to estimate the volume of each ROI and 
the total number of immunopositive cells in that ROI. The ROI for each section was 
delineated under 10x magnification using defined anatomical landmarks (see 
2.5.3.5.1), and overlaid with a grid (X=94.6µm; Y=182.5µm) from which an unbiased 
selection of virtual counting frames was extracted. The size of each counting frame 
was set at 50x50µm, and there were 50 desired sampling sites per ROI based on 
parameters previously validated (Dias et al. 2014). Using this systematic random 
sampling method, immunopositive cells within each sampling site were then 
identified at 40x magnification, and the optical fractionator probe with a dissector 
height of 15µm was used to manually count the cells in each ROI (see 2.5.3.5.1) in 
relation to the acceptance and rejection guidelines of the counting frame 
(Gundersen, 1977) (see Figure 2.19.A). For each section, ROI volume was then 
subsequently estimated according to the Cavalieri principle (Gundersen et al. 1988), 
and unbiased cell population estimates were obtained by extrapolating the number of 
cells counted within the counting frames to the total estimated volume of each ROI 
(Slomianka & West, 2005). Finally, immunopositive cell density was subsequently 
calculated by dividing the estimated cell population number by the estimated volume 
of the ROI. The sampling approach used, that is, the number of sections analysed 




Figure 2.18.A. Uploading images and delineating region of interest  
Once images containing the region of interest (ROI) were extracted from the Aperio 
Imagescope software v12.2.2 they were subsequently uploaded into ImageJ software v1.51. 
Using the polygon tool and macro recorder, the ROI was defined and the associated polygon 
coordinates were inputted into the python macro, which randomly generated a set of five X 




























































Figure 2.18.B. Generating sampling images  
(i) The five coordinate sets generated from the python macro were transferred to another 
macro, (ii) which subsequently captured five random non-overlapping sampling squares, each 
































Figure 2.18.C. Thresholding analysis  
Thresholding analysis was then performed for each of the five captured sampling images. 
Specifically, a mean threshold method was used, based on the following parameters: hue at 
0-30; saturation at 0. Antigen percentage area coverage was then generated for each sample 















of error (CE), which is a measure of the precision of the cell population estimate, as 
influenced by the number and dispersion of the antigen across sampled sections 
(Gundersen et al. 1999). In all instances, the CE was capped at 20%, and as such 
the number of sections sampled ranged from 4-11 sections per mouse (see Figure 
2.19.B). For all stereological analyses the experimenter was blinded to the stress 
group status. 
 
2.5.3.7.2.  Immature neuron classification based on DCX morphology 
 
DCX positive cell morphology in the DG was visually classified as previously 
described (Plümpe et al. 2006). DCX positive cells were classified according to four 
neuroblast subtypes based on their level of maturation (see Figure 2.19.C). 
Specifically, DCX positive cells in their most immature form, that is, the proliferative 
neuroblasts, were defined as DCX positive cells with no, or short, plump processes. 
The next subtype and subsequent stage of maturation is signified by the intermediate 
neuroblasts, which were classified as DCX positive cells with medium length 
processes without branching. Next, the early stage postmitotic neuroblasts were 
defined as DCX positive cells with one strong dendrite branching out into the 
molecular layer, and finally the most mature form of neuroblasts, which are classified 
as the late stage postmitotic neuroblasts, were defined as cells with delicate dendritic 
tree branching extending to the granule cell layer. The cell density for each 
neuroblast type in both the dorsal and ventral DG was determined using stereological 
analysis as described in section 2.5.3.7.1.  
 
2.5.3.7.3.  Morphometric analyses of Iba1 positive cells 
 
Using ImageJ software (v1.51; Rasband, 1997; Schneider et al. 2012) Sholl and 
skeleton analyses were performed to examine Iba1 positive cell morphology and 
were carried out as previously described (Morrison & Filosa, 2013; Derecki et al. 
2014; Ferreira et al. 2014). Briefly, blinded for stress group, images of Iba1 labelled 
cells were imported into ImageJ and single, whole Iba1 cells were isolated and 
traced at 40x magnification. For analyses, a total of 18 Iba1 cells were randomly 
selected across three hippocampal sections for each mouse. Three mice per 
experimental group were used for morphological quantification, giving a total of 54 
Iba1 cells per experimental group for analysis.  Sholl analysis was performed for 
each cell image using the ShollAnalysis plugin (v.3.6.2; http://imagejdocu.tudor.lu/). 
For all analyses, the log-log Sholl method was used as per recommendations  
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Figure 2.19. Stereological analyses and DCX classification guide 
(A) Acceptance and rejection guidelines applied during the manual count stage of the 
stereological process. Specifically, as depicted in the schematic, cells bordering the red line 
of the counting frame were not eligible and thus not counted. Only cells within the counting 
frame or touching the green line were acceptable counts (www.stereology.info) (B) Table 
detailing the number of sections sampled per mouse for each antigen and the associated 
coefficients of error. (C) Classification guide of DCX-neuroblast morphology. This guide was 
used to categorise DCX positive cells according to morphology in both the dorsal and ventral 
dentate gyrus in both experiments.  However, due to the stark difference in the morphology 
for postmitotic neuroblasts, this particular stage of neuroblast development was divided into 
two subtypes in the context of this thesis.  Therefore, DCX positive cells were classified as 
either (1) proliferative neuroblasts, with no processes or short plump process; (2) intermediate 
stage neuroblasts, with medium processes, potentially reaching the molecular layer; (3) early 
postmitotic stage neuroblasts, with one strong dendrite branching into the molecular layer, or 
(4) late postmitotic neuroblasts, those with a delicate dendritic tree branching in the granule 
cell layer.  
 
Image A was taken from www.stereology.info; and image C was adapted from Plümpe et al. (2006). Variability 
of doublecortin-associated dendrite maturation in adult hippocampal neurogenesis is independent of the 
regulation of precursor cell proliferation. BMC neuroscience. 7: 77. 
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(Cătălin et al. 2013), with the starting radius, step size and ending radius set as 
10µm, 5µm, and 150µm respectively, and a linear profile selected. For each Iba1 
cell, a Sholl plot was then generated, and an Schoenen ramification index score, a 
parameter of cell branching density, was calculated, with a high ramification index 
number indicative of more complex dendritic branching (Schoenen, 1982; Reeves et 
al. 2011).  All cell images were also converted into binary images and skeletonized. 
The AnalyzeSkeleton plugin (http://imagejdocu.tudor.lu/), based on a prune cycle 
method using the lowest intensity branch, was then applied to all skeletonized 
images to collect data on average branch length and branch number. Cell soma area 
measurements, and the overall volume occupied by each Iba1 cell were also 
obtained using ImageJ software, and the measure tool. For a visual guide on some 
of the morphometric analyses see Figure 2.20.  
 
2.5.4.  Immunofluorescence 
 
Given that GFAP is also a marker for neural stem cells (see 1.2.4.3), to determine 
whether changes observed in immunoreactivity (see 2.5.3.6) were related specifically 
to astrocytes, sections were fluorescently double labelled to determine the extent of 
co-localisation of GFAP and SOX2. Immunofluorescent labelling was performed only 
for experimental groups showing significant changes in immunoreactivity relative to 
control, and for Experiment 1 only, due to time constraints.  
 
2.5.4.1.  Immunofluorescent double labelling of GFAP and SOX2 
 
For all immunofluorescence, like with immunohistochemistry, every sixth section was 
stained, the protocol was performed over a two-day period, and in each instance, 
sections from eleven mice, and one negative control were simultaneously stained. 
However, unlike immunohistochemistry, immunofluorescence was carried out on 
slide-mounted sections. Therefore, coronal sections were triple washed with 0.1M  
TBS (pH 7.6), mounted as per conditions described in 2.5.3.2, and air-dried for 24h 












































Figure 2.20. Sholl and skeleton analysis in ImageJ 
(A) Whole Iba1 cells were isolated, traced and converted into binary images. Using the 
multipoint icon, the centre of each soma was marked followed by each primary process as 
depicted by the yellow markers in the image. (B) User interface of Sholl Analysis plugin:  A 
linear sholl method, and a log-log normalised profile was selected for data analyses, and the 
sample was defined by a starting radius of 10µm, an ending radius of 150µm, and a radius 
step size of 5µm. (C) Binary images were converted into skeleton profiles using the 
skeletonise tool. (D) User interface of Analyze Skeleton plugin: a lowest intensity branch 






2.5.4.1.1.  General protocol 
  
Mounted sections were rehydrated in graded dilutions of IMS (100%, 95% and 70%) 
at five-minute intervals, and then washed in distilled water before undergoing heat 
induced epitope retrieval, which involved incubating sections in sodium citrate buffer 
(10 mM sodium citrate, 0.05% Tween 20, pH 6.0) in the microwave for fifteen 
minutes. After antigen retrieval, sections were washed in distilled water, and then 
triple washed in TBS. After washing, non-specific binding was blocked by incubating 
sections in 10% normal donkey serum (NDS; Abcam, Cambridge, UK) in 0.1M TBS 
(pH 7.6) with 0.25% TritonX (TBST; Sigma-Aldrich, Poole, UK) for 1h at room 
temperature.  Finally, sections were incubated with both primary antibodies (rabbit 
anti-SOX2, 1:400, EMD Millipore, Merck, USA; goat anti-GFAP, 1:500, Abcam, 
Cambridge, UK) in 10% NDS in TBST, overnight for 16h, at 4°C. The following day, 
sections were triple washed, incubated with both secondary antibodies (donkey anti-
rabbit, Alexa Fluor 488, 1:200; donkey anti-goat, Alexa Flour 594, 1:200; both Life 
Tech, USA) for 2h at room temperature, triple washed again, and incubated in 0.3% 
Sudan Black B solution in ethanol (all Sigma Aldrich, Poole, UK) for ten minutes at 
room temperature to suppress autofluorescence. Sections were subsequently tripled 
washed, and finally incubated with 1 µg/mL Hoescht 33342 solution (Thermo Fisher, 
USA) in water for ten minutes, in the dark, to stain all cell nuclei, before being 
washed for the final time with distilled water. TBS (pH 7.6) was used for all wash 
steps, unless otherwise specified, at five-minute intervals.  For the TBS recipe see 
Appendix 2.2.3, and for representative images of the immunofluorescent stain see 
Figure 2.21. 
 
2.5.4.2.  Coverslipping 
 
Immediately after staining, slides were coverslipped with 50µl anti-fading mowiol 
mounting medium (Sigma-Aldrich, Poole, UK) using 24x60mm borosilicate glass 





Figure 2.21. Representative images of immunofluorescent stains in the dentate gyrus of the hippocampus 
(A). All cell nuclei stained with Hoescht (blue); (B). All progenitor cells stained for SOX2 (green); (C). All glial fibrillary acidic protein (GFAP) positive cells 
(red); and (D). A merged image of all three stains: Hoescht/SOX2/GFAP. All images were taken from a representative control animal at 40x magnification. 
Scale bar = 20µm.  
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2.5.4.3.  Image processing and cell counting 
 
Images of double-labelled sections were obtained using a Leica SP5 confocal 
microscope. Specifically, an objective of 63x (oil immersion, NA 1.42) was used for 
each image captured, and wavelength laser lines of 405nm (diode laser), 488nm 
(argon laser), and 594nm (HeNe laser) were used. All images were acquired as 
confocal stacks of ten images separated by a 0.64µm z-axis step size. Each image 
was taken at a resolution of 1024x1024 pixels, with the picture dwell time set to 3.36, 
giving a rate of 0.185 z-planes per second, and each frame was averaged four times 
to reduce signal noise. Additional settings of gain, offset and pinhole size were 
optimized prior to imaging and were held constant for all images at 600V, 800V and 
1.0 airy unit, respectively. For each confocal stack, the percentage of double-labelled 
cells for GFAP and SOX2 in the DG of the hippocampus was examined as previously 
described (Yu et al. 2009). Briefly, 100 GFAP positive cells per mouse were counted 
and the percentage of radial glial cells (GFAP+/SOX2+) and astrocytes 
(GFAP+/SOX2-) were calculated. For each mouse, cells were counted from a total of 
twelve acquired z-stacks across six hippocampal sections.  
 
2.6.  Statistical analyses  
 
2.6.1.   Data cleaning, exclusions and meta-analysis  
 
All animals underwent all experimental stages, and thus all data collected from all 
animals were statistically analysed. However, some animals from some groups were 
excluded prior to analysis as shown and explained in Figure 2.22. Specifically, 
animals were excluded due to fighting related injuries and/or unplanned stress 
exposure. Moreover, given that one stress group in Experiment 1 was studied at a 
different time point to the other two groups, there were two separate control groups 
for this experiment. To be able to compare all groups, these control groups were 
statistically combined using meta-analysis based on Cochrane guidelines as 
previously described (Higgins & Green, 2011), and the applied formulae of which are 
shown in Figure 2.23. Separate analyses were initially performed comparing each 
control group with its respective stress group(s), to initially confirm findings, and 
ensure that combining the control groups to compare all four groups did not alter 
separate group findings. As shown in Appendix 2.3, given that there were no 
significant differences between the two control groups with respect to any of the  
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Reasons for exclusion: 
a Animals excluded from statistical analyses because they had to be separated and/or culled due to fighting 
b Animal culled due to illness 
c Animals excluded from statistical analyses because the night prior to being culled animals escaped from their cages and ended up 
in a neighbouring cage. As such, three animals were found in one cage and one was isolated. Due to the acute stress of this event, 
histological data from these four animals were not included in statistical analyses.  
* For ELISA and Luminex data, the numbers per group varied and will be highlighted in the appropriate results section. Specifically, 
any readout with a CV above 20% was excluded from statistical analysis due to unreliability. Moreover, due to a technical issue with 
the Luminex platform machine some analyte readouts from one plate in Experiment 1 had to be excluded from further analyses due 
to significant variance between plates and potential unreliability.  
Investigating the impact of stress on inflammation, neurogenesis and depression 
 
Animals; n = 70 
Experiment 1: The effect(s) of physical, 
psychosocial, and both physical and psychosocial, 
stress on behaviour, inflammation and adult 
hippocampal neurogenesis. 
Animals; n = 50 
 
Experiment 2: Using a modified version of UCMS 
to determine the impact of stress on behaviour, 
inflammation and adult hippocampal neurogenesis.  
Animals; n = 20 
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Stress Treatment Stress Treatment 
Behaviour Behaviour 
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Group 3: n = 9b Group 4: n = 9b 
Group 1: n = 8a 
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Group 1: n = 18a 
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Figure 2.22. Flowchart showing the number of animals used for statistical analyses at each stage 




Figure 2.23. Statistically combining the two control groups 
A meta-analysis was performed to combine the two control groups from Experiment 1 for 
each data variable. The following formulae were applied using Excel (v.14; 2011, Microsoft) 
based on the Cochrane guidelines for meta-analysis.  
 
Taken from Higgins, & Green (2011). Cochrane Handbook for Systematic Reviews of 






























Combined Control Group 
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readouts, findings were indeed the same whether stress groups were compared with 
their respective control, or with the combined control group. 
 
2.6.2.  Data analysis protocols  
 
All statistical analyses were conducted in IBM SPSS Statistics Version 23 (IBM Ltd., 
Portsmouth, UK), and all graphs were generated using GraphPad Prism (v6; 
GraphPad Software, Inc., California, USA). Data was assessed for normality using 
probability-probability plots and the Kolmogorov-Smirnov test, and for homogeneity 
of variance using Levene’s test. For data that did not conform to normality and/or 
homoscedasticity non-parametric statistical tests were applied. In text descriptive 
statistics are presented with the associated test statistic and p value. For graphs, the 
mean and standard error of the mean (SEM), or the median and interquartile range 
(IQR) is presented. Typically, either an independent samples t-test, one-way or two-
way analysis of variance (ANOVA), repeated measures two-way ANOVA, three-way 
factorial ANOVA, or repeated measures generalized linear mixed modelling (GLMM) 
were used for group comparisons of normally distributed data. For data that was not 
normally distributed, group comparisons were made using the Mann-Whitney, 
Kruskal Wallis, or Friedman’s test, reported by z score. For parametric data, the 
Bonferroni test was applied in post hoc analyses of pairwise comparisons, while 
Dunn’s test was applied in post hoc analyses of pairwise comparisons of non-
parametric data. The details for specific analyses pertaining to specific variables will 
be outlined in the following subsections. The alpha criterion for all statistical analyses 
was p < .05, and as a general rule, p values > .05 are reported to two decimal 
places, except where two decimal places would yield particularly informative further 
information. In tables and graphs, all significant results are highlighted in bold or with 
the use of an asterisk (*).  
 
2.6.2.1.  Repeated behavioural measures 
 
Body weight, food intake and sucrose preference data were analysed using a 
repeated measures two-way ANOVA with ‘stress group’ as the between subjects 
variable (two or four levels) and ‘time’ as the within subjects variable (four, six or 
twelve levels). Coat state was analysed using the repeated measures non-parametric 
equivalent, the Friedman’s test, with ‘stress group’ as the between subjects variable 
(two or four levels) and ‘time’ as the within subjects variable (six or twelve levels).  
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2.6.2.2.  Behavioural analyses 
 
For both experiments, behavioural readouts were analysed using the independent 
samples t-test, one-way ANOVA, Mann-Whitney, or Kruskal Wallis test where 
appropriate for group comparisons. Moreover, in Experiment 2, social interaction 
data were analysed using a repeated measures two-way ANOVA with ‘stress group’ 
as the between subjects variable (two levels: control and stress) and ‘time’ as the 
within subjects variable (1-5 minutes). 
 
2.6.2.3.  Biochemical analyses  
 
All plasma readouts for both experiments were analysed using a repeated measures 
two-way ANOVA with ‘stress group’ as the between subjects variable (two or four 
levels) and ‘time’ as the within subjects variable (two levels: pre and post-FST). 
 
2.6.2.4.  Immunohistochemical analyses  
 
In both experiments, immunoreactivity, cell density and/or immunofluorescent data in 
the hippocampus were analysed using two-way ANOVA with ‘stress group’ as the 
between subjects variable (two or four levels) and ‘region’ as the within subjects 
variable (two levels: dorsal and ventral). Immature neuron and GFAP classification, 
and associated cell density, data were analysed using three-way factorial ANOVA 
(i.e., a general linear model) with ‘stress group’ as the between subjects variable (two 
or four levels) and ‘region’ and ‘DCX classification’ as the within subjects variables 
(region: two levels, dorsal and ventral; DCX classification: four levels). Data for all 
immunohistochemical parameters pertaining to the PFC were analysed using one-
way ANOVA, or the independent samples t-test for group comparisons. Iba1 
morphometric analyses were analysed using a repeated measures GLMM to control 
for any clustering effects associated with sampling, with ‘stress group’ as the 
between subjects variable (two levels: control and stress), and ‘Iba1 cell’ as the 







3.  RESULTS 
 
3.1. PART A: Does the type of stress matter? Effect(s) of physical, 
psychosocial, and both physical and psychosocial, stress on 
behaviour, inflammation and adult hippocampal neurogenesis 
 
3.1.1.  Effect(s) of physical, psychosocial, and both physical and psychosocial 
stress on physical health and behaviour 
 
In line with the AIM 1 of this part of the thesis (see 1.4.1.1.1), the effect of physical, 
psychosocial and combined stress on health and behaviour was assessed. 
 
3.1.1.1.  Effect(s) of physical, psychosocial, and both physical and 
psychosocial stress on physical health  
 
3.1.1.1.1.  Repeated injection decreases absolute body weight, two weeks after 
stress exposure, compared with social isolation, and combined 
stress 
 
Figure 3.1 shows the changes in absolute body weight for the differentially stressed 
experimental groups (Two-way RM ANOVA: Effect of exposure: F [18,210] = 2.7, p = 
.06; Effect of time: F [6,210] = 443.8, p < .001; Interaction: F [18,210] = 8.9, p < .001; 
Area under the curve: controls: 150.1; injected: 143.4; isolated: 154.3; combined: 
154.3). Specifically, there were no significant baseline differences in absolute body 
weight between experimental groups, and no significant differences in body weight 
were observed for repeatedly injected mice, socially isolated mice, or mice exposed 
to combined stress when compared with control animals over the course of stress 
exposure. However, mice repeatedly injected had significantly reduced absolute 
body weight when compared with the other two stress exposure groups from Week 
two onwards. Generally, repeatedly injected animals weighed between 8-9% less 
from Week 2 to Week 4 compared with socially isolated animals (Post hoc analyses: 
Week 2-4: t [245] = 3.1, p = .01), and weighed 8-9% less from Week 2 onwards 
compared with animals exposed to combined stress (Post hoc analyses: Week 2-3: t 
[245] = 2.9, p = .02; Week 4: t [245] = 3.0; p = .03; Week 5: t [245] = 2.8; p = .02; 





















Figure 3.1. Effect of repeated injection, social isolation, and combined stress on absolute body weight during stress exposure  
From week two to week four, mice exposed to repeated injection (Group 2) weighed significantly less when compared with both socially isolated mice (Group 
3) and animals exposed to combined stress (Group 4). From weeks five and six, repeatedly injected mice (Group 2) weighed significantly less than animals 
exposed to combined stress only (Group 4). No significant differences were observed at baseline or at week one for any of the experimental groups. No 
significant differences were observed for any stress exposed group compared with control animals (Group 1) at any time point across exposure. 
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=18; Group 2: n=10; Group 3: n=9; Group 4: n=9  
Analysis: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Area under the curve values: Controls: 150.1; Injected: 143.4; Isolated: 154.3; Combined stress: 154.3 
Adjusted p values: repeated injection relative to social isolation * p < .05; ** p < .01; repeated injection relative to combined stress $ p < .05 
Abbreviations: g, grams; SEM, standard error of the mean   
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3.1.1.1.2.  Repeated injection increases body weight loss, while social isolation, 
and combined stress reduces body weight loss, one week after 
stress exposure 
 
Figure 3.2A shows the changes in weight change relative to baseline for the 
differentially stressed experimental groups (Two-way RM ANOVA: Effect of 
exposure: F [3,35] = 11.2, p < .001; Effect of time: F [5, 175] = 9.9, p < .001; 
Interaction: F [15, 175] = 4.9, p < .001; Area under the curve: controls: 12.6; injected: 
10.6; isolated: 11.7; combined: 14.2). Interestingly, animals exposed to combined 
stress had a 3% and 5% decrease in weight loss compared with controls and 
repeatedly injected animals, respectively (Post hoc analyses: relative to controls: t 
[210] = 4.0, p < .001; relative to injected: t [210] = 5.5, p < .001). Similarly, socially 
isolated mice had a 3% and 4% decrease in weight loss compared with controls and 
repeatedly injected animals, respectively (Post hoc analyses: relative to controls: t 
[210] = 3.3, p = .006; relative to injected: t [210] = 4.9, p < .001). However, by the 
following week, body weight gain in both groups was comparable with that of control 
animals.  Conversely, repeatedly injected animals had significantly increased weight 
loss the first week after stress exposure, with a 3-4% increase in weight loss 
compared with all other experimental groups (Post hoc analyses: relative to isolated: 
t [210] = 4.3, p < .001; relative to combined: t [210] = 4.4, p < .001; relative to 
controls: t [210] = 5.3, p < .001). However, by the following week, weight change was 
comparable with that of all experimental groups.  
 
3.1.1.1.3.  Repeated injection decreases food intake one week after stress 
exposure 
 
Food intake profiles across the six weeks of stress exposure were consistent with 
those pertaining to body weight change as shown in Figure 3.2.B (Two-way RM 
ANOVA: Effect of exposure: F [3,33] = 7.9, p < .001; Effect of time: F [5, 165] = 14.2, 
p < .001; Interaction: F [15, 165] = 0.95, p = .51). Specifically, only mice repeatedly 
injected consumed 19-28% less food, as measured over a 24h period, one week 
after stress exposure compared with all other experimental groups (Post hoc 
analyses: relative to isolated: t [210] = 4.3, p < .001; relative to combined: t [210] = 
4.4, p < .001; relative to controls: t [210] = 5.3, p < .001). However, by the following 
week, and in all subsequent weeks, no differences were observed between any of 




Data represents mean ± SEM 
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=18; Group 2: n=10; Group 3: n=9; Group 4: n=9 
Analysis: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Area under the curve values: Controls: 12.6; Injected: 10.6; Isolated: 11.7; Combined stress: 14.2 
Adjusted p values: social isolation relative to control ** p < .01; social isolation relative to repeated injection $$$ p < .001; combined stress relative to control £££ p < .001; combined stress 
relative to repeated injection ### p < .001; repeated injection relative to control &&& p < .001. 
Abbreviations: g, grams; SEM, standard error of the mean; A denotes one week after permanent social isolation; B denotes one week after repeated injection 
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Figure 3.2.A. Effect of repeated injection, social isolation, and combined stress on percentage body weight change relative to baseline during 
stress exposure  
At one week after stress exposure, mice exposed to social isolation (Group 3) and combined stress (Group 4) had significantly increased weight gain 
compared with control animals (Group 1) and repeatedly injected animals (Group 2). A week later, and in all subsequent weeks, both these stress-exposed 
groups had a percentage weight change similar to that of control animals (Group 1). Conversely, at week two, and one week after repeated injection, 
repeatedly injected mice (Group 2) had significantly increased weight loss compared with all other experimental groups. A week later, and in all subsequent 




























Figure 3.2.B. Effect of repeated injection, social isolation, and combined stress on food intake during stress exposure  
Consistent with percentage body weight change data, one week after stress exposure, mice exposed to repeated injection (Group 2) consumed significantly 
less food than all other experimental groups. No other differences in food consumption at any other time point across exposure were observed between 
experimental groups.  
Data represents mean ± SEM 
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=18; Group 2: n=10; Group 3: n=9; Group 4: n=9 
Analysis: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: repeated injection relative to control & p < .05; repeated injection relative to social isolation $ p < .05; repeated injection relative to combined stress ### p < .001 
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3.1.1.2. Effect(s) of physical, psychosocial, and both physical and 
psychosocial stress on anxiety- and depressive-like behaviour  
 
3.1.1.2.1.  All types of stress induce anxiety-like behaviour  
 
All stress-exposed mice, irrespective of the type of stress, exhibited significantly 
increased anxiety-like behaviour, when compared with control animals, in the open 
field test (OFT) (Centre duration: One way ANOVA: F [3,41] = 8.9, p < .001; Centre 
frequency: One way ANOVA: F [3,42] = 7.7, p < .001; Figure 3.3), and in the 
novelty suppressed feeding test (NSFT) (Latency to feed: Kruskal Wallis: K [4,35] = 
21.6, p < .001; Homecage consumption: One way ANOVA: F [3,42] = 4.7, p = .006; 
Figures 3.4).  
 
Specifically, repeatedly injected animals spent 59% less time in the centre of the 
OFT arena (Post hoc analysis: t [41] = 4.3, p = .02; Figure 3.3.B), entered the centre 
zone 2.1 times less (Post hoc analysis: t [42] = 2.8, p = .046; Figure 3.3.C), took 1.6 
times longer to initiate feeding in the NSFT (Post hoc analysis: z  = 14.8, p = .01; 
Figure 3.4.A), and consumed 40% less food in the NSFT arena (Post hoc analysis: t 
[42] = 2.8, p = .04; Figure 3.4.B), all when compared with control animals. Similarly, 
socially isolated mice spent 92% less time in the centre of the OFT arena (Post hoc 
analysis: t [41] = 6.2, p < .001; Figure 3.3.B), entered the centre zone 5.4 times less 
(Post hoc analysis: t [42] = 4.2, p < .001; Figure 3.3.C), took 2.6 times longer to 
initiate feeding in the NSFT (Post hoc analysis: z = 23.0, p < .001; Figure 3.4.A), and 
consumed 47% less food in the NSFT arena (Post hoc analysis: t [42] = 3.3, p = .01; 
Figure 3.4.B), all compared with control animals. Meanwhile, animals exposed to 
combined stress spent 74% less time in the centre of the OFT arena (Post hoc 
analysis: t [41] = 5.3, p = .003; Figure 3.3.B), entered the centre zone 3.2 times less 
(Post hoc comparison: t [42] = 3.5, p = .007; Figure 3.3.C), and took 1.8 times longer 
to initiate feeding in the NSFT (Post hoc analysis: z = 15.7, p = .003; Figure 3.4.A), 
compared with control animals. However, no significant differences in food 
consumption in the NSFT arena were observed for this particular treatment group 
(Post hoc analysis: t [42] = 1.3, p > .99; Figure 3.4.B). Furthermore, although all 
stress-exposed animals took longer to enter the centre zone of the OFT compared 
with control animals, there were no statistically significant differences between 
experimental groups for this particular parameter (Kruskal Wallis: K [4, 39] = 3.8, p = 


























Figure 3.3. Behaviour in the Open Field Test (OFT) after at least six weeks of stress 
exposure 
(A) Latency to enter the centre: Although it took all stress-exposed animals longer to enter 
the centre zone, there were no statistically significant differences between experimental 
groups.  (B) Duration spent in the centre: All stress exposed mice spent significantly less 
time in the centre of the OFT compared with control animals (Group 1). (C) Centre 
frequency: All stress-exposed mice entered the centre zone significantly less frequently 
compared with control animals (Group 1). (D) Locomotor activity: No significant differences 







Data represents (1) median ± IQR; (2) mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=18; Group 2: n=10; Group 3: n=9; Group 4: n=9 
Analyses: (1) Kruskal-Wallis Test; Dunn’s post hoc analyses; (2) One-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05; ** p < .01; *** p < .001 
Abbreviations: s, seconds; n, number; cm, centimetres; IQR, interquartile range; SEM, standard error of the mean  
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Figure 3.4. Behaviour in the Novelty Suppressed Feeding Test (NSFT) after at least six 
weeks of stress exposure 
(A) Latency to feed in the arena: All stress-exposed mice took significantly longer to initiate 
feeding in the NSFT arena compared with control animals (Group 1). (B) Food 
consumption in the arena: Mice exposed to repeated injection (Group 2) and mice exposed 
to social isolation (Group 3) both ate significantly less food in the arena compared with 
control animals (Group 1).  
 
Data represents (1) median ± IQR; (2) mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=18; Group 2: n=10; Group 3: n=9; Group 4: n=9 
Analyses: (1) Kruskal-Wallis Test; Dunn’s post hoc analyses; (2) One-way ANOVA; Bonferroni post hoc 
analyses 
Adjusted p values: * p < .05; ** p < .01; *** p < .001 
Abbreviations: s, seconds; g, grams; IQR, interquartile range; SEM, standard error of the mean 
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Importantly, all behaviour in the OFT and NSFT was not confounded by locomotor 
activity, with no differences in the total distance travelled in the outer zone of the OFT 
arena (One way ANOVA: F [3,34] = 1.4; p = .25; Figure 3.3.D), or in the number of 
crossings in the NSFT arena (Kruskal Wallis: K [4,38] = 6.0; p = .11; Figure 3.5.C) 
observed between experimental groups. Moreover, behaviours in the NSFT were not 
confounded by olfactory ability, again with no differences observed between 
experimental groups in the Buried Food/Cookie Test  (Kruskal Wallis: K [4,39] = 2.4; 
p = .31; Figure 3.5.D). Interestingly however, animals exposed to combined stress 
lost 21-31% more body weight, after food restriction, 24h prior to the NSFT 
compared with all other experimental groups (Kruskal Wallis: K [4,39] = 18.4; p < 
.001; Post hoc analyses: relative to control: z = 20.8, p < .001; relative to injected: z = 
16.3, p = .008; relative to isolated: z = 8.8, p = .02; Figure 3.5.B), which could have 
influenced feeding in the NSFT. Furthermore, social dominance did not confound any 
of the behaviours seen in pair-housed animals in either behavioural assay (see 
Table 3.1). Interestingly, although the effect size for each of the behavioural readouts 
varied according to the type of stress exposure, no significant differences between 
the three stress groups were observed in either the OFT, or in the NSFT, for any of 
the measured parameters, with the exception of NSFT weight loss as 
aforementioned. Furthermore, although stress-exposed mice exhibited increased 
anxiety-like behaviour in the NSFT, there was no statistical evidence to support 
increased anhedonic-like behaviour in this same task, as no differences in homecage 
consumption were observed between any of the experimental groups (Kruskal 
Wallis: K [4,38] = 1.1; p = .77; Figure 3.5.A).  
 
3.1.1.2.2.  Only social isolation increases depressive-like behaviour 
 
Interestingly, only mice exposed to social isolation exhibited signs of significant 
depressive-like behaviour when compared with controls, as shown in Figures 3.6.A 
and 3.7.B;D (Sucrose consumption: One way ANOVA: F [3,43] = 3.0, p = .04;  
Immobility duration: One way ANOVA: F [3,42] = 2.9, p = .045; Swimming 
duration: One way ANOVA: F [3,42] = 9.5, p < .001). Specifically, this particular 
stress exposure induced anhedonic-like behaviour, with animals consuming 16% 
less sucrose in the sucrose preference test (SPT) (Post hoc analysis: t [43] = 4.0; p = 
.03; Figure 3.6.A), and increased behavioural despair/fatigue, with mice spending 
38% more time immobile (Post hoc analysis: t [42] = 4.1; p = .03; Figure 3.7.B), 
and/or 43% less time swimming (Post hoc analysis: t [42] = 3.7; p = .004; Figure  
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Figure 3.5. Behaviour and weight loss in the Novelty Suppressed Feeding Test (NSFT) 
and olfaction in the Buried Food/Cookie Test after at least six weeks of stress 
exposure 
(A) Food consumption in the homecage: No significant differences in food consumption in 
the homecage were observed between experimental groups. (B) Weight loss after 24h food 
restriction prior to the NSFT: Mice exposed to combined stress (Group 4) lost significantly 
more weight after 24h of food restriction compared with all other experimental groups. (C) 
Locomotor activity in the NSFT: No significant differences in the number of centre 
crossings in the arena were observed between experimental groups. (D) Olfactory ability in 
Buried Food/Cookie Test: All mice allocated the cookie within the designated time frame, 
and no significant differences in the time it took to locate the hidden cookie between 
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The Novelty Suppressed Feeding Test: Weight loss 
(1) 
(1) (2) 
B.  A.  
D.  
Data represents (1) median ± IQR; (2) mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=18; Group 2: n=10; Group 3: n=9; Group 4: n=9 
Analyses: (1) Kruskal-Wallis Test; Dunn’s post hoc analyses; (2) One-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05; ** p < .01; *** p < .001 
Abbreviations: s, seconds; g, grams; IQR, interquartile range; SEM, standard error of the mean 
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Table 3.1. Effect of social hierarchy on behavioural outcomes in the Open Field Test and 
Novelty Suppressed Feeding Test 














OFT       
Centre frequency (1) MR: 5.2 MR: 5.8 0.84 MR: 4.8 MR: 6.2 0.55 
Centre duration (1) MR: 5.0 MR 6.0 0.69 MR: 6.2 MR: 4.8 0.55 
NSFT       
Latency to feed (1) MR: 6.3 MR: 4.7 0.42 MR: 5.8 MR: 5.2 0.84 
Food consumption in 
arena (2) 
0.15 (0.02) 0.14 (0.02) 0.75 0.15 (0.02) 0.14 (0.02) 0.85 
 
Subjects: adult male BALB/c mice 
Sample sizes: Subordinates = 5; Dominants = 5 
Analyses: (1) Mann Whitney U; (2) Independent samples t test; Bonferroni correction for multiple testing - threshold: p < 
.0125 





















































Figure 3.6. Behaviour in the Sucrose Preference Test (SPT) after at least six weeks of 
stress exposure  
(A) Sucrose consumption: Mice exposed to social isolation (Group 3) consumed 
significantly less sucrose compared with control animals (Group 4). No other significant 
differences were observed between experimental groups. (B) Total liquid consumption: No 
significant differences in total liquid consumption in the SPT were observed between 
experimental groups (C) Food consumption: No significant differences in food consumption 
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The Sucrose Preference Test: Food consumption
A. 
B. C. 
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=18; Group 2: n=10; Group 3: n=9; Group 4: n=9 
Analyses: One-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05 


























Figure 3.7. Behaviour in the Forced Swim Test (FST) after at least six weeks of stress 
exposure 
(A) Latency to become immobile: No significant differences in the average latency to 
become immobile were observed between experimental groups. (B) Immobility duration: 
Mice exposed to social isolation (Group 3) spent significantly more time immobile in the FST 
compared with control animals (Group 4). No other significant differences were observed 
between experimental groups. (C) Immobility frequency: Mice exposed to social isolation 
(Group 3) were immobile significantly more frequently than repeatedly injected mice (Group 
2) and mice exposed to combined stress (Group 4), but not when compared with control 
animals (Group 1). (D) Swimming duration: Mice exposed to social isolation (Group 3) 




Data represents (1) median ± IQR; (2) mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=18; Group 2: n=10; Group 3: n=9; Group 4: n=9 
Analyses: (1) Kruskal-Wallis Test; Dunn’s post hoc analyses; (2) One-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05; ** p < .01; *** p < .001 
Abbreviations: s, seconds; n, number; IQR, interquartile range; SEM, standard error of the mean  
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3.7.D) in the forced swim test (FST), all when compared with control animals. 
Moreover, socially isolated mice became immobile 2-4 times more frequently (Post 
hoc analyses: relative to injected: t [42] = 2.8; p = .04; relative to combined: t [42] = 
3.0; p = .03; Figure 3.7.C), and spent 45-55% less time swimming (Post hoc 
analyses: relative to injected: t [42] = 5.2; p < .001; relative to combined: t [42] = 3.5; 
p = .007; Figure 3.7.D) than either repeatedly injected mice, or mice exposed to 
combined stress. However, there were no differences in the latency to become 
immobile (Kruskal Wallis: K [4,37] = 6.0; p = 0.11; Figure 3.7.A), the latency to 
struggle (Kruskal Wallis: K [4,38] = 4.9; p = .18; Figure 3.8.A), the amount of time 
spent struggling (One way ANOVA: F [3,42] = 2.3; p = .09; Figure 3.8.B), or the 
frequency of struggling (One way ANOVA: F [3,34] = 2.4; p = .08; Figure 3.8.C), 
between experimental groups. Furthermore, no significant differences were observed 
between the other two stress-exposed groups and control animals for any of the 
parameters associated with either the SPT or FST. 
 
Importantly, observed differences in the SPT between socially isolated mice and 
controls were not confounded by either total liquid consumption (see Figure 3.6.B), 
food consumption (see Figure 3.6.C) or olfactory ability (see Figure 3.5.C), with no 
significant differences being observed between experimental groups for any 
parameter (One way ANOVA: liquid: F [3,36] = 2.2; p = .11; One way ANOVA: food: 
F [3,36] = 1.8; p = .16; Kruskal Wallis: olfaction: K [3,29] = 2.4; p = .31). Moreover, 
social dominance did not influence behaviour in pair-housed animals in the FST (see 
Table 3.2). 
 
For a full summary of all the behavioural changes associated with the three chronic 
stress exposures, as described throughout this subsection, see Table 3.3.   
 
3.1.2.  Effect(s) of physical, psychosocial, and both physical and psychosocial 
stress on peripheral inflammation and stress responsivity  
 
In line with AIM 2 of this part of the PhD thesis (see 1.4.1.1.1.2), the impact of these 
distinct types of stress on inflammatory profiles were next examined at baseline and 
following acute stress exposure to determine what impact acute stress may have on 
peripheral inflammation in already chronically stressed mice. Data were analysed as 






























Figure 3.8. Effect of repeated injection, social isolation, and combined stress on 
struggling behaviour in the Forced Swim Test (FST) after at least six weeks of stress 
exposure 
(A) Struggling latency: There were no significant differences in the latency to struggle in the 
FST between experimental groups. (B) Struggling duration: There were no significant 
differences in the total time spent struggling in the FST between experimental groups. (C) 
Struggling frequency: There were no significant differences in the number of times each 
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Data represents (1) median ± IQR; (2) mean ± SEM     
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=18; Group 2: n=10; Group 3: n=9; Group 4: n=9 
Analyses: (1) Kruskal-Wallis Test; Dunn’s post hoc analyses; (2) One-way ANOVA; Bonferroni post hoc analyses 
Abbreviations: s, seconds; n, number; IQR, interquartile range; SEM, standard error of the mean 
 
(2)  
(2)  (1)  
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Table 3.2. Effect of social hierarchy on behavioural outcomes in the Forced Swim Test 










FST       
Immobility frequency  20.3 (0.3) 15.6 (2.5) 0.15 20.4 (1.9) 19.0 (2.4) 0.66 
Immobility duration  148.2 (13.6) 122.9 (7.8) 0.15 178.6 (21.4) 160.6 (18.5) 0.54 
Swimming duration  196.2 (20.2) 200.3 (36.7) 0.93 173.7 (21.2) 156.3 (9.0) 0.44 
 
Subjects: adult male BALB/c mice 
Sample sizes: Subordinates = 5; Dominants = 5 
Analyses: Independent samples t test; Bonferroni correction for multiple testing - threshold: p < .016 
Abbreviations: SE, standard error; FST, forced swim test 
 































Table 3.3. Summary of all behavioural changes associated with chronic stress exposure 
 




   
OFT: Centre duration - - - 
OFT: Centre latency = = = 
OFT: Centre frequency - - - 
OFT: Locomotor 
activity  
= = = 
NSFT: Latency to feed + + + 
NSFT: Arena food 
consumption  
- - = 
NSFT: Homecage food 
consumption  
= = = 
NSFT: Body weight 
after food restriction  
= = - 
NSFT: Locomotor 
activity  
= = = 




   
SPT: Sucrose 
consumption  
= - = 
SPT: Total liquid 
consumption  
= = = 
SPT: Food 
consumption 




   
FST: Immobility latency  = = = 
FST: Immobility 
duration  
= + = 
FST: Immobility 
frequency 
= = = 
FST: Swimming 
duration  
= - = 
FST: Struggling latency = = = 
FST: Struggling 
duration 
= = = 
FST: Struggling 
frequency 
= = = 
 
a  Combined stress = repeated injection and social isolation 
 
Key: 
+ Represents a significant increase in readout relative to control; highlighted in green 
-  Represents a significant decrease in readout relative to control; highlighted in red 
= Represents no significant change in readout relative to control; unhighlighted 
 
Subjects: adult male BALB/c mice 
Abbreviations: OFT, open field test; NSFT, novelty suppressed feeding test; SPT, sucrose preference test; FST, forced 






3.1.2.1.  Effect(s) of physical, psychosocial, and both physical and 
psychosocial stress on peripheral levels of inflammation 
 
All ten analytes measured using the Luminex platform reached detection levels. 
However, readouts from two analytes, that is, CRP and IGF-1, were above the 
standard curve and could not be analysed. Thus, data pertaining to the remaining 
eight analytes will be presented in this thesis. Moreover, due to technical issues with 
the Luminex platform, one plate had to wait over 24h to be read and as such all 
concentration values obtained were significantly lower for all animals assigned to that 
particular plate. Due to this variation, readouts from this plate were excluded from 
analyses for most analytes. Therefore, with the exception of IL10 and IL12, four 
animals were excluded from Group 1, four from Group 2, two from Group 3 and three 
from Group 4. The overall intra-assay variability for all analytes ranged from 1.2-
8.7%. All sample sizes for each analyte will be provided in the graphs throughout the 
following subsections.  
 
3.1.2.1.1. The impact of chronic stress on plasma levels of pro-inflammatory 
cytokines, TNF-α , IL1β  and IL2 
 
3.1.2.1.1.1. Social isolation increases TNF-α, while repeated injection decreases 
TNF-α  
 
Figure 3.9 shows the effect of chronic stress exposure on plasma levels of TNF-α, 
both before, and after, acute stress exposure (Two way RM ANOVA: Effect of 
chronic stress exposure: F [3,60] = 21.8, p < .001; Effect of acute stress: F [1,60] = 
3.6, p = .06; Interaction: F [3,60] = 3.2, p = .03). Specifically, after nine weeks of 
stress exposure and 24h prior to the FST, mice exposed to repeated injection had a 
35% decrease in TNF-α compared with control animals (Post hoc analysis: t [60] = 
3.6, p = .004).  Conversely, socially isolated mice had a 26-52% increase in TNF-α 
compared with all other experimental groups after nine weeks of chronic stress (Post 
hoc analyses: relative to control: t [60] = 4.1, p < .001; relative to injected: t [60] = 6.8, 
p < .001; relative to combined: t [60] = 5.9, p < .001). Meanwhile, TNF-α levels in 
mice exposed to combined stress, although lower, did not differ statistically from 



























Figure 3.9. Effect of repeated injection, social isolation, and combined stress on 
plasma tumour necrosis factor (TNF)- α profiles  
Baseline: Nine weeks after chronic stress exposure, and 24h prior to the forced swim test, 
repeatedly injected mice (Group 2) had significantly decreased levels of TNF-α compared 
with socially isolated mice (Group 3) and control animals (Group 1). Conversely, socially 
isolated mice (Group 3) had significantly increased levels of TNF-α compared with all other 
experimental groups. Post-acute stress: Thirty minutes after the forced swim test, socially 
isolated mice (Group 3) had significantly increased levels of TNF-α compared with repeatedly 
injected mice (Group 2) and control animals (Group 1). Baseline vs. post-acute stress: 
There were no significant differences in TNF-α between baseline and post-acute stress for 
any of the experimental groups. 
 
 
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=14; Group 2: n=6; Group 3: n=7; Group 4: n=6 – Exclusions due to unreliable data derived from 
multiplex assay on account of a technical issue with the Luminex platform  
Analysis: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05; ** p < .01; *** p < .001 
Abbreviations: TNF, tumour necrosis factor; ng/ml, nanogram/millimetre; h, hour; min, minutes; FST, forced swim test; 
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Interestingly, after acute stress exposure, that is, 30 minutes after the FST, the only 
difference seen in TNF-α was in socially isolated mice, in which levels remained 
elevated at 28% and 35% relative to repeatedly injected (Post hoc analysis: t [60] = 
3.7, p = .003) and control animals (Post hoc analysis: t [60] = 3.5, p = .005), 
respectively. However, there was no difference between pre-stress and post-stress 
TNF-α levels for socially isolated animals, or for any of the other experimental 
groups.  
 
3.1.2.1.1.2.  Social isolation decreases IL1β, but increases IL1β in response to 
acute stress, while combined stress decreases IL1β post-acute stress 
 
The effect of chronic stress exposure on plasma levels of IL1β both before, and after, 
acute stress exposure is depicted in Figure 3.10 (Two way RM ANOVA: Effect of 
chronic stress exposure: F [3,54] = 9.7, p < .001; Effect of acute stress: F [1,54] = 
2.9, p = .09; Interaction: F [3,54] = 4.1, p = .01).  As illustrated, in addition to elevated 
levels of TNF-α after nine weeks of chronic stress exposure, mice exposed to social 
isolation had a 3.8-4.7% reduction IL1β compared with control animals (Post hoc 
analysis: t [54] = 5.9, p < .001), and animals exposed to combined stress (Post hoc 
analysis: t [54] = 3.8, p = .01). Moreover, only socially isolated mice showed a trend 
for a 3% increase in IL1β levels in response to acute stress relative to baseline (Post 
hoc analysis: t [54] = 3.3, p = .052), but did not show any difference in IL1β post-
acute stress. Finally, while no post-acute stress differences were observed for 
repeatedly injected or socially isolated mice, animals exposed to combined stress did 
however, show a 3% decrease in IL1β post-acute stress compared with control 
animals (Post hoc analysis: t [54] = 3.4, p = .04).  
 
3.1.2.1.1.3.  Chronic stress does not alter IL2, but following acute stress, IL2 
reduces in socially isolated mice  
 
Figure 3.11 highlights the effect of chronic stress on IL2 plasma levels before and 
after acute stress exposure (Two way RM ANOVA: Effect of chronic stress exposure: 
F [3,60] = 14.6, p < .001; Effect of acute stress: F [1,60] = 12.6, p < .001; Interaction: 
F [3,60] = 3.1, p = .03). Specifically, no significant differences in IL2 were found 
between experimental groups after nine weeks of stress exposure. However, socially 
isolated mice showed a 15% decrease in IL2 in response to novel acute stress 

























Figure 3.10. Effect of repeated injection, social isolation, and combined stress on 
plasma interleukin (IL) 1β  profiles  
Baseline: Nine weeks after chronic stress exposure, and 24h prior to the forced swim test, 
socially isolated mice (Group 3) had significantly decreased levels of IL1β compared with 
mice exposed to combined stress (Group 4) and control animals (Group 1). Post-acute 
stress: Thirty minutes after the forced swim test, mice exposed to combined stress (Group 4) 
had significantly decreased levels of IL1β compared with control animals (Group 1). Baseline 
vs. post-acute stress: Mice exposed to social isolation (Group 3) had a trend for an 







Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=14; Group 2: n=6; Group 3: n=7; Group 4: n=6 – Exclusions due to unreliable data derived from 
multiplex assay on account of a technical issue with the Luminex platform 
Analysis: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05; ** p < .01; *** p < .001 
Abbreviations: IL, interleukin; ng/ml, nanogram/millimetre; h, hour; min, minutes; FST, forced swim test; SEM, standard 
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Figure 3.11. Effect of repeated injection, social isolation, and combined stress on 
plasma interleukin (IL)-2 profiles  
Baseline: Nine weeks after chronic stress exposure, and 24h prior to the forced swim test, 
there were no significant differences in IL2 between experimental groups. Post-acute stress: 
Thirty minutes after the forced swim test, socially isolated mice (Group 3) had significantly 
decreased levels of IL2 compared with animals exposed to combined stressed (Group 4), 
and control animals (Group 1). Baseline vs. post-acute stress: Mice exposed to social 
isolation (Group 3) had a significant decrease in IL2 in response to acute stress compared 
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Stress level 2 
Permanent isolation and 
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Plasma interleukin 2 profile
**
*** ***
Baseline: 24h prior to the FST Post stress: 30min after the FST
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=14; Group 2: n=6; Group 3: n=7; Group 4: n=6 – Exclusions due to unreliable data derived from 
multiplex assay on account of a technical issue with the Luminex platform 
Analysis: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: ** p < .01; *** p < .001 
Abbreviations: IL, interleukin; ng/ml, nanogram/millimetre; h, hour; min, minutes; FST, forced swim test; SEM, standard 
error of the mean 
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these stress-exposed mice also exhibited a 15% decrease in IL2 post-acute stress 
when compared with control animals (Post hoc analysis: t [60] = 5.9, p < .001), and a 
23% decrease when compared with mice exposed to combined stress (Post hoc 
analysis: t [60] = 6.1, p < .001). No other differences in IL2 were observed for any of 
the other experimental groups. 
 
3.1.2.1.2.  The impact of chronic stress on plasma levels of anti-
inflammatory cytokines, IL10 and IL4 
 
3.1.2.1.2.1.  Only social isolation decreases IL10 
  
Figure 3.12 depicts the impact of chronic stress exposure on plasma levels of IL10 
both before and after the FST (Two way RM ANOVA: Effect of chronic stress 
exposure: F [3,60] = 9.3, p < .001; Effect of acute stress: F [1,60] = 0.02, p = .88; 
Interaction: F [3,60] = 0.1, p = .98).  As shown, in addition to altered pro-inflammatory 
cytokine levels, mice exposed to social isolation had a 17-19% decrease in IL10 
levels, both in the absence and presence of acute stress, compared with all other 
experimental groups (Post hoc analyses: Pre FST: relative to control: t [60] = 3.6, p = 
.004; relative to injected: t [60] = 3.0, p = .02; relative to combined: t [60] = 2.8, p = 
.04; Post FST: relative to control: t [60] = 3.9, p = .001; relative to injected: t [60] = 
2.8, p = .04; relative to combined: t [60] = 2.8, p = .04). However, IL10 levels were 
unaltered in either repeatedly injected mice, or mice exposed to combined stress in 
either the presence or absence of acute stress exposure. Moreover, there were no 
differences in IL10 post-acute stress relative to baseline for any of the experimental 
groups.  
 
3.1.2.1.2.2.  Combined stress decreases IL4, but all types of chronic stress 
decrease IL4 post-acute stress 
 
The effect of chronic stress exposure on plasma levels of IL4 both before and after 
the FST is shown in Figure 3.13 (Two way RM ANOVA: Effect of chronic stress 
exposure: F [3,60] = 12.6, p < .001; Effect of acute stress: F [1,60] < 0.01, p = .98; 
Interaction: F [3,60] = 1.6, p = .20).  Specifically, only animals exposed to combined 
stress had a 19% decrease in IL4 compared with control animals in the absence of 
acute stress (Post hoc analysis: t [60] = 3.3, p = .009).  Interestingly however, all 

























Figure 3.12. Effect of repeated injection, social isolation, and combined stress on 
plasma interleukin (IL)-10 profiles  
Baseline: Nine weeks after chronic stress exposure, and 24h prior to the forced swim test, 
socially isolated mice (Group 3) had significantly decreased levels of IL10 compared with all 
other experimental groups. Post-acute stress: Thirty minutes after the forced swim test, 
socially isolated mice (Group 3) had significantly decreased levels of IL10 compared with all 
other experimental groups. Baseline vs. post-acute stress: There were no significant 









Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=18; Group 2: n=10; Group 3: n=9; Group 4: n=9  
Analysis: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05; ** p < .01 
Abbreviations: IL, interleukin; ng/ml, nanogram/millimetre; h, hour; min, minutes; FST, forced swim test; SEM, standard 
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Figure 3.13. Effect of repeated injection, social isolation, and combined stress on 
plasma interleukin (IL)-4 profiles  
Baseline: Nine weeks after chronic stress exposure, and 24h prior to the forced swim test, 
mice exposed to combined stress (Group 4) had significantly decreased levels of IL4 
compared with control animals (Group 1).  Post-acute stress: Thirty minutes after the forced 
swim test, all stress-exposed animals (Groups 2-4) had significantly decreased levels of IL4 
compared with controls (Group 1). Baseline vs. post-acute stress: There were no 







Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=14; Group 2: n=6; Group 3: n=7; Group 4: n=6 – Exclusions due to unreliable data derived from 
multiplex assay on account of a technical issue with the Luminex platform 
Analysis: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: ** p < .01; *** p < .001 
Abbreviations: IL, interleukin; ng/ml, nanogram/millimetre; h, hour; min, minutes; FST, forced swim test; SEM, standard 
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compared with control animals (Post hoc analyses: injected: t [60] = 3.6, p = .004; 
isolated: t [60] = 5.1, p < .001; combined: t [60] = 5.5, p < .001), but there were no 
differences in IL4 post-acute stress relative to baseline for any of the experimental 
groups.  
 
3.1.2.1.3.  The impact of chronic stress on plasma levels of cytokines that 
are both pro-and anti-inflammatory (IL6 and IL12) 
 
3.1.2.1.3.1.  Chronic stress does not alter IL6 or IL12  
 
As depicted in Figure 3.14, no significant differences in IL6 or IL12 were found 
between (or within) experimental groups after nine weeks of stress exposure either in 
the absence or presence of acute stress (Two way RM ANOVA: Effect of chronic 
stress exposure: IL6: F [3,80] = 0.06, p = .99; IL12: F [3,84] = 0.9, p = .45; Effect of 
acute stress: IL6: F [1,80] = 0.01, p = .94; IL12: F [1,84] = 0.1, p = .74; Interaction: 
IL6: F [3,80] = 0.04, p = .99; IL12: F [3,84] = 1.1, p = .37).  
 
3.1.2.1.4.  The impact of chronic stress on plasma levels of vascular 
endothelial growth factor  
 
3.1.2.1.4.1.  Both social isolation and combined stress decrease plasma levels of 
vascular endothelial growth factor 
 
Figure 3.15 depicts the impact of chronic stress on plasma levels of VEGF before 
and after the FST (Two way RM ANOVA: Effect of chronic stress exposure: F [3,60] 
= 8.9, p < .001; Effect of acute stress: F [1,60] = 21.5, p < .001; Interaction: F [3,60] = 
2.4, p = .08). As highlighted, mice exposed to either nine weeks of social isolation, or 
combined stress, had a 13% decrease in VEGF when compared with control animals  
(Post hoc analyses: isolated: t [60] = 4.6, p < .001; combined: t [60] = 3.6, p = .02). 
However, only mice exposed to combined stress also had a 10% decrease in VEGF 
post-acute stress relative to controls (Post hoc analysis: t [60] = 3.3, p = .04), while 
only socially isolated animals had a 15% increase in VEGF in response to acute 
stress relative to baseline (Post hoc analysis: t [60] = 5.0, p < .001). Intriguingly, no 
differences in VEGF were observed for repeatedly injected animals in the absence or 





























Figure 3.14. Effect of repeated injection, social isolation, and combined stress on 
plasma interleukin (IL)-6 and IL12 profiles  
(A): Plasma IL6 profile: Baseline: Nine weeks after chronic stress exposure, and 24h prior 
to the forced swim test, there were no significant differences in IL6 between experimental 
groups. Post-acute stress: Thirty minutes after the forced swim test, there were no 
significant differences in IL6 between experimental groups. Baseline vs. post-acute stress: 
There were no significant differences in IL6 between baseline and post-acute stress levels for 
any of the experimental groups. (B): Plasma IL12 profile: Baseline: Nine weeks after 
chronic stress exposure, and 24h prior to the forced swim test, there were no significant 
differences in IL12 between experimental groups. Post-acute stress: Thirty minutes after the 
forced swim test, there were no significant differences in IL12 between experimental groups. 
Baseline vs. post-acute stress: There were no significant differences in IL12 between 
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Baseline: 24h prior to the FST Post stress: 30min after the FST
Data represents mean ± SEM  
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=14-18; Group 2: n=6-10; Group 3: n=7-9; Group 4: n=6-9 – Exclusions for IL6 due 
to unreliable data derived from multiplex assay on account of a technical issue with the Luminex platform 
Analysis: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Abbreviations: IL, interleukin; ng/ml, nanogram/millimetre; h, hour; min, minutes; FST, forced swim test; SEM, 




































Figure 3.15. Effect of repeated injection, social isolation, and combined stress on 
plasma vascular endothelial growth factor (VEGF) profiles  
Baseline: Nine weeks after chronic stress exposure, and 24h prior to the forced swim test, 
socially isolated mice (Group 3), and mice exposed to combined stress (Group 4) had 
significantly reduced plasma levels of VEGF compared with control animals (Group 1). Post-
acute stress: Thirty minutes after the forced swim test, animals exposed to combined 
stressed (Group 4) had significantly reduced VEGF compared with control animals (Group 
1). Baseline vs. post-acute stress: Mice exposed to social isolation (Group 3) had a 








Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=14; Group 2: n=6; Group 3: n=7; Group 4: n=6 – Exclusions due to unreliable data 
derived from multiplex assay on account of a technical issue with the Luminex platform 
Analysis: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05; *** p < .001 
Abbreviations: VEGF, vascular endothelial growth factor; ng/ml, nanogram/millimetre; h, hour; min, minutes; FST, 
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3.1.2.2.  Effect(s) of physical, psychosocial, and both physical and 
psychosocial stress on plasma corticosterone levels 
 
Overall corticosterone intra-assay variability was calculated as 9.1%.  Any readout 
with a coefficient of variation (CV) above 20% was not included in statistical 
analyses, and as such six animals across three groups were excluded from 
corticosterone analyses. Samples sizes for each analysis will be given in the graphs 
throughout each subsection.  
 
3.1.2.2.1.  Chronic stress does not alter corticosterone levels after stress 
exposure, but the type of stress differentially alters 
corticosterone responsivity  
 
Figure 3.16 shows the effect of chronic stress exposure and the impact of acute 
stress on plasma levels of corticosterone (Two way RM ANOVA: Effect of chronic 
stress exposure: F [3,72] = 10.6, p < .001; Effect of acute stress: F [1,72] = 317.5, p 
< .001; Interaction: F [3,72] = 5.1, p = .003). Specifically, no significant differences in 
corticosterone across experimental groups were found after chronic stress exposure, 
but all experimental groups had a 168-245% increase in corticosterone post-acute 
stress relative to baseline (Post hoc analyses: controls: t [72] = 11.5, p < .001; 
injected: t [72] = 11.6, p < .001; isolated: t [72] = 5.4, p < .001; combined: t [72] = 8.5, 
p < .001). Interestingly, although no baseline plasma corticosterone differences were 
observed, post-acute stress levels did significantly alter between experimental 
groups. Specifically, repeatedly injected mice had corticosterone levels 22-41% 
higher than all other experimental groups in response to novel acute stress (Post hoc 
analyses: relative to control: t [72] = 4.2, p < .001; relative to isolated: t [72] = 6.2, p < 
.001; relative to combined: t [72] = 3.6, p = .003). Conversely, socially isolated mice 
had corticosterone levels 22-41% lower than all other experimental groups in 
response to acute stress (Post hoc analyses: relative to control: t [72] = 2.9, p < .03; 
relative to injected: t [72] = 6.2, p < .001; relative to combined: t [72] = 2.8, p = .04), 
while mice exposed to combined stress had a stress response similar to that of 
































Figure 3.16. Effect of repeated injection, social isolation, and combined stress on 
plasma corticosterone profiles  
Baseline: Nine weeks after chronic stress exposure, and 24h prior to the forced swim test, 
there were no significant differences in corticosterone between experimental groups. Post-
acute stress: Thirty minutes after the forced swim test, repeatedly injected animals (Group 
2) had a significant increase in corticosterone compared with all other experimental groups.  
Conversely, socially isolated animals (Group 3) had a significant decrease in corticosterone 
compared with all other experimental groups. Baseline vs. post-acute stress: All 
experimental groups had a significant increase in corticosterone post-acute stress compared 
with baseline.  
 
 
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=17; Group 2: n=6; Group 3: n=8; Group 4: n=9 – Exclusions due to unreliable data derived from 
immunoassays. Values with a CV above 20% were not included in subsequent analyses.  
Analysis: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05; ** p < .01; *** p < .001 
Abbreviations: ng/ml, nanogram/millimetre; h, hour; min, minutes; FST, forced swim test; SEM, standard error of the mean; 
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3.1.2.3.   Effect(s) of social hierarchy on biochemical data 
 
3.1.2.3.1.   Social hierarchy does not confound any of the biochemical data 
 
As depicted in Table 3.4, social dominance did not influence any of the 
aforementioned findings pertaining to peripheral levels of inflammation, vascular 
endothelial growth factor, or corticosterone as presented in this subsection, and 
summarised in Table 3.5.  
 
3.1.3.  Effect(s) of physical, psychosocial, and both physical and psychosocial 
stress on neuroinflammation  
 
Given that (i) chronic stress was shown to alter peripheral inflammation in 
experimental animals, as presented in the previous subsection, and that (ii) 
peripheral levels of inflammation can be an indirect indictor of neuroinflammation 
(Miller and Raison, 2017), microglia and astrocyte biology was next evaluated, as 
identified by Iba1 and GFAP, respectively, in line with AIM 3 of this part of the thesis 
(see 1.4.1.1.3). 
 
3.1.3.1. Effect(s) of physical, psychosocial, and both physical and 
psychosocial stress on Iba1 positive cells in the hippocampus and 
prefrontal cortex 
 
3.1.3.1.1.  The impact of chronic stress on Iba1 positive cell 
immunoreactivity in the hippocampus and prefrontal cortex 
 
3.1.3.1.1.1.  Chronic stress does not alter Iba1 positive cell immunoreactivity in the 
prefrontal cortex, but does alter Iba1 immunoreactivity in the dentate 
gyrus of the hippocampus 
 
Exposure to chronic stress did not significantly alter Iba1 immunoreactivity in the 
prefrontal cortex (PFC), with no differences found between experimental groups 
(One way ANOVA: F [3,28] = 1.2; p = 0.33; Figure 3.18). However, chronic stress 
did significantly reduce Iba1 immunoreactivity in the DG of the hippocampus as 
highlighted in Figures 3.19.A and 3.19.B (Two way ANOVA: Effect of exposure: F 
[3,47] = 5.7, p = .002; Effect of region: F [1,47] = 1.2, p = .29; Interaction: F [3,47] =  
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Table 3.4. Effect of social hierarchy on biochemical outcomes 












      
TNFα baseline 0.042 (0.005) 0.035 (0.002) 0.25 0.031 (0.004) 0.032 (0.005) 0.96 
TNFα post stress 0.031 (0.002) 0.041 (0.008) 0.22 0.028 (0.002) 0.028 (0.001) 0.75 
IL1β baseline 1.41 (0.03) 1.41 (0.04) > 0.99 N/A N/A N/A 
IL1β post stress 1.43 (0.04) 1.40 (0.03) 0.51 N/A N/A N/A 
IL2 post stress 0.035 (0.004) 0.035 (0.005) 0.97 N/A N/A N/A 
IL4 baseline 0.30 (0.002) 0.30 (0.1) 0.57 N/A N/A N/A 
IL4 post stress 0.35 (0.003) 0.30 (0.08) 0.54 N/A N/A N/A 
IL10 baseline 0.18 (0.06) 0.18 (0.002) 0.92 0.18 (0.02) 0.18 (0.03) 0.35 
IL10 post stress 0.19 (0.1) 0.18 (0.002) 0.69 0.18 (0.01) 0.18 (0.02) 0.93 
Growth factors       
Plasma VEGF 
baseline 
0.035 (0.003) 0.034 (0.003) 0.73 N/A N/A N/A 
Plasma VEGF post 
stress 
0.036 (0.002) 0.037 (0.003) 0.81 N/A N/A N/A 
Hormones       
Corticosterone post 
stress 
94.7 (16.1) 69.8 (18.9) 0.37 13.3 (7.1) 16.2 (17.1) 0.16 
 
Subjects: adult male BALB/c mice 
Sample sizes: Subordinates = 5; Dominants = 5 
Analyses: Independent samples t test; Bonferroni correction for multiple testing – threshold: p < .004 (control animals) or p < 
.008 (repeatedly injected stressed animals) 
Abbreviations: SE, standard error; TNF, tumour necrosis factor; IL, interleukin; VEGF, vascular endothelial growth factor; 
baseline, 24 hours prior to acute stress; post stress, 30 minutes after acute stress; N/A, not applicable – no significant findings 
were observed for this group with any other experimental group for these parameters 





















Table 3.5. Summary of all biochemical changes associated with chronic stress exposure 
 
Variable Repeated injection Social isolation  Combined stress a 
Peripheral 
inflammation 
   
TNFα pre-stress - + = 
TNFα post-stress = + = 
TNFα pre- vs. post-
stress 
= = = 
IL1β pre-stress = - = 
IL1β post-stress = = - 
IL1β pre- vs. post-
stress 
= + = 
IL2 pre-stress = = = 
IL2 post-stress = - = 
IL2 pre- vs. post-stress = - = 
IL4 pre-stress = = - 
IL4 post-stress - - - 
IL4 pre- vs. post-stress = = = 
IL6 pre-stress = = = 
IL6 post-stress = = = 
IL6 pre- vs. post-stress = = = 
IL10 pre-stress = - = 
IL10 post-stress = - = 
IL10 pre- vs. post-
stress 
= = = 
IL12 pre-stress = = = 
IL12 post-stress = = = 
IL12 pre- vs. post-
stress 
= = = 
Growth factors    
VEGF pre-stress = - - 
VEGF post-stress = = - 
VEGF pre- vs. post-
stress 
= + = 
Hormones    
Corticosterone pre-
stress 
= = = 
Corticosterone post-
stress 
+ - = 
Corticosterone pre- vs. 
post-stress 
+ + + 
 
a  Combined stress = repeated injection and social isolation 
 
Key: 
+ Represents an increase in plasma levels relative to control; highlighted in green 
-  Represents a decrease in plasma levels relative to control; highlighted in red 
= Represents no change in plasma levels relative to control; unhighlighted 
 
Subjects: adult male BALB/c mice 
Abbreviations: TNF, tumour necrosis factor; IL, interleukin; VEGF, vascular endothelial growth factor; pre-stress, 24 hours 









Figure 3.17. Effect of repeated injection, social isolation and combined stress on Iba1 positive cell immunoreactivity in the prefrontal cortex 
(A) Iba1 Immunoreactivity: Chronic stress exposure did not alter Iba1 positive cell immunoreactivity in the prefrontal cortex.  No significant differences in 
Iba1 were found between experimental groups. (B) Representative photomicrographs of the prefrontal cortex taken from control animals stained for Iba1 
for illustrative purposes. 
 
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = 6 (2) Animals per group: Group 1: n=18; Group 2: n=6; Group 3: n=9; Group 4: n=9 – Group 2 exclusions due to technical issue with housing conditions. Animals 
were excluded from all histological analyses.  
Analysis: One-way ANOVA; Bonferroni post hoc analyses 
Images: Whole coronal section at 2x magnification; two representative averages of the prefrontal cortex taken from control animal at 20x magnification for illustrative purposes; scale bar = 50µm 
Abbreviations: Iba1, ionized calcium binding adaptor molecule 1; SEM, standard error of the mean 
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Figure 3.18.A Effect of repeated injection, social isolation, and combined stress on 
Iba1 positive cell immunoreactivity in the dentate gyrus of the hippocampus 
After nine weeks of chronic stress exposure, repeatedly injected mice (Group 2) and socially 
isolated mice (Group 3) had significantly reduced Iba1 positive cell immunoreactivity in the 
hippocampus as a whole compared with controls (Group 1). Stratification analyses revealed 
that for repeatedly injected mice (Group 2), this reduction in Iba1 was specific to the ventral 
dentate gyrus, but for socially isolated mice (Group 3), the reduction in Iba1 was specific to 
the dorsal dentate gyrus, all when compared with control animals (Group 1). There were no 
significant differences in Iba1 immunoreactivity between mice exposed to combined stress 











































Stress level 2 
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Iba-1 positive cell immunoreactivity in the dentate 
gyrus of the hippocampus
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = whole DG, 6; dorsal DG, 3; ventral DG, 3. (2) Animals per group: Group 1: 
n=18; Group 2: n=6; Group 3: n=9; Group 4: n=9 – Group 2 exclusions due to technical issue with housing conditions. 
Animals were excluded from all histological analyses.  
Analysis: Two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05; ** p < .01 




























Figure 3.18.B Representative photomicrographs of the hippocampus for experimental 
groups all stained for Iba1  
(A) Representative photomicrographs of the ventral dentate gyrus for repeatedly injected 
mice (INJ; Group 2) and control animals (CON; Group 1) stained for Iba1. (B) 
Representative photomicrographs of the dorsal dentate gyrus for socially isolated (ISO; 
Group 3) and control animals (CON; Group 1) stained for Iba1. Both stress-exposed groups 
(Groups 2 and 3) had significantly reduced Iba1 immunoreactivity in the dentate gyrus 








Subjects: adult male BALB/c mice 
Images: Whole dorsal and ventral hippocampal sections at 2x magnification; representative averages of each hippocampal region 
taken from control animals for illustrative purposes.  
Close up snapshots from each stress exposure group taken from the dentate gyrus. Each image represents the average for each 
of the experimental conditions. Images taken at 20x magnification; scale bar = 50µm 




0.9, p = .45). Specifically, repeatedly injected and socially isolated mice had a 21% 
and 14% decrease, respectively, in Iba1 immunoreactivity in the DG when compared 
with control animals (Post hoc analyses: injected: t [47] = 3.8, p = .003; isolated: t 
[47] = 3.0, p = .02). Interestingly, this decrease in Iba1 immunoreactivity was region 
specific for each of these exposure groups, with socially isolated mice having a 19% 
decrease in Iba1 in the dorsal DG (Post hoc analysis: t [47] = 2.8, p = .048), while 
repeatedly injected mice had a 25% decrease in Iba1 in the ventral DG (Post hoc 
analysis: t [47] = 3.2, p = .02), all when compared with control animals. Although 
mice exposed to combined stress did have reduced Iba1 immunoreactivity in the DG 
compared with controls, this did not reach statistical significance. 
 
Given that immunoreactivity is essentially the quantification of positive cell 
percentage area coverage, it is primarily dependent on either cell density and/or cell 
morphology. Therefore, to further understand what these significant changes in Iba1 
immunoreactivity represented for repeatedly injected and socially isolated mice, Iba1 
cell density and cell morphology was next examined, as compared with control 
animals.  Due to the very time consuming nature of these further analyses, a 
hypothesis driven, targeted approach was adopted and thus, only the regions (i.e., 
dorsal or ventral hippocampus) found to be significantly altered in Iba1 
immunoreactivity were analysed further.  
 
3.1.3.1.2.  The impact of chronic stress on Iba1 positive cell density in the 
hippocampus 
 
3.1.3.1.2.1.  Repeated injection increases Iba1 positive cell density in the ventral 
dentate gyrus, while social isolation decreases Iba1 positive cell 
density in the dorsal dentate gyrus 
 
Interestingly, despite both stress-exposed groups showing a decrease in Iba1 
positive cell immunoreactivity, albeit in different regions of the DG, the type of chronic 
stress exposure differentially altered cell density when compared with control 
animals, as depicted in Figure 3.20. Surprisingly, repeatedly injected mice had a 
22% increase in Iba1 cell density in the ventral DG when compared with controls 
(Independent t test: t [11] = 2.7; p = .02; Figure 3.20.A). Conversely, but more in line 
with immunoreactivity data, socially isolated mice had a 24% decrease in Iba1 cell 
density in the dorsal DG when compared with control animals (Independent t test: t 































Figure 3.19. Effect of repeated injection, social isolation, and combined stress on Iba1 
positive cell density in the dentate gyrus of the hippocampus 
(A) Physical stress: After nine weeks of chronic stress exposure, repeatedly injected mice 
(Group 2) had significantly increased Iba1 positive cell density in the ventral dentate gyrus 
compared with control animals (Group 1). (B) Psychosocial stress: Conversely, socially 
isolated mice (Group 3) had significantly reduced Iba1 positive cell density in the dorsal 








































Stress free controls - 
no injection/isolation
Group 2: 
Stress level 1: 
Chronic injection
Iba-1 cell density in the ventral dentate gyrus of the 
hippocampus for physically stressed mice compared 
with control animals
Data represents mean ± SEM  
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = dorsal DG, 4; ventral DG, 4. (2) Animals per group: Group 1: n=8; 
Group 2: n=6; Group 3: n=9 - Group 2 exclusions due to technical issue with housing conditions. Animals were 
excluded from all histological analyses.  
Analyses: Independent samples t test 
p values: * p < .05; ** p < .01 















































Iba-1 cell density in the dorsal dentate gyrus of the 
hippocampus for psychosocially stressed mice 
compared with control animals
B.  
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3.1.3.1.3.  The impact of chronic stress on Iba1 positive cell morphology in 
the hippocampus 
 
3.1.3.1.3.1.  Iba1 cells in the ventral dentate gyrus assume a dystrophic 
morphology in response to repeated injection stress 
 
Although repeatedly injected mice had significantly more Iba1 cells in the ventral DG, 
the morphological characteristics of these cells, as listed in Table 3.6, were altered 
such that they assumed a more dystrophic morphology, which may explain the 
decreased Iba1 immunoreactivity data for this group. Specifically, as shown in 
Figure 3.21, Iba1 cells from repeatedly injected mice had 1.3 times fewer processes  
(GLMM: F [1,70] = 16.4; p < .001), a 1.2 times shorter maximum process length 
(GLMM: F [1,78] = 12.9; p = .001), and had a 31% reduction in branching complexity 
(GLMM: F [1,70] = 48.1; p < .001), all when compared with Iba1 cells from control 
animals. Furthermore, in addition to having a dystrophic morphology, cells also 
occupied 28% less space within the ventral DG compared with cells from controls 
(GLMM: F [1,18] = 53.7; p < .001), changes of which could be potential 
consequences of increased Iba1 cell density. Interestingly, Iba1 cell soma size and 
average process length was not significantly different between experimental groups 
(GLMM: soma size: F [1,51] = 1.8; p = .19; average process length: F [1,51] = 0.4; p 
= .51). 
 
3.1.3.1.3.2.  Iba1 cells in the dorsal dentate gyrus assume a ramified morphology 
in response to social isolation  
 
In addition to having fewer Iba1 cells in the dorsal DG, socially isolated mice had 
altered Iba1 cell morphology, the characteristics of which are listed in Table 3.6. 
Unlike repeatedly injected mice, Iba1 cells of animals exposed to social isolation 
assumed a more ramified morphology, as signified by unaltered soma size (GLMM: F 
[1,70] = 1.5; p = .23), average process length, and number (GLMM: length: F [1,780] 
= 0.2; p = .65; number: F [1,54] = 0.1; p = .99), but a 24% increase in branching 
complexity (GLMM: F [1,74] = 25.3; p < .001; see Figure 3.22), all when compared 
with control animals. Interestingly, although socially isolated mice had significantly 
fewer Iba1 cells in the dorsal DG, there were no differences in the amount of space 










Table 3.6. Morphological characteristics of Iba1 cells in the dentate gyrus of the hippocampus 
 
















Sholl Analysis Summary:     
Number of primary processes (Np) 4.5  
(0.16) ***  
5.42  
(0.15) ***  
7.7  
(0.26) ***  
5.96  
(0.12) ***  








Schoenen ramification index score 
(Nm/Np) 
3.25  
(0.1) ***  
2.25  
(0.1) ***  
1.98  
(0.11) ***  
2.45  
(0.05) ***  






























0.89   
(0.004) 
Skeleton Analysis Summary:     
Average number of processes 82.94  
(3.66) ***  
61.83 













Max process length (µm) 109.34  
(3.75) **  
90.04  





Iba1 Cell and Soma Analysis 
Summary: 
    
Overall area occupied by cell (µm 2) 586.57 
(15.01) ***  
421.78  





















n = cell/animal: 18/3 18/3 18/3 18/3 
 
Subjects:  adult male BALB/c mice 
Analysis: Mixed linear model; controlled for Iba1 geographical clustering; Bonferroni post hoc analyses  
Adjusted p values: * p < .05; ** p < .01; *** p < .001 




Subjects: adult male BALB/c mice 
Images: Each Iba1 cell represents the average for each of the experimental conditions. Images taken at 40x magnification; scale bar = 40µm. Sholl masks in (A); red denotes a greater degree of 
branching complexity, while blue denotes the lowest degree of branching complexity 









Figure 3.20. Representative photomicrographs, sholl masks and skeleton images of Iba1 cells from repeatedly injected mice and control animals taken from the 
ventral dentate gyrus of the hippocampus 
(A) Representative photomicrographs of Iba1 cells in the ventral dentate gyrus of repeatedly injected mice (INJ; Group 2) and control animals (CON; Group 1), and the 
associated sholl masks for each cell. Repeatedly injected mice (Group 2) had significantly less “complex” or ramified Iba1 cells in the ventral dentate gyrus signified by having 
a significantly reduced ramification index compared with control animals (Group 1). (B) Representative photomicrographs of Iba1 cells in the ventral dentate gyrus of 
repeatedly injected mice (INJ; Group 2) and control animals (CON; Group 1) and the associated skeletons for each cell. Repeatedly injected mice (Group 2) had significantly 







































Figure 3.21. Representative photomicrographs and sholl masks of Iba1 cells from 
socially isolated mice and control animals taken from the dorsal dentate gyrus of the 
hippocampus 
Representative photomicrographs of Iba1 cells in the dorsal dentate gyrus of socially isolated 
mice (ISO; Group 3) and control animals (CON; Group 1) and the associated sholl masks for 
each cell. Socially isolated mice (Group 3) had significantly more ramified Iba1 cells in the 
dorsal dentate gyrus signified by having a significantly higher ramification index compared 
with control animals (Group 1).  
 
 
Subjects: adult male BALB/c mice 
Images: Each Iba1 cell represents the average for each of the experimental conditions. Images taken at 40x 
magnification; scale bar = 40µm. Sholl masks; red denotes a greater degree of branching complexity, while blue 
denotes the lowest degree of branching complexity 




3.1.3.2.  Effect(s) of physical, psychosocial, and both physical and 
psychosocial stress on GFAP positive cells in the hippocampus 
and prefrontal cortex 
 
3.1.3.2.1.  The impact of chronic stress on GFAP positive cell 
immunoreactivity in the hippocampus and prefrontal cortex 
 
3.1.3.2.1.1.  Chronic stress does not alter GFAP positive cell immunoreactivity in 
the prefrontal cortex, but social isolation stress does alter GFAP 
immunoreactivity in the dentate gyrus of the hippocampus 
 
Similar to the Iba1 data, there were no significant differences in GFAP 
immunoreactivity in the PFC between any of the experimental groups (One way 
ANOVA: F [3,27] = 1.0; p = 0.39; Figure 3.23). However, chronic stress did 
significantly increase GFAP immunoreactivity in the DG of the hippocampus as 
depicted in Figures 3.24.A and 3.24.B (Two way ANOVA: Effect of exposure: F 
[3,53] = 15.7, p < .001; Effect of region: F [1,53] = 2.1, p = .15; Interaction: F [3,53] = 
0.9, p = .45). Specifically, only socially isolated animals had a 37-45% increase in 
overall GFAP immunoreactivity in the DG when compared with all other experimental 
groups (Post hoc analyses: relative to control: t [53] = 4.4, p < .001; relative to 
injected: t [53] = 4.8, p < .001; relative to combined: t [53] = 5.0, p < .001). Moreover, 
this change was not DG region specific, as socially isolated mice had a 43-63% and 
30-38% increase in GFAP immunoreactivity in both the dorsal and ventral DG, 
respectively, when compared with almost all other experimental groups (Post hoc 
analyses: Dorsal: relative to control: t [53] = 4.5, p < .001; relative to injected: t [53] = 
4.9, p < .001; relative to combined: t [53] = 4.9, p < .001; Ventral: relative to control: t 
[53] = 2.9, p = .06; relative to injected: t [53] = 3.1, p = .03; relative to combined: t [53] 
= 3.0, p = .049). No differences in GFAP immunoreactivity relative to controls were 
observed for repeatedly injected mice, or for animals exposed to combined stress.  
 
Given that GFAP is also expressed in neural progenitor cells (see 1.2.4.3), to further 
understand what GFAP positive cells represent in the context of this work, 
immunofluorescent double labelling was performed (see 2.5.4.1). Since only social 
isolation relative to control conditions induced increased GFAP immunoreactivity in 
the DG of the hippocampus, only these two stress conditions in this particular brain 
region were investigated further.  
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Figure 3.22. Effect of repeated injection, social isolation, and combined stress on GFAP positive cell immunoreactivity in the prefrontal cortex 
(A) Iba1 Immunoreactivity: Chronic stress exposure did not alter GFAP positive cell immunoreactivity in the prefrontal cortex.  No significant differences in 
GFAP were found between experimental groups. (B) Representative photomicrographs of the prefrontal cortex taken from control animals stained for 
GFAP for illustrative purposes. 
 




































Stress level 2 
Permanent isolation and 
chronic injection
GFAP positive cell immunoreactivity in the 
prefrontal cortex
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = 6 (2) Animals per group: Group 1: n=18; Group 2: n=6; Group 3: n=9; Group 4: n=9 – Group 2 exclusions due to technical issue with housing conditions. Animals 
were excluded from all histological analyses.  
Analysis: One-way ANOVA; Bonferroni post hoc analyses 
Images: Whole coronal section at 1.5x magnification; two representative averages of the prefrontal cortex taken from control animals at 20x magnification for illustrative purposes; scale bar = 50µm 
Abbreviations: GFAP, glial fibrillary acidic protein; SEM, standard error of the mean 
 























Figure 3.23.A. Effect of repeated injection, social isolation, and combined stress on 
GFAP positive cell immunoreactivity in the dentate gyrus of the hippocampus 
After nine weeks of chronic stress exposure, only socially isolated mice (Group 3) had 
significantly increased GFAP positive cell immunoreactivity in the hippocampus as a whole 
compared with all other experimental groups. Stratification analyses revealed that these 
increases in GFAP were not dentate gyrus region specific as socially isolated animals (Group 
3) had significantly increased GFAP positive cell immunoreactivity in both the dorsal and 






Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = whole DG, 6; dorsal DG, 3; ventral DG, 3. (2) Animals per group: Group 
1: n=18; Group 2: n=6; Group 3: n=9; Group 4: n=9 – Group 2 exclusions due to technical issue with housing 
conditions. Animals were excluded from all histological analyses.  
Analysis: Two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05; *** p < .001 
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Figure 3.23.B. Representative photomicrographs of the dorsal dentate gyrus of the 
hippocampus for experimental groups all stained for GFAP  
Representative photomicrographs of the dorsal dentate gyrus for control animals (CON; 
Group 1), repeatedly injected mice (INJ; Group 2), socially isolated animals (ISO; Group 3) 
and mice exposed to combined stress (INJ/ISO; Group 4), all stained for GFAP. Only socially 
isolated mice (Group 3) had significantly increased GFAP positive cell immunoreactivity in 
the dentate gyrus compared with all other experimental groups.  
 
 
CON INJ ISO INJ/IS
O 
Subjects: adult male BALB/c mice 
Images: Whole dorsal dentate gyrus image taken at 10x magnification; scale bar = 100µm; represents the average and was 
taken from control animals for illustrative purposes. Close up snapshots from each exposure group taken from the dorsal 
dentate gyrus. Each image represents the average for each of the experimental conditions. Images taken at 20x 
magnification; scale bar = 50µm 
Abbreviations: CON, controls - Group 1; INJ, repeatedly injected - Group 2; ISO, socially isolated - Group 3; INJ/ISO, 
combined stress (repeatedly injected and socially isolated) – Group 4 
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3.1.3.2.2.  GFAP positive cell characterisation in controls and 
psychosocially stressed animals  
 
3.1.3.2.2.1.  Both experimental groups had a significantly greater proportion of 
radial glial cells compared with astrocytes 
 
Figure 3.25 illustrates the breakdown of GFAP positive cells in the DG as a whole for 
control, and socially isolated, mice (Two way ANOVA: Effect of exposure: F [1,26] = 
4.5, p = .04; Effect of cell type: F [1,26] = 213.7, p < .001; Interaction: F [1,26] = 3.4, 
p = .08). In general, both experimental groups had a radial glia to astrocyte cell ratio 
of 9:1 (Post hoc analyses: controls: t [26] = 8.3, p < .001; isolated: t [26] = 8.3, p < 
.001).  
 
Knowing that approximately 10% of GFAP positive cells in the DG are astrocytes 
(i.e., controls: 12%; isolated: 11%) cell density estimates using stereological 
analyses were next obtained to determine whether differences observed in GFAP 
immunoreactivity between socially isolated mice and control animals were related to 
one or both types of GFAP positive cells.  
 
3.1.3.2.3.  The impact of psychosocial stress on GFAP positive cell density 
in the hippocampus 
 
3.1.3.2.3.1.  Social isolation increases radial glial cell density in the dentate gyrus 
of the hippocampus 
 
The effect of social isolation on radial glia and astrocyte positive cell density in the 
dorsal and ventral DG is shown in Figure 3.26 (Factorial three way ANOVA: Effect of 
exposure (a): F [1,52] = 6.9, p = .01; Effect of region (b): F [1,52] = 3.6, p = .06; 
Effect of cell type (c): F [1,52] = 350.8, p < .001; Interactions: (a*b); F [1,52] = 0.03, p 
= .87; (a*c); F [1,52] = 5.2, p = .03; (b*c); F [1,52] = 2.2, p = .15; (a*b*c); F [1,52] = 
0.02, p = .88). Specifically, socially isolated mice had a trend for a significant 
increase of 25%, and a 26% increase, in the number radial glial cells in the dorsal 
and ventral DG, respectively, all when compared with controls (Post hoc analyses: 
Dorsal: t [52] = 2.5, p = .054; Ventral: t [52] = 2.7, p = .048). Meanwhile, no significant 
differences in the number of astrocytes were observed between experimental 




Figure 3.24. Effect of social isolation on GFAP positive cell characterisation in the 
dentate gyrus of the hippocampus 
(A) GFAP positive cell characterisation: Chronic stress did not alter the ratio of radial glia 
to astrocyte cells in the dentate gyrus between experimental groups. Irrespective of exposure, 
all mice had significantly more radial glial cells, that is, GFAP+/SOX2+ cells, in the dentate 
gyrus compared with GFAP positive astrocytes, that is, GFAP+/SOX2- cells. (B) 
Representative photomicrographs of GFAP positive cells in the dorsal dentate gyrus in 
coronal sections taken from control animals  (CON; Group 1): representative 




























GFAP positve cell characterisation in the dentate gyrus 
of the hippocampus
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = whole DG, 6; dorsal DG, 3; ventral DG, 3. (2) Animals per group: Group 
1: n=6; Group 3: n=8 
Analysis: Two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: *** p < .001 
Images: Close up microphotographs of a radial glial cell (GFAP+/SOX2+) and astrocyte (GFAP+/SOX2-) taken 
at 40x magnification from the dorsal dentate gyrus of isolated animals. Scale bar = 40µm 








Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = whole DG, 6; dorsal DG, 3; ventral DG, 3. (2) Animals per group: Group 1: n=8; Group 3: n=9 
Analysis: Factorial three-way ANOVA; Bonferroni post hoc analyses. 
Adjusted p values: * p < .05; *** p < .001  
Images: Representative maximum intensity 2D z-stack projections of 10 confocal images taken at 20x magnification from the ventral dentate gyrus of a socially isolated animal (ISO) and control animal (CON). 
Scale bar = 50µm.  







































GFAP positve cell density in the dentate gyrus 
stratified by GFAP positive cell type and region
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***  
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Figure 3.25. Effect of social isolation on GFAP positive cell density in the dentate gyrus of the hippocampus stratified by GFAP cell type and 
dentate gyrus region 
(A) GFAP positive cell density: Both experimental groups had significantly more radial glial cells than astrocytes in the dentate gyrus, irrespective of region. 
However, socially isolated mice (Group 3) had a trend for significantly more radial glial cells in the dentate gyrus as a whole, and in the dorsal dentate gyrus, 
all when compared with control animals (Group 1). Moreover, these stressed mice (Group 3) had significantly more radial glial cells in the ventral dentate 
gyrus when compared with controls (Group 1). No significant differences in GFAP positive astrocyte cell density were found between experimental groups in 
dentate gyrus as a whole, or in either the dorsal or ventral dentate gyrus. (B) Representative photomicrographs of the ventral dentate gyrus for control 
animals (CON; Group 1), and socially isolated animals (ISO; Group 3), all double labelled for GFAP (red) and SOX2 (green).  
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However, given that only a small proportion of GFAP positive cells were actually 
astrocytes, tissue from these two exposure groups was subsequently stained for 
s100β , a mature astrocyte marker (see 1.2.3.2.2), in order to gain a more 
comprehensive understanding of the impact that social isolation has on astrocyte 
biology.  
 
3.1.3.2.4.  The impact of psychosocial stress on s100β  positive cell density 
in the hippocampus 
 
3.1.3.2.4.1.  Social isolation increases s100β cell density in the dentate gyrus of 
the hippocampus 
  
Figure 3.27 demonstrates how social isolation increases s100β cell density in the 
DG (Two way ANOVA: Effect of exposure: F [1,24] = 24.0, p < .001; Effect of region: 
F [1,24] = 0.2, p = .64; Interaction: F [1,24] = 0.3, p = .61). Specifically, stressed mice 
had a 52% and 65% increase in the number of s100β positive cells in the dorsal and 
ventral DG, respectively, all when compared with control animals (Post hoc analyses: 
Dorsal: t [24] = 3.1, p = .01; Ventral: t [24] = 3.8, p = .002).  
 
3.1.3.3.   Effect(s) of social hierarchy on neuroinflammation 
 
3.1.3.3.1.  Social hierarchy may confound GFAP immunoreactivity data for 
repeatedly injected mice only, but this does not alter the 
interpretation of data  
 
Interestingly, social dominance in repeatedly injected animals may be confounding or 
modifying GFAP immunoreactivity data for this particular group. As highlighted in 
Table 3.7, repeatedly injected subordinate animals had an increase in GFAP 
immunoreactivity in the dentate gyrus compared with repeatedly injected dominant 
animals (Independent t test: t [4] = 4.9; p = .008). Therefore, caution should be taken 
when interpreting GFAP findings pertaining to social isolation relative to repeated 
injection. However, given that further analyses pertaining to GFAP were conducted in 
socially isolated animals relative to control animals only, this finding does not impact 
the interpretation of the data in this subsection. No other significant differences were 
observed between dominant and subordinate animals regarding any of the other 
neuroinflammatory readouts as shown in Table 3.7. 
 224 
 
Figure 3.26. Effect of social isolation on s100β  positive cell density in the dentate gyrus of the hippocampus 
(A) S100β  positive cell density: Socially isolated mice (Group 3) had significantly increased s100β cell density in both the dorsal and ventral dentate gyrus 
compared with control animals (Group 1). (B) Representative photomicrographs of s100β positive cells in the ventral dentate gyrus of control animals 
(CON; Group 1), and socially isolated mice (ISO; Group 3). 
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = whole DG, 6; dorsal DG, 3; ventral DG, 3. (2) Animals per group: Group 1: n=8; Group 3: n=9 
Analysis: Two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: ** p < .01 
Images: Ventral dentate gyrus images taken at 10x magnification: represents the average from each experimental condition: control animals (CON) and socially isolated animals (ISO). Scale bar 
= 100µm. Close up photomicrographs of s100β taken at 40x magnification. Scale bar = 50µm 
Abbreviations: GFAP, glial fibrillary acidic protein; SEM, standard error of the mean 
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Table 3.7. Effect of social hierarchy on neuroinflammatory outcomes 










Iba1       
Immunoreactivity in 
the DG 
10.9 (0.3) 12.7 (1.1) 0.19 0.031 (0.004) 0.032 (0.005) 0.96 






0.76 N/A N/A N/A 











GFAP       
Immunoreactivity in 
the DG 
34.7 (2.1) 33.4 (1.6) 0.64 29.3 (0.5) 33.5 (0.7) 0.008 
Radial glial cell 





0.75 N/A N/A N/A 






0.55 N/A N/A N/A 
 
Subjects: adult male BALB/c mice 
Sample sizes: Subordinates = 5; Dominants = 5 
Analyses: Independent samples t test; Bonferroni correction for multiple testing threshold: p < .008 (control animals) or p < .01 
(repeatedly injected animals) 
Abbreviations: SE, standard error; Iba1, ionized calcium binding adaptor molecule 1; GFAP, glial fibrillary acidic protein; DG, 






















3.1.4.   Effect(s) of physical, psychosocial, and both physical and psychosocial 
stress on adult hippocampal neurogenesis  
 
Lastly, in line with AIM 4 of this part of the PhD thesis (see 1.4.1.1.4), the effect of 
chronic stress on hippocampal volume and neurogenesis related outcomes were 
investigated.  
 
3.1.4.1.  Effect(s) of physical, psychosocial, and both physical and 
psychosocial stress on hippocampal volume  
 
3.1.4.1.1.  Chronic stress does not alter hippocampal volume 
 
Figure 3.28 illustrates how chronic stress exposure did not alter hippocampal volume 
for any of the exposure groups. There were no significant differences in the volume 
of either the dorsal or ventral hippocampus, or the hippocampus as a whole between 
experimental groups (Two way ANOVA: Effect of exposure: F [3,54] = 1.0; p = .40; 
Effect of region: F [2,54] = 370.4; p < .001; Interaction: F [6,54] = 0.1; p > .99). 
However, for all groups, irrespective of exposure, the dorsal hippocampus was 
significantly smaller than the ventral hippocampus (Post hoc analyses: controls: t [54] 
= 9.3, p < .001; injected: t [54] = 6.8, p < .001; isolated: t [54] = 6.5, p < .001; 
combined: t [54] = 7.8, p < .001), a consequence of the way in which the tissue was 
sectioned. 
 
3.1.4.2.   Effect(s) of physical, psychosocial, and both physical and 
psychosocial stress on overall proliferative cell density  
 
3.1.4.2.1. Chronic stress did not alter Ki67 cell density in the dentate gyrus of 
the hippocampus 
 
As shown in Figure 3.29, exposure to nine weeks of chronic stress did not alter Ki67 
cell density in the DG of the hippocampus for any of the exposure groups (One way 
ANOVA: F [3,21] = 0.01, p > .99). Stratification analyses of the dorsal/ventral DG 




























Figure 3.27. Effect of repeated injection, social isolation, and combined stress on 
hippocampal volume 
Between group analyses: Chronic stress exposure did not alter hippocampal volume 
between exposure groups. No significant differences in the volume of the hippocampus as a 
whole, or in the volume of the dorsal or ventral hippocampus were found between 
experimental groups. Within group analyses: For all groups the dorsal hippocampus was 
significantly smaller than the ventral hippocampus. Unsurprisingly, the total hippocampus was 







Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = whole DG, 6; dorsal DG, 3; ventral DG, 3. (2) Animals per group: Group 1: n=18; Group 
2: n=6; Group 3: n=9; Group 4: n=9. Group 2 exclusions due to technical issue with housing conditions. Animals were excluded 
from all histological analyses.  
Analysis: Two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: *** p < .001 
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Figure 3.28. Effect of repeated injection, social isolation, and combined stress on 
hippocampal Ki67 positive cell density  
Chronic stress exposure did not alter neuronal proliferation in the dentate gyrus of the 
hippocampus, with no significant differences in overall Ki67 positive cell density found 









Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = whole DG, 11 (2) Animals per group: Group 1: n=16; Group 2: n=6; Group 3: n=9; 
Group 4: n=7 – Exclusions due to unreliable data obtained from stereological analyses. Estimates with a CE above 20% were 
excluded. Dorsal/ventral stratification analyses could not be performed due to CE estimates all being above 20%.  Group 2 
exclusions due to technical issue with housing conditions. Animals were excluded from all histological analyses.  
Analysis: One-way ANOVA; Bonferroni post hoc analyses 
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3.1.4.3.  Effect(s) of physical, psychosocial, and both physical and 
psychosocial stress on overall immature neuron cell density  
 
3.1.4.3.1.  Repeated injection, and combined stress decreases immature neuron 
cell density in the dentate gyrus of the hippocampus 
 
Although no changes in neuronal proliferation were found for any of the exposure 
groups, mice exposed to repeated injection, with or without social isolation, did show 
altered neuronal differentiation as depicted in Figure 3.30 (Two way ANOVA: Effect 
of exposure: F [3,63] = 28.9; p < .001; Effect of region: F [2,63] = 2.0; p = .14; 
Interaction: F [6,63] = 0.3; p = .94). Specifically, repeatedly injected animals, and 
mice exposed to combined stressed, showed a 38-57% decrease in overall DCX 
positive cell density in the DG as a whole when compared with control animals, and 
mice exposed to social isolation (Post hoc analyses: Injected: relative to controls: t 
[63] = 6.6, p < .001; relative to isolated: t [63] = 7.7, p < .001; Combined: relative to 
controls: t [63] = 5.4, p = .002; relative to isolated: t [63] = 6.7, p < .001).  As 
illustrated in Figure 3.30, this reduction in cell density was more evident in the dorsal 
DG when compared with controls (Post hoc analyses: Injected: t [63] = 4.4, p < .001; 
Combined: t [63] = 3.5, p = .004), but when compared with socially isolated animals, 
this reduction was found in both the dorsal and ventral DG of the hippocampus (Post 
hoc analyses: Injected: dorsal: t [63] = 4.6, p < .001; ventral: t [63] = 4.2, p < .001; 
Combined: dorsal: t [63] = 3.9, p < .001; ventral: t [63] = 3.6, p = .004).  Meanwhile, 
socially isolated mice had an overall DCX positive cell density similar to that of 
control animals.  
 
To gain a better understanding of whether these reductions in DCX cell density were 
related to all DCX cell types, or whether they were specific to a particular stage of 
DCX maturation, all DCX positive cells were classified into one of four morphology 







































Neuronal differentiation: DCX positive cell density 
in the dentate gyrus of the hippocampus
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Stress level 0















Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = whole DG, 8; dorsal DG, 4; ventral DG, 4. (2) Animals per group: Group 1: n=16; Group 2: n=6; Group 3: n=9; Group 4: n=8 – Exclusions due to unreliable data obtained 
from stereological analyses. Estimates with a CE above 20% were excluded. Group 2 exclusions due to technical issue with housing conditions. Animals were excluded from all histological analyses.  
Analysis: Two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: ** p < .01; *** p < .001 
Images: Dorsal dentate gyrus images taken at 10x magnification: represents the average from each experimental condition. Scale bar = 100µm.  
Abbreviations: DCX, doublecortin; DG, dentate gyrus; CON, controls - Group 1; INJ, repeatedly injected - Group 2; ISO, socially isolated - Group 3; INJ/ISO, combined stress (repeatedly injected and socially 

















Figure 3.29. Effect of repeated injection, social isolation, and combined stress on hippocampal DCX positive cell density  
(A) DCX positive cell density: After nine weeks of chronic stress exposure, repeatedly injected mice (Group 2) had significantly reduced DCX positive cell 
density in the dentate gyrus as a whole compared with controls (Group 1) and socially isolated mice (Group 3). Mice exposed to combined stress (Group 4) 
also had significantly reduced DCX positive cell density in the dentate gyrus as a whole compared with controls (Group 1). Stratification analyses revealed 
that these reductions for both experimental groups were more evident in the dorsal dentate gyrus when compared with control animals, but when compared 
with socially isolated mice, these reductions were found in both the dorsal and ventral dentate gyrus. (B) Representative photomicrographs of the dentate 
gyrus for each of the experimental groups stained for DCX. 
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3.1.4.4. Effect(s) of physical, psychosocial, and both physical and 
psychosocial stress on immature neuron cell morphology 
 
3.1.4.4.1. Repeated injection reduces proliferative and post mitotic stage 
neuroblast cell density, while social isolation increases post mitotic 
stage neuroblast cell density  
 
DCX classification analyses revealed significantly altered DCX morphology for all 
stress-exposed animals, as shown in Figure 3.31 (Factorial three way ANOVA: 
Effect of exposure (a): F [3,144] = 26.9, p < .001; Effect of region (b): F [1,144] = 2.2, 
p = .14; Effect of cell type (c): F [3,144] = 20.3, p < .001; Interactions: (a*b); F [3,144] 
= 1.1, p = .36; (a*c); F [9,144] = 2.2, p = .02; (b*c); F [3,144] = 1.5, p = .22; (a*b*c); F 
[9,144] = 0.8, p = .59). Specifically, repeatedly injected mice had a 63% decrease in 
proliferative neuroblasts (Post hoc analysis: t [144] = 2.9, p = .03), and a 69% 
decrease in early post mitotic stage neuroblasts (Post hoc analysis: t [144] = 3.1, p = 
.02) in the dorsal DG when compared with control animals. Moreover, these stressed 
mice also had a 61-71% decrease in all neuroblast cell types, except those in the 
intermediate stage, in the dorsal DG when compared with socially isolated mice 
(Post hoc analyses: proliferative: t [144] = 3.1, p = .02; early post mitotic: t [144] = 
3.5, p = .007; late post mitotic: t [144] = 3.1, p = .02). Interestingly, mice exposed to 
combined stress had a change in only one particular neuroblast cell type, those in 
the early post mitotic stage. Specifically, they had a 55% decrease in these DCX 
cells in the dorsal DG when compared with both control (Post hoc analysis: t [144] = 
2.7, p = .056), and socially isolated (Post hoc analysis: t [144] = 3.3, p = .01), mice. In 
addition to the aforementioned changes, socially isolated animals had a 61-81% 
increase in post mitotic stage neuroblasts in the ventral DG compared with all other 
experimental groups (Post hoc analyses: controls: t [144] = 4.5, p < .001; injected: t 
[144] = 6.0, p < .001; combined: t [144] = 5.9, p < .001). 
 
Intriguingly, no significant differences in intermediate stage neuroblast cell density 
between experimental groups in either the dorsal or ventral DG was found. To help 
comprehend these immature neuron cell morphology findings, the compositional 
breakdown of the total DCX cell mass for each group was next calculated to 
determine whether certain experimental groups had (i) more or less of a particular 
neuroblast cell type, and/or (ii) whether DCX cells were potentially maturing at 


























































DCX positive cell morphology 
































Stress level 2 
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and chronic injection

















DCX positive cell density based on morphology in the dentate gyrus of the 
hippocampus
* ** ** *
p = .056 ***
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = 4. (2) Animals per group: Group 1: n=16; Group 2: n=6; Group 3: n=9; Group 4: n=8 Exclusions 
due to unreliable data obtained from stereological analyses. Estimates with a CE above 20% were excluded. Group 2 exclusions due to 
technical issue with housing conditions. Animals were excluded from all histological analyses.  
Analysis: Factorial three-way ANOVA; Bonferroni post hoc analyses.  
Adjusted p values: * p < .05; ** p < .01; *** p < .001 





Figure 3.30. Effect of repeated injection, social isolation, and combined stress on  
hippocampal DCX positive cell morphology  
Dorsal: After nine weeks of chronic stress exposure, repeatedly injected mice (Group 2) had 
significantly reduced proliferative, and early post mitotic, stage neuroblasts in the dorsal 
dentate gyrus compared with both controls (Group 1) and socially isolated mice (Group 3). 
Moreover, these mice (Group 2) also had significantly reduced late post mitotic stage 
neuroblasts in the dorsal dentate gyrus compared with socially isolated mice (Group 3). 
Similarly, mice exposed to combined stress (Group 4) had a trend for significantly reduced 
early post mitotic stage neuroblasts in the dorsal dentate gyrus compared with controls 
(Group 1), and significantly reduced early post mitotic stage neuroblasts when compared with 
socially isolated mice (Group 3). Ventral: After nine weeks of chronic stress exposure, 
socially isolated mice (Group 3) had significantly increased late post mitotic stage 

























3.1.4.4.2.  The type of chronic stress differentially alters the maturation rate of 
immature neurons   
 
All experimental groups had a greater proportion of proliferative neuroblasts 
compared with other DCX cell types. Indeed, the proportions of each neuroblast type 
typically reduced in a graded fashion from proliferative to late post mitotic for all 
experimental groups as illustrated in Figure 3.32 (Factorial three way ANOVA: Effect 
of exposure (a): F [3,288] = 13.3, p < .001; Effect of region (b): F [1,288] = 0.01, p = 
.93; Effect of cell type (c): F [3,288] = 1.1, p = .33; Interactions: (a*b); F [3,288] = 
0.02, p > .99; (a*c); F [9,288] = 0.2, p = .99; (b*c); F [3,288] = 0.1, p = .99; (a*b*c); F 
[9,288] = 0.04, p > .99). For within group compositional statistical analyses see 
Appendix 3.1.1.  In line with the DCX positive cell density data, when looking at the 
composition of DCX positive cells between experimental groups, repeatedly injected 
mice had a 1.7-1.8 times higher proportion of intermediate stage neuroblasts in the 
dorsal DG compared with control (Post hoc analysis: t [288] = 3.2, p = .02), and 
socially isolated (Post hoc analysis: t [288] = 3.1, p = .02), animals. Moreover, 
socially isolated mice had a 2.3 times higher proportion of late post mitotic cells in the 
dorsal DG when compared with repeatedly injected mice (Post hoc analysis: t [288] = 
3.3, p = .01), and a 1.8-1.9 times higher proportion of this same cell type in the 
ventral DG when compared with control animals (Post hoc analysis: t [288] = 3.2, p = 
.02), and mice exposed to combined stress (Post hoc analysis: t [288] = 2.9, p = .04). 
 
3.1.4.5. Effect(s) of social hierarchy on adult hippocampal neurogenesis  
 
3.1.4.5.1.  Social hierarchy does not confound any of the neurogenesis data 
 
Social dominance did not influence DCX measures as highlighted in Table 3.8. 
However, although overall DCX cell density (Independent t test: t [5] = 4.2; p = .014), 
proliferative stage neuroblast cell density (Independent t test: t [5] = 4.1; p = .015), 
and early post mitotic stage neuroblast cell density (Independent t test: t [5] = 4.2; p = 
.013) were significantly lower in stressed subordinate animals compared with 
stressed dominant animals, these findings did not survive multiple testing correction. 
Moreover, although there were within group differences when stratifying by social 
hierarchy, both stressed dominant and stressed subordinate animals had significantly 
reduced DCX cell density compared with subordinate and dominant control animals 










































Data represents mean ± SEM  
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = dorsal DG, 4; ventral DG, 4. (2) Animals per group: Group 1: n=16; Group 2: n=6; Group 3: n=9; 
Group 4: n=8. Exclusions due to unreliable data obtained from stereological analyses. Estimates with a CE above 20% were excluded. 
Group 2 exclusions due to technical issue with housing conditions. Animals were excluded from all histological analyses.  
Analysis: Factorial three-way ANOVA; Bonferroni post hoc analyses.  
Adjusted p values: * p < .05 
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Compostional breakdown of DCX positive cells in the 
dentate gyrus of the hippocampus 
* * *
 237 
Figure 3.31. Effect of repeated injection, social isolation, and combined stress on 
neuroblast composition in both the dorsal and ventral dentate gyrus 
Dorsal: After nine weeks of chronic stress exposure, repeatedly injected mice (Group 2) had 
a significantly greater proportion of intermediate stage neuroblasts in the dorsal dentate gyrus 
compared with both controls (Group 1) and socially isolated mice (Group 3). Moreover, these 
mice (Group 2) also had significantly reduced proportion of late post mitotic stage 
neuroblasts in the dorsal dentate gyrus compared with socially isolated mice (Group 3). 
Ventral: After nine weeks of chronic stress exposure, socially isolated mice (Group 3) had a 
significantly greater proportion of late post mitotic stage neuroblasts in the ventral dentate 
gyrus compared with both control animals (Group 1) and mice exposed to combined stress 
(Group 4).  
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Table 3.8. Effect of social hierarchy on neurogenesis outcomes 

































DCX cell density: 











DCX cell density: late 












Subjects: adult male BALB/c mice 
Sample sizes: Subordinates = 5; Dominants = 5 
Analyses: Independent samples t test; Bonferroni correction for multiple testing threshold: p < .0125 (control animals) or p < 
.0125 (repeatedly injected animals) 
Abbreviations: SE, standard error; DCX, doublecortin; DG, dentate gyrus 
























For a full summary of all the neurobiological changes, that is, changes in 
neuroinflammation and neurogenesis, associated with the three chronic stress 




































Table 3.9. Summary of all neurobiological changes associated with chronic stress 
exposure 
 
Variable Repeated injection Social isolation  Combined stress a 
Neuroinflammation 
readouts 
   
Iba1 positive cell 
immunoreactivity in the 
PFC 
= = = 
Iba1 positive cell 
immunoreactivity in the 
DG 
- - = 
Iba1 positive cell 
density in the DG 
+ - N/A 
Iba1 positive cell 
morphology in the DG 
b c N/A 
GFAP positive cell 
immunoreactivity in the 
PFC 
= = = 
GFAP positive cell 
immunoreactivity in the 
DG 
= + = 
GFAP positive cell 
density in the DG 
N/A + N/A 
S100β positive cell 
density in the DG 
N/A + N/A 
Neurogenesis 
measures 
   
Hippocampal volume  = = = 
Overall Ki67 positive 
cell density in the DG  
= = = 
Overall: DCX positive 
cell density in the DG 
- = - 
Proliferative stage: 
DCX positive cell 
density in the DG 
- = = 
Intermediate stage:  
DCX positive cell 
density in the DG 
= = = 
Early post mitotic 
stage:  DCX positive 
cell density in the DG 
- = - 
Late post mitotic stage:  
DCX positive cell 
density in the DG 
= + = 
 
a  Combined stress = repeated injection and social isolation 
 
Key: 
+ Represents a significant increase in readout relative to control; highlighted in green 
-  Represents a significant decrease in readout relative to control; highlighted in red 
= Represents no significant change in readout relative to control; unhighlighted 
a Represents a dystrophic morphology  
b Represents a hyper ramified morphology 
 
Subjects: adult male BALB/c mice 
Abbreviations: Iba1, ionized calcium binding adaptor molecule 1; PFC, prefrontal Cortex; DG, dentate gyrus; N/A, not 
applicable due to not being assessed; GFAP, glial fibrillary acidic protein; DCX, doublecortin 
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3.2.  PART B: Effect(s) of UCMSI on behaviour, inflammation and adult 
hippocampal neurogenesis 
 
3.2.1.  Effect of UCMSI on physical health and behaviour 
 
In line with the AIM 1 of this part of the thesis (see 1.4.2.1.1), the effect of UCMSI on 
health and behaviour was assessed. 
 
3.2.1.1. Effect of UCMSI on physical health  
 
3.2.1.1.1.  UCMSI does not impact body weight change during stress 
exposure  
 
Figure 3.33 shows the impact of UCMSI on absolute body weight (Two way RM 
ANOVA: Effect of exposure: F [1,9] = 7.0; p = .03; Effect of time: F [9,81] = 219.2; p < 
.001; Interaction: F [9,81] = 2.4; p = .02; Area under the curve: control: 315.4; 
UCMSI: 325.7). As shown, there were no significant baseline differences in absolute 
body weight between experimental groups, but UCMSI animals did weigh 5-6% more 
than control animals from Week 10 onwards (Post hoc analyses: Week 10: t [81] = 
3.3, p = .02; Week 12: t [81] = 4.4, p < .001).  However, as illustrated in Figure 3.34, 
unlike absolute body weight, there were no significant differences in weight change 
relative to baseline between experimental groups throughout stress exposure (Two 
way RM ANOVA: Effect of exposure: F [1,18] = 0.02; p = .88; Effect of time: F [7,126] 
= 100.9; p < .001; Interaction: F [7,126] = 1.7; p = .11; Area under the curve: control: 
95.9; UCMSI: 98.2).  
 
3.2.1.1.2.  UCMSI deteriorates coat state condition during exposure, but not 
in response to extended social isolation 
 
Figure 3.35 illustrates the impact of chronic stress on coat state condition 
(Friedman’s RM test: Effect of exposure: K [10,45] = 39.5; p < .001; Effect of time: F 
[10,45] = 24.7; p < .001). As shown, UCMSI mice had visibly worse coat state 
compared with controls throughout the first part of the stress paradigm. Specifically, 
the coat state of UCMSI mice worsened from Week two onwards, reaching 
significance from Week four, where it was 2.5-3.7 times worse than that of control 
animals (Post hoc analyses: Week 4: 2.5x; z = 12; p = .02; Week 5: 3.7x; z = 5.5; p < 






























Figure 3.32. Effect of UCMSI on absolute body weight during stress exposure  
Ten weeks into stress exposure, UCMSI mice (Group 2) weighed significantly more 










Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10 
Analyses: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Area under the curve values: Control:  315.4; UCMSI: 325.7 
Adjusted p values: * p < .05; *** p < .001 
Abbreviations: g, grams; UCMSI, unpredictable mild chronic stress and isolation; A denotes the start of UCMSI; SEM, standard 
error of the mean 
 

























































Figure 3.33. Effect of UCMSI on percentage body weight change relative to baseline 
during stress exposure  
No significant differences in weight change relative to baseline were observed at any point 
during exposure between experimental groups.  
 
 
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10 
Analyses: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Area under the curve values: Control: 95.9; UCMSI: 98.2 
Abbreviations: g, grams; UCMSI, unpredictable mild chronic stress and isolation 
 




































Figure 3.34. Effect of UCMSI on coat state condition during stress exposure 
Four weeks into stress exposure, UCMSI mice (Group 2) had significantly worse coat state 
condition than control animals (Group 1), which persisted at Week five and Week six. 
Interestingly, at Week 8, two weeks after the cessation of the UCMS part of the stress 
paradigm, the coat state condition of UCMSI mice was comparable to that of control animals, 





Data represents median ± IQR 
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10 
Analysis: Repeated measures Friedman’s test; Dunn’s post hoc analyses 
Adjusted p values: * p < .05; *** p < .001 
Abbreviations: UCMSI, unpredictable mild chronic stress and isolation; UCMS, unpredictable mild chronic stress; SI, social 
isolation; IQR, interquartile range 
 





























cessation of the UCMS part of the stress exposure, the coat state of stressed 
animals was comparable to that of control animals. Not only did coat state restore to 
baseline, but it also did not worsen at any point during the last six weeks of the 
experiment, despite animals being socially isolated during this period. 
 
3.2.1.2.  Effect of UCMSI on anxiety- and depressive-like behaviour  
 
3.2.1.2.1.   UCMSI increases anhedonic-like behaviour during exposure 
 
During the first six weeks of exposure, the sucrose preference test (SPT) was 
repeatedly performed to confirm the effect of stress exposure on anhedonic-like 
behaviour. Figure 3.36.A illustrates how sucrose preference altered across the first 
six weeks of exposure (Two way RM ANOVA: Effect of exposure: F [1,18] = 0.7; p = 
.42; Effect of time: F [3,54] = 0.8; p = .52; Interaction: F [3,54] = 4.3; p = .008). 
Specifically, UCMSI mice showed a gradual decrease in sucrose consumption after 
two weeks of UCMSI, such that by five weeks of exposure, UCMSI mice had a 23% 
decrease in sucrose consumption compared with controls (Post hoc analysis: t [72] = 
2.8, p = .02). While this reduction in sucrose consumption was not influenced by total 
liquid consumption as depicted in Figure 3.36.B (Effect of exposure: F [1,9] = 0.2; p 
= .66; Effect of time: F [3,27] = 4.3; p = .01; Interaction: F [3,27] = 1.3; p = .29), food 
intake profiles during the SPT suggest that there may have been a general decrease 
in appetite-motivated behaviour. As seen in Figure 3.36.C, food profiles closely 
paralleled sucrose consumption profiles across bi-weekly testing (Effect of exposure: 
F [1,9] = 9.9; p = .01; Effect of time: F [3,27] = 0.3; p = .86; Interaction: F [3,27] = 
21.5; p < .001). Specifically, in line with sucrose consumption, UCMSI animals 
consumed 1.4 times more food at Week two (Post hoc analysis: t [27] = 8.2, p < 
.001), but consumed 1.1 times less food at Week six (Post hoc analysis: t [27] = 2.9, 
p = .03), all when compared with control animals. 
 
3.2.1.2.2.  UCMSI increases anxiety-like behaviour 
 
Stress-exposed mice exhibited significantly increased anxiety-like behaviour in the 
open field test (OFT) and the novelty suppressed feeding test (NSFT) when 
compared with control animals (Figures 3.37.A;B and Figures 3.38.A;B). 
Specifically, in the OFT, UCMSI mice took 15 times longer to enter the centre zone 





























Figure 3.35. Effect of UCMSI on anhedonic-like behaviour in the Sucrose Preference 
Test (SPT) during stress exposure 
(A) Sucrose consumption: Mice exposed to UCMSI (Group 2) consumed significantly less 
sucrose at Week 6, five weeks after exposure, compared with control animals (Group 1). 
Although stressed animals consumed less sucrose at Week 4, this did not reach statistical 
significance. (B) Total liquid consumption: No significant differences in total liquid 
consumption in the SPT were observed between experimental groups (C) Food 
consumption: Food profiles during testing closely mirrored the sucrose consumption profiles 
of experimental groups. Specifically, UCMSI mice (Group 2) consumed significantly more 
food at Week 2, one week after exposure, but consumed significantly less food at Week 6, 
five weeks after exposure, all when compared with control animals (Group 1). 
 


















The Sucrose Preference Test: Food consumption
Group 1: 
Stress level 0




























The Sucrose Preference Test: Total liquid consumption
Group 1: 
Stress level 0






Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10 
Analyses: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05; *** p < .001 
Abbreviations: g, gram; UCMSI, unpredictable mild chronic stress and isolation; SEM, standard error of the mean; A denotes the 
start of UCMSI  
 



















The Sucrose Preference Test: Sucrose consumption
Group 1: 
Stress level 0



































Figure 3.36. Behaviour in the Open Field Test (OFT) after at least twelve weeks of 
stress exposure 
Latency to enter the centre: UCMSI-exposed mice (Group 2) took significantly longer to 
enter the centre zone of the arena compared with control animals (Group 1).  (B) Duration 
spent in the centre: There was a trend for a significant decrease in the amount of time that 
stress-exposed mice spent in the centre of the OFT compared with control animals (Group 
1). (C) Centre frequency: Although UCMSI mice (Group 2) entered the centre zone less 
frequently than control animals (Group 1), this did not reach statistical significance. (D) 
Locomotor activity: No significant differences in locomotor activity in the outer zone of the 




































































































The Open Field Test: Frequency in centre
Group 1: 
Stress level 0






































Data represents (1) median ± IQR; (2) mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10 
Analyses: (1) Denotes Mann Whitney U test (2) Denotes Independent samples t test 
p values: * p < .05 
Abbreviations: s, seconds; n, number; cm, centimetres; UCMSI, unpredictable mild chronic stress and isolation; SEM, standard error 






















Figure 3.37. Anxiety-like behaviour in the Novelty Suppressed Feeding Test (NSFT) 
after at least twelve weeks of stress exposure 
(A) Latency to feed in the arena: UCMSI mice (Group 2) took significantly longer to initiate 
feeding in the NSFT arena compared with control animals (Group 1). (B) Food 
consumption in the arena: Mice exposed to UCMSI (Group 2) consumed significantly less 

















Data represents (1) median ± IQR; (2) mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10 
Analyses: (1) Denotes Mann Whitney U test (2) Denotes Independent samples t test 
p values: *** p < .001 
Abbreviations: s, seconds; g, grams; UCMSI, unpredictable mild chronic stress and isolation; SEM, standard error of the mean; 
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UCMSI mice to spend less time in the centre of the arena (Mann-Whitney U test: z = 
19; p = .06; Figure 3.37.B), all when compared with control animals. Moreover, 
stressed animals also entered the centre zone less frequently than control animals, 
although this finding did not reach statistical significance (Independent t test: t [7] = 
1.9; p = .09; Figure 3.37.C). Meanwhile, in the NSFT, UCMSI mice took 2.7 times 
longer to initiate feeding in the test arena (Mann-Whitney U test: z = 0; p < .001; 
Figure 3.38.A), and consumed 79% less food in the arena (Independent t test: t [9] = 
5.0; p < .001; Figure 3.38.B), all when compared with control animals. However, 
although stress-exposed mice exhibited increased anxiety-like behaviour in this 
behavioural task, there was no statistical evidence to support an increased change in 
anhedonic-like behaviour, with no differences in homecage consumption observed 
between experimental groups (Independent t test: t [16] = 0.7; p = .52; Figure 
3.39.A). 
 
Importantly, behaviour in the OFT and NSFT was not confounded by locomotor 
activity, with no statistical differences in the total distance travelled in the outer zone 
of the OFT arena (Independent t test: t [16] = 0.3; p = .75; Figure 3.37.D), or in the 
number of crossings in the NSFT arena (Independent t test: t [16] = 0.5; p = .63; 
Figure 3.39.C), observed between experimental groups. Furthermore, social 
dominance did not confound any of the anxiety-like behaviours seen in pair-housed 
control animals in either behavioural assay as shown in Table 3.10.  Interestingly, 
despite stress exposed mice losing 20% more weight (Independent t test: t [16] = 3.0; 
p = .009; Figure 3.39.B) in response to food restriction prior to the NSFT, this did not 
appear to influence their behaviour in the arena of the NSFT by encouraging the 
desire to feed. Moreover, although UCMSI animals did take 2.6 times longer to find 
the buried cookie in the Buried Food/Cookie Test (Mann-Whitney U test: z = 11; p = 
.008; Figure 3.39.D), all animals did find the buried cookie within the designated 
fifteen-minute time frame of this test. Therefore, the observed group differences in 
the latency to find the cookie could reflect changes in either anxiety-like, or appetite-
motivated, behaviours rather than olfactory ability.  
 
3.2.1.2.3.   UCMSI increases depressive-like behaviour  
 
In addition to increased anxiety-like behaviour, stress-exposed mice showed signs of 
significant depressive-like behaviour in the SPT and forced swim test (FST) when 
compared with controls. Figures 3.40.A and 3.41.B;D illustrate how after twelve 




Figure 3.38. Anhedonic-like behaviour, weight loss and locomotor activity in the 
Novelty Suppressed Feeding Test (NSFT) and olfaction in the Buried Food/Cookie Test 
after at least twelve weeks of stress exposure 
(A) Food consumption in the homecage: No significant differences in food consumption in 
the homecage were observed between experimental groups. (B) Weight loss after 24h food 
restriction prior to the NSFT: UCMSI mice (Group 2) lost significantly more weight after 
24h of food restriction compared with controls (Group 1). (C) Locomotor activity in the 
NSFT: No significant differences in the number of crossings in the arena were observed 
between experimental groups during testing. (D) Olfactory ability in Buried Food/Cookie 
Test: Although no deficits in olfactory ability were observed in any of the experimental mice, 
since all animals successfully located the buried cookie within the given time-frame, UCMSI 
mice (Group 2) did however, take significantly longer to locate the hidden cookie than control 




































































































B.  A.  
 
Data represents (1) median ± IQR; (2) mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10 
Analyses: (1) Denotes Mann Whitney U test (2) Denotes Independent samples t test 
p values: ** p < .01 
Abbreviations: s, seconds; g, grams; UCMSI, unpredictable mild chronic stress and isolation; SEM, standard error of the 
































Locomotor activity in the 
Novelty Supressed Feeding Test
Group 1: 
Stress level 0
































Table 3.10. Effect of social hierarchy on behavioural outcomes in the Open Field Test and 
Novelty Suppressed Feeding Test in pair-housed control animals  
Variable Dominants 
Mean/Mean rank (SE) 
Subordinates  
Mean/Mean rank (SE) 
p value 
OFT    










NSFT    













Subjects: adult male BALB/c mice 
Sample sizes: Subordinates = 4; Dominants = 4 
Analyses: (1) Mann Whitney U; (2) Independent samples t test; Bonferroni correction for multiple testing - threshold: p < 
.0125 


























Figure 3.39. Behaviour in the Sucrose Preference Test (SPT) after at least twelve weeks 
of stress exposure  
(A) Sucrose consumption: Mice exposed to UCMSI (Group 2) consumed significantly less 
sucrose compared with control animals (Group 1). (B) Total liquid consumption: No 
significant differences in total liquid consumption in the SPT were observed between 
experimental groups (C) Food consumption: No significant differences in food consumption 
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Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10 
Analyses: Independent samples t test 
p values: * p < .05 
























Figure 3.40. Behaviour in the Forced Swim Test (FST) after at least twelve weeks of 
stress exposure 
(A) Latency to become immobile: No significant differences in the average latency to 
become immobile were observed between experimental groups. (B) Immobility duration: 
UCMSI mice (Group 2) spent significantly more time immobile in the FST compared with 
control animals (Group 1). (C) Immobility frequency: No significant differences in the 
number of times animals become immobile were observed between experimental groups. (D) 
Swimming duration: Mice exposed to UCMSI (Group 2) spent significantly less time 
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The Forced Swim Test: Immobility latency
Group 1: 
Stress level 0





Data represents (1) median ± IQR; (2) mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10 
Analyses: (1) Denotes Mann Whitney U test (2) Denotes Independent samples t test 
p values: * p < .05 
Abbreviations: s, seconds; n, number; UCMSI, unpredictable mild chronic stress and isolation; SEM, standard error of the mean; 
IQR, interquartile range  
 
A.  B.  




consuming 15% less sucrose in the SPT (Independent t test: t [16] = 2.9; p = .01; 
Figure 3.40.A), and had increased behavioural despair/fatigue, spending 25% more 
time immobile (Independent t test: t [14] = 2.7; p = .02; Figure 3.41.B) and swimming 
17% less (Independent t test: t [14] = 2.4; p = .03; Figure 3.41.D) in the FST, all 
when compared with control animals. However, there were no differences in the 
latency to become immobile (Mann-Whitney U test: z = 22.5; p = .22; Figure 3.41.A), 
in the frequency of immobility (Independent t test: t [16] = 1.8; p = .10; Figure 
3.41.C), in the latency to struggle (Mann-Whitney U test: z = 25.5; p = .21; Figure 
3.42.A), in the amount of time spent struggling (Independent t test: t [16] = 0.1; p = 
.89; Figure 3.42.B), or in the struggling frequency (Independent t test: t [16] = 1.3, p 
= .22; Figure 3.42.C) between experimental groups in the FST. 
 
Importantly, observed differences in the SPT between experimental groups were not 
confounded by either total liquid consumption (see Figure 3.40.B), or food 
consumption (see Figure 3.40.C), with no significant differences being observed 
between experimental groups for either SPT parameter (Independent t tests: liquid: t 
[18] = 0.5; p = .64; food: t [18] = 0.2; p = .83). Moreover, as depicted in Table 3.11, 
social dominance did not influence behaviour in pair-housed animals in the FST.  
 
3.2.1.3.   Effect(s) of UCMSI on social interaction  
 
3.2.1.3.1.   UCMSI increases social behaviour  
 
Interestingly, UCMSI mice were significantly more sociable after twelve weeks of 
stress exposure as shown in Figure 3.43 (Two way ANOVA: Effect of exposure: F 
[1,64] = 8.3; p = .01; Effect of behaviour type: F [4,64] = 113.0; p < .001; Interaction: 
F [4,64] = 2.9; p = .03).  Specifically, stressed animals spent 46% more time engaged 
in social behaviour, overall, during the social interaction task compared with controls 
(Post hoc analysis: t [80] = 4.1, p < .001). Although, stressed animals did spend more 
time engaged in investigative, affiliative and play soliciting behaviours during testing, 
there were no significant differences for these individual behaviours compared with 
controls.   
 
Reassuringly, these differences in overall social behaviour in this behavioural task 
were not confounded by olfactory ability, as all animals could locate the buried cookie 
(Figure 3.39.D). Moreover, social dominance did not influence overall social 


























Figure 3.41. Effect of UCMSI on struggling behaviour in the Forced Swim Test (FST) 
after at least twelve weeks of stress exposure 
(A) Struggling latency: Although UCMSI mice took less time to start struggling, there were 
no significant differences in the latency to struggle in the FST between experimental groups. 
(B) Struggling duration: There were no significant differences in the total time spent 
struggling in the FST between experimental groups. (C) Struggling frequency: There were 




























The Forced Swim Test: Stuggling latency
Group 1: 
Stress level 0























The Forced Swim Test: Struggling frequency
Group 1: 
Stress level 0
























The Forced Swim Test: Struggling duration
Group 1: 
Stress level 0





A.  B.  
C.  
Data represents (1) median ± IQR; (2) mean ± SEM     
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10 
Analyses: (1) Mann Whitney U test; (2) Independent samples t test 
Abbreviations: s, seconds; n, number; SEM, standard error of the mean; IQR, interquartile range  
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Table 3.11. Effect of social hierarchy on behavioural outcomes in the Forced Swim Test in 






FST    











Subjects: adult male BALB/c mice 
Sample sizes: Subordinates = 4; Dominants = 4 
Analysis: Independent samples t test; Bonferroni correction for multiple testing - threshold: p < .025 
Abbreviations: SE, standard error; FST, forced swim test 





























































Figure 3.42. Behaviour in the Social Interaction Test after at least twelve weeks of 
stress exposure 
UCMSI mice (Group 2) spent significantly more time engaged in social behaviour during 
testing compared with control animals (Group 1). When stratifying social behaviour into its 
main categories, stressed animals (Group 2) did indeed display more investigative, affiliative 
and play-soliciting behaviours than control animals (Group 1), but these differences did not 
reach statistical significance. With respect to aggressive behaviour, no differences were 








Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10 
Analyses: Two-way ANOVA, Bonferroni post hoc analyses 
Adjusted p values: *** p < .001  
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For a full summary of all the behavioural changes associated with UCMSI, as 
discussed throughout this subsection, see Table 3.12.   
 
3.2.2.   Effect of UCMSI on peripheral inflammation and stress responsivity  
 
In line with AIM 2 of this part of the PhD thesis (see 1.4.2.1.2), the impact of UCMSI 
on inflammatory, corticosterone, and vascular endothelial growth factor, profiles was 
next examined.  
 
3.2.2.1.  Effect of UCMSI on peripheral levels of inflammation 
 
All ten analytes measured using the Luminex platform reached detection levels. 
However, readouts from two analytes, that is, CRP and IGF-1, were above the 
standard curve and could not be analysed. Thus, data pertaining to the remaining 
eight analytes will be presented. The overall intra-assay variability for all analytes 
ranged from 1.1-11.5%.  
 
3.2.2.1.1.   The impact of UCMSI on pro-inflammatory cytokine plasma levels 
 
3.2.2.1.1.1.  UCMSI does not alter plasma levels of IL1β, IL2 or TNF-α 
 
Figure 3.44 highlights how no significant differences in plasma levels of IL1β, IL2 or 
TNF-α were found between (or within) experimental groups after twelve weeks of 
UCMSI either in the absence or presence of acute stress (Two way RM ANOVA: 
IL1β: Effect of chronic stress exposure: F [1,16] = 0.5; p = .51; Effect of acute stress: 
F [1,16] = 0.1; p = .78; Interaction: F [1,16] = 1.2; p = .28; IL2: Effect of chronic stress 
exposure: F [1,16] = 3.4; p = .08; Effect of acute stress: F [1,16] = 0.9; p = .36; 
Interaction: F [1,16] = 2.8; p = .11; TNF-α: Effect of chronic stress exposure: F [1,16] 
= 0.4; p = .52; Effect of acute stress: F [1,16] = 0.1; p = .73; Interaction: F [1,16] = 








Table 3.12. Summary of all behavioural changes associated with 
unpredictable chronic mild stress and isolation  
 





OFT: Centre duration - 
OFT: Centre latency + 




NSFT: Latency to feed + 
NSFT: Arena food 
consumption  
- 
NSFT: Homecage food 
consumption  
= 
NSFT: Body weight 










































Sociability measures:  
Overall time spent 





+ Represents a significant increase in readout relative to control; highlighted in green 
-  Represents a significant decrease in readout relative to control; highlighted in red 
= Represents no significant change in readout relative to control; unhighlighted 
 
Subjects: adult male BALB/c mice 
Abbreviations: OFT, open field test; NSFT, novelty suppressed feeding test; SPT, sucrose 
























Figure 3.43. Effect of UCMSI on plasma levels of pro-inflammatory cytokines   
(A) Plasma interleukin (IL) 1β  profiles: Baseline: Twelve weeks after UCMSI exposure, and 24h prior to the forced swim test, there were no significant differences in IL1β 
between experimental groups.  Post-acute stress: Thirty minutes after the forced swim test, there were no significant differences in IL1β between experimental groups. 
Baseline vs. post-acute stress: There were no significant differences in IL1β between baseline and post-acute stress levels for any of the experimental groups. (B) Plasma 
interleukin (IL) 2 profiles: Baseline: Twelve weeks after UCMSI exposure, and 24h prior to the forced swim test, there were no significant differences in IL2 between 
experimental groups. Post-acute stress: Thirty minutes after the forced swim test, there were no significant differences in IL2 between experimental groups. Baseline vs. 
post-acute stress: There were no significant differences in IL2 between baseline and post-acute stress levels for any of the experimental groups. (C) Plasma tumour 
necrosis factor (TNF)- α profiles: Baseline: Twelve weeks after UCMSI exposure, and 24h prior to the forced swim test, there were no significant differences in TNF-α 
between experimental groups. Post-acute stress: Thirty minutes after the forced swim test, there were no significant differences in TNF-α between experimental groups. 
Baseline vs. post-acute stress: There were no significant differences in TNF-α between baseline and post-acute stress levels for any of the experimental groups.
 
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10  
Analyses: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
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3.2.2.1.2.  The impact of UCMSI on anti-inflammatory cytokine plasma 
levels 
 
3.2.2.1.2.1.   UCMSI does not alter plasma levels of IL4 or IL10 
 
As shown in Figure 3.45 there were no significant differences in plasma levels of IL4 
or IL10 between (or within) experimental groups after twelve weeks of UCMSI 
exposure either in the absence or presence of acute stress (Two way RM ANOVA: 
IL4: Effect of chronic stress exposure: F [1,14] = 1.5; p = .24; Effect of acute stress: 
F [1,14] = 1.0; p = .33; Interaction: F [1,14] = 0.5; p = .49; IL10: Effect of chronic 
stress exposure: F [1,16] = 1.3; p = .27; Effect of acute stress: F [1,16] = 2.5; p = .13; 
Interaction: F [1,16] > 0.01; p = .98).  
 
3.2.2.1.3.  The impact of UCMSI on cytokines which are both pro-and anti-
inflammatory 
 
3.2.2.1.3.1.  UCMSI does not alter plasma levels of IL6 or IL12 
 
Figure 3.46 highlights how no significant differences in IL6 or IL12 were found 
between (or within) experimental groups after twelve weeks of UCMSI exposure 
either in the absence or presence of acute stress (Two way RM ANOVA: IL6: Effect 
of chronic stress exposure: F [1,15] = 1.9; p = .18; Effect of acute stress: F [1,15] = 
3.8; p = .08; Interaction: F [1,15] = 0.6; p = .45; IL12: Effect of chronic stress 
exposure: F [1,17] = 4.1; p = .06; Effect of acute stress: F [1,17] = 0.1; p = .80; 
Interaction: F [1,17] = 0.2; p = .69).  
 
3.2.2.1.4.  Effect of UCMSI on plasma levels of vascular endothelial growth 
factor  
 
3.2.2.1.4.1.  UCMSI decreases plasma levels of vascular endothelial growth factor, 
but only control animals show a decrease in VEGF post-acute stress 
 
Although chronic stress did not alter cytokine peripheral levels, it did significantly 
reduce VEGF (Two way RM ANOVA: Effect of chronic stress exposure: F [1,14] = 
6.9; p = .02; Effect of acute stress: F [1,14] = 7.4; p = .02; Interaction: F [1,14] = 8.3; 




















Figure 3.44. Effect of UCMSI on plasma levels of anti-inflammatory cytokines   
(A) Plasma interleukin (IL) 4 profiles: Baseline: Twelve weeks after UCMSI exposure, and 24h prior to the forced swim test, there were no significant differences in IL4 
between experimental groups.  Post-acute stress: Thirty minutes after the forced swim test, there were no significant differences in IL4 between experimental groups. 
Baseline vs. post-acute stress: There were no significant differences in IL4 between baseline and post-acute stress levels for any of the experimental groups. (B) Plasma 
interleukin (IL) 10 profiles: Baseline: Twelve weeks after UCMSI exposure, and 24h prior to the forced swim test, there were no significant differences in IL10 between 
experimental groups. Post-acute stress: Thirty minutes after the forced swim test, there were no significant differences in IL10 between experimental groups. Baseline vs. 
post-acute stress: There were no significant differences in IL10 between baseline and post-acute stress levels for any of the experimental groups. 
 
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10  
Analysis: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
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Figure 3.45. Effect of UCMSI on plasma levels of interleukin (IL) 6 and IL12 
(A) Plasma interleukin 6 profiles: Baseline: Twelve weeks after UCMSI exposure, and 24h prior to the forced swim test, there were no significant differences in IL6 between 
experimental groups.  Post-acute stress: Thirty minutes after the forced swim test, there were no significant differences in IL6 between experimental groups. Baseline vs. 
post-acute stress: There were no significant differences in IL6 between baseline and post-acute stress levels for any of the experimental groups. (B) Plasma interleukin 12 
profiles: Baseline: Twelve weeks after UCMSI exposure, and 24h prior to the forced swim test, there were no significant differences in IL12 between experimental groups. 
Post-acute stress: Thirty minutes after the forced swim test, there were no significant differences in IL12 between experimental groups. Baseline vs. post-acute stress: 
There were no significant differences in IL12 between baseline and post-acute stress levels for any of the experimental groups.  
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10  
Analysis: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
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Figure 3.46. Effect of UCMSI on plasma vascular endothelial growth factor (VEGF) 
profiles  
(A) Baseline: Twelve weeks after UCMSI exposure, and 24h prior to the forced swim test, 
stressed mice (Group 2) had significantly reduced plasma levels of VEGF compared with 
control animals  (Group 1). Post-acute stress: There were no significant differences in 
VEGF between experimental groups thirty minutes after the forced swim test. Baseline vs. 
post-acute stress: Only control animals (Group 1) had a significant decrease in VEGF in 






Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10  
Analyses: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05; ** p < .01  
Abbreviations: VEGF, vascular endothelial growth factor; ng/ml, nanogram/millimetre; h, hour; min, minutes; FST, 
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had a 25% decrease in VEGF when compared with control animals (Post hoc 
analysis: t [28] = 3.8, p = .002). However, only control animals had a decrease in 
VEGF post-acute stress compared with baseline levels (Post hoc analysis: t [14] = 
3.7, p = .004), while no differences were found for UCMSI mice. Moreover, there 
were no differences in VEGF post-acute stress between experimental groups. 
Furthermore, as highlighted in Table 3.13, social dominance was not confounding 
any of the VEGF data. 
 
3.2.2.2.  Effect of UCMSI on plasma corticosterone levels 
 
Overall corticosterone intra-assay variability was calculated as 6.7%. A maximum CV 
threshold of 20% was imposed, however there were no corticosterone readouts with 
a CV above this cutoff. Samples sizes for each analysis will be given throughout 
each subsection.  
 
3.2.2.2.1.  Chronic stress does not alter corticosterone, but UCMSI animals 
show elevated plasma levels of corticosterone in response to 
acute stress 
  
Figure 3.48 depicts the impact of UCMSI on plasma corticosterone levels both 
before and after acute stress exposure (Two way RM ANOVA: Effect of chronic 
stress exposure: F [1,16] = 6.5; p = .02; Effect of acute stress: F [1,16] = 72.9; p < 
.001; Interaction: F [1,16] = 9.0; p = .008). As shown, no significant differences in 
corticosterone across experimental groups were found after chronic stress exposure. 
However, all animals, irrespective of exposure, had a 111-196% increase in 
corticosterone in response to acute stress relative to baseline (Post hoc analyses: 
controls: t [16] = 7.7, p < .001; UCMSI: t [16] = 4.1, p = .002). 
 
3.2.2.2.2.  UCMSI decreases corticosterone reactivity to acute stress 
 
Although no baseline plasma corticosterone differences were observed, post-acute 
corticosterone levels did significantly alter between experimental groups. Specifically, 
as shown in Figure 3.48, UCMSI mice had corticosterone levels 40% lower than 






Table 3.13. Effect of social hierarchy on vascular endothelial growth factor profiles in pair-
housed control animals 

















Subjects: adult male BALB/c mice 
Sample sizes: Subordinates = 4; Dominants = 4 
Analyses: Independent samples t test; Bonferroni correction for multiple testing threshold: p < .025  
Abbreviations: SE, standard error; VEGF, vascular endothelial growth factor; baseline, 24 hours prior to acute stress; post 




















































Figure 3.47. Effect of UCMSI on plasma corticosterone profiles  
Baseline: Twelve weeks after chronic stress exposure, and 24h prior to the forced swim test, 
there were no significant differences in corticosterone between experimental groups. Post-
acute stress: Thirty minutes after the forced swim test, UCMSI animals (Group 2) had a 
significant decrease in corticosterone compared with control mice. Baseline vs. post-acute 
stress: Both experimental groups had a significant increase in corticosterone post-acute 








Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: Group 1: n=8; Group 2: n=10  
Analysis: Repeated measures two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: ** p < .01; *** p < .001 
Abbreviations: ng/ml, nanogram/millimetre; h, hour; min, minutes; FST, forced swim test; UCMSI, unpredictable chronic 
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Importantly, this effect was not confounded by social dominance, as no differences in 
corticosterone levels post acute stress was observed between subordinate and 
dominant pair-housed control animals (Independent t test: t [6] = 1.2; p = .29). 
 
For a full summary of all the biochemical changes associated with UCMSI, as 
described throughout this subsection, see Table 3.14.  
 
3.2.3.   Effect(s) of UCMSI on neuroinflammation  
 
Although there was no evidence of altered peripheral inflammation in response to 
UCMSI, microglia and astrocyte immunoreactivity was nonetheless evaluated, as 
identified by Iba1 and GFAP, respectively.  
 
3.2.3.1.  Effect of UCMSI on Iba1 positive cell immunoreactivity in the 
hippocampus and prefrontal cortex 
 
3.2.3.1.1.  UCMSI does not alter Iba1 positive cell immunoreactivity in the 
prefrontal cortex or in the dentate gyrus of the hippocampus 
 
Figure 3.50.A illustrates how exposure to UCMSI did not significantly alter Iba1 
immunoreactivity in the PFC, with no differences found between experimental groups 
(Independent t test: t [15] = 0.8; p = .42). Moreover, as shown in Figure 3.50.B, 
UCMSI also did not significantly alter Iba1 immunoreactivity in the DG of the 
hippocampus, again with no differences found between experimental groups (Two 
way ANOVA: Effect of exposure: F [1,42] = 0.3; p = .56; Effect of region: F [2,42] = 














Table 3.14. Summary of all biochemical changes associated with 
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+ Represents an increase in plasma levels relative to control; highlighted in green 
-  Represents a decrease in plasma levels relative to control; highlighted in red 
= Represents no change in plasma levels relative to control; unhighlighted 
 
Subjects: adult male BALB/c mice 
Abbreviations: TNF, tumour necrosis factor; IL, interleukin; VEGF, vascular endothelial 
growth factor; pre-stress, 24 hours prior to acute stress; post stress, 30 minutes after acute 

































Figure 3.48. Effect of UCMSI on Iba1 positive cell immunoreactivity  
(A) Prefrontal cortex: UCMSI exposure did not alter Iba1 positive cell immunoreactivity in the prefrontal cortex, with no significant differences in Iba1 found 
between experimental groups. (B) Dentate gyrus of the hippocampus: UCMSI exposure did not alter Iba1 positive cell immunoreactivity in either the dorsal 
or ventral dentate gyrus of the hippocampus, with no significant differences in Iba1 found between experimental groups.  
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = PFC, 5; whole DG, 6; dorsal DG, 3; ventral DG, 3. (2) Animals per group: Group 1: n=8; Group 2: n=10 
Analyses: (1) Independent samples t test; (2) Two-way ANOVA; Bonferroni post hoc analyses 
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3.2.3.2.  Effect of UCMSI on GFAP positive cells in the hippocampus and 
prefrontal cortex 
 
3.2.3.2.1.  UCMSI does not alter GFAP positive cell immunoreactivity in the 
prefrontal cortex, but increases GFAP immunoreactivity in the 
dentate gyrus of the hippocampus 
 
Figure 3.51 details how exposure to UCMSI did not significantly alter GFAP positive 
cell immunoreactivity in the PFC, with no differences found between experimental 
groups (Independent t test: t [15] = 1.0; p = .32). However, although no differences in 
GFAP in the PFC were found, UCMSI did significantly increase GFAP 
immunoreactivity in the DG of the hippocampus as depicted in Figure 3.52 (Two way 
ANOVA: Effect of exposure: F [1,42] = 30.0; p < .001; Effect of region: F [2,42] = 
0.07; p = .93; Interaction: F [2,42] < 0.01; p > .99). Specifically, UCMSI mice had a 
38% increase in GFAP immunoreactivity in the DG when compared with control 
animals (Post hoc analysis: t [42] = 3.2, p = .009). Hippocampal stratification 
analyses revealed how this change was not DG region specific, as stressed mice 
had a 38% increase in GFAP immunoreactivity in both the dorsal and ventral DG 
when compared with control mice (Post hoc analyses: Dorsal: t [42] = 3.2, p = .007; 
Ventral: t = [42] = 3.1, p = .01). 
 
Given that UCMSI increased GFAP immunoreactivity in the DG, GFAP positive cell 
density was quantified to ascertain whether this could be attributing to the GFAP 
immunoreactivity findings.  
 
3.2.3.2.2.  UCMSI does not alter GFAP positive cell density in the 
hippocampus 
 
Interestingly, there were no significant differences in GFAP cell density in either the 
dorsal or ventral DG between experimental groups (Two way ANOVA: Effect of 
exposure: F [1,22] = 0.8; p = .38; Effect of region: F [1,22] = 2.1; p = .16; Interaction: 
F [1,22] < 0.01; p = .98; see Figure 3.53).  
 
Due to time constraints GFAP positive cells could not be characterised as in PART A 
of this thesis. However, given that GFAP could be representing changes in radial 



































Figure 3.49. Effect of UCMSI on GFAP positive cell immunoreactivity in the prefrontal 
cortex 
UCMSI exposure did not alter GFAP positive cell immunoreactivity in the prefrontal cortex, 





Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = 5. (2) Animals per group: Group 1: n=8; Group 2: n=10 
Analyses: Independent samples t test 
Abbreviations: GFAP, glial fibrillary acidic protein; UCMSI, unpredictable chronic mild stress and isolation; SEM, standard 
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Figure 3.50. Effect of UCMSI on GFAP positive cell immunoreactivity in the dentate gyrus after at least twelve weeks of exposure  
(A) Dentate gyrus of the hippocampus: After twelve weeks of UCMSI exposure, stressed mice (Group 2) had significantly increased GFAP positive cell immunoreactivity in 
the dentate gyrus as a whole compared with controls (Group 1). Stratification analyses revealed that this increase in GFAP was not dentate gyrus region specific as UCMSI 
mice (Group 2) had significantly increased GFAP positive cell immunoreactivity in both the dorsal and ventral dentate gyrus compared with control animals (Group 1). (B) 
Representative photomicrographs of the dorsal dentate gyrus for control animals (CON; Group 1), and UCMSI mice (UCMSI; Group 4), all stained for GFAP.
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = whole DG, 6; dorsal DG, 3; ventral DG, 3. (2) Animals per group: Group 1: n=8; Group 2: n=10 
Analyses: Two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05; ** p < .01 
Images: Whole dorsal dentate gyrus image taken at 10x magnification; represents the average and was taken from control animals for illustrative purposes. Scale bar = 100µm.  Close 
up snapshots from each exposure group taken from the dorsal dentate gyrus. Each image represents the average for each of the experimental conditions. Images taken at 20x 
magnification; scale bar = 50µm 
Abbreviations: GFAP, glial fibrillary acidic protein; DG, dentate gyrus; UCMSI, unpredictable chronic mild stress and isolation; CON, control - Group 1; UCMSI - Group 2; SEM, standard 
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Figure 3.51. Effect of UCMSI on GFAP positive cell density in the dentate gyrus of the 
hippocampus 
UCMSI exposure did not alter GFAP positive cell density in either the dorsal or ventral 











































Whole DG Dorsal DG Ventral DG
GFAP positive cell density in the dentate gyrus of the 
hippocampus
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = whole DG, 6; dorsal DG, 3; ventral DG, 3. (2) Animals per group: Group 1: n=8; Group 
2: n=10 
Analyses: Two-way ANOVA; Bonferroni post hoc analyses 
Abbreviations: GFAP, glial fibrillary acidic protein; DG, dentate gyrus; UCMSI, unpredictable chronic mild stress and isolation; 
SEM, standard error of the mean 
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context of this part of the thesis, UMCSI tissue was stained for s100β and cell density 
in the DG was quantified.   
 
3.2.3.3.  The impact of UCMSI on s100β  positive cell density in the 
hippocampus 
 
3.2.3.3.1.   UCMSI increases s100β  positive cell density in the dentate gyrus 
 
Figure 3.54 illustrates how UCMSI significantly increased s100β cell density in the 
DG of the hippocampus (Two way ANOVA: Effect of exposure: F [1,31] = 32.9; p < 
.001; Effect of region: F [2,31] = 0.4; p = .70; Interaction: F [2,31] = 0.3; p = .72). 
Specifically, stressed mice had a 38% increase in s100β in the DG when compared 
with control animals (Post hoc analysis: t [31] = 3.0, p = .02). Hippocampal 
stratification analyses revealed how this change was not DG region specific, as 
stressed mice had a 45% and 38% increase in s100β in the dorsal and ventral DG, 
respectively, when compared with controls (Post hoc analyses: Dorsal: t [31] = 4.1, p 
< .001; Ventral: t = [31] = 2.9, p = .02).  
 
3.2.3.4.  Effect of social hierarchy on neuroinflammation 
 
3.2.3.4.1.  Social hierarchy does not confound any of the 
neuroinflammation data 
 
Table 3.15 shows how social dominance did not influence any of the findings 
pertaining to GFAP as presented in this subsection.  
 
3.2.4.  Effect(s) of UCMSI on adult hippocampal neurogenesis  
 
Lastly, the final part of AIM 2 of this part of the thesis (see 1.4.2.1.2) was to 




Figure 3.52. Effect of UCMSI on s100β  positive cell density in the dentate gyrus after at least twelve weeks of exposure  
(A) Dentate gyrus of the hippocampus: After twelve weeks of UCMSI exposure, stressed mice (Group 2) had significantly increased s100β positive cell density in the 
dentate gyrus as a whole compared with controls (Group 1). Stratification analyses revealed that this increase in GFAP was not dentate gyrus region specific as UCMSI mice 
(Group 2) had significantly increased s100β positive cell density in both the dorsal and ventral dentate gyrus compared with control animals (Group 1). (B) Representative 
photomicrographs of the dorsal dentate gyrus for control animals (CON; Group 1), and UCMSI mice (UCMSI; Group 4), all stained for s100β.  
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = whole DG, 6; dorsal DG, 3; ventral DG, 3. (2) Animals per group: Group 1: n=8; Group 2: n=10 
Analyses: Two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05; *** p < .001 
Images: Photomicrographs from each exposure group taken from the dorsal dentate gyrus. Each image represents the average for each of the experimental conditions. Images taken at 20x 
magnification; scale bar = 50µm 
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Table 3.15. Effect of social hierarchy on neuroinflammatory outcomes in pair-housed control 
animals 









25.9 (2.5) 25.0 (2.0) 
 
0.79 
S100β cell density 
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Subjects: adult male BALB/c mice 
Sample sizes: Subordinates = 4; Dominants = 4 
Analyses: Independent samples t test; Bonferroni correction for multiple testing threshold: p < .025 
Abbreviations: SE, standard error; GFAP, glial fibrillary acidic protein; DG, dentate gyrus 
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3.2.4.1.  Effect of UCMSI on hippocampal volume  
 
3.2.4.1.1. UCMSI does not alter hippocampal volume 
 
Figure 3.55 illustrates how UCMSI exposure did not alter hippocampal volume for 
any of the exposure groups. There were no significant differences in the volume of 
either the dorsal or ventral hippocampus, or the hippocampus as a whole between 
experimental groups (Two way ANOVA: Effect of exposure: F [1,18] = 0.5; p = .50; 
Effect of region: F [2,18] = 231.4; p < .001; Interaction: F [2,18] = 0.03; p = .97). 
However, for all groups, irrespective of exposure, the dorsal hippocampus was 
significantly smaller than the ventral hippocampus (Post hoc analyses: controls: t [18] 
= 8.3, p < .001; UCMSI: t [18] = 8.3, p < .001), due to the way the tissue was 
sectioned. 
 
3.2.4.2.   Effect of UCMSI on overall proliferative cell density  
 
3.2.4.2.1.  UCMSI decreases Ki67 cell density in the dentate gyrus of the 
hippocampus 
 
Figure 3.56 demonstrates how exposure to twelve weeks of UCMSI significantly 
decreased Ki67 positive cell density, indicating decreased neuronal proliferation, in 
the DG. Specifically, UCMSI mice had a 31% decrease in Ki67 positive cell density in 
the DG compared with control animals (Independent t test: t [10] = 2.7; p = .02). 
Stratification analyses could not be performed for this particular marker due to 
reliability issues, where CE values were all above 20%. 
 
3.2.4.3.  Effect of UCMSI on overall immature neuron cell density  
 
3.2.4.3.1.  UCMSI decreases immature neuron cell density in the dentate 
gyrus of the hippocampus 
 
In addition to altered neuronal proliferation, mice exposed to UCMSI showed a 
decrease in overall DCX positive cell density, indicating altered neuronal 
differentiation, as depicted in Figure 3.57 (Two way ANOVA: Effect of exposure: F 
[1,36] = 182.5; p < .001; Effect of region: F [2,36] = 3.1; p = .06; Interaction: F [2,36] 
= 5.0; p = .01). Specifically, UCMSI animals had a 71% decrease in overall DCX 





































Figure 3.53. Effect of UCMSI on hippocampal volume 
Between group analyses: Chronic stress exposure did not alter hippocampal volume 
between exposure groups. No significant differences in the volume of the dorsal or ventral 
hippocampus, or the hippocampus as a whole, were found between experimental groups. 
Within group analyses: For both groups the dorsal hippocampus was significantly smaller 
than the ventral hippocampus, and unsurprisingly, the total hippocampus was significantly 










Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = whole DG, 6; dorsal DG, 3; ventral DG, 3. (2) Animals per group: Group 1: n=8; Group 
2: n=10  
Analysis: Two-way ANOVA; Bonferroni post hoc analyses 



























































Figure 3.54. Effect of UCMSI on hippocampal Ki67 positive cell density after at least twelve weeks of exposure 
(A) Ki67 cell density: UCMSI significantly decreased neuronal proliferation. Specifically, UCMSI mice (Group 2) had a significant decrease in Ki67 positive 
cell density in the dentate gyrus of the hippocampus compared with control animals (Group 1). (B) Representative photomicrographs of the dentate gyrus 
for each of the experimental groups stained for Ki67.  
B. 
Data represents mean ± SEM 
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = whole DG, 11 (2) Animals per group: Group 1: n=6; Group 2: n=5 – Exclusions due to unreliable data obtained from stereological analyses. 
Estimates with a CE above 20% were excluded. Dorsal/ventral stratification analyses could not be performed due to CE estimates all being above 20%.   
Analyses: Independent samples t test 
p value: * p < .05 
Images: Images for each exposure group taken from the dorsal dentate gyrus. Each image represents the average for each of the experimental conditions. Images taken at 20x 
magnification; scale bar = 50µm. Arrows point out Ki67 positive cells.  
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Figure 3.55. Effect of UCMSI on hippocampal DCX positive cell density after at least twelve weeks of exposure 
(A) DCX cell density: After twelve weeks of UCMSI exposure, stressed mice (Group 2) had significantly reduced DCX positive cell density in the 
hippocampus as a whole compared with controls (Group 1). Stratification analyses revealed that these reductions for were not dentate gyrus region specific, 
as UCMSI mice (Group 2) had significantly reduced DCX positive cell density in both the dorsal and ventral dentate gyrus when compared with control 
animals (Group 1).  (B) Representative photomicrographs of the dentate gyrus for each of the experimental groups stained for DCX.
Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = whole DG, 6; dorsal DG, 3; ventral DG, 3. (2) Animals per group: Group 1: n=6; Group 2: n=8; Exclusions due to unreliable data obtained 
from stereological analyses. Estimates with a CE above 20% were excluded.  
Analysis: Two-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: *** p < .001 
Images: Images for each exposure group taken from the dorsal dentate gyrus. Each image represents the average for each of the experimental conditions. Images taken at 20x 
magnification; scale bar = 50µm 
Abbreviations: DCX, doublecortin; DG, dentate gyrus; CON, control - Group 1; UCMSI - Group 2; SGZ, subgranular zone; GCL, granule cell layer; SEM, standard error of the mean; 
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hoc analysis: t [36] = 8.4, p < .001).  Further analyses revealed that this reduction in 
cell density was not specific to a particular region of the DG, as stressed mice had a 
78% and 61% decrease in DCX cell density in the dorsal and ventral DG, 
respectively, when compared with control mice (Post hoc analyses: Dorsal: t [36] = 
9.7, p < .001; Ventral: t [36] = 5.3, p < .001). 
 
To ascertain whether this reduction in DCX cell density was related to all DCX cell 
types, positive cells were classified into one of four morphology types and cell 
density estimates were obtained for both the dorsal and ventral DG.  
 
3.2.4.4.  Effect of UCMSI on immature neuron cell morphology 
 
3.2.4.4.1.  UCMSI reduces all neuroblast cell types in the dentate gyrus of 
the hippocampus 
 
As expected, DCX classification analyses revealed significantly altered DCX 
morphology for UCMSI animals as shown in Figure 3.58 (Factorial three way 
ANOVA: Effect of exposure (a): F [1,96] = 181.7, p < .001; Effect of region (b): F 
[1,96] = 10.9, p = .001; Effect of cell type (c): F [3,96] = 38.1, p < .001; Interactions: 
(a*b); F [1,96] = 11.4, p = .001; (a*c); F [3,96] = 6.4, p = .001; (b*c); F [3,96] = 2.6, p 
= .06; (a*b*c); F [3,96] = 0.3, p = .83). Specifically, UCMSI mice had a 70-85% 
decrease in all neuroblast cell types in the dorsal DG (Post hoc analyses: 
proliferative: t [24] = 6.5, p < .001; intermediate: t [24] = 4.9, p < .001; early post 
mitotic: t [24] = 7.8, p < .001; late post mitotic: t [24] = 10.0, p < .001), and had a 56-
64% decrease in all neuroblast cell types, except those in the late post mitotic stage, 
in the ventral DG (Post hoc analyses: proliferative: t [24] = 4.3, p < .001; 
intermediate: t [24] = 3.0, p = .04; early post mitotic: t [24] = 5.3, p < .001), all when 
compared with control animals.  
 
3.2.4.4.2.  Mice exposed to UCMSI have an attenuated DCX maturation rate 
in the dorsal dentate gyrus of the hippocampus 
 
All experimental groups had a greater proportion of proliferative neuroblasts 
compared with all other DCX cell types. Indeed, the proportions of each type of 
neuroblast were typically reduced in a graded fashion from proliferative to late post 
mitotic for all experimental groups (Factorial three way ANOVA: Effect of exposure 







































Data represents mean SEM 
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = Dorsal DG, 4; Ventral DG, 4 (2) Animals per group: Group 1: n=6; Group 2: n=8 
Analysis: Factorial three-way ANOVA; Bonferroni post hoc analyses 
Adjusted p values: * p < .05;  *** p < .001 
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Figure 3.56. Effect of UCMSI on hippocampal DCX positive cell morphology after at 
least twelve weeks of exposure 
Dorsal: After twelve weeks of UCMSI exposure, stressed mice (Group 2) had a significant 
decrease in all neuroblast cell types in the dorsal dentate gyrus compared with controls 
(Group 1). Ventral: After twelve weeks of UCMSI exposure, stressed mice (Group 2) had a 
significant decrease in all neuroblast cell types, except those in the late post mitotic stage, in 































cell type (c): F [3,144] = 1.4, p = .25; Interactions: (a*b); F [1,144] < 0.01, p > .99; 
(a*c); F [3,144] = 0.3, p = .88; (b*c); F [3,144] = 0.1, p = .95; (a*b*c); F [3,144] = 0.1, 
p = .93; Figure 3.59). For within group compositional statistical analyses see 
Appendix 3.3.1.  Interestingly, although UCMSI mice had significantly reduced DCX 
positive cell density across all DCX morphology cell types, stressed mice had a 1.4 
times higher proportion of proliferative stage neuroblasts (Post hoc analysis: t [48] = 
3.1, p = .01), and a 7.9 times smaller proportion of late post mitotic cells (Post hoc 
analysis: t [48] = 3.2, p = .01), in the dorsal DG all when compared with controls. No 
other differences in the proportion of cells in the dorsal DG were observed between 
exposure groups, and no differences in the compositional breakdown of DCX positive 
cells were found in the ventral DG between experimental groups. 
 
3.2.4.5.   Effect(s) of social hierarchy on adult hippocampal neurogenesis  
 
3.2.4.5.1.   Social hierarchy does not confound any of the neurogenesis data 
 
Table 3.16 highlights how social dominance did not influence any of the findings 
pertaining to Ki67, or DCX as presented in this subsection.  
 
For a full summary of all the neurobiological changes, that is, changes in 
neuroinflammation and neurogenesis, associated with UCMSI, as reported in this 























































Data represents mean SEM 
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = Dorsal DG, 4; Ventral DG, 4 (2) Animals per group: Group 1: n=6; Group 2: n=8 
Analysis: Factorial three-way ANOVA; Bonferroni post hoc analyses.  
Adjusted p values: * p < .05; ** p < .01; *** p < .001 
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Figure 3.57. Effect of UCMSI on neuroblast composition in both the dorsal and ventral 
dentate gyrus after at least twelve weeks of exposure 
Dorsal: After twelve weeks of UCMSI, stressed mice (Group 2) had a significantly greater 
proportion of proliferative stage neuroblasts, but a significantly reduced proportion of late post 
mitotic stage neuroblasts in the dorsal dentate gyrus compared with controls (Group 1). 
Ventral: There were no significant differences in the proportion of each neuroblast cell type 































































Table 3.16. Effect of social hierarchy on neurogenesis outcomes in pair-housed control 
animals 
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Subjects: adult male BALB/c mice 
Sample sizes: Subordinates = 4; Dominants = 4 
Analyses: Independent samples t test; Bonferroni correction for multiple testing threshold: p < .008  
Abbreviations: SE, standard error; DCX, doublecortin; DG, dentate gyrus 
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Table 3.17. Summary of all neurobiological changes associated 
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+ Represents a significant increase in readout relative to control; highlighted in green 
-  Represents a significant decrease in readout relative to control; highlighted in red 
= Represents no significant change in readout relative to control; unhighlighted 
 
Subjects: adult male BALB/c mice 
Abbreviations: Iba1, ionized calcium binding adaptor molecule 1; PFC, prefrontal Cortex; 











4.1. Overview  
 
This thesis is comprised of two parts. The first investigated whether the type of 
chronic stress could differentially alter behaviour, inflammation and hippocampal 
neurogenesis, while the second part examined the effects of a more chronic and 
more translational UCMS stress paradigm on behaviour, inflammation and 
hippocampal neurogenesis, all in adult male BALB/c mice.  First, results for each 
experiment will be summarised, the findings will then be embedded into a broader 
literature context, and potential mechanisms of action will be hypothesised.   Second, 
the strengths and limitations of each experiment will be highlighted, and suggestions 
for future research provided. Lastly, the implications and translational value of the 
findings from each experiment will be discussed.  
 
4.2.  PART A: Does the type of stress matter? Effect(s) of physical, 
psychosocial, and both physical and psychosocial, stress on 
behaviour, inflammation and adult hippocampal neurogenesis 
 
4.2.1.  Summary of main findings  
 
4.2.1.1.  Impact of the type of chronic stress on behavioural responses 
 
Exposure to different types of chronic stress elicits distinct behavioural phenotypes, 
such that physical stress, that is, repeated injection, induces an anxiety-like 
phenotype, while psychosocial stress, that is, permanent social isolation, promotes a 
depressive-like phenotype. Interestingly, there is no apparent additive effect of 
combining physical and psychosocial stress, that is, permanent social isolation and 
repeated injection, which induces an anxiety-like phenotype.  
 
4.2.1.2.  Impact of the type of chronic stress on biological responses 
 
Exposure to different types of chronic stress elicits distinct inflammatory and 
hormonal profiles. Specifically, physical stress decreases TNFα; psychosocial stress 
increases TNFα, but decreases IL1β, IL10 and VEGF, while exposure to both 
stressors decreases IL4. Interestingly, psychosocial stress only induces a significant 
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immunological response to acute stress by increasing IL1β and VEGF, and 
decreasing IL2.  Although there were no other differences in cytokine levels in 
response to acute stress within groups, the type of chronic stress exposure 
distinctively alters immunological profiles post acute stress between experimental 
groups, such that physical stress decreases IL4; psychosocial stress decreases IL4 
and IL10, but increases TNFα, while exposure to both stressors decreases IL4 and 
IL1β. Moreover, although all mice irrespective of exposure have a corticosterone 
response to acute stress, the degree of corticosterone reactivity between groups 
differs according to exposure. For example, physical stress increases corticosterone 
reactivity; psychosocial stress decreases corticosterone reactivity; while interestingly, 
exposure to both stressors does not alter corticosterone reactivity. Furthermore, 
these biological changes extend beyond the periphery and into the brain, such that 
physical stress increases Iba1 cell density and promotes microglial activation in the 
ventral DG of the hippocampus; while psychosocial stress decreases Iba1 cell 
density and induces microglial hyper-ramification in the dorsal DG. Again, as with 
corticosterone reactivity, there is no difference in Iba1 biology for mice exposed to 
both stressors. Moreover, exposure to psychosocial stress only increases both radial 
glial and s100β cell density in the DG, but intriguingly, chronic stress, irrespective of 
type, does not alter either microglial or astrocyte biology in the PFC. Finally, 
exposure to different types of chronic stress also elicit distinct neurogenic profiles, 
such that physical stress decreases the number of almost all DCX morphology cell 
types in the dorsal DG, while exposure to chronic psychosocial stress increases the 
number of mature neuroblasts in the ventral DG. Interestingly, chronic stress does 
not alter hippocampal volume, or neuronal cell proliferation in the DG.  For a 
schematic summary of the main biological changes associated with the three types 
of chronic stress exposure see Figure 4.1.  
 
4.2.2.   The type of chronic stress does indeed matter 
  
4.2.2.1.  The type of chronic stress differentially alters behavioural responses 
 
4.2.2.1.1.  Exposure to physical stress promotes an anxiety-like phenotype 
 
The finding that physical stress independently induces an anxiety-like phenotype, 
confirms the first hypothesis for this part of the thesis, that is, that exposure to 
chronic stress will independently induce anxiety- and/or depressive-like behaviour  
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Figure 4.1. Schematic summary of the biological changes associated with the three 
types of stress exposure  
The top half of the schematic depicts the neurobiological changes associated with repeated 
injection (INJ), social isolation (ISO), and exposure to both repeated injection and isolation 
(INJ/ISO). Specifically, changes in microglial and astrocyte cell biology and neurogenesis in 
the hippocampus are summarised for each of the exposures relative to control animals. The 
bottom half of the schematic depicts the systemic changes associated with the three stress 
exposures. Specifically, changes in plasma levels of various pro- and anti-inflammatory 
cytokines, and vascular endothelial growth factor both in the presence and absence of acute 






























(e.g., Izumi et al. 1996; Waters & McCormick, 2011; Drude et al. 2011; Rainer et al. 
2012; Wanasuntronwong et al. 2012; Choi et al. 2013; Zhao et al. 2015; Robinson et 
al. 2016). However, although these studies demonstrate an increase in anxiety-like 
behaviour, it is noteworthy that most of these studies do not measure any form of 
depressive-like behaviour, so it is unknown whether stress exposure in these studies 
is specific to anxiety. Reassuringly though, one study does confirm that physical 
stress specifically elicits anxiety-like behaviour and not depressive-like behaviour, 
which is in corroboration with findings from this experiment (Rainer et al. 2012).   
 
Interestingly, the only other study to date that has examined the effect of different 
types of stress in a single study, found no differences in either anxiety- or 
depressive-like behaviour in mice exposed to physical stress, which was modelled by 
restraint stress (Liu et al. 2013). However, although the researchers used the same 
mouse strain, of the same age and sex, two potential explanations could account for 
their lack of any aberrant behavioural response. First, the duration of stress exposure 
employed by Liu and colleagues (2013) was significantly shorter, being only three 
weeks in length. Second, the type of physical stress used was different not only in 
the duration of contact, but also in the acute physiological response it elicits. 
Injections are quick with a short duration of handling compared to the duration of 
restraint exposure. However, it is important to note that the injection itself can initiate 
a pain response that restraint stress technically should not. The pain response 
initiated by repeated injection could therefore offer an alternative explanation for the 
discrepancy between the findings of this study and those of Liu and colleagues 
(2013).  Indeed, studies using electric foot shock treatment, which also elicits a pain 
response, report an increase in anxiety-like behaviour in their animals (Choi et al. 
2013; Zhao et al. 2015).  This reinforces the notion that pain or the response to pain 
could potentially be attributing to the increased anxiety-like behaviour observed in 
studies using physical stressors, which induce a painful stress-related stimulus. 
Pertinently, several lines of research support that chronic pain is associated with 
anxiety (Lerman et al. 2015; Koga et al. 2015; Zhuo, 2016), which further 
emphasises the plausibility of this point.  
 
4.2.2.1.2.  Exposure to psychosocial stress results in a depressive-like 
phenotype 
 
Interestingly, unlike physical stress exposure, psychosocial stress elicits a 
depressive-like phenotype, one that incorporates anxiety- and anhedonic-like 
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behaviour, in addition to fatigue/behavioural despair. This finding not only supports 
the first hypothesis, but also is in agreement with previous research using chronic 
social isolation in adult male mice (e.g., Fonken & Nelson, 2013; Yang et al. 2016; 
Ieraci et al. 2016). In truth, it is unsurprising that permanent social isolation would 
promote aberrant behaviour across multiple domains, especially in a social species. 
It is important to acknowledge that mice are social due the various advantages that 
an organised social structure provides with regards to, for example, mating selection, 
resource allocation, and social status (Tinbergen, 1990; 2012). Therefore, by socially 
isolating mice that are biologically and evolutionarily suited to social living, it is 
understandable how the removal of social structure could impair physiology, and/or 
physiological responses that then ultimately manifest into aberrant behaviours.  
Moreover, in humans, who are also a social species, the lack of social support is an 
important risk factor for depression (see section 1.1.3). Although caution should be 
taken when translating between animals and humans (see subsection 4.4.1.1), it 
confirms the importance of sociability across various species in maintaining 
normotypic functioning and behaviour.  
 
Despite the plausibility and consistency of this finding, it is not in agreement with the 
findings pertaining to the only other study evaluating the impact of different types of 
stress (Liu et al. 2013). Specifically, Liu and colleagues (2013) find that three weeks 
of social isolation elicits an anxiety- not depressive-like phenotype (Liu et al. 2013). 
Although, given that the duration of this study was only three weeks, it remains 
unknown whether this outcome would differ upon further stress exposure. Moreover, 
it is noteworthy that depressive-like behaviour was characterised based on 
performance in the forced swim test (FST), which is a behavioural assay with limited 
construct, face, and ethological validity (see subsection 4.4.1.2). Given that the 
authors did not measure other facets of depressive-like behaviour such as, 
anhedonic-like behaviour, which is a core feature of depression, it remains unclear 
whether these animals truly lack depressive-like behaviour.  
 
4.2.2.1.3.  Exposure to both chronic physical and psychosocial stress 
induces an anxiety-like phenotype 
 
Surprisingly, my data reveals how exposure to both physical and psychosocial stress 
elicits an anxiety-like phenotype. Interestingly, although this finding is in line with 
some of the literature (e.g., Tanti et al. 2012; Wang et al. 2014; Yu et al. 2016), it 
does not support the first hypothesis that exposure to multiple stressors will have an 
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additive effect and induce depressive-like behaviour (e.g., Mutlu et al. 2012; Pao et 
al. 2012; Nollet et al. 2012; Liu et al. 2013; Zhang et al. 2014; Liu et al. 2015; Zhang 
et al. 2015; Zhuang et al. 2016; Wu et al. 2016). However, most of these studies 
have used UCMS, which includes exposure to a variety of multiple stressors in a 
single day over a chronic period of time, and represents a much more severe stress 
model than the one employed in this experiment. Thus, it remains plausible that 
severity and/or multiple stress exposure may be the factor influencing behavioural 
response and contributing to the inconsistency between the findings of this thesis 
and that of the wider literature.  
 
Interestingly, in studies that use only two stressors as part of their paradigm an 
increase in depressive-like behaviour is still the predominate finding (e.g., Liu et al. 
2013; Sturm et al. 2015; Ding et al. 2016). However, reassuringly, Demuyser and 
colleagues (2016) corroborate my findings pertaining to the behavioural impact of 
chronic physical and psychosocial stress, reporting an increase in anxiety-like, and 
not depressvie-like, behaviour in mice exposed to social isolation and repeated 
injection  (Demuyser et al. 2016). A potential explanation for why no additive effect 
was observed for physical and psychosocial stress in the context of this work could 
relate to the concept that stressors such as, injection, which elicits a pain response, 
could counteract, override or dominate some of the effects of the other individual 
stressors used in the paradigm. Given that most of the stressors used in current 
stress paradigms do not initiate pain, it remains possible that the biological response 
to the pain induced by some stressors may be influencing behavioural findings 
overall, as briefly discussed in subsection 4.2.2.1.1. Therefore, in the context of this 
work, it is possible that (a) chronic injection, and/or pain, is a stronger stressor that 
overrides the effects of social isolation, or that (b) the pain response biologically 
counteracts the negative effects of social isolation; all of which could account for why 
no additive behavioural effect was observed in this experiment for this exposure 
group.  
 
4.2.2.2.  The type of chronic stress differentially alters biological responses 
 
Perhaps one of the most interesting insights of this thesis is the finding that distinct 
types of chronic stress differentially alter the way animals respond to stress, which 
may be the basis by which different behavioural phenotypes manifest. This is 
particularly pertinent given that behavioural phenotypes are mostly distinct for the 
three exposures, and that each phenotype is determined by behavioural tests that 
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can in themselves result in an acute stress response. Therefore, given that animals 
respond differently to stress, it seems unsurprising that this would reflect their 
behavioural response in assays that by their very nature are novel and stressful.  
Thus, given that the type of chronic stress differentially alters behavioural 
phenotypes, and more importantly differentially alters corticosterone and 
inflammatory responses to acute stress, it seems highly likely that the HPA axis 
could be potentially modulating behavioural responses.  
 
4.2.2.2.1.  Could the type of stress exposure be differentially dysregulating 
the HPA axis? Insights from immune and corticosterone profiles 
in the presence and absence of acute stress 
 
4.2.2.2.1.1.  Exposure to chronic physical stress may induce GR resistance 
 
The first line of evidence to suggest that chronic physical stress may promote GR 
resistance in the context of this work came from the finding that exposure to nine 
weeks of physical stress, in the absence of an acute stress stimulus, specifically 
decreases peripheral levels of pro-inflammatory cytokine, TNFα. Indeed, several 
lines of evidence support that when the HPA axis becomes hyperactive one potential 
consequence is the enhanced inhibition of the immune system (reviewed in 
Silverman & Sternberg, 2012; Ramamoorthy & Cidlowski, 2013). Interestingly, this 
finding is not only consistent with the second hypothesis pertaining to this 
experiment, but is also in line with previous research showing reduced inflammation 
in response to chronic restraint stress (Voorhees et al. 2013; Han et al. 2015).  
Although, it is noteworthy that Voorhees and colleagues (2013) find a decrease in 
IL1β, and not TNFα in the context of their work, while Han and colleagues see 
reductions in a much wider array of cytokines, including IL1β, IL4, IL6 and IL10, 
which may represent a more severe form of GR resistance.  However, several 
explanations could account for the differences in the findings of this study and those 
of the previous literature, ranging from the study design, to the length of treatment, 
and to even the way in which blood samples were collected and stored (Hoff, 2000; 
Bielohuby et al. 2012).  To elaborate on the last point; blood samples should ideally 
be collected from the same site, using the same procedure. Sufficient coagulation 
time prior to centrifugation should be permitted, and frequent freezing and re-thawing 
should be avoided. In this thesis, efforts were made to ensure this, but not all studies 
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may have adhered to these same principles, which could influence the biochemical 
readouts.   
 
To further ascertain whether physical stress may be promoting HPA axis 
hyperactivity as hypothesised, circulating corticosterone was concurrently measured 
after nine weeks of stress exposure, in the absence of an acute stress stimulus.  
Surprisingly though, corticosterone levels were unaltered in the context of this work; 
findings, which do not support HPA axis hyperactivity, or align with the third 
hypothesis that chronic stress increases corticosterone (Wanasuntronwong et al. 
2012; Choi et al. 2013; Voorhees et al. 2013; Hashikawa et al. 2015; Han et al. 2015; 
Shen et al. 2016; Demusyer et al. 2016). Two possible caveats however, could 
account for this inconsistency. First, although physically stressed mice do have a 
32% increase in circulating corticosterone relative to control animals (M: 31 vs. 41; 
see Figure 3.16), these findings are not statistically significant. However, it is 
possible that there may be insufficient power in this study to detect any significant 
change, especially when the physically stressed animal group comprised of fewer 
animals than all other experimental groups, and the effect size is likely to be small in 
the absence of an acute stress stimulus (see section 4.4.2). Second, a single 
measurement of corticosterone taken in the morning may be insufficient to detect 
changes in HPA axis activity, especially when corticosterone fluctuates throughout 
the day (Montano et al. 1991; Gong et al. 2015). Moreover, it is notable that most of 
the clinical literature supporting an association between hypercortisolemia and 
depression does so in response to awakening. Given that that rodents are nocturnal, 
and a morning corticosterone measure was taken in the context of this work, which 
reflects corticosterone levels at their lowest (Montano et al. 1991; Gong et al. 2015), 
it is possible that this could create a floor effect that may potentially account for null 
findings.  
 
In order to gain a more comprehensive overview of HPA axis activity, cytokine and 
corticosterone levels in response to a novel acute stressor were also evaluated. 
Interestingly, my data show how in response to a novel acute stressor, physically 
stressed mice show an increase in corticosterone, and a concomitant reduction in 
IL4, which all substantiates the possibility that chronic physical stress may promote 
HPA axis hyperactivity as a potential consequence of GR resistance. Therefore, in 
the context of this work, one could speculate that the observed peripheral changes 
may be due to GR resistance, which impairs the GR-mediated inhibition of the HPA 
axis, and subsequently promotes an increase in circulating glucocorticoids. Given the 
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anti-inflammatory nature of glucocorticoids, this subsequently then inhibits 
inflammation.  Moreover, it is particularly pertinent to see a reduction in IL4, which, 
similar to IL10, plays an important role in regulating HPA axis homeostasis, and can 
inhibit GR function (Kam et al. 1993; Irusen et al. 2002; Derecki et al. 2010; Raison & 
Miller, 2016).  
 
Interestingly, one of the potential hypotheses put forward to account for the 
behavioural response observed in physically stressed mice involved the 
nociception/pain pathway (see section 4.2.2.1.1), which is another system 
synergistically related to the HPA axis. Indeed, several lines of evidence support that 
chronic pain activates the HPA axis, and that glucocorticoids possess anti-
nociceptive qualities and can decrease nociceptive behaviour in adult mice (Li et al. 
2007; Hayashi et al. 2008; Kang et al. 2013). Therefore, if physically stressed mice 
do have a hyperactive HPA axis, and glucocorticoids have a strong anti-nociceptive 
effect, then it remains conceivable that physically stressed mice may also have an 
inhibited pain response, as a likely consequence of both HPA axis and immune 
system dysregulation.  Thus, all three of these systems may play an important role in 
the context of this work, and the synergistic alteration of these systems may 
potentially account for the behavioural and biological phenotypes thus far observed 
for chronic physical stress. In fact, alterations in the nociceptive/pain pathway could 
potentially account for the finding that TNFα is reduced in physically stressed mice, 
especially given that TNFα plays an important role in the pain response (reviewed in 
Leung & Cahill, 2010; Hess et al. 2011). If indeed chronic physical stress promotes 
GR resistance, which increases corticosterone, which both inhibit the pain and 
inflammatory response; it is credible that this would account for the observed 
reduction in TNFα in these stressed animals.  
 
4.2.2.2.1.2.  Exposure to chronic psychosocial stress may induce GR 
hypersensitivity, GR resistance or enhance MR activity 
 
Several lines of evidence support that psychosocial stress, like physical stress, albeit 
in a contrasting way, promotes HPA axis dysregulation. First, like with physical 
stress, chronic psychosocial stress alters immune system functioning. However, 
unlike physical stress, psychosocial stress increases peripheral levels of TNFα after 
nine weeks of chronic exposure, a finding which not only supports the second 
hypothesis, but one that has previously been reported in socially isolated adult 
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BALB/c male mice (Wu et al. 2000).  Moreover, in addition to increasing TNFα, 
psychosocial stress also decreases circulating levels of IL1β, IL10 and VEGF, which 
have previously been reported following restraint stress or UCMS (Voorhees et al. 
2013; Hutton et al. 2015; Han et al. 2015). Given that very few studies have 
evaluated the impact of chronic social isolation on peripheral cytokine levels in adult 
male mice, it is difficult to determine whether these findings are simply novel, or 
contradictory. However, Bowers and colleagues (2008) do find that four weeks of 
periodic social isolation significantly decreases circulating levels of monocytes, T 
cells and B cells (Bowers et al. 2008), which is somewhat in agreement with these 
findings, given that T cell and B cells are either a primary source of release, or a 
target of function, for IL10 and IL1β (see Table 1.1).  
 
Conversely though, Bartolomucci and colleagues (2003) find no differences in IL4 or 
IL10 in socially isolated adult male mice, but reasons for these differences could 
stem from (a) the timing, method and duration of blood collection, and the 
subsequent way in which blood samples were stored and analysed, (b) the length of 
treatment, which was only six weeks, and/or (c) strain differences, with Bartolomucci 
and colleagues (2003) using an outbred rather than an inbred mouse strain 
(Bartolomucci et al. 2003). Moreover, although the stress paradigm used in this 
thesis is more chronic in nature, lasting nine weeks, it is also important to 
acknowledge that only one ‘baseline’ blood sample was taken, which represents a 
single biological snapshot. It therefore remains possible that the immune profiles 
observed at nine weeks may simply be different to those at six weeks. By capturing 
only a single snapshot we cannot be sure that the observed changes are direct 
effects of chronic exposure, indirect effects of alterations in other biological systems, 
or simply adaptive changes, all of which could further account for some of the 
differences in the existing literature, particularly when different durations of exposure 
are employed (see 4.4.2). Future studies should measure the trajectory of these 
changes to untangle causative versus adaptive changes. 
 
Although the literature is sparse regarding the effects of social isolation on immune 
system functioning, it is not surprising to see an increase in pro-inflammatory 
cytokine TNFα, and a concomitant decrease in anti-inflammatory cytokine IL10, 
which is an important mediator for suppressing the immune response by inhibiting 
Th1 and Th2 responses. Moreover, IL10 in particular can directly inhibit the 
proliferation and production of TNFα (Couper et al. 2008), and so finding a decrease 
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in IL10 could account for the increase in TNFα. Furthermore, increased TNFα and 
decreased IL10 are both strongly associated with depressive-like behaviour and 
clinical depression (e.g., Kubera et al. 2001; Mesquita et al. 2009; Manosso et al. 
2013; Karson et al. 2013; Goldsmith et al. 2016; Kohler et al. 2017). Given that 
psychosocially stressed animals have a depressive-like phenotype in the context of 
this experiment (see 3.1.1.2.2), it remains plausible that dysregulation of the immune 
system could be driving the aberrant behavioural responses observed for 
psychosocially stressed mice.  
Although findings pertaining to TNFα and IL10 are not unexpected, the finding that 
psychosocial stress reduces levels of IL1β is somewhat surprising and 
counterintuitive, especially when chronic stress is shown to predominantly increase 
IL1β (e.g., Lu et al. 2014; Liu et al. 2015; Zhang et al. 2015b; Yu et al. 2016; Zhuang 
et al. 2016).  Although, we should be mindful that these findings are in the context of 
UCMS, which is very different stress paradigm to social isolation. Finding that IL1β is 
reduced however, could stem from three possible explanations. First, it may relate to 
the different ways in which IL1β and TNFα is released and trafficked. For example, 
unlike TNFα, which is released via activation of the NF-κB pathway, and trafficked 
via a classical secretory pathway, IL-1β is converted into its active form via the 
activation of NLRP3 and trafficked via a “non-classical” pathway (Qin et al. 2004; 
Block et al. 2007; Lacy & Stow, 2011; Iwata et al. 2012; Maslanik et al. 2012). Thus, 
given that the release and trafficking of these cytokines involves distinct pathways, it 
is possible that one or both of these pathways may be altered in the context of this 
experiment. Second, and alternatively, there may be no impairment in the 
release/trafficking of IL1β, but it may simply take more time to convert and release 
IL1β into its active form than it does to release TNFα. Third, and finally, it remains 
possible that the rate of saturable transport across the blood brain barrier and into 
the brain may occur at a much faster and more efficient rate for IL1β than for TNFα 
(reviewed in Banks, 2005), which may also partially contribute to the findings. A 
measure of TNFα and IL1β mRNA expression and protein levels in relevant brain 
regions would help to determine whether this is a possibility in the context of this 
experiment. Therefore, given that the pathways associated with each cytokine is 
starkly different, with respect to its release and trafficking, it may be a misconception 
to assume that although both cytokines are pro-inflammatory in nature that the 
direction of their effect at a single snapshot in time should therefore be identical. It is 
noteworthy that Voorhees and colleagues (2013), who likewise find a decrease in 
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peripheral levels of IL1β, also observe a simultaneous increase in IL6 and a 
decrease in IL10, the former of which is released and trafficked via the same 
pathways as those pertaining to TNFα (Voorhees et al. 2013). 
Intriguingly, Han and colleagues (2015) who in the context of their work also find 
reduced IL1β, hypothesise that this finding could be a likely consequence of HPA 
axis hyperactivity (Han et al., 2015). While the authors find a consistent decrease in 
all cytokines, making this a plausible theory, in the context of this thesis however, 
hyperactivity of the HPA axis is unlikely to account for this finding given the observed 
increase in TNFα. Although hyperactivity is unlikely, HPA axis dysregulation, albeit in 
a different way, could still be influencing immune system functioning in 
psychosocially stressed mice. Indeed, when I examine the impact of acute stress on 
corticosterone, and immune, responsivity, my data show how, in contrast to physical 
stress, psychosocial stress decreases corticosterone reactivity, and concomitantly 
increases IL1β and TNFα, while decreasing IL10 and IL4, all in response to the same 
acute stressor: evidence all to support that psychosocial stress elicits HPA axis 
dysregulation. However, it is noteworthy that corticosterone levels, in the absence of 
a stress stimulus, are unaltered, which is counter to what would be expected in the 
presence HPA axis dysregulation. However, as aforementioned, the timing of 
corticosterone collection, together with the absence of a stress stimulus could create 
a floor effect that may contribute to null findings (see 4.2.2.2.1.1).  
Although, corticosterone levels were unaltered in the absence of acute stress, all 
other hormonal and immune profiles support that psychosocial stress may be 
dysregulating the HPA axis. Interestingly, this dysregulation could occur via three 
potential mechanisms of action. First, chronic psychosocial stress may promote GR 
hypersensitivity (reviewed in Anacker et al. 2011; Murani et al. 2016), which results in 
the increased inhibition of the HPA axis, and the subsequent decrease in circulating 
levels of corticosterone. Moreover, this increased inhibition of the HPA axis would 
then also account for the concomitant increase in IL1β and TNFα, as there is simply 
less active corticosterone to suppress immune response. Second, and alternatively, 
these findings may also represent glucocorticoid resistance, as a consequence of 
insufficient intracellular levels of biologically active glucocorticoids (Ramamoorthy & 
Cidlowksi, 2013), which could likewise reflect observed findings. Third, and finally, 
the data could suggest a shift from GR- to MR-mediated glucocorticoid effects, which 
can alter the balance of pro- and anti-inflammatory mediators (Chantong et al. 2012), 
and/or impair the ability of GR to repress the activity of NF-kB (Coutinho and 
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Chapman, 2011). A shift from reduced GR to enhanced MR activity would essentially 
increase pro-inflammatory mediators, while reducing anti-inflammatory ones, an 
effect, which is indeed observed in the context of this study. Interestingly, GR 
resistance often attributes to the shift from GR to MR activity (Chantong et al. 2012). 
Therefore, while any of the proposed mechanisms could be at play in the context of 
this work, it is clear however, that altered GR or MR functioning and/or expression is 
likely playing a key role.   
 
4.2.2.2.1.3.  Exposure to both chronic physical and psychosocial stress does not 
appear to alter HPA axis activity, but does alter immune system 
functioning  
 
In stark contrast to both physical, and psychosocial, stress, my data show how the 
combined exposure to physical and psychosocial stress does not alter corticosterone 
levels after nine weeks of exposure, nor does it alter stress reactivity. This suggests 
that this particular exposure does not alter HPA axis functioning, and that the 
observed behavioural perturbations, that is, increased anxiety-like behaviour, are 
likely a manifestation of some other biological system alteration. Interestingly, my 
data supports that the immune system could be responsible for the anxiety-like 
behaviour exhibited in these animals, given that exposure to both stressors reduces 
circulating levels of anti-inflammatory cytokine, IL4, both in the presence and 
absence of acute stress, and decreases pro-inflammatory cytokine, IL1β, post acute 
stress.  Moreover, these findings are in line with previous research using chronic 
restraint stress (Voorhees et al. 2013; Han et al. 2015). Interestingly, it is also 
pertinent that in IL4 knockout studies, the lack of IL4 is found to be associated 
specifically with an anxiety- not depressive-like phenotype (Moon et al. 2015), which 
is a finding in strong agreement with the work in this experiment. Furthermore, it is 
not entirely surprising that a reduction in IL4, which similar to IL10 is important for 
inhibiting the immune response, could promote aberrant behaviour. Maintaining the 
balance between pro-and anti-inflammatory cytokines is thought to be a crucial factor 
in ensuring healthy immune system functioning, therefore, a skew in this balance 
could have detrimental effects on physiology and behaviour (see 1.2.2.4). Therefore, 
it is possible that the dysregulation of the immune system could be driving the 
aberrant behavioural responses observed for these stressed mice, and indeed, 
several lines of evidence supports that the immune system can independently 
promote anxiety/depression (see section 1.2.2.3).  
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However, it is notable that the finding pertaining to IL4 is not in line with the second 
hypothesis, which expects an increase in TNFα, IL1β, and IL6 in response to chronic 
combined stress (Mutlu et al. 2012; Lu et al. 2014; Liu et al. 2015; Wu et al. 2016; Yu 
et al. 2016; Zhuang et al. 2016). Although it is important to note that in all these 
studies, UCMS is the stress model utilised, which is not entirely comparable to the 
study performed in this thesis.  Furthermore, as already discussed, several 
methodological and/or technical distinctions could all account for differences in 
findings.  
 
4.2.2.2.2.  Exposure to different types of chronic stress differentially alters 
microglial and astrocyte biology in the dentate gyrus of the 
hippocampus 
 
4.2.2.2.2.1.  Physical stress increases microglial cell density and promotes 
microglial activation, while psychosocial stress decreases microglial 
cell density, promotes microglial hyper-ramification, and increases the 
number of mature astrocytes 
 
Consistent with previous data showing how distinct types of stress differentially 
modify behavioural responses, stress reactivity and immune profiles, the 
immunohistochemical data show that the type of chronic stress also induces distinct 
microglia and astrocyte profiles.  For example, my data show that physical stress 
increases Iba1 cell density in the ventral DG, and alters Iba1 morphology such that 
Iba1 cells have a dystrophic morphology, evident by a reduced number of processes, 
a decrease in their branching complexity, and a shorter maximum process length. 
Conversely, psychosocial stress decreases Iba1 cell density in the dorsal DG, alters 
Iba1 morphology such that Iba1 cells have an increase in branching complexity and a 
more ramified morphology. Moreover, unlike physical stress, psychosocial stress 
also increases GFAP positive immunoreactivity and S100β cell density in both the 
dorsal and ventral DG. Intriguingly, my data also show that there is a regional 
difference in the impact of chronic physical, and psychosocial, stress upon Iba1 and 
GFAP biology between the PFC and DG of the hippocampus, with no differences 
observed in the PFC for experimental groups. Furthermore, and even more 
interestingly, in contrast to both physical, and psychosocial, stress, mice exposed to 
both stressors show no alterations in either Iba1 or GFAP in either brain region.  
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Although this is the first study to compare the type of stress on microglia and 
astrocyte biology, the findings pertaining to the effect of combined stress are not in 
line with the third hypothesis, and/or previous literature, which finds an increase and 
decrease in Iba1 and GFAP immunoreactivity, respectively, for chronically stressed 
mice (Czeh et al. 2005; Tynan et al. 2010; 2012; Liu et al. 2011; Araya-Callís et al. 
2012; Kriesel et al., 2014; Hellwig et al. 2016). However, differences in the nature of 
the stress treatment, and duration of exposure could potentially account for these 
disparities, and interestingly, in support of my findings, previous research shows how 
exposure to heterotrophic stressors may not promote microglial activation (Kopp et 
al. 2013).  
While the data pertaining to combined stress is inconsistent with the wider literature, 
findings pertaining to the effect of physical stress on microglial biology supports the 
hypothesis that chronic stress can trigger a neuroinflammatory response involving 
microglia (Johnson et al. 2005; Nair & Bonneau, 2006; Blandino et al. 2009; Tynan et 
al. 2010; Kriesel et al. 2014; Hellwig et al. 2016), Moreover, while the effect of social 
isolation on Iba1 and GFAP biology is entirely novel, it nonetheless aligns with 
previous research documenting that chronic stress increases GFAP and/or s100β in 
the hippocampus (e.g., Margis et al. 2004; Jang et al. 2008; Kwon et al. 2008; Ye et 
al. 2011), promotes Iba1 cell hyper-ramification (Hinwood et al. 2012), and that this 
hyper-ramification is associated with depressive-like behaviour (Hellwig et al. 2016).  
 
4.2.2.2.2.2.  Interpretation of the observed changes in microglia biology 
 
The finding that the type of stress either increases or decreases Iba1 cell density in 
the DG can stem from three possible explanations. First, chronic stress exposure 
may be differentially altering the expression of Iba1. For example, chronic physical 
stress may increase Iba1 expression such that cells previously present, but below 
detection levels, now become detectable, while the opposite may be true for 
psychosocial stress. Second, the altered number of Iba1 positive cells could be a 
consequence of altered apoptosis, whereby, for example, chronic psychosocial 
stress could promote an increase in Iba1 positive cell death thereby accounting for 
reduced cell density. Interestingly, research shows that microglial overactivation 
promotes microglial apoptosis (Liu et al. 2001), which raises the possibility that 
psychosocial stress may enhance the overactivation-induced apoptosis of microglia, 
which would then contribute to reduced microglial density. However, as apoptosis 
was not measured in the context of this work, it would be profitable for future studies 
to collect data on this particular parameter (see section 4.5). Third, and finally, the 
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increased/decreased numbers of Iba1 positive cells could likewise be a result of 
altered cell proliferation. However, my data pertaining to Ki67, a nuclear protein 
expressed during mitosis (Scholzen & Gerdes, 2000) that has previously been used 
to identify mitotically active microglia (Klein & Roggendorf, 2001), finds no difference 
in the number of mitotically active cells in the DG between experimental groups. This 
finding suggests that the altered number in Iba1 positive cells for chronically stressed 
animals is likely due to either altered Iba1 expression or altered cell death. Although 
this seems the most likely explanation given my data, it is noteworthy that (a) Ki67 is 
not the only marker of cell proliferation, and is often weakly expressed (see section 
4.4.2), (b) without double labelling for Ki67 and Iba1, it remains a possibility that the 
mitotically active cells in stressed animals may correspond to a different population to 
those for stress-free control animals, (c) it is entirely credible that an increase in cell 
proliferation for stressed animals may have occurred at an earlier time point, which is 
subsequently missed due to the design of this current study, and (d) Ki67 cell density 
data could not be stratified by DG region in this study. Therefore, finding no 
differences in Ki67 in the DG as whole does not negate the possibility that specific 
DG region differences may still exist, that is, dorsal/ventral, given that issues with 
power, or that findings in one region may be masking/counteracting findings in the 
other, could all account for null findings.  
 
Interestingly, the Iba1 morphology data for physically stressed mice supports the 
notion that an increase in cell proliferation could still be accounting for said findings, 
at least for this particular exposure group, especially when microglia can proliferate 
rapidly once activated (Dailey & Waite, 1999). Indeed, my data supports that 
exposure to chronic physical stress may promote Iba1 activation, given that Iba1 
cells have a shorter max process length, fewer processes, and reduced branching 
ramification, which are all morphological alterations typically observed in reactive 
microglia (Stoll et al. 1998; Walker et al. 2014). Moreover, these findings are 
consistent with previous research (Tynan et al. 2010; Wohleb et al. 2011; Hinwood et 
al. 2012), and therefore, microglia activation could account for the observed increase 
in cell density for these stressed animals, by promoting cell proliferation (Dailey & 
Waite, 1999).  Strikingly though, it is noteworthy that Iba1 cell soma size was 
unaltered under these stress conditions, and if indeed cells were more reactive, cell 
soma size would be significantly larger (Beynon & Walker, 2012). However, it is still 
reasonable to conclude that these Iba1 cells are activated, but may simply not be in 
the final most stages of activation, where soma size is much larger as cells adopt an 
amoeboid morphology (Beynon & Walker, 2012). Furthermore, it remains plausible 
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that the biological snapshot captured in the context of this study, may be between 
morphology transitional states, which could likewise account for this finding. For 
example, this biological snapshot may simply have captured the transitional state just 
prior to the final stage of microglial activation, or conversely, may have captured a 
morphological state just after complete activation, when cells are in the process of 
returning to ‘resting’ state. 
 
However, evidence to support an alternative explanation for the aforementioned 
morphological alterations, comes from the finding that each Iba1 cell in response to 
chronic physical stress occupies significantly less overall cell space. Given that 
microglia maintain their own independent space or footprint (Jinno et al. 2007), this 
alteration in the available space could therefore partly drive the morphological 
changes observed for these cells, which are simply an adaptation to reduced overall 
cell space. Thus, it is credible that the observed changes in cell density may be 
accounting for the morphological changes, rather than the reverse. Although, it is 
noteworthy that the two need not be mutually exclusive, and irrespective of the 
temporal sequence, my data shows that physical stress increases the number of 
Iba1 cells, which have a more activated/dystrophic morphology.  Given that microglia 
structure is intimately linked to their function (Kreutzberg et al. 1996), these changes 
in morphology are highly likely to have functional implications (see subsections 
1.2.3.1.1 and 1.2.3.1.4).  
In direct contrast to physical stress, psychosocial stress decreases Iba1 cell density, 
and promotes hyper-ramification, both of which may likely stem from microglial 
overactivation (Liu et al. 2001; Hinwood et al. 2012; Tynan et al. 2013). Interestingly 
however, unlike physical stress, this change in Iba1 density does not seem to 
account for the hyper-ramification of these cells, given that the area each cell 
occupies remains unchanged.  Moreover, this is further supported by the fact that 
neither process length nor the number of processes alters despite more available 
space. Therefore, it seems unlikely that cell density, in this context, is responsible for 
driving the observed concomitant Iba1 morphology changes. Furthermore, and more 
excitingly, given that psychosocial stress does not alter the overall area each cell 
occupies, but simultaneously increases branching complexity, it would appear that 
psychosocial stress specifically increases the internal complexity of microglia. 
Intriguingly, this finding is consistent with previous research, albeit in the context of 
restraint stress on microglial biology in the PFC (Hinwood et al. 2012).  
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However, while most studies to date report an increase in microglial activation, that 
is, a reduction in complexity, hyper-ramification is an under-reported finding, and one 
that is not well understood. While it has been proposed that hyper-ramification 
represents one of the earliest microglial transformations in response to injury (Streit 
et al. 1999), real time studies find no evidence to support this theory (Stence et al. 
2001). Therefore, it is unknown whether hyper-ramification is part of the injury 
schema, or is a response to, for instance, intense neuronal activity. Interestingly, 
previous in vitro work has demonstrated how astrocyte conditioned medium can 
promote ramification (Wilms et al. 1997).  Given that my data also show an increase 
in astrocyte number in the DG, it is therefore possible that Iba1 hyper-ramification 
may be associated with the increase in astrocyte number and/or altered astrocyte 
functioning. However, whether one outcome promotes the other, or whether some 
other cellular change is responsible for promoting both outcomes, remains unclear. 
  
4.2.2.2.2.3.   Interpretation of the observed changes in astrocyte biology 
 
The finding that psychosocial stress increases GFAP and s100β cell density in the 
DG can stem from the same three possible explanations as those pertaining to Iba1 
(see 4.2.2.2.2.2). Briefly, psychosocial stress may be (a) increasing GFAP 
expression, (b) decreasing apoptosis, or (c), increasing cell proliferation. However, 
while apoptosis was not measured in this thesis, making it difficult to evaluate altered 
cell death as a possible mechanism for this effect, increased cell proliferation seems 
like the most likely explanation for this finding, given that upon further 
characterisation, psychosocial stress shows an increase in the number of radial glia 
in the DG relative to control conditions. Interestingly, this could also account for the 
increase in s100β cell density, given that radial glial cells ultimately differentiate into 
astrocytes, neurons, or oligodendrocytes, and that s100β is particularly expressed in 
and secreted by astro- and oligodendrocytes (Steiner et al. 2007; Donato et al. 
2009). However, it is notable that Ki67 data does not support an increase in cell 
proliferation for psychosocially stressed mice. This inconsistency could be a 
reflection of the caveats already described in 4.2.2.2.2.2, and that co-labelling GFAP 
with SOX2 was used to characterise radial glial cells, not Ki67. 
 
Although the work for this study cannot speculate on the functional importance of 
GFAP in relation to astrocyte biology, given that only 10% of GFAP positive cells 
were astrocytes and no GFAP astrocyte-specific differences were found, the finding 
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that psychosocial stress increases s100β can reflect several important points. First, 
psychosocial stress may increase astrocyte activation and/or distress, given that 
s100β is widely associated with this effect (Hu & Van Eldik, 1996). Therefore, this 
change in s100β may represent an indirect impairment in astrocyte biology, and 
although speculations on how psychosocial stress may have altered astrocyte 
structure cannot be made, if s100β is a proxy for astrocyte activation/distress, it is 
likely that psychosocial stress may alter astrocyte functioning such as, 
neurotransmitter modulation, glucose and glutamate metabolism, synaptogenesis 
and/or synaptic integrity maintenance (see 1.2.3.2.1). Indeed, several lines of 
research support an important role for glutamate and its receptors in the 
pathogenesis of depression, and in altered microglial functioning  (Kim et al. 1982; 
Piani et al. 1992; Barger & Basile, 2001; Mitani et al. 2006). Therefore, it raises the 
possibility that altered astrocyte functioning may be triggering the alterations in 
microglial biology and the behavioural disturbances observed in our psychosocially 
stressed animals, which warrants further clarification (see 4.5). Alternatively, given 
that s100β is a calcium binding globulin, and astrocyte communication is governed 
by calcium waves (see 1.2.3.2.1), an increase in s100β could suggest an alteration in 
astrocyte communication, which may contribute to observed changes in Iba1, such 
as hyper-ramification, and the observed alterations in DCX morphology (see 
subsections 3.1.3.1.3 and 3.1.4.4). Indeed, research supports the involvement of 
s100β in astrocyte communication (Morquette et al. 2015).  
 
Second, the specific functions of s100β are concentration-dependent such that 
nanomolar concentrations are known to promote neurogenesis, cell survival, growth 
and differentiation (Van Eldik & Griffin, 1994; Huttunen et al. 2000), while micromolar 
concentrations increase glial and neuronal apoptosis (Hu & Van Eldkik, 1996; 
Huttunen et al. 2000; Bianchi et al. 2010). Therefore, given the deleterious effects 
associated with s100β at high concentrations, it is possible that, in the context of this 
work, an increase in s100β could be a more direct marker of impairment, and 
promote increased glial and neuronal cell death. Interestingly, if this were the case, 
this could then potentially contribute to the reductions in Iba1 seen in these same 
animals (see 3.1.3.1.2). However, given that apoptosis was not measured in this 
study, this remains to be elucidated.  
 
Third, and finally, the finding that s100β expression is increased in psychosocially 
stress mice, which also exhibit an increase in depressive-like behaviour, aligns well 
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with clinical research demonstrating how an increase circulating s100β is associated 
with major depression (Schoeter et al. 2008; 2011). However, we should be cautious 
in assuming that changes in the brain correspond to changes in the periphery, and 
as such it would be interesting for future research to measure s100β in both the 
periphery and the brain.  
 
4.2.2.2.2.4.  Brain region specificity  
 
A particularly interesting finding from this study is that there is a regional difference in 
the impact of chronic stress exposure upon microglia and astrocytes between two 
stress-sensitive brain regions, that is, the PFC and DG of the hippocampus. 
Although, the finding that regional differences exist is not novel (Gosselin et al. 2009; 
Tynan et al. 2010), my data shows no alterations in Iba1 or GFAP biology in the 
PFC, which is not in line with previous research (Tynan et al. 2010; 2012; Hinwood et 
al. 2012; Imbe et al. 2012). Although, it is noteworthy that the stress paradigm often 
used in these studies was that of restraint stress, the duration of exposure was 
typically two-three weeks, and the species used was rats, which could all account for 
these differences.  Moreover, given that the duration of exposure in this thesis was 
nine weeks, and the effect of exposure can have important implications on microglia 
and/or astrocyte biology (Kriesel et al. 2013), it remains possible that alterations in 
microglia/astrocyte biology in the PFC may have occurred, but at an early time point, 
which was missed in this study. As such, it would be highly advantageous for future 
studies to collect tissue samples from parallel groups throughout the protocol to 
determine whether microglial activation and/or changes in biology occur at earlier 
time points. 
 
An even more exciting and novel finding from this study is that there exists a regional 
difference within the DG concerning the impact that different types of chronic stress 
have on microglia biology. As aforementioned, Iba1 changes for physically stressed 
mice are specific to the ventral DG, while the changes for psychosocially stressed 
mice are specific to the dorsal DG. While the basis for this difference is unclear, one 
potential explanation could be that the microglial response to the type of chronic 
stress develops at different rates, or alternatively, endures for different periods of 
time within the DG of the hippocampus. Therefore, null findings, for example, in the 
dorsal DG of physically stressed mice, may not mean that this region is unaffected by 
chronic stress, but that more simply the time course of the microglial response is 
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different such that it was missed or yet to be captured in the context of this 
experiment. Moreover, given that animals in this study respond so distinctively to 
acute stress, depending on the type of chronic stress they were previously exposed 
to, a differentially altered microglial response represents a parsimonious explanation, 
especially when glucocorticoids are well-known modulators of microglial function 
(Nair & Bonneau, 2006).  Interestingly, it is notable that the ventral hippocampus 
responds entirely differently to glucocorticoids than the dorsal hippocampus, such 
that in response to stress it has a reduced firing frequency accommodation and more 
depolarization-associated spikes (Maggio & Segal, 2009). In essence, this differential 
response may allow for a longer window of acquisition when activated during a 
stressful experience (reviewed in Joëls et al. 2012), and given the prominent role of 
the ventral hippocampus in inhibiting HPA axis stress responses, this raises the 
possibility that the differential actions of glucocorticoids on synaptic function may be 
relevant to stress regulation. Therefore, given that (a) HPA axis activity seems 
differentially affected for the different types of exposure, and (b) the regions of the 
hippocampus differentially respond to stress, together this could potentially account 
for the regional differences observed with respect to Iba1.   
 
4.2.2.2.2.5.  Biological mechanisms that could account for changes in microglial 
and astrocyte biology 
 
Glucocorticoid and noradrenergic signalling are the two most well understood 
pathways through which stress can affect microglia and astrocyte structure and 
functioning (reviewed in Walker et al. 2013). Although delineating the precise 
molecular mechanisms driving the observed behavioural and biological changes is 
beyond the scope of this thesis, it is interesting that my data supports that the type of 
chronic stress seems to differentially alter HPA axis activity. Given that (a) microglia 
and astrocytes possess both the MR and GR (Vielkind et al. 1990; Bohn et al. 1991; 
Tanaka et al. 1997; Hwang et al. 2006; Sierra et al. 2008), (b) glucocorticoids can 
directly impact microglial cells, by exerting both a suppressive and a stimulatory 
effect (Walker et al. 2013), and (c) glucocorticoids can directly increase the velocity 
of calcium waves, and the subsequent rate of gliotransmitter release of astrocytes 
(Chatterjee & Sikdar, 2013), it therefore, stands to reason that this may be one of the 
key systems involved in altering microglia/astrocyte biology for physically, and/or 
psychosocially, stressed mice in the context of this study.  Furthermore, it is 
particularly pertinent that my data show no evidence to support that exposure to both 
stressors alters HPA axis activity, nor does it show a change in either Iba1 or GFAP 
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in either the PFC or the hippocampus for these same animals. Indeed, previous 
research showing that exposure to homotypic, rather than heterotopic, stressors 
promotes microglial activation, supports that glucocorticoid action may be modulating 
microglia activation under these stress conditions (Kopp et al. 2013).  
Interestingly, activation of the β-adrenoceptor signalling pathway can also directly 
modify microglia activity by altering IL1β receptor expression and/or IL1β production 
(e.g., O’Sullivan et al. 2009; Wohleb et al. 2011; Tynan et al. 2012), and thus, it is 
intriguing that in the context of my research, my data show that psychosocial stress 
significantly alters circulating IL1β after nine weeks of exposure, in the presence and 
absence of acute stress (see 3.1.2.1.1.2). Therefore, it is possible that this may 
represent an alternative pathway by which psychosocial stress decreases Iba1 cell 
density and promotes hyper-ramification. Moreover, by the same token, it could also 
account for why less circulating IL1β is seen nine weeks after stress exposure in 
these animals (see 3.1.2.1.1.2). However, we should be mindful that peripheral levels 
may not equate to brain levels of IL1β, and that measuring cytokine levels in the 
brain would represent a more robust way of supporting this hypothesis (see 
subsection 4.5). Interestingly though, one could speculate that it may, given that 
several studies show a directly proportional relationship between cytokine levels in 
the periphery and those in the brain (e.g., Lu et al. 2014; Liu et al. 2015; Zhang et al. 
2015b; Zhuang et al. 2016).   
 
4.2.2.2.3.  Exposure to different types of chronic stress differentially alters 
hippocampal neurogenesis in the dentate gyrus of the 
hippocampus 
 
As described in the Introduction (see 1.2.4.5.1.1) microglia and astrocytes play an 
important role in maintaining synaptic integrity. Given that the type of stress exposure 
also differentially alters microglia and astrocyte biology, to determine whether one of 
the functional implications of these changes could be an alteration in hippocampal 
neurogenesis, cell proliferation and differentiation in the DG was subsequently 
examined. Moreover, given that glucocorticoids also play an important role in 
modulating neurogenesis, and that the type chronic stress appears to differentially 
alter HPA axis dysregulation, it seems pertinent to ascertain whether the type of 
stress would likewise differentially alter neurogenesis.   
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4.2.2.2.3.1.  Physical stress decreases neuroblast cell density across most 
morphology types, while psychosocial stress specifically increases the 
number of mature neuroblasts in the dentate gyrus of the 
hippocampus 
 
Consistent with the conclusion that the type of chronic stress differentially alters 
biological profiles, is the finding that the type of chronic stress also differentially alters 
hippocampal neurogenesis. Interestingly, my data show how exposure to chronic 
physical stress, and the combined exposure of physical and psychosocial stress, 
significantly decreases overall DCX cell density in the dorsal DG, a finding supported 
by the fourth hypothesis that chronic stress decreases hippocampal neurogenesis 
(e.g., Yun et al. 2010; Nollet et al. 2012; Elysad et al. 2012; Rainer et al. 2014; Lu et 
al. 2014).  Moreover, the physical-stress induced reduction in DCX cell density is 
associated with almost all cell types, with the exception of intermediate stage 
neuroblasts, which again aligns with previous research (Lussier et al. 2013). In 
contrast, exposure to psychosocial stress does not alter overall DCX cell density, but 
does, unexpectedly, increase the number of mature neuroblasts in the ventral DG; a 
finding not consistent with the fourth hypothesis that psychosocial stress decreases 
neurogenesis (e.g., Silva et al. 2011; Van Bokhoven et al. 2011; Famitafreshi et al. 
2015). Interestingly, my data shows that chronic stress does not alter hippocampal 
volume, which also does not align with previous research (e.g., Lee et al. 2009; Tse 
et al. 2014; Rahman et al. 2016). However, given that my data shows altered 
neurogenesis for all exposure groups, it certainly questions the general assumption, 
as per the wider literature, that reduced hippocampal volume is associated with 
altered neurogenesis, at least in mice.  
 
4.2.2.2.3.2.        Interpretation of the observed changes in hippocampal neurogenesis 
 
While the DCX profile pertaining to psychosocial stress is surprising, it is interesting 
that, consistent with previously described behavioural and biological profiles, it 
contrasts the DCX profile associated with chronic physical stress, which decreases 
neurogenesis. Intriguingly, the observed decrease in overall DCX cell density for 
physically stressed mice is not associated with a decrease in cell proliferation, as no 
alterations in Ki67 were observed, suggesting that this alteration may be due to an 
increase in cell death. Although it is unknown whether apoptosis is indeed altered in 
these animals, it seems appropriate however, that we do see an increase in the 
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density of Iba1 cells in the DG, which assume an activated morphology (see 
3.1.3.1.2.1 and 3.1.3.1.3.1). Moreover, it is known that upon activation microglia 
assume a phagocytotic role, which contributes to the death of newborn neurons 
(Hanisch & Kettenmann, 2007; Ekdahl et al. 2009).  Therefore, together this raises 
the likelihood that the altered microglial biology as observed in the DG of these 
stressed animals might be contributing to the decrease in DCX cell density by 
promoting increased neuronal cell death.  
 
Furthermore, based on the DCX morphology data we may be able to pinpoint when 
during the process of neurogenesis this event may likely be occurring.  For example, 
previous research suggests that there are two critical periods for newborn cell 
survival in the DG: a main, early critical period (1–4 days after cell birth), and a 
secondary, late critical period (1–3 weeks after cell birth) (Sierra et al. 2010). Given 
that there is no change in Ki67, which is predominately expressed during the earlier 
critical period, we can conclude that perhaps newborn neuron cell death may be 
occurring during the later period. Support for this comes from the finding that the 
more mature neuroblast morphologies, and not the intermediate stage neuroblasts, 
are significantly reduced upon chronic exposure to physical stress. Interestingly 
however, we also see a significant reduction in proliferative stage neuroblasts, which 
counters the argument that cell death occurs predominately in the later critical period. 
Given that null findings associated with Ki67 may be a consequence of the caveats 
discussed in section 4.2.2.2.2.2, it may be worthwhile to determine cell proliferation 
using another marker. Moreover, given that cell death occurs while cells are still in a 
highly proliferative stage, apoptosis and mitosis could be functionally related (Sierra 
et al. 2010), which only further supports the profitability of measuring apoptosis in 
future work.  
The finding that intermediate stage neuroblasts are seemingly unaffected in the 
context of physical stress is a particularly interesting finding. Although, it helps to 
support that cell death at the later critical period may be contributing to the observed 
DCX profile, it may alternatively represent a change in the rate of DCX maturation. 
Indeed, when we look at the compositional breakdown of DCX cells I find that for 
control animals there is gradual linear decrease from proliferative to mature 
neuroblasts, while this is not the case for physically stressed mice. Moreover, 
stressed mice have a significant increase in the proportion of intermediate stage 
neuroblasts relative to control animals. Therefore, from the single neurogenesis 
snapshot obtained in the context of this study, we could conclude that physical stress 
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not only reduces the DCX cell pool, but also potentially slows down the rate of 
maturation for available DCX cells relative to that of control animals, given the 
significantly different compositional makeup of the DCX cell pool.  
While the changes in neurogenesis in physically stressed animals may be easier to 
explain, it is relatively unclear why psychosocial stress would promote an increase in 
the number of mature neuroblasts in the DG.  Instinctively, this finding questions 
whether this may be some form of stress resilience (Ekdahl et al. 2009), however, 
given that these exposed animals display a robust depressive-like phenotype, this 
explanation seems unlikely. Therefore, there are two potential explanations that may 
promote such a finding. First, while this is not a consequence of increased cell 
proliferation, given that there is no change in either overall Ki67 or DCX cell density 
for these animals, it could suggest impairment in the maturation rate of newborn 
neurons within the DG, whereby psychosocial stress promotes an accelerated rate of 
maturation. Indeed, the compositional analyses of DCX mass data confirms that 
psychosocially stressed mice have a greater proportion of mature neuroblasts than 
that of control animals. Interestingly, in line with the idea that DCX cells may be 
maturing at a potentially accelerated rate is the possibility that this may also be 
associated with an increase in neuronal migration. Although DCX migration was not 
measured in the context of this work, so one may only speculate, it is interesting that 
an increase in radial glia in the DG was likewise observed for these stressed 
animals. Given the important role that radial glial play in neuronal migration 
(reviewed in Barry et al. 2014), it would therefore, be interesting for future work to 
measure DCX migration in the context of this work.  
Second, the increase in the number of mature neuroblasts could reflect impairment in 
synaptic pruning, which is necessary for the maintenance of healthy synaptic function 
and brain connectivity (reviewed Paolicelli et al. 2011; Wu et al. 2015; Hong et al. 
2016). Pertinently, one of the primary functions of microglia is that of synaptic 
pruning (see 1.2.3.1.1), and given that psychosocial stress alters microglia biology, 
specifically decreasing the number of Iba1 cells, and promoting hyper-ramification, it 
seems plausible that these changes could promote impairment in normal functioning, 
and subsequently reduce synaptic pruning in the DG. Moreover, further evidence to 
support that psychosocial stress may alter synaptic pruning comes from the finding 
that VEGF is altered in our stressed animals, which is appropriate given the 
association between VEGF, synaptic pruning and synapse formation (reviewed Tillo 
et al. 2012).  However, it should be noted while VEGF in the periphery is significantly 
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altered in these animals, both in the presence and absence of acute stress, it is 
unclear whether this would correlate with expression levels in the hippocampus.  
Thus far, I have speculated that the altered DCX profiles for physically, and 
psychosocially, stressed mice could be associated with the altered microglial profiles 
observed for this groups, which is subsequently modulated by altered HPA axis 
functioning.  However, it is curious, that there also exists a significant decrease in 
DCX cell density for mice exposed to both stressors, despite finding no evidence to 
support HPA axis dysregulation or alterations in microglial biology. Therefore, this 
reduction in DCX likely stems from another associated mechanism yet to be 
determined in the context of this work. While altered cell death and/or cell 
proliferation will still ultimately account for the observed reduction, as with physical 
stress, it is unclear what may be driving these cellular alterations. Interestingly, given 
that these animals show altered immune dysregulation (see 3.1.2.1), and cytokines 
can independently modulate neurogenesis (reviewed in Borsini et al. 2015; Kim et al. 
2016), this may offer a potential explanation for the observed decrease in DCX. 
Moreover, it is pertinent that these stress-exposed animals also show reduced levels 
of VEGF, a pro-neurogenic factor, which could also contribute to the observed 
decrease in neuronal differentiation (see subsection 1.2.4.5). However, cytokine and 
VEGF expression levels in the hippocampus were not measured in this study so 
these theories require substantiation (see subsection 4.4.2). 
 
4.2.2.2.3.3.  Dorsal-ventral specificity and functional relevance 
 
As previously discussed (see 4.2.2.2.2.4), a particularly interesting finding is that the 
type of chronic stress exposure not only differentially alters the biological profile, 
whether DCX or Iba1, but it also seems to differ according to the region of the DG. 
As discussed above, physical stress alters Iba1 in the ventral DG, while psychosocial 
stress alters Iba1 biology in the dorsal DG. While there still is a region-specific effect 
of chronic stress with respect to DCX, it is curious that, counter to the Iba1 profiles, 
physical stress alters DCX in the dorsal DG, while the effect of psychosocial stress is 
confined to the ventral DG.   
 
One explanation to account for this, which coincides with the point clarified in 
4.2.2.2.2.4, is that Iba1 and DCX responses may be time dependent and/or last for 
different periods of time.  This is particularly pertinent given that neurogenesis is a 
process that lasts up to two months, while the microglial response may be more 
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immediate. Therefore, it is not necessarily surprising that the two profiles are not 
parallel. For example, in the context of this experimental snapshot, it is highly likely 
that the observed effect in DCX may be the outcome of a microglial response earlier 
in time that has been subsequently missed in this experiment. Furthermore, even if 
the microglial response was ‘missed’ in certain regions of the DG, such that no 
differences in morphology or cell density can be observed, functional changes 
related to the ‘missed’ event may still continue, but via mechanisms of residual 
trophic effects such as through altered glutamate, and or glucocorticoid signalling 
(Nair & Bonneau, 2006; Alexander et al. 2009). Therefore, these changes in DCX 
may simply be the residual effects of a just ‘missed’ microglial response.  
 
With regard to a broader interpretation of the functional significance of the DCX 
findings, it is well known that the dorsal DG plays a role in memory and cognition, 
while the ventral DG controls stress responsivity and emotional processing. 
Therefore, it is not entirely surprising that DCX in the ventral region of the DG is 
altered in the context of psychosocial stress, which promotes a robust depressive-
like phenotype (see 3.1.1.2.2), and a decrease in stress responsivity (see 3.1.2.2.1). 
Moreover, these findings also align with previous research showing how chronic 
stress in animal models of depression preferentially affects the ventral part of the 
hippocampus (Jayatissa et al. 2006; Brummelte & Galea, 2010; Oomen et al. 2010; 
Tanti et al. 2012).   
 
Although the data pertaining to psychosocial stress aligns with the functional 
relevance of the ventral DG, it is unknown whether this applies to physical stress and 
its associated changes in the dorsal DG, particularly given that cognitive behaviour 
was not measured in the context of this thesis. However, it is noteworthy that anxiety-
like behaviour and cognitive impairment are closely associated in the context of 
chronic stress (e.g., Bondi et al. 2008; George et al. 2015; Park & Moghaddam, 
2017). Therefore, it would be appropriate for future research to measure the impact 
of physical stress on cognitive functioning to extend upon the findings of this study.  
Moreover, it is important to point out that DCX is also decreased in the ventral DG for 
physically stressed animals, albeit non-significantly, and thus, issues with power 
could account for null findings (see 4.4.2). Therefore, it is possible that physical 
stress may indeed reduce neurogenesis in both regions of the DG. 
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4.3.  PART B: Effect(s) of UCMSI on behaviour, inflammation and adult 
hippocampal neurogenesis 
 
4.3.1.  Summary of main findings  
 
Exposure to twelve weeks of UCMSI promotes a depressive-like phenotype, 
increases social interaction, and decreases corticosterone responsivity to novel 
acute stress. Interestingly though, UCMSI does not alter immune system functioning, 
or Iba1 immunoreactivity in either the DG of the hippocampus, or in the PFC. 
However, UCMSI does induce a significant increase in GFAP immunoreactivity in the 
DG of the hippocampus, but not in the PFC, across both the dorsal and ventral 
region, which surprisingly does not equate to an increase in GFAP cell density. 
Moreover, UCMSI also increases s100β cell density in both the dorsal and ventral 
DG.  Finally, although UCMSI does not alter hippocampal volume, it does decrease 
both neuronal cell proliferation and differentiation in the dentate gyrus of the 
hippocampus. For a schematic summary of the main biological changes associated 
with UCMSI see Figure 4.2. 
 
4.3.2.  UCMSI is a robust animal model of depression 
 
4.3.2.1.   The behavioural characterisation of UCMSI  
 
One of the key outcomes of this study is the behavioural characterisation of the 
UCMSI model. The results of this study are consistent with the first hypothesis, and 
the wider literature from which it is based, in that chronic stress promotes both 
profound alterations in general physical health, but also corresponding perturbations 
to the animals’ behaviour (e.g., Nollet et al. 2012; Ping et al., 2014; Wang et al. 2014; 
Wang et al. 2015; Wu et al. 2016; Zhuang et al. 2016). Specifically, UCMSI elicits a 
wide range of depressive-like behavioural changes, including an increase in anxiety-
like behaviour, an increase in anhedonic-like behaviour in the SPT, and an increase 
in behavioural despair/fatigue in the FST, all of which have previously been reported 
in adult male BALB/c mice (Nollet et al. 2012; Pao et al. 2012; Tanti et al. 2012; 
Wang et al. 2015; Liu et al. 2015; Zhang et al. 2015). Interestingly, while the 
magnitude of the behavioural and physiological response to stress increases during 
the first six weeks of exposure, as shown by the gradual increase in anhedonic-like 
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Figure 4.2. Schematic summary of the biological changes associated with 
unpredictable chronic mild stress and isolation (UCMSI) 
The top half of the schematic depicts the neurobiological changes associated with UCMSI. 
Specifically, changes in microglial and astrocyte cell biology and neurogenesis in the 
hippocampus are summarised relative to control animals. The bottom half of the schematic 
depicts the systemic changes associated with UCMSI. Specifically, changes in plasma levels 

































dissipates when only the social isolation part of the paradigm is carried out. This 
suggests that (a) novel unpredictable stressors are necessary to maintain the 
physiological response to stress, that is, animals habituate to homotypic stressors 
like social isolation, or (b) that physiological responses such as coat state are only 
sensitive to a more severe form of stress exposure. However, regardless of whether 
animals exposed to UCMSI habituate to social isolation, it is clear that social 
isolation, at the very least, maintains the presence of depressive-like behaviours, 
given that stressed animals exhibit a wide range of behavioural perturbations at the 
end of the twelve week paradigm. Since behaviour is not measured after the first six 
weeks, it is uncertain whether the social isolation part of the UCMSI paradigm has a 
cumulative effect on behavioural disturbance, or may be responsible for the observed 
behavioural phenotype. Although the latter seems less likely because anhedonic-like 
behaviour is present six weeks after stress exposure. 
 
Interestingly, contrary to expectation, UCMSI significantly increases social 
engagement, which does not align with the hypothesis that chronic stress decreases 
sociability (e.g., Warren et al. 2013; Green et al. 2013; Berry & Kaufer, 2015; Sial et 
al., 2016). However, it is not necessarily surprising that animals, which have been 
socially deprived, that is, individually housed, for twelve weeks would be more social 
than group-housed control animals, for whom sociability is not novel. Indeed, 
previous research measuring the effect of social isolation on social behaviour also 
shows an increase in social interaction for socially isolated animals (Berry et al. 
2012). Moreover, it is noteworthy that in all studies upon which our hypothesis is 
based, social interaction is measured in the context of social defeat, which is an 
entirely different chronic stress paradigm. Furthermore, most studies using UCMS 
measure aggression specifically rather than sociability (Mutlu et al. 2012; Nollet et al. 
2012), and therefore, to my knowledge, the finding that UCMSI increases sociability 
may indeed be entirely novel.  
 
All this data taken together, clearly demonstrates that the UCMSI protocol sufficiently 
induces substantial alterations to both the animals’ general physical condition and 
behaviour, consistent with what is commonly reported within the literature.  
 
4.3.2.2.  The biological characterisation of UCMSI  
 
The second key objective to this study encompasses the biological characterisation 
of UCMSI, which involves analysing changes in the periphery with respect to 
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inflammation, corticosterone, and immunohistochemical analyses of microglia, 
astrocytes and hippocampal neurogenesis. As such, this is the first study to assess 
the impact of UCMSI on all these biological outcomes.  
 
4.3.2.2.1.  UCMSI does not alter immune system functioning, but does alter 
stress responsivity 
 
Interestingly, contrary to our hypotheses that UCMSI will increase peripheral 
inflammation and microglial activation (Mutlu et al. 2012; Lu et al. 2014; Liu et al. 
2015; Zhang et al. 2015; Wu et al. 2016), this study finds no evidence to support that 
UCMSI alters immune system functioning. Specifically, there is no change in any of 
the measured pro- or anti-inflammatory cytokines, in the presence or absence of 
novel acute stress, after twelve weeks of UCMSI. Moreover, UCMSI does not alter 
Iba1 immunoreactivity in either the DG of the hippocampus or the PFC, further 
supporting the notion that UCMSI does not alter immune system functioning. 
However, although these findings contradict our hypotheses, this is not the first time 
that microglia are shown to be unaltered in the context of UCMS in adult male mice 
(Kaster et al. 2015). 
 
In addition to the finding that UCMSI does not alter immune system functioning, my 
data also show no change in corticosterone twelve weeks after exposure. Again 
however, while this finding is not in line with our hypothesis that UCMSI will increase 
corticosterone (e.g., Deng et al. 2015; Filho et al. 2015; Liu et al. 2015; Wu et al. 
2016), it is not the first time that this has been reported in the context of UCMS in 
mice (Moretti et al. 2012). Interestingly, while UCMSI does not alter ‘baseline’ 
corticosterone levels, that is, in the absence of acute stress, it does significantly alter 
the way that animals respond to novel acute stress, by significantly reducing stress 
responsivity. Interestingly, the reasons for this are not immediately clear given that, 
to my knowledge, the only other study to report this finding was in the context 
corticosterone treatment in female rats (Kott et al. 2016). However, one potential 
explanation to account for this finding could be that UCMSI changes the way that 
these animals perceive stress, which then alters their physiological response. Since 
UCMSI animals have been exposed to a wide variety of stressors over a twelve-
week period, it is perhaps understandable that this could alter what they perceive to 
be stressful. It is therefore possible that UCMSI may have increased their stress 
threshold, such that more potent stressors may be required to elicit the same 
response as in stress naïve animals. 
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4.3.2.2.2.  UCMSI increases GFAP expression, increases s100β  cell density, 
and decreases adult hippocampal neurogenesis 
 
While the UCMSI-induced behavioural disturbances may not be related to alterations 
in the immune system and/or HPA axis, they may indeed be associated with the 
observed changes in astrocyte biology and hippocampal neurogenesis. Although this 
is not the first study to investigate the impact of UCMS on neurogenesis and 
astrocyte biology (Cuccurazzu et al. 2013; Wang et al. 2014; Mizuki et al. 2014), it is 
the first to clearly demonstrate that UCMSI promotes a significant alteration to both 
astrocytes and neurogenesis in the DG of the hippocampus. Specifically, my data 
show that UCMSI increases GFAP immunoreactivity and s100β cell density, and 
decreases neurogenesis in both the dorsal and ventral DG. While GFAP data does 
not support our hypothesis that chronic stress decreases GFAP immunoreactivity 
(Czeh et al. 2005; Banasr & Duman, 2008; Gosselin et al. 2009; Ye et al. 2011; Liu et 
al. 2009; 2011; Sun et al. 2012; Li et al. 2013; Tynan et al. 2013), the finding that 
UCMSI increases s100β cell density, and decreases Ki67 and DCX cell density is 
consistent with our hypotheses (Ye et al. 2011; Nollet et al. 2012; Elysad et al. 2012; 
Mutlu et al. 2012; Tanti et al. 2012; Lu et al. 2014; Mizuki et al. 2014). Moreover, it is 
also noteworthy that although our finding pertaining to GFAP is not in line with 
previous research, it is not the first time that UCMS has been shown to increase 
GFAP immunoreactivity (Kaster et al. 2015). Indeed, this inconsistency in GFAP 
likely stems from the differences in stress exposure and duration, given that previous 
work tends to be in the context of chronic restraint stress, typically two-three weeks 
in duration.  
 
4.3.2.2.2.1.   Interpretation of the changes in astrocyte biology 
 
Interestingly, in this study, UCMSI promotes a specific upregulation in GFAP, as 
there is no concomitant increase in GFAP cell density. A finding in line with several 
previous studies, which all support that chronic stress specifically alters GFAP 
expression (Gosselin et al. 2009; Liu et al. 2009; Araya-Callis et al. 2012; Tynan et 
al. 2013; Kaster et al. 2015). The functional implication of this however, is uncertain, 
but could suggest that UCMSI activates astrocytes, since under pathological 
conditions astrocytes are known to increase their expression of GFAP (Laping et al. 
1994; Mongin et al. 2005). Moreover, UCMSI also promotes an increase in s100β, 
which further supports the notion of an increase in astrocyte activation/distress, given 
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that astrocytes are known to release this protein in response to trauma (Hu & Van 
Eldik, 1996). However, it is notable that there is no evidence to support that UCMSI 
promotes an inflammatory response in either the periphery, or with respect to 
microglial activation in the DG or PFC, which potentially contests this point (see 
3.2.2.1 and 3.2.3.1).  
 
While it is indeed possible that the increase in GFAP expression may represent an 
increase in astrocyte activation, it could alternatively reflect an important 
structural/morphological change, since GFAP is the core component of cytoskeletal 
intermediate filaments typically found in astrocyte main processes. Furthermore, it 
may also represent important functional changes, given that GFAP is important for 
the maintenance of the mechanical strength and shape of astrocytes, astrocyte cell 
movement facilitation, and cell-to-cell communication (see 1.2.3.2.1). Interestingly, it 
seems then appropriate that if GFAP represents an astrocyte functional change, one 
of which may be cell communication, it is unsurprising that there is an increase in 
s100β, which is a protein strongly associated with astrocyte communication 
(Morquette et al. 2015). Moreover, it is notable that astrocytes actively regulate 
glutamate metabolism, and glutamatergic input plays a key role in the differentiation 
and survival of newborn neurons (Tashiro et al. 2006). Given that my data show 
impairment in neurogenesis, it is an intriguing possibility that UCMSI may be altering 
the differentiation and survival of newborn neurons by altering glia interactions at the 
level of the synapse.  
 
While it seems likely that alterations in GFAP expression and s100β cell density are 
synergistically related, it is possible that S100β cell density could also have an 
independent effect on some of the other observed behavioural and biological 
changes. For instance, an increase in S100β could support an increase in cell death, 
since at high concentrations S100β promotes glial and neuronal death (Hu & Van 
Eldkik, 1996; Huttunen et al. 2000; Bianchi et al. 2010), which then interestingly, 
could potentially account for the observed reduction in hippocampal neurogenesis. 
Furthermore, given that GFAP positive cells were not further characterised, due to 
time constraints, it is unknown what proportion of GFAP truly represent astrocytes, 
and therefore it is entirely plausible that the changes in GFAP expression and s100β 
may exert independent effects, especially if GFAP, as in Experiment 1 (see 
3.1.3.2.2), is a reflection of radial glia.  
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Another interesting finding from this study is that the changes in GFAP are regionally 
specific, as UCMSI does not alter GFAP in the PFC, a finding at odds with previous 
research (Gosselin et al. 2009; Tynan et al. 2013). However, as already discussed 
(see 4.2.2.2.2.4) this inconsistency could be a reflection of methodological 
differences, particular with reference to the type and duration of exposure. Given that 
the duration of UCMSI was twelve weeks, when in previous research stress 
exposure is typically around six weeks, it remains possible that any alterations in 
astrocyte biology in the PFC may have been missed, assuming that, if there are any, 
they occur earlier on. Therefore, it seems essential for future work to collect tissue 
throughout stress exposure at regular intervals (see 4.4.2). However, it is noteworthy 
that UCMSI may simply not affect GFAP in the PFC, as this is not the first time that 
this null finding has been reported in a UCMS model of depression (Wang et al. 
2014). More research addressing whether UCMS has regional specificity on GFAP 
expression would help clarify this controversy.  
 
4.3.2.2.2.2.         Interpretation of the changes in adult hippocampal neurogenesis 
 
Consistent with what is commonly reported within the literature, UCMSI decreases 
hippocampal neurogenesis, and this effect is governed by a reduction in overall cell 
proliferation. However, whether the reduction in Ki67, and thus DCX, is a 
consequence of impaired cell proliferation, and/or a consequence of increased cell 
death remains to be elucidated. Therefore, as aforementioned, it would be 
advantageous for future work to incorporate a measure of apoptosis.  
 
Interestingly, UCMSI does not preferentially effect DCX cell differentiation, as there is 
a consistent reduction across all DCX cell morphologies in both the dorsal and 
ventral DG. This suggests that the impact of UCMSI on neurogenesis occurs mainly 
during the first critical period of newborn neuron survival during the first four days 
after birth (Sierra et al. 2010), given that all cell morphologies are equally affected.  
However, there is some evidence to support that neuroblast survival during the 
second critical window, that is, 1-3 weeks post birth (Sierra et al. 2010), may be 
affected in the dorsal DG. Specifically, my compositional data show a decrease in the 
proportion of mature neuroblasts, but only in the dorsal DG, suggesting that these 
cells in particular may be undergoing apoptosis. Alternatively, this data could suggest 
impairment in the maturation of DCX cells in the dorsal DG of UCMSI animals, such 
that cells mature at an attenuated rate. Evidence to support this comes from the 
finding that the composition of DCX consists of not only a reduced proportion of 
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mature neuroblasts, but also a significantly increased proportion of proliferative stage 
neuroblasts. While understanding what may be contributing to this process is yet to 
be elucidated, one could speculate that altered astrocyte functioning may be 
involved. For example, astrocytes play an important role in encouraging 
differentiation by promoting Wnt signalling, and upregulating the expression of 
NeuroD1, an important transcription factor involved in neuronal differentiation (Lie et 
al. 2005; Kuwabara et al. 2009). Therefore, it remains possible that impairment in this 
signalling process, could potentially contribute to the attenuated differentiation of 
DCX cells.  
 
4.3.2.2.2.3.  What could be driving the changes to astrocytes and neurogenesis 
in UCMSI animals? 
 
It is not immediately clear what may be contributing to the observed increases in 
GFAP expression and s100β, given that UCMSI does not appear to alter immune 
system functioning, dysregulate the HPA axis, or activate microglia in the DG (see 
4.3.2.2.1). However, it does seem probable that the alterations in astrocyte biology 
may be contributing to the observed impairments in hippocampal neurogenesis, as 
already described throughout sections 4.3.2.2.2.1 and 4.3.2.2.2.2. Moreover, it is 
intriguing that UCMSI also reduces peripheral levels of VEGF, which is known to 
stimulate neurogenesis (Jin et al. 2002; Sun et al. 2003; Fabel et al. 2003; Cao et al. 
2004; Han et al. 2017), and is growth factor released by astrocytes (Mu et al. 2010; 
Waterhouse et al. 2012; Fournier & Duman 2012). Interestingly, this is not the first 
study to show that UCMS reduces VEGF (Hutton et al. 2015), but it is the first to 
show a concomitant decrease in both VEGF and neurogenesis. Furthermore, as 
aforementioned, an increase in S100β could support an increase in neuronal cell 
death, since high concentrations are known to promote this process. Therefore, 
given the evidence, this study supports that UCMSI reduces hippocampal 
neurogenesis possibly through impaired astrocyte functioning, and that together this 
is associated with the observed increase in depressive-like behaviour. Indeed, as 
outlined in the Introduction several preclinical and clinical studies support an 
association between astrocyte impairment, and/or hippocampal neurogenesis and 
depression (see subsections 1.2.3.2.3 and 1.2.4.5.1).  
 
However, while there is some evidence to speculate what may be contributing to 
reduced neurogenesis, it is less obvious what may be accountable for the changes in 
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GFAP and S100β. Glucocorticoid and noradrenergic signalling are the two most well 
understood pathways through which stress can affect astrocyte structure and 
function (see subsection 1.2.2.4). There is a very limited amount of evidence to 
support altered glucocorticoid signaling in my study, it would be profitable for future 
work to determine whether these UCMSI-induced changes in astrocyte biology are a 
likely consequence of altered noradrenergic signalling.  
 
4.4.  Strengths and methodological considerations 
 
To my knowledge, this is the first time that it has been demonstrated that different 
types of chronic stress can induce both contradistinctive phenotypes in adult male 
mice, which span across behaviour, the periphery and into the brain. Moreover, this 
is also the first time that UCMS has been modified to develop an even more 
translatable model of depression, which incorporates social withdrawal, an outcome 
often accompanying or following exposure to stressful life events, and show that this 
model sufficiently promotes depressive-like behaviour and alterations to both 
astrocytes and neurogenesis. The strength of both these studies lie in the 
behavioural and biological characterisation of the various stress paradigms, that is, 
chronic injection, social isolation, injection and isolation, and UCMSI, which involves 
(i) using a wide range of behavioural assays, while controlling for the effect of food 
consumption, weight change, olfactory ability, locomotor activity, and social 
dominance on behavioural performance, and (ii) incorporates the assessment of 
corticosterone, vascular endothelial growth factor, a variety of pro-and anti-
inflammatory cytokines, microglial and astrocyte biology, and adult hippocampal 
neurogenesis.  Furthermore, it is also the first time that the impact of acute stress on 
immune profiles in already chronically stressed mice has been examined to gain a 
more comprehensive overview of stress responsivity. Therefore, the work in this 
thesis significantly extends on our current knowledge of the impact of chronic stress 
on anxiety- and depressive-like behaviour and it’s associated biological basis, and 
not only highlights that the type of stress exposure does indeed matter, but also 
provides a potentially new model of depression in the form of UCMSI.  Although 
there are numerous strengths to these studies, there are some caveats that need to 





4.4.1.   Wider caveats beyond the details of each study 
 
4.4.1.1.   Issues of translation 
 
No animal model of depression, to date, satisfies all concepts of validity, given two 
main difficulties. First, the neurobiological aetiology of depression has not yet been 
fully elucidated and hence cannot be fully replicated in animal models. Moreover, 
depression does not currently map onto objectively ascertainable molecular, 
synaptic, cellular or neural circuitry abnormalities. Indeed, no single neurochemical or 
neuroendocrine abnormality, sufficiently robust or consistent enough, exists to either 
provide diagnostic criteria, or validate an animal model. Second, clinical depression 
is diagnosed on the basis of a cluster of highly variable symptoms (see 1.1.1), the 
core features of which are uniquely human. As such, only a subset of symptoms can 
be measured objectively in rodents, and even when reasonable behavioural 
correlates in animals exist, for example, abnormal social interaction or grooming 
behaviour, the correspondence to human symptoms may not be straightforward, or 
may fall subject to anthropomorphism. Moreover, since the clinical features of 
depression may vary significantly from one patient to another, it is not directly clear 
which behavioural profile should be reproduced and validated in an animal model 
(Nestler & Hyman, 2010). Therefore, given the heterogeneous nature of depression, 
both in terms of symptom manifestation and neurobiological underpinnings, and 
given that apparent differences between rodents and humans exist in behaviour and 
physiology, no established animal model of depression will be completely 
translatable, which is a consideration to take when interpreting the findings from the 
work in this thesis.  
 
However, despite these considerations, it has become widely accepted that models 
of depression are not expected to fully mirror clinical depression, as currently defined 
in DSM-5, but rather would be required to simulate endophenotypes, or a subset of 
symptoms analogous to clinical depression, which indeed the models used in the 
context of this thesis have been successful in achieving. Moreover, while the 
pathogenesis of depression is not yet fully understood, both paradigms in this thesis 
show high construct validity, given that all of the associated biological underpinnings 
observed in each study have been associated with clinical depression, on the basis 
of what is currently known about the disorder. Therefore, while there are several 
challenges in translating the findings of any animal work, the studies conducted in 
this thesis were designed to use realistic input conditions and output measures to 
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ensure the legitimacy of the underlying pathology, and make the findings of this 
thesis as translatable as they can possibly be.   
 
4.4.1.2.  How valid are the behavioural assays used in this thesis? 
 
As aforementioned, while the work in this thesis used the most suitable output 
measures, it is important to acknowledge that not all the behavioural assays used in 
the context of this work are necessarily appropriately valid. For example, the FST is 
an assay with particularly poor ethological relevance. Moreover, the interpretation of 
immobility in this assay has received much criticism, with many rejecting the idea that 
immobility represents behavioural despair. Indeed, it has been suggested that 
immobility may represent energy conservation, and thus, may actually be a more 
efficient coping strategy (West, 1990), and others have pointed out that the 
interpretation of immobility as behavioural despair is highly anthropomorphic 
(Holmes, 2003). Therefore, the FST has superficial face validity, and low construct 
validity, and as such this represents a limitation to using this particular assay to 
characterise depressive-like behaviour. Furthermore, although the OFT confers 
better ethological relevance and face validity, as animals do indeed avoid open 
spaces, and may often be confronted with the conflict between avoidance and 
exploration, it is unknown how much of this anxiety stems from, or is an artifact of, 
fear. Therefore, the face and construct validity of this particular tasks may be also be 
potentially limited.  
 
However, although there may be some limitations to the FST and OFT, such that the 
interpretation of the readouts should be done with caution, the other behavioural 
assays (i.e., SPT and NSFT) are considered to be appropriately valid, given their 
ethological relevance, and their useful predictive, face and construct validity. For 
example, regarding the SPT, comparable tests have been performed in patients with 
MDD with similar results (Wichers et al. 2009), while treatment response in the NSFT 
has been associated with changes in adult hippocampal neurogenesis (Santarelli et 
al. 2003), both of which demonstrate the useful validity of these paradigms. 
Moreover, the SPT and NSFT only show response to antidepressant treatment after 
stress exposure, and in response to chronic, not acute treatment, further reinforcing 
their appropriateness in the context of depression (reviewed in Powell et al. 2012).  
Furthermore, it is noteworthy that in the context of this thesis, the characterisation of 
behavioural phenotypes was based on the collective readouts of all assays, not just 
one. Therefore, the questionable validity of one or two assays does not alter the 
 330 
interpretation and/or conclusions of the behavioural phenotypes associated with the 
stress paradigms used in this thesis.  
 
4.4.1.3.   Issues of generalisability  
 
Although the work in this thesis was designed to ensure maximum validity, by using 
an appropriate input and mostly valid output measures, it is unknown how 
generalisable the findings of this work are to those of wider animal research. This 
stems primarily from the fact that several aspects relating to the animal itself can 
have important implications in preclinical research, and specifically within the context 
of depression.  For example, the animal species, and/or animal strain can impact 
both the behavioural and neurobiological phenotypes associated with stress 
exposure. Indeed, several studies have shown how strain, sub-strain and genetic 
background can alter behavioural outcomes, such as sucrose preference, and can 
even determine whether an animal is more or less sensitive to stress exposure (e.g., 
Pothion et al., 2004; Ducottet & Belzung, 2004; Surget & Belzung, 2009; reviewed in 
van der Staay et al. 2009).  Indeed, it is pertinent to indicate that BALB/c mice are 
known to be highly stress-reactive (Priebe et al. 2005), therefore the impact of the 
stress paradigms used in this thesis may not necessarily promote the same 
behavioral and biological outcomes in a different strain of mouse and/or rodent 
species. Additionally, age and sex are also important factors, with several studies 
reporting both age and sex differences (e.g., Stone & Quartermain, 1997; Huynh et 
al. 2011; Kubera et al. 2013; Ver Hoeve et al. 2013; Pisu et al. 2016; Shoji et al. 
2016). Moreover, it is noteworthy that in the context of this work, adult male animals 
were used, but given that the prevalence of depression is significantly higher in 
women, and in adolescence and old age (Cyranowksi et al. 2000; Ford & Erlinger, 
2004; Kessler et al. 2010), again the generalisability of these findings is uncertain. 
However, given that adult males are less susceptible to clinical depression, one 
could speculate that in the context of this work, female BALB/c mice would be 
equally, if not more, sensitive to the impact of the different types of stress and/or 
UCMSI.  
 
4.4.2.  Specific caveats that apply to the details of each study 
 
In addition to the wider caveats, inherent in all animal research, there are some 
specific limitations to the particular work carried out within each study of this thesis.  
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First, it is important to acknowledge that the impact of psychosocial stress was not 
conducted alongside the other two stress exposures, but at a separate time point in 
Experiment 1. In order to statistically compare the three stress treatments, and to 
allow for an easier to follow presentation of the data, the control groups from these 
two experiments were statistically combined into one control group.  However, while 
the design of this study is indeed not optimal, statistically combining the control 
groups does not alter the overall interpretation of the data for two main reasons. 
First, while there is inherent variability within the two control groups, there was very 
little difference between the control groups (see Appendix 2.3.1). Second, analyses 
were run both separately for the two experiments, and with the combined control 
group, and outcomes relative to control were not altered for any of the stress-
exposed groups. Therefore, given that the findings are the same whether the effect 
of psychosocial stress is analysed separately, or together with the other stress 
groups using a combined control, it seems appropriate to have analysed and 
presented the data in this manner. However, future work should simultaneously 
investigate the impact of these three stress paradigms in a single study.  
 
The loss of four animals from the physically stressed group (see 2.6.1) could have 
reduced statistical power for this particular group, which may then account for null 
findings pertaining to corticosterone and neurogenesis in Experiment 1. As such, the 
lack of statistical power for some of the analyses could alter the interpretation of the 
data pertaining to this group in particular.  
 
Given the duration of each study, that ranged from nine to twelve weeks, it remains 
unknown whether the observed biological changes are direct consequences of 
chronic stress exposure, indirect changes from other biological system alterations, or 
simply adaptive compensatory changes. Moreover, by characterising biological 
phenotypes at the end of treatment, based on a single snapshot, we simply cannot 
be sure of the temporal sequence of these changes, and more importantly, may have 
missed biological changes that may have preceded the ones observed in the context 
of each experiment. Together this makes it difficult to truly understand the magnitude 
and implications of the observed biological phenotypes, and how these may 
ultimately relate to the observed behavioural phenotypes. It remains entirely 
plausible that earlier biological changes, not captured at the end of treatment, may 
be responsible for the behavioural perturbations.  
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The blood samples collected, again, represent a single biological snapshot of HPA 
axis, and immune system, functioning. Given that each system fluctuates throughout 
the day, a single measure is unlikely to be truly reflective of overall system 
functioning. Moreover, it is uncertain how chronic stress may have directly impacted 
corticosterone and inflammatory levels, since a true baseline measure, one before 
the commencement of treatment, was not obtained. However, in the context of this 
work, I was unable to collect both a baseline sample, and measure stress 
responsivity, which required two sample acquisitions, due to ethical limitations, 
whereby a limited number of tails cuts per mouse were permitted. Furthermore, with 
respect to corticosterone, it is notable that sample collection in the morning may have 
important implications on the data collected, given that in rodents corticosterone 
levels are at their lowest at this time (Montano et al. 1991; Gong et al. 2015).  
 
It is unknown whether the observed biological phenotypes were influenced by the 
stress of behavioural testing in both studies. It is possible that the three weeks of 
behavioural testing may have contaminated or influenced biological phenotypes, and 
thus it would be important for future work to control for this by running parallel 
groups, where samples from animals not undergoing behavioural testing are 
collected.  
 
Due to time constraints it was not possible to measure Iba1 cell density and 
morphology in all DG and PFC regions for all animals. Therefore, it remains possible 
the Iba1 cell density and/or morphology may have been altered in animals and brain 
regions where no significant differences in Iba1 immunoreactivity were found. 
However, this is unlikely because when the morphology and cell density data for 
control animals, which was collected in both regions of the DG is compared with 
stressed animals, no differences in either parameter were found in regions were no 
significant difference in immunoreactivity data was found.  
 
There are also inherent caveats with some of the protein markers used to quantify 
microglia and astrocytes. For example, Iba1 does not solely mark microglia, but also 
macrophages (Imai et al. 1996), s100β is not solely synonymous with astrocytes, but 
is also expressed in certain neuronal populations, Schwann cells, melanocytes, 
chondrocytes, adipocytes, skeletal myofibers, and certain dendritic cell and 
lymphocyte populations (Donato et al. 2009; 2013), while GFAP is also expressed by 
radial glia (Choi & Lapman, 1978; Choi, 1986). Moreover, GFAP was not a 
particularly useful astrocyte marker in the context of this work, particularly in 
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Experiment 1, given that only 10% of GFAP positive cells were astrocytes. 
Furthermore, since GFAP positive cells were not characterised in Experiment 2, it is 
unknown whether GFAP represents astrocytes or radial glia, and therefore whether 
UCMSI impacts astrocytes specifically.  Moreover, given that GFAP was not 
representative of astrocytes in Experiment 1, it would have been more appropriate to 
stain the tissue from all groups for s100β in both the DG and PFC, rather than for just 
psychosocially stressed mice in the DG. However, given that I had to adopt a 
targeted approach, due to time constraints, and did not envision that GFAP would 
mostly represent radial glia, it is unlikely that this outcome could have been avoided. 
Nonetheless it remains unknown whether the other two types of stress, that is, 
physical and combined exposure, would differentially alter s100β, or indeed, if GFAP 
would represent the same proportion of radial glia under these other stress 
conditions.  
 
With respect to cell proliferation, Ki67 may not have been the most appropriate 
marker given that it is has weak expression in proliferating cells in all phases of 
mitosis. Moreover, because it is predominantly a M-phase mitotic marker, relatively 
few cells are labelled for Ki67 because cells spend very little time in the M-phase 
relative to the other phases of the cell cycle. Furthermore, due to these caveats Ki67 
cell density in both the dorsal and ventral DG could not be quantified due to issues of 
reliability. Given that region specific differences across the hippocampus were found 
relative to Iba1 and DCX, this represents another limitation.  
 
Finally, a limitation to the hippocampal neurogenesis analyses conducted in this 
thesis is the absence of any data on the long-term survival of adult-born neurons. 
While, there is evidence to show that chronic stress alters neurogenesis in the 
context of this work, this impairment relates to a specific phase of neurogenesis, 
confined to the earlier phases of the process. Therefore, it is unknown whether the 
type of chronic stress, or whether UCMSI, impacts the long-term survival of adult-
born neurons. Intuitively, based on the evidence it seems likely, however the 
absence of any assessment on the adult-born neuron population by BrdU/NeuN 






4.5.  Directions for future research  
 
Based on the work of this PhD thesis, I propose several areas that would be 
profitable for future research. First and foremost, the work herein needs to be 
replicated, and the findings confirmed across various strains, species and sexes. For 
example, it would be pertinent to determine whether the findings of this work would 
apply to different mouse strains (e.g., C57Bl/6 mice), to a different rodent species 
(e.g., rats), and importantly, whether the findings are applicable to female rodents. 
Moreover, given that so few studies have examined the impact of chronic injection 
and/or social isolation on animal behaviour and biology, it is essential that future 
work continues to do so, especially given the practical implications (see section 4.6). 
 
In addition to replicating the findings of this thesis, future work ultimately needs to 
address the identified limitations, which would require several additional lines of 
inquiry. For example, it is crucial for future studies to collect behavioural readouts, 
blood samples, and tissue from parallel groups throughout the protocol to determine 
the temporal sequence of the observed changes associated with chronic stress 
exposure. Moreover, to confirm HPA axis dysregulation, it would be highly 
advantageous to conduct the dexamethasone suppression test, attain measures of 
ACTH, and quantify CRH, GR and MR expression in the brain. Furthermore, 
assessment of Iba1 biology should first be conducted in both the dorsal and ventral 
DG for all groups, and then be extended to other regions of the hippocampus, such 
as the CA1 and CA3, and indeed, to other stress sensitive regions such as the 
amygdala (Tynan et al. 2010), and a more comprehensive investigation into 
astrocyte biology should be undertaken, one that incorporates morphological 
analyses using Sholl (e.g., Tynan et al. 2013), and one that assesses astrocyte 
functioning. Lastly, a more comprehensive look at how the different stress treatments 
impact hippocampal neurogenesis is needed, by focusing on newborn neuron cell 
survival (co-labelling BrdU and NeuN), and the concomitant assessment of 
apoptosis, together with cell proliferation and differentiation.  
 
Finally, not only should future research replicate and address the limitations of the 
work presented in this PhD thesis, but it should also try to extend upon the findings. 
Perhaps the most logical first step would be to identify and examine the molecular 
mechanisms by which the different types of stress promote anxiety- and depressive-
like phenotypes.  One way to study these neurobiological mechanisms in their full 
complexity would be to utilise a hypothesis-free explorative approach of the genome-
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wide transcriptome changes in selected tissues and/or brain regions (Gao et al. 
2015; Xu et al. 2015; Hepgul et al. 2016).  Moreover, in addition to elucidating some 
of the molecular mechanisms, it would be highly profitable to investigate the capacity 
of antidepressants to attenuate/reverse the observed biological alterations, and the 
corresponding changes to the animal’s behaviour in the context of both studies. This 
would not only extend on the findings of this thesis, but would also measure the 
predictive validity of each of the stress models.  
 
4.6.  Preclinical and clinical implications 
 
The findings of this PhD thesis have significant practical implications and some 
important clinical ones. First, my findings demonstrate that chronic injection, and/or 
social isolation promotes aberrant behavioural and physiological responses, which is 
highly relevant for any animal research involving repeated injection and/or using an 
experimental design that incorporates individually housed animals. Given that a 
plethora of studies may proceed by either individually housing control animals due to 
logistical ease, and/or inject animals with saline as a control measure in drug testing 
studies, it is crucial that researchers thoroughly test the effects of these conditions 
before interpreting the findings, as they may simply not be appropriate control 
conditions.  
 
Second, in addition to the effects of these findings on animal preclinical practice, the 
finding that the type of chronic stress can differentially alter behavioural and 
biological phenotypes in animals may have important clinical implications. It seems 
obvious that the type of stress exposure may matter clinically, and indeed, this idea 
is not entirely novel in a clinical setting, with some research already showing that the 
type of maltreatment can differentially alter depression (Fergusson et al. 2008; 
Infurna et al. 2016). Therefore, it seems appropriate that the type of stress exposure 
could differentially alter depressive symptomology and/or its biological basis, and as 
such this research questions warrants being investigated in a clinical setting, which 
surprisingly, to my knowledge, is yet to be done. Being able to more precisely identify 
the impact of different types of stress on depression aetiology could help to identify 
vulnerable individuals, help practitioners and individuals to monitor and report stress 
exposure, and ultimately may aid in the discovery of novel therapeutic treatments by 
determining important stress associated risk factors.  
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Finally, using a more translatable model of depression, such as UCMSI, will 
ultimately help to identify more relevant biological pathways and/or therapeutic 
treatments. Moreover, UCMSI allows future research to focus on adult hippocampal 
neurogenesis and astrocyte biology specifically in the context of depression, given 
that these are the main biological changes observed. Therefore, as aforementioned, 
it offers the unique potential to further understand the role that astrocytes play in the 
pathogenesis of depression, which is a relatively new field of interest.  
 
4.7.  Conclusions 
 
In essence, several novel findings emanate from the data of this PhD thesis. First, 
this work highlights how the type of chronic stress exposure can differentially alter 
behavioural and biological responses in adult male mice. For instance, physical 
stress exposure, that is, chronic injection, promotes an anxiety-like phenotype, 
reduces systemic inflammation, increases corticosterone reactivity, increases 
microglial activation, and reduces hippocampal neurogenesis. In contrast, 
psychosocial stress, that is, social isolation, elicits a depressive-like phenotype, 
increases systemic inflammation, reduces corticosterone reactivity, induces 
microglial hyper-ramification, increases the number of radial glial cells and mature 
astrocytes, and increases the number of mature neuroblasts in the hippocampus. 
Meanwhile, the combined effect of physical and psychosocial stress induces an 
anxiety-like phenotype, decreases systemic inflammation and hippocampal 
neurogenesis, but does not alter HPA axis functioning, microglia, or astrocyte, 
biology. Overall, these findings demonstrate that the type of chronic stress exposure 
does indeed matter.  
 
Second, this thesis puts forward an alternative, yet appropriate model of depression, 
based on a modified version of UCMS. My findings demonstrate that UCMSI is not 
only a robust model of depression, one that successfully promotes depressive-like 
behaviour, alters astrocyte biology, and reduces hippocampal neurogenesis, but is 
also a more chronic and translatable model, which incorporates a period of social 
withdrawal commonly seen in clinical settings. Moreover, the model more 
appropriately mimics the clinical trajectory of depression, where patients do not 
immediately present with symptoms after stress exposure, and as such represents a 
more suitable model for some depression related research, particularly with respect 
to subtypes of depression where HPA axis activity and/or immune system 
dysfunction is not the biological basis.    
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In summation, our understanding of the impact of chronic stress in depression 
research has evolved considerably over the past century, yet despite substantial 
advances there still remains much to learn. The outcomes of this current PhD thesis 
provide some novel insight into the changes that occur behaviourally, in the 
periphery, and within the brain following exposure to chronic stress, and how the type 
of stress can make a difference in terms of these changes. The work presented 
contributes to our understanding of the impact of chronic stress on neurogenesis, 
immune system, and HPA axis, functioning, and its association with depressive-like 
behaviour, and not only highlights the importance of considering the nature of stress 
in future research, but also puts forward a more chronic and translatable animal 























A.2.1. Standard curves for ELISA and Luminex  
 
Figures A1-11 show the standard curves pertaining to Plate 1 of Experiment 1 of 
each assay. These standard curves were generally representative for all plates 
across both experiments. Each standard curve (and associated concentrations) was 
derived from either a four-parameter logistic algorithm (denoted as 4PL in the graph) 
or from a five-parameter logistic algorithm (denoted as 5PL in the graph). 
 
A.2.2.  Histological assessment  
 
A.2.2.1.  Recipe for 4% paraformaldehyde (PFA) in phosphate buffered 
saline (PBS)  
 
A. Combine the following to make PBS (1X pH 7.4):  
 
2x PBS tablets  
1L dH2O 
 
B. Combine the following to make 4% PFA in PBS (1X pH 7.4): 
 
800ml PBS heated to 60°C 
40g PFA powder  
1N sodium hydroxide (NaOH) – to facilitate dissolution 
 
- Filter solution once cooled 
- Adjust the pH to 7.4 with 5M hydrochloric acid (HCl) and bring the final volume to 






Figure A.1. Representative standard curve from which corticosterone absorbance 





Figure A.2. Representative standard curve from which tumour necrosis factor (TNF)-α  




























































Figure A.3. Representative standard curve from which interleukin (IL)-1β  fluorescent 





Figure A.4. Representative standard curve from which interleukin (IL) 2 fluorescent 





























































Figure A.5. Representative standard curve from which interleukin (IL) 4 fluorescent 




Figure A.6. Representative standard curve from which interleukin (IL) 6 fluorescent 




























































Figure A.7. Representative standard curve from which interleukin (IL) 10 fluorescent 







Figure A.8. Representative standard curve from which interleukin (IL) 12 fluorescent 


























































Figure A.9. Representative standard curve from which C-reactive protein (CRP) 




Figure A.10. Representative standard curve from which insulin growth factor (IGF)-1 



























































Figure A.11. Representative standard curve from which vascular endothelial growth 










































A.2.2.2.  Recipe for anti-freeze storage buffer (1X TBS-AF pH 7.6) 
 
A. Combine the following to make Tris Buffered Saline/Triphosphate Buffer Saline 
(TBS) with 0.05% sodium azide: 
 
2.42g tris base 
8g sodium chloride (NaCl) 
800ml ultrapure H2O  
0.5g sodium azide (NaN3)  
 
- Adjust the pH to 7.6 with 5M HCl and bring the final volume to 1L with ultrapure 
H2O.   
 





-  Bring the final volume to 1L with TBS solution made in previous step.  
 
A.2.2.3.  Recipe for TBS (pH 7.6) 
 
A.2.2.3.1.  1L TBS (10X pH 7.6)  
 
Combine the following: 
 
60.6g tris base  
87.6g NaCl  
500ml ultrapure H20 
 
- Adjust the pH to 7.6 with approximately 75ml 5M HCl and bring the final volume to 
1L with ultrapure H2O.   
 
A.2.2.3.2.  1L TBS (1X pH 7.6) 
 
Dissolve 100ml 10X TBS into 900ml ultrapure H20 
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A.2.3.  Statistical analyses  
 
A.2.3.1.  Comparing the two control groups 
 
As highlighted in Tables A.1 to A.3, there were no statistical differences between the 
two control groups for any of the main behavioural and biological parameters. 
Therefore, statistically combining the two groups into one main group for all analyses 































Table A.1. Comparisons between the two control groups for all main behavioural 
readouts 
Variable  Control animals 1 
Mean (SE)/ Mean Rank 
Control animals 2 





OFT      
Centre duration (1) 126.9 (29.2) 91.4 (14.7) t [17] = 1.0 0.31 
Centre latency (2) MR: 10.2 MR: 8.6 z = 0.6 0.57 
Centre frequency (1) 36.6 (13.7) 18.7 (5.7) t [15] = 1.0 0.31 
NSFT     
Latency to feed (2) MR: 8.9 MR: 10.3 z = 0.5 0.63 
Arena food consumption (1) 0.14 (0.02) 0.14 (0.02) t [16] = 0.01 0.99 
Homecage consumption (1) 0.14 (0.02) 0.18 (0.02) t [16] = 1.5 0.17 
SPT     
Sucrose preference (1) 71.2 (1.4) 75.5 (2.3) t [16] = 1.6 0.13 
FST     
Immobility latency (2) MR: 8.5 MR: 10.8 z = 1.0 0.41 
Immobility frequency (1) 17.7 (1.6)  14.4 (0.8) t [15] = 1.8 0.09 
Immobility duration (1) 135.5 (8.5) 130.9 (14.1) t [16] = 0.3 0.77 
Swimming duration (1) 198.4 (21.0) 125.9 (7.2) t [14] = 2.9 0.01* 
Cookie test     
Latency to find cookie (2) MR: 11.3 MR: 7.3 z = 1.6 0.12 
 
Subjects: adult male BALB/c mice 
Sample sizes: Control animals 1 = 8; Control animals 2  = 8 
Analyses: (1) Independent samples t test; (2) Mann Whitney-U test; Bonferroni correction for multiple testing - threshold: p 
< .003 
Abbreviations: SE, standard error; MR; mean rank; OFT, open field test; NSFT, novelty suppressed feeding test; SPT; 
sucrose preference test; FST, forced swim test 



























Table A.2. Comparisons between the two control groups for all main biochemical 
readouts 
Variable  Control animals 1 
Mean (SE)/ Mean Rank 
Control animals 2 





Peripheral inflammation     
TNFα baseline 0.038 (0.003) 0.037 (0.002) t [16] = 0.3 0.79 
TNFα post stress 0.036 (0.004) 0.038 (0.002) t [16] = 0.4 0.71 
IL1β  baseline 1.41 (0.02) 1.47 (0.01) t [16] = 2.4 0.03 * 
IL1β  post stress 1.41(0.03) 1.48 (0.01) t [16] = 2.4 0.04 * 
IL2 baseline 0.035 (0.003) 0.032 (0.004) t [16] = 1.0 0.34 
IL2 post stress 0.035 (0.004) 0.035 (0.005) t [16] = 0.9 0.37 
IL4 baseline 0.30 (0.002) 0.30 (0.1) t [16] = 1.5 0.15 
IL4 post stress 0.35 (0.003) 0.30 (0.08) t [16] = 1.9 0.07 
IL6 baseline 0.19 (0.1) 0.18 (0.2) t [16] = 0.2 0.82 
IL6 post stress 0.19 (0.2) 0.18 (0.2) t [16] = 0.3 0.80 
IL10 baseline 0.18 (0.2) 0.19 (0.1) t [16] = 2.5 0.02 * 
IL10 post stress 0.18 (0.2) 0.19 (0.1) t [16] = 0.6 0.50 
IL12 baseline 0.19 (0.2) 0.15 (0.08) t [16] = 1.7 0.10 
IL12 post stress 0.24 (0.3) 0.25 (0.05) t [16] = 0.3 0.81 
Growth factors     
Plasma VEGF baseline 0.034 (0.002) 0.041 (0.004) t [16] = 1.4 0.18 
Plasma VEGF post stress 0.036 (0.002) 0.034 (0.0004) t [16] = 1.3 0.20 
Hormones     
Corticosterone baseline 30.6 (0.6) 38.5 (1.2) t [15] = 0.6 0.58 
Corticosterone post 
stress 
82.2 (11.2) 115.6 (6.0) t [15] = 2.4 0.05 * 
 
Subjects: adult male BALB/c mice 
Sample sizes: Control animals 1 = 8; Control animals 2  = 8 
Analyses: (1) Independent samples t test; Bonferroni correction for multiple testing - threshold: p < .0025 
Abbreviations: SE, standard error; TNF, tumour necrosis factor; IL, interleukin; VEGF, vascular endothelial growth factor; 
baseline, 24 hours prior to acute stress; post stress, 30 minutes after acute stress 























Table A.3. Comparisons between the two control groups for all main neuroinflammatory 
and neurogenesis readouts 
Variable  Control animals 1 
Mean (SE)/ Mean Rank 
Control animals 2 





Iba1     
Immunoreactivity in the 
DG 
11.8 (0.6) 12.1 (0.4) t [16] = 0.3 0.77 
Immunoreactivity in the 
PFC 
22.7 (1.4) 25.2 (0.8) t [16] = 1.5 0.15 
GFAP     
Immunoreactivity in the 
DG 
34.1 (1.3) 34.2 (1.3) t [16] = 0.1 0.95  
Immunoreactivity in the 
PFC 
9.1 (1.1) 9.1 (1.1) t [16] = 0.01 0.99 
Ki67     
Overall cell density in DG 3711.7 (489.4) 4146.3 (299.7) t [12] = 0.8 0.45 
DCX     
Overall cell density in DG 39634.2 (3211.4) 34461.6 (1638.3) t [15] = 1.2 0.24 
DCX cell density in DG: 
proliferative stage 
neuroblasts 
14236 (2171.7) 13652.8 (347.8) t [15] = 0.2 0.81 
DCX cell density in DG: 
intermediate stage 
neuroblasts 
11515.2 (1341.7) 12011.4 (190.4) t [15] = 0.3 0.77 
DCX cell density in DG: 
early post mitotic stage 
neuroblasts 
8618 (1309.9) 8773.3 (327.6) t [15] = 0.9 0.93 
DCX cell density in DG: 
last post mitotic stage 
neuroblasts 
3508.2 (538.9) 3190.8 (472.1) t [15] = 0.4 0.69 
 
Subjects: adult male BALB/c mice 
Sample sizes: Control animals 1 = 8; Control animals 2  = 8 
Analyses: (1) Independent samples t test; Bonferroni correction for multiple testing - threshold: p < .005 
Abbreviations: SE, standard error; Iba1, ionized calcium binding adaptor molecule 1; GFAP, glial fibrillary acidic protein; 




















PART A: Effect(s) of physical, psychosocial, and both physical and 
psychosocial, stress on behaviour, inflammation and adult hippocampal 
neurogenesis 
 
A.3.1.  Effect(s) of physical, psychosocial, and both physical and 
psychosocial, stress on adult hippocampal neurogenesis  
 
A.3.1.1.  DCX compositional data 
 
A.3.1.1.1.  Within group DCX compositional analyses in the dentate gyrus 
 
All animals, irrespective of stress exposure, had a significantly greater proportion of 
“less mature” neuroblasts, that is, proliferative and intermediate neuroblasts, 
compared with more mature neuroblast cell types in the dorsal and ventral DG as 
shown in Figure A.12 (Factorial three way ANOVA: Effect of exposure (a): F [3,144] 
= 26.9, p < .001; Effect of region (b): F [1,144] = 2.2, p = .14; Effect of cell type (c): F 
[3,144] = 20.3, p < .001; Interactions: (a*b); F [3,144] = 1.1, p = .36; (a*c); F [9,144] = 
2.2, p = .02; (b*c); F [3,144] = 1.5, p = .22; (a*b*c); F [9,144] = 0.8, p = .59).  Control 
animals and socially isolated mice had a significantly greater proportion of 
proliferative stage neuroblasts compared with all other neuroblast cell types in the 
dorsal DG (Post hoc analyses: controls: relative to intermediate: t [91] = 3.4, p = 
.005; relative to early post mitotic: t [91] = 4.8, p < .001; relative to late post mitotic: t 
[91] = 5.4, p < .001; isolated: relative to intermediate: t [91] = 3.1, p = .02; relative to 
early post mitotic: t [91] = 4.8, p < .001; relative to late post mitotic: t [91] = 3.6, p = 
.003). Meanwhile, mice exposed to repeated injection had a significantly greater 
proportion of proliferative and intermediate stage neuroblasts compared with both 
early and late, post mitotic stage neuroblasts in the dorsal DG (Post hoc analyses: 
proliferative: relative to early post mitotic: t [91] = 2.7, p = .049; relative to late post 
mitotic: t [91] = 3.6, p = .003; intermediate: relative to early post mitotic: t [91] = 4.2, 
p < .001; relative to late post mitotic: t [91] = 5.1, p < .001). Similarly, mice exposed 
to combined stress also had a significantly greater proportion of proliferative stage 
neuroblasts compared with both early, and late, post mitotic stage neuroblasts (Post 
hoc analyses: relative to early post mitotic: t [91] = 2.9, p = .02; relative to late post 








































Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = Dorsal DG, 4; Ventral DG, 4. (2) Animals per group: Group 1: n=18; Group 2: 
n=6; Group 3: n=9; Group 4: n=9. Group 2 exclusions due to technical issue with housing conditions. Animals were 
excluded from all histological analyses.  
Analysis: Factorial three-way ANOVA; Bonferroni post hoc analyses.  
Adjusted p values: * p < .05; ** p < .01; *** p < .001 







DCX positive cell morphology 










































Stress level 2 




























Compostional breakdown of DCX positive cells in the 





















Figure A.12. Effect of repeated injection, social isolation, and combined stress on 
neuroblast composition in the dentate gyrus of the hippocampus 
Dorsal: Controls: Control animals (Group 1) had a significantly greater proportion of 
proliferative stage neuroblasts compared with all other neuroblast cell types. Repeated 
injection: Animals exposed to repeated injection (Group 2) had a significantly greater 
proportion of proliferative and intermediate stage neuroblasts compared with both early and 
late, post mitotic stage neuroblasts.. Social isolation: Socially isolated mice (Group 3) had a 
significantly greater proportion of proliferative stage neuroblasts compared with all other 
neuroblast cell types. Combined stress: Animals exposed to combined stress (Group 4) had 
a significantly greater proportion of proliferative stage neuroblasts compared with both early 
and late, post mitotic stage neuroblasts. Moreover, these animals also had a significantly 
greater proportion of intermediate stage neuroblasts compared with late post mitotic stage 
neuroblasts. Ventral: Controls: Control animals (Group 1) had a significantly greater 
proportion of proliferative stage neuroblasts compared with all other neuroblast cell types. 
Moreover, these animals also had a significantly greater proportion of intermediate stage 
neuroblasts compared with late post mitotic stage neuroblasts. Repeated injection: Animals 
exposed to repeated injection (Group 2) had a significantly greater proportion of proliferative 
and intermediate stage neuroblasts compared with both early and late, post mitotic stage 
neuroblasts. Social isolation: Socially isolated mice (Group 3) had a significantly greater 
proportion of proliferative stage neuroblasts compared with early post mitotic stage 
neuroblasts.. Combined stress: Animals exposed to combined stress (Group 4) had a 
significantly greater proportion of proliferative and intermediate stage neuroblasts compared 


















greater proportion of intermediate stage neuroblasts compared with late post mitotic 
stage neuroblasts (Post hoc analyses: t [91] = 3.5, p = .005). 
 
Like in the dorsal DG, all animals, irrespective of stress exposure, had a significantly 
greater proportion of proliferative and intermediate neuroblasts compared with more 
mature neuroblast cell types in the ventral DG. Specifically, control animals had a 
significantly greater proportion of proliferative stage neuroblasts compared with all 
other neuroblast cell types (Post hoc analyses: relative to intermediate: t [91] = 4.0, p 
< .001; relative to early post mitotic: t [91] = 6.2, p < .001; relative to late post mitotic: 
t [91] = 8.2, p < .001). Moreover, these animals also had a significantly greater 
proportion of intermediate stage neuroblasts compared with late post mitotic stage 
neuroblasts (Post hoc analysis: t [91] = 4.0, p < .001). Meanwhile, mice exposed to 
repeated injection had a significantly greater proportion of proliferative and 
intermediate stage neuroblasts compared with both early and late, post mitotic stage 
neuroblasts (Post hoc analyses: proliferative: relative to early post mitotic: t [91] = 
3.2, p = .02; relative to late post mitotic: t [91] = 3.8, p = .001; intermediate: relative 
to early post mitotic: t [91] = 4.7, p < .001; relative to late post mitotic: t [91] = 5.3, p < 
.001). Similarly, mice exposed to combined stress also had a significantly greater 
proportion of proliferative and intermediate stage neuroblasts compared with both 
early, and late, post mitotic stage neuroblasts (Post hoc analyses: proliferative: 
relative to early post mitotic: t [91] = 4.8, p < .001; relative to late post mitotic: t [91] = 
5.7, p < .001; intermediate: relative to early post mitotic: t [91] = 5.5, p < .001; 
relative to late post mitotic: t [91] = 6.5, p < .001). Lastly, socially isolated mice had a 
greater proportion of proliferative stage neuroblasts compared with early post mitotic 








PART B: Effect(s) of UCMSI on behaviour, inflammation and adult 
hippocampal neurogenesis 
 
A.3.3. Effect of UCMSI on adult hippocampal neurogenesis 
 
A.3.3.1. DCX compositional data 
 
A.3.3.1.1.  Within group DCX compositional analyses in the dentate gyrus 
 
All animals, irrespective of stress exposure, had a significantly greater proportion of 
proliferative and intermediate neuroblasts compared with more mature neuroblast 
cell types in the dorsal DG as shown in Figure A.13 (Factorial three way ANOVA: 
Effect of exposure (a): F [1,144] = 32.9, p < .001; Effect of region (b): F [1,144] < 
0.01, p > .99; Effect of cell type (c): F [3,144] = 1.4, p = .25; Interactions: (a*b); F 
[1,144] < 0.01, p > .99; (a*c); F [3,144] = 0.3, p = .88; (b*c); F [3,144] = 0.1, p = .95; 
(a*b*c); F [3,144] = 0.1, p = .93). Specifically, control animals had a significantly 
greater proportion of proliferative stage neuroblasts compared with both early (Post 
hoc analysis: t [48] = 4.2, p < .001), and late (Post hoc analysis: t [48] = 3.8, p = 
.003), post mitotic neuroblasts in the dorsal DG.  
 
Meanwhile, mice exposed to UCMSI had a significantly greater proportion of 
proliferative stage neuroblasts compared with all other neuroblast cell types (Post 
hoc analyses: relative to intermediate: t [48] = 6.3, p < .001; relative to early post 
mitotic: t [48] = 9.8, p < .001; relative to late post mitotic: t [48] = 12.6, p < .001). 
Moreover, they had a greater proportion of intermediate stage neuroblasts compared 
with both early (Post hoc analysis: t [48] = 3.5, p = .006), and late (Post hoc analysis: 
t [48] = 6.3, p < .001), post mitotic stage neuroblasts. Finally, they also had a greater 
proportion of early post mitotic stage neuroblasts compared with late post mitotic 
stage neuroblasts (Post hoc analysis: t [48] = 2.8, p = .046).  
 
Like in the dorsal DG, all animals, irrespective of stress exposure, had a significantly 
greater proportion of proliferative and intermediate neuroblasts compared with more 
mature neuroblast cell types in the ventral DG. Specifically, control animals had a 
significantly greater proportion of proliferative stage neuroblasts compared with both 























Data represents mean ± SEM   
Subjects: adult male BALB/c mice 
Sample sizes: (1) Sections per animal = Dorsal DG, 4; Ventral DG, 4. (2) Animals per group: Group 1: n=8; Group 2: n=10 
Analysis: Factorial three-way ANOVA; Bonferroni post hoc analyses.  
Adjusted p values: * p < .05; ** p < .01; *** p < .001 
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Compositional breakdown of DCX positive cells in the 






























Figure A.13. Effect of UCMSI on neuroblast composition in the dentate gyrus of the 
hippocampus 
Dorsal: Controls: Control animals (Group 1) had a significantly greater proportion of 
proliferative stage neuroblasts compared with both early, and late post mitotic stage 
neuroblast cell types in the dorsal dentate gyrus. UCMSI: Animals exposed to UCMSI (Group 
2) had a significantly greater proportion of proliferative stage neuroblasts compared with all 
other cell types in the dorsal dentate gyrus. Moreover, they had a greater proportion of 
intermediate stage neuroblasts compared with both early, and late post mitotic stage 
neuroblast cell types, and a greater proportion of early mitotic stage neuroblasts compared 
with late post mitotic stage neuroblast cell types. Ventral: Controls: Control animals (Group 
1) had a significantly greater proportion of proliferative stage neuroblasts compared with both 
early, and late post mitotic stage neuroblast cell types in the ventral dentate gyrus. Moreover, 
they had a greater proportion of intermediate stage neuroblasts compared with late post 
mitotic stage neuroblast cell types. UCMSI: Animals exposed to UCMSI (Group 2) had a 
significantly greater proportion of proliferative stage neuroblasts compared with both early, 
and late post mitotic stage neuroblast cell types in the ventral dentate gyrus. Moreover, they 
had a greater proportion of intermediate stage neuroblasts compared with late post mitotic 




















4.6, p < .001), post mitotic stage neuroblasts. Moreover, they had a greater 
proportion of intermediate stage neuroblasts compared with late post mitotic stage 
neuroblasts (Post hoc analysis: t [48] = 3.1, p = .02). Similarly, mice exposed to 
UCMSI also had a significantly greater proportion of proliferative stage neuroblasts 
compared with both early (Post hoc analysis: t [48] = 2.8, p = .04), and late (Post hoc 
analysis: t [48] = 4.6, p < .001), post mitotic stage neuroblasts. Moreover, they had a 
greater proportion of intermediate stage neuroblasts compared with late post mitotic 
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